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Abstract 
Extracellular Matrix in Developing, Aging, and 
Pathological Valves 
for application in the design of age-specific tissue engineered heart valves 
by 
Elizabeth Humes Stephens 
Debilitating valve disease necessitating valve replacement affects patients of all 
ages, all of whom would benefit from a tissue engineered heart valve with 
immunocompatibility, the ability of the valve to remodel in response to altered 
hemodynamics or patient growth, and physiologic mechanics. However, there may be 
age-specific requirements for such a valve. The overarching goal of this thesis was to 
characterize the extracellular matrix in developing, aging, and pathological mitral and 
aortic valves (MV, AV) in order to provide design criteria for an age-specific tissue 
engineered heart valve. The extracellular matrix plays a vital role in valve function; not 
only does it comprise the bulk of the valve tissue, but it determines the material 
properties of the valve, is integrally involved in biological signaling processes, and is 
altered in a number of valve pathologies. To this end, the composition, structure, and 
material properties of normal MV and AV were characterized with particular attention 
paid to valve heterogeneity and aging-related changes. Valves from disease states such 
as functional mitral regurgitation, dilated cardiomyopathy, iatrogenic valve wounds, 
calcific aortic valve disease, and myxomatous mitral valve disease were also analyzed to 
provide negative design criteria for a tissue engineered heart valve. Lastly, preliminary 
work was performed in developing a tissue engineered heart valve using poly(ethylene) 
glycol (PEG) hydrogels and valve cells of different ages. In sum, this body of work 
provides necessary design criteria for an age-specific tissue engineered heart valve, but in 
the process of analyzing various aspects of normal and diseased MV and AV, this thesis 
additionally provides insight into a variety of aspects of normal valve physiology, such as 
the relationship between valve composition and material properties and the mechanical 
environment, as well as insight into various valve diseases, such as the role of MV 
remodeling in functional mitral regurgitation and disease progression, with potential 
clinical implications for patients with these diseases. 
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Chapter 1: Background 
A. Congenital Valve Disease 
/. Epidemiology 
Approximately 1 million Americans are diagnosed with a congenital heart defect 
(CHD).1 CHD is the most common congenital defect, occurring in one out of every 100 
live births.2 Of the 36,000 babies born with congenital heart defects in the US each year, 
9200 require invasive treatment or die in the first year of life.3 In 2000 alone 213,000 life 
years were lost before age 65 because of CHD, nearly equal to the sum of leukemia, 
prostate cancer, and Alzheimer's disease.4 Of the many abnormalities seen in CHD, the 
majority involve the valves and/or septa.5 Clearly congenital valve disease produces a 
great burden on our society both in terms of resources and loss of life. Congenital valve 
disease is both prevalent and deadly and as such presents an important challenge for 
biomedical science to overcome. 
//. Types of Congenital Valve Disease 
The wide range of congenital valve disease types adds to the difficulty of treating 
the disease. Diseased valves can be divided into four categories: those that affect the 1) 
valve leaflet, 2) commissures, 3) chordae tendinae, and/or 4) papillary muscle.6 These 
abnormal valves can occur in isolation or within a complex of cardiac defects. When the 
valve malformation is the result of a developmental defect, tissues derived from the same 
cells as the valves, or reliant on the same factor (be it gene, protein, transcription factor), 
1 
will be malformed as well, accounting for some of the complex malformations. 
Furthermore, systemic diseases including connective tissue diseases, metabolic diseases, 
and various storage diseases may present with a dysmorphic heart and valves. In addition 
to isolated cases of valve disease and those that are part of more extensive disease, there 
is congenital polyvalvular disease in which multiple valves are malformed but not in 
conjunction with broader disease.7 
Systemic congenital diseases that affect the heart may be considered outside of 
the above classification. These include metabolic disorders such as Hurler's syndrome 
and connective tissue diseases such as Marfan's syndrome.8 Children can also have valve 
disease that is acquired. In the past, the majority of acquired heart disease was secondary 
to rheumatic fever, however this is much less common today. Valve disease may also be 
acquired secondary to infection,8 but this research focuses on congenital disease and its 
treatment methods. 
Hi. Current Treatments 
Current treatment for congenital valve disease is suboptimal at best. Patients 
require 4-6 open-heart operations before they reach adulthood to replace valves that have 
become too small as the child grows. Operations continue in their adult years.9 Current 
valves have an average durability of 10-15 years,10 making re-operation unavoidable. 
However re-operation carries significantly increased surgical risk.11 Adhesions have 
formed from previous operations making access to the heart more difficult and the risk of 
heart rupture greater. The old valve, now ingrown to the native tissue, must be 
painstakingly dissected leaving enough tissue to anchor the new valve. Lastly, the tissue 
to which the new valve must be sewn is weakened because of previous sutures and the 
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aforementioned dissection." Not only does this bring higher risk to the operation but it 
substantially increases the duration of time that the patient must be supported by the 
cardiopulmonary bypass machine. Cardiopulmonary bypass, of course, carries its own 
risks including brain injury from lack of cerebral blood flow and an often fatal syndrome 
in which the body reacts to antigens on the tubing of the cardiopulmonary bypass 
machine. 
Even if these surgical risks could be eliminated, there still is no satisfactory 
treatment for congenital valve disease. The two current, effective treatments for adult 
valve disease, mechanical and bioprosthetic, are problematic in children. Mechanical 
valves, usually made of pyrolytic carbon, require continual anticoagulation therapy that is 
often not compatible with a child's active lifestyle." Warfarin therapy is further 
complicated by a variety of circumstances which alter its metabolism and prothrombin 
time, such as the rate of growth and nutritional status of the patient and antibiotics that 
the patient is given for infection." Complications of warfarin therapy include bruising, 
excessive bleeding, stroke, and infarct." Furthermore, warfarin requires strict daily 
dosing and frequent hospital visits to check coagulation status." As these children 
mature, anti-coagulation during pregnancy becomes an additional problem. Warfarin is 
teratogenic, so pregnant mothers must use injectable heparin and face major 
complications upon delivery." While a mechanical valve is not practical because of the 
need for anti-coagulation, porcine replacement valves have the difficulty of rapid 
calcification and mechanical failure. In children this calcification is on the order of a few 
years and in infants on the order of months (Fig. l-l).12 
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Fig. 1-1: Bioprosthetic valve: Left shows valve before implantation, Right panel shows 
valve after explantation with severe calcification. 
This lack of treatment options would be solved with a tissue engineered heart 
valve made of a patient's own (autologous) cells. Implanted when the patient is an 
infant, the valve would grow with the child. Because it would be made out of the 
patient's own cells, neither an immune reaction nor coagulation would be problematic. 
Furthermore, such a valve would be able to remodel to adapt to its hemodynamic 
environment as well as regenerate and repair itself. 
B. Heart Valve Anatomy 
/. The Four Valves 
There are four valves found in the heart. The mitral and tricuspid valves are 
known as atrioventricular valves, as they separate the atria and ventricle of the left and 
right side of the heart respectively. The two other valves, the aortic and pulmonic, are 
known as semilunar valves. The pulmonic valve controls flow between the right 
ventricle and the pulmonary circulation, while the aorta controls flow from the left 
ventricle to the systemic circulation (via the aorta). Each of these valves exists in a 
distinct environment and has a unique structure and function. The tricuspid and pulmonic 
4 
valves function within the low pressure environments of the right ventricle and 
pulmonary circulation, and therefore are thinner. The mitral and aortic valves, however, 
experience high pressure blood flow on its way to systemic circulation, and therefore are 
considerably thicker, among other differences. Another obvious difference between the 
four valves is chordae tendinae. Chordae tendinae are fibrous strings that attach to the 
edges of the atrioventricular valves and secure them to the heart via papillary muscles. 
Another obvious difference between the four valves is the number of valve leaflets. The 
mitral valve consists of two leaflets, the anterior and posterior, while the tricuspid and 
semilunar valves consist of three leaflets. The tricuspid valve will not be covered in 
depth in this Background section, as it is not a subject of this research. 
/#. Mitral Valve 
On closer examination more unique features of the mitral valve are noted. The 
mitral valve leaflets are not identical. The posterior leaflets is considerably smaller in 
radial depth (measured from annulus to free edge) than the anterior with a number of 
scallops in its leaflet; usually there are three scallops and the middle scallop is the 
largest.13 These scallops and the lack of clear landmarks has made identifying portions of 
the posterior leaflet difficult.14 According to Ranganathan et al., the posterior leaflet 
includes all tissue posterior to the two anterior leaflet commissures, which usually are 
clearly distinguishable and defined by chordal attachments.14 Three zones are 
distinguished in the posterior leaflet: the rough zone from the line of leaflet closure to the 
free edge, the membranous or clear zone, which is clear upon transillumination, and the 
basal zone which spans the region from the clear zone to the annulus.14 
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The anterior leaflet similarly has distinct regions that can be identified upon gross 
examination. The atrial surface of the anterior leaflet has a distinct ridge 0.8 to 1.0 cm 
from the free edge that is the line of leaflet closure.14 Distal to the ridge is a region rough 
to palpation, appropriately called the rough zone. Upon closure the rough zone of the 
anterior leaflet apposes the similar rough zone on the posterior leaflet. The greater 
thickness of this region of the anterior leaflet, in part, is due to the numerous chordal 
insertions in that area.14 The area between the rough zone and the valve annulus is called 
the clear zone, because it is clear on transillumination, or "anterior center."14 This area is 
about twice the height of the rough zone and is free from chordal insertions.14 
Hi. Aortic and Pulmonic Valves 
The aortic and pulmonic valves have three leaflets (a.k.a "cusps") of equal size 
and shape, without chordae. The aortic valve additionally has the sinuses of Valsalva, 
which are pockets formed by localized dilatations in the aortic wall on one side and the 
aortic leaflets on the other side. Behind the right coronary leaflet and left coronary cusps, 
at the center of these pockets are the ostia for the right and left coronary arteries 
respectively. Vortices that form within these sinuses are thought to be important in 
facilitating cusp closure.15 After the heart contracts, blood flow enters these sinuses and 
provides blood flow to the heart muscle itself. The presence of the coronary arteries and 
their blood flow creates distinct hemodynamic environments for the right and left aortic 
valve cusps as compared to the non-coronary cusp. The aortic valve also has unique 
localized thickenings in the center near the free edge of each cusp, known as the nodules 
of Arantius. 
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iv. Histological Valve Layers 
Macroscopically the heart valves are formed by layers of tissue with distinct 
compositions, mechanical properties, and functional roles. For the atrioventricular valves 
there are four layers named atrialis, spongiosa, fibrosa, and ventricularis, aptly named as 
the atrialis faces the atrium and the ventricularis faces the ventricle.1 Each of these 
layers has a different composition. The fibrosa is dominated by collagen, the atrialis and 
ventricularis are dominated by elastic fibers, while the spongiosa contains many 
proteoglycans and hyaluronan (see explanation of proteoglycans below).16 The relative 
thickness of these layers throughout portions of the valve also varies.17 
Similar to the atrioventricular valves, in the semilunar valves there are three 
layers, the fibrosa, spongiosa, and ventricularis, with again the ventricularis facing the 
ventricle.18 In the aortic valve the fibrosa faces the aorta and, similar to the fibrosa of the 
atrioventricular valves, is principally composed of circumferential collagen in a crimped 
configuration which stretches out during valve closure." The ventricularis is much 
thinner than the fibrosa and is composed of a sheet of predominantly elastic fibers 
arranged radially with some collagen.11' 19 The intermediate layer, the spongiosa, has 
very loosely arranged collagen with an abundance of glycosaminoglycans, as evident in 
the atrioventricular valves.'' 
C. Extracellular Matrix 
In recent years the importance of the extracellular matrix (ECM) in tissue 
formation, maintenance, and function has become increasingly evident. Previously 
7 
thought to merely fill in the spaces between cells, it has become clear that the 
extracellular matrix is vital to healthy tissue of all types. Besides this, research shows 
that the extracellular matrix plays an active role in multiple important processes including 
cell migration, proliferation, differentiation, and regeneration. The extracellular matrix is 
actively involved in these processes through the expression of different receptors and the 
binding and controlled release of growth factors and other cytokines. The contents of the 
extracellular matrix include collagen and elastic fibers, proteoglycans (PGs) and 
glycosaminoglycans (GAGs), and various receptors and adhesion molecules, which are 
covered in the subsequent sections. 
/. Collagen 
Collagen provides the valve with the tensile strength necessary to withstand its 
hemodynamic environment. The dominant collagen type in the adult aortic valve is 
collagen I (74%) with some type III (24%) and a small amount of collagen type V (2%). 
Collagen type I is concentrated in the fibrosa layer.21 The crimped configuration of the 
collagen fibers is critical to the material properties of the valve. As tension is applied to 
heart valves the collagen fibers uncrimp and then begin to bear load.22 The uncrimping 
of the collagen fibers creates the pre-transition region and extensibility evident within the 
valve stress-strain or tension-strain curves (Fig. 1-2).22 The modulus of the post-
transition region of the valve stress-strain curve (calculated as the slope of that region of 
the curve) is then believed to be mainly determined by the stiffness of the uncrimped 
collagen.22 The alignment of collagen I fibers, at least in part, creates the anisotropic 
properties of the valve. For example, in the aortic valve collagen I fibers are primarily 
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aligned in the circumferential direction,23 which gives aortic valves a much stiffer 
modulus in the circumferential direction as compared to the radial direction.24 
Collagen III, the second main collagen type seen in valves, is known as "reticular" 
collagen. Collagen type III has qualities of flexibility that collagen I does not possess. 
At the micro structural level collagen III is also different. Instead of forming bundles of 
fibrils to within a thick fiber like collagen type I, collagen III forms networks, ' 
thereby explaining its mechanical role in flexibility. Collagen III distribution within the 
































Fig. 1-2: Typical tension-strain curve of a valve 28 
ii. Elastic Fibers 
Elastic fibers are predominantly found in the atrialis and ventricularis of the mitral 
valve, and the ventricularis of the AV. They are formed by an amorphous core of elastin 
protein surrounded by fibrillin.29 In the process of elastic fiber formation, fibrillin is 
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29 present first and acts as a scaffold on which the elastin is then deposited. Elastic fibers 
provide recoil to valves so that after each heart beat the valve returns to its original 
configuration.22 Within the valve tension-strain curve, elastic fibers are thought to create 
the slope within the "toe" or transition regions of the curve (Fig. 1-2).22 Lysyl oxidase, a 
crosslinking enzyme in collagen fiber formation, is also involved in crosslinking elastic 
fibers 29 
Hi. Proteoglycans and Glycosaminoglycans 
PGs and GAGs have multiple roles in connective tissues including providing 
hydration, compliance, viscosity, regulation of collagen fibrillogenesis, and prevention of 
calcification and thrombogenecity.30"32 PGs contain a core chain of protein and chains of 
GAGs covalently attached to that core protein like the bristles of a bottle brush (Fig. 1-
3) 32 
Schematic of PGs and Repeating units of several common GAGs 
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Fig. 1-3: Structure of PGs and GAGs. The nomenclature to describe GAGs is complex. The 
terms "iduronate " and "glucuronate" are based on the susceptibility to digestion by various 
enzymes. The term dermatan sulfate is used whenever there is any iduronate present. If the GAG 
contains glucuronate alone, it is referred to as chondroitin sulfate. 
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PGs as a family are quite diverse. The protein cores size range from 10 kDa to 
400,000 kDa.33 Some are soluble, others are insoluble, some are membrane-spanning, 
others lipid-tailed, and others secreted.33 Even the number of GAG chains can vary 
substantially, from one to one hundred.33 PGs are divided into many different families. 
The small, leucine-rich interstitial matrix PGs include decorin, biglycan, fibromodulin, 
and lumican, among others. The large CS PGs include aggrecan, versican, neurocan, and 
brevican, and the cell surface PGs include syndecans and glypicans. There are also the 
basement membrane PGs perlecan and agrin.33 However, the predominant PGs found in 
heart valves are versican, decorin, and biglycan; therefore, these PGs are discussed in 
more detail in the following sections. 
Versican, with its large hydrodynamic domains, contributes to tissue's material 
properties of viscoelasticity and turgidity (including providing resistance to 
compression).34'35 Versican remains at the cell surface via interaction with HA36 where 
is contributes to the pericellular matrix and plays a role in cellular interactions.34 
Versican appears to play a critical role in cell migration during development and diseased 
states by creating an expanded nonfibrillar extracellular space.34 Evidence also suggests 
that versican plays an active role in elastin formation by its interaction with the 
microfibril components fibulin and fibrillin-1.37'38 
Decorin was identified years ago "decorating" collagen at the d band.39' 40 It is 
now known that decorin and biglycan play key roles in collagen fiber formation, as 
evidenced by mutant animals showing severe defects in collagen fiber formation and 
packing.41 Indeed decorin shows strong association with collagen type I/III in the 
collagen bundles.35 Both decorin and biglycan are from the same family of small leucine 
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rich PGs, and both are seen widely in connective tissues. The leucine rich repeat 
regions that make decorin and biglycan unique are important in mediating protein-protein 
interactions, specifically interactions with other matrix proteins, including collagens, 
fibronectin, elastin, and thrombospondin, as well as play a part in matrix assembly and 
fibrillogenesis.34 Evidence also suggests that both decorin and biglycan can modify the 
response of cells to growth factors, like transforming growth factor-beta (TGF(3) and 
epidermal growth factor.34 Despite the similar roles and structures of decorin and 
biglycan, each is unique. Decorin is found more extracellularly attached to collagen I, 
while biglycan is found closer to the cell.42 Not only do they show different expression 
patterns, but they are differentially regulated.34 For example, TGF(3 tends to 
downregulate decorin in a number of cell types while it strongly upregulates biglycan.43" 
49
 It has been suggested that decorin may play an important role in interacting with 
versican to produce the ultrastructure of collagen within soluble ECM.35 
The basic structure of GAGs is relatively simple. GAGs are composed of 
repeating disaccharides of uronic acid and an amino sugar. GAGs become complex and 
diverse in their post-translational modifications that occur throughout the GAG chain. 
Hyaluronan (HA), as a GAG, is unique in that it does not attach to a protein core and has 
no modifications.50 HA polymers can be extremely long, with molecular masses in the 
millions.50 Although HA does not attach to a core protein, it can aggregate with other 
PGs.50 HA is prevalent in the heart valve where it is primarily localized to the spongiosa 
layer. HA has many roles in a variety of areas, including in embryonic development, 
tissue organization, wound healing, angiogenesis, tumorogenesis, and cell adhesion and 
mobility.51"62 HA also has important mechanical functions. HA bears compression as 
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well as lubricates articulating surfaces in the body.63 The role of HA in tissue 
organization is via cell-surface receptors CD44 and "receptor for HA mediated motility" 
RHAMM.63 More recent studies in HA metabolism show that there is a receptor 
involved in HA clearance named "HARE" (HA receptor for endocytosis), which among 
other locations in the body, is expressed in heart valves.64 
iv. Matrix Metalloproteinases 
The matrix metalloproteinases (MMPs) are a family of enzymes predominantly 
responsible for matrix degradation. The specificity of each MMP is unique, although 
there is a large amount of overlap; a partial compilation of MMPs, those relevant to this 
thesis, and their substrates are included in Table 1-1. MMPs have been found to have a 
number of important roles in health and disease in a variety of tissues. Pressure induced 
heart failure has been linked with a number of MMPs including 1, 2, 3, 9, 13, and 14, and 
expression increases as heart failure worsens.65 Similarly in aortic stenosis studies have 
demonstrated an increase in MMP2, 3 and 9, and tissue inhibitor of MMP2.66'67 
Table 1-1; MMP 1, 2, 9, and 13 Specificity. 
MMP Alternate Name ECM Substrates 
MMP1 Interstitial Collagens I, II, III, VII, X, XI; versican, aggrecan, fibronectin, vitronectin, 
collagenase laminin, entactin, tenascin, gelatin, myelin basic protein, link protein 
MMP2 GelatinaseA 
Collagens I, II, III, IV, V, VII, X, XI; versican, aggrecan, fibronectin, 
vitronectin, laminin, entactin, tenascin, gelatin, elastin, myelin basic protein, 
link protein, SPARC, galectin-3 
MMP9 Gelatinase B Collagens IV, V, XI, XIV; versican, decorin, aggrecan, vitronectin, laminin, 
gelatin, elastin, myelin basic protein, link protein, SPARC, galectin-3 
MMP13 Collagenase 3 Collagens I, II, III, IV, VI, IX, X, XIV, collagen telopeptides; aggrecan, 
fibronectin, large tenascin-C, gelatin, perlecan 
Adapted from Crit Rev Oral Biol Med 12(5): 373-398. Highlighted and bolded substrates 
indicate matrix components that have been stained for in the studies that comprise this thesis. 
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D. Characterization of Adult Valves in Health and Disease 
/. Valvular Interstitial Cells (VICs) and Cell Phenotype 
It was not until recently that researchers discovered the importance of the cells 
within these histologically defined valve layers, cells called "valvular interstitial cells" or 
VICs. Not only do the VICs produce the collagen, elastin, PGs, and GAGs that comprise 
the extracellular matrix, but they produce cytokines and chemokines, modulate the 
immune response, and produce matrix MMPs that break down and remodel the matrix, 
and in so doing release growth factors within the matrix.69 
VICs are a heterogeneous population comprised of cells with a range of cell 
phenotypes, some of which appear more fibroblast-like and some of which appear more 
myofibroboblast-like.70 The more fibroblast-like cell population consists of spindle-
shaped, elongated cells, that once confluent exhibit a swirling pattern and pile on top of 
each other, features characteristic of fibroblasts.69 These cells contain organelles 
predominantly for matrix synthesis and secretion.69 Correspondingly, they express prolyl 
4-hydroxylase (P4H), which indicates active collagen synthesis.69 Another VIC 
population consists of cuboidal cells that displays prominent stress fibers, and 
accordingly expresses smooth muscle alpha-actin (SMaA).69 Besides these two groups of 
VICs, smooth muscle cells are found within valves either alone or in small bundles.69 It 
is not clear how or by what means these phenotypes are genetically or otherwise 
determined by the body. 
Understanding the unique phenotype of VICs is important with respect to 
understanding valve disease, as well as manipulation of cell sources for use in tissue 
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engineering (the topic of cell sources in tissue engineering is discussed below). There are 
a number of methods for studying cell phenotype, the most common being 
immunocytochemistry (ICC) and flow cytometry (FC). One of the challenges of 
investigating cell phenotype in VICs is that these techniques require some period of time 
in cell culture before testing can occur. Depending on the different environments these 
cells are put in, their phenotype may be altered during this time. 
With these limitations on the techniques in mind, much has been reported 
regarding cell phenotype, although the results often do not agree. Latif et al. took valve 
cells from three humans (ages 50-60 years old) and tested these cells (all four valves 
together) using ICC.71 Those authors found a >90% prevalence of fibroblast surface 
antigen (FSA) expression, 50-100% SMaA expression, <2% desmin expression, and 
highly variable expression of smooth muscle myosin (SMM) expression.71 In a second 
study Latif et al. reported on a number of additional markers on these set of valve cells.72 
By ICC they reported myosin heavy chain (MHC) I expression in almost all VICs, while 
variable expression of MHCII.72 SMM and desmin were expressed by low numbers of 
cells, while vimentin showed strong, uniform expression.72 Fibronectin was found to stain 
strongly surrounding the cells.72 In a similar study Rabkin et al. looked at the cell 
phenotype of human valves (all four valves considered together) using ICC.73 Those 
authors found that normal human VICs were negative for expression of SMaA, SMM, 
vimentin, and MMP13.73 These results clearly contradict those of Latif et al. 
Dreger et al. compared the four different valves' cell phenotype in human VICs.74 
They found that MMP2 was expressed only in the AV and PV, MMP3 and 9 were not 
expressed in any valves, TIMP1 and 2 were expressed in all valves, and TIMP3 was only 
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expressed in the TV. In a similar study in which Delia Rocca et al. used 
immunohistochemistry (IHC) and western blot analysis to compare AV and PV cell 
phenotypes, they reported increased vimentin and expression in AV compared to PV 
detected by IHC.75 They also reported a sparse population of SMaA and SMM positive 
cells only on the outer edge of the fibrosa.75 Analysis by western blot showed that AV 
and PV had equal amounts of vimentin and non-muscle myosin, while AV had increased 
amounts of SMaA and both AV and PV were negative for SMM and the related smooth 
muscle specific protein 22.75 In a third study, Taylor et al. used ICC and IHC to look at 
human VICs from each valve.76 They found that vimentin was expressed by almost all 
VICs, desmin by 1.3±2.3% of AV, and SMaA by 78±28% of AV and 66±33% of MV.76 
Expression of SMM was found to be 4±6%, with no detectable difference between 
valves.76 Their results using IHC showed SMM, SMaA, FSA, and vimentin expressed by 
almost all VICs, while P4H and desmin expressed by few.76 The VICs in culture were 
found to express less SMM, P4H, and FSA.76 
While these studies have not come to a consensus as to the specific expression 
profiles of VICs from different valves, as a whole this body of work supports the notion 
of multiple subpopulations of VICs within valves. Studies in diseased valves have 
demonstrated enrichment of certain VIC subpopulations, such as the VIC 
myofibroblast,73 that are thought to play a role in pathogenesis of these valve diseases. 
Future studies further elucidating these VIC subpopulations and their expression profiles 
both in normal and diseased valves, as well as techniques allowing the isolation of these 
subpopulations, will likely yield insight into the pathogenesis of these valve diseases. 
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//. Mechanical Characterization of Valves 
Different parts of the valves experience different loading patterns and appear to 
have different functional roles. For example, in the mitral valve the chordae and central 
region of the anterior leaflet experience tension, while the free edge of the anterior leaflet 
and the majority of the posterior leaflet predominantly experience compression.1 The 
physical loads on the three layers are complex. In the aortic valve the fibrosa and 
ventricularis are inherently preloaded, due to their attachment to each other.19 The 
fibrosa is under compression and the ventricularis under tension.19 Studies suggest that in 
the aortic valve the collagen in the belly of the cusp experiences the membrane stresses, 
"collects" them, and distributes them to the aortic wall via branching chords of 
collagen." The belly of the cusp contains a nearly isotropic mesh of collagen that is held 
in a crimped conformation via connections to the ventricularis, causing the collagen to be 
under axial compression.11 Vesely et al., in analyzing the collagen bundles, found that 
about half of these collagen bundles are highly branched, contributing to stress 
distribution, while the other half span the entire length of the cusp without branching." 
Elastin is found within the aortic valve in the form of a continuous amorphous sheet that 
often transitions to a network of fibers." This elastin appears to store energy during 
diastolic loading, and then uses the stored energy to return the collagen, when unloaded, 
to its crimped conformation." It is believed that the spongiosa acts as a buffer zone and 
enables shearing between the ventricularis and fibrosa as the valves open and close." In 
modeling the forces and stresses on the valves and the mechanical responses of valves, it 
is clear that the unique properties of valves are, in part, due to the multilayered nature of 
the valve and the crimped collagen configuration within the fibrosa layer.77 
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The material properties of valves, such as ultimate tensile strength, Young's 
modulus, and viscoelasticity, have been predominantly assessed using either biaxial or 
uniaxial tensile testing of tissue. This mechanical testing has revealed a number of 
differences between the material properties of the different valves and valve regions. In 
pig, Christie et al. found that PV and AV had similar mechanical properties in the 
circumferential direction, but that the PV was more extensible in the radial direction. In 
human valves, Stradins et al. found that the ultimate stress in the radial direction for AV 
and PV were nearly equal, while ultimate stress in the circumferential direction was 
higher in PV.79 Comparison of AV and PV mechanical properties has also been assessed 
within a pulsatile flow simulator.80 In this study PV were found to be more compliant 
than AV under systemic pressures, as well as had a smaller pressure drop, suggesting that 
PV can mechanically withstand systemic pressures and under those conditions may even 
perform better.80 Others have exposed porcine PV to aortic pressures to see how the 
tissue would respond and found that PV responded by increasing collagen content as well 
as sulfated GAGs. Differences in the mechanical properties between the different 
leaflets of the MV have also been demonstrated. Using uniaxial tensile testing 
Kunzelman et al. demonstrated that the posterior leaflet of the MV was not as stiff 
circumferentially or radially compared to the anterior leaflet.82 
/7i. Valve Composition and its Mechanical Environment 
The valve undergoes dynamic, regionally heterogeneous mechanical loading, and 
studies have demonstrated that regional valve composition appears to be related to that 
local mechanical environment. For instance, the mitral valve is known to have distinct 
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loading patterns among the different valve regions. When the valve is closed, the central 
region of the anterior leaflet and chordae experience tension, while the free edge of the 
anterior leaflet and most of the posterior leaflet are under compression.16 Appropriately, 
the chordae and anterior center region of the anterior leaflet contain the most collagen.17 
In the compressive regions, the free edge of the anterior leaflet and the majority of the 
posterior leaflet, the collagenous layer is thinner and the spongiosa layer is thicker.16 
Furthermore, these regions differ in collagen fiber alignment. The center of the anterior 
leaflet of the mitral valve and the chordae tendinae contains more highly aligned 
collagen,83' 84 whereas the posterior leaflet and free edge of the anterior leaflet 
demonstrate less collagen fiber alignment.17 These different regions were also found to 
have different PG and GAG content. The regions of tension were found to contain less 
water, less hyaluronan, and iduronate.16 These GAGs likely are part of the small PGs 
decorin and biglycan, which were found to be prominent in these regions.16 In contrast, 
areas of compression, such as posterior leaflet and the free edge of the anterior leaflet, 
had significantly more water, more hyaluronan, and more glucoronate.16 These GAGs 
are likely part of versican, a large PG that binds a particularly large amount of water.16 
This study also demonstrated a significant decrease in GAGs with age.16 
GAG composition in the MV has also been shown to change during disease. 
Studies of myxomatous mitral valves found that the chordae in particular had a different 
biochemical composition as compared to those of healthy mitral valves.31 The chordae 
were found to have 3-9% more water content and 30-159% higher concentrations of 
GAGs mostly due to increased hyaluronan and chondroitin-6-sulfate.31 It is thought that 
this elevation in GAGs and deficiency in elastin in the chordae may cause the mechanical 
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weakness of the valves that results in valve prolapse in myxomatous mitral valve 
disease.31 
iv. Valve Changes in Mitral Regurgitation 
Mitral regurgitation (MR) has been the subject of many adult valve studies. 
However, this disease often appears in the context of dilated cardiomyopathy and heart 
failure which has made understanding MR and the role of the valve in MR quite complex. 
For many years MR in the context of heart failure has been considered a functional 
problem. That is, the valve is thought to be normal, but the ventricle has been distorted in 
such a way as to prevent adequate valve coaptation. However, Timek et al. found 
changes in the MV in an animal model of dilated cardiomyopathy, a type of functional 
MR.85 The anterior leaflet lengthened significantly in the free-edge region.85 The 
posterior leaflet showed a significant decrease in curvature once functional MR was 
created.85 In a related study, MVs from patients with functional MR and heart failure 
were found to have greater DNA and collagen content, particularly in the free edge, 
compared to controls.86 Altered material properties were also demonstrated in these 
valves, including a 61% decrease in stiffness in the radial direction and 50% decrease in 
stiffness in the circumferential direction compared to control valves.86 In total these 
studies show that the valve itself is altered in functional MR. 
Similarly, Kunzelman and Quick specifically looked at collagen concentration in 
hearts with coronary ligation ("ischemic controls") and papillary infarct which created 
ischemic regurgitation.87 Collagen content was then analyzed and found to be the 
greatest percentage of dry weight in the normal leaflets, lower in the ischemic controls, 
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and further lowered in the papillary infarct group. The collagen content was also found 
to be the highest in the center of the leaflet and decrease towards the commissures. 
v. Valve Response to Acute Injury 
Studies examining the response of the valve to acute injury have been largely 
limited to pathological characterization of the wound area. In a study of a slice wound in 
the free edge of the MV, Tamura et al. characterized two types of granulation tissue, one 
which was myxoid and one which was fibrous.88 During the wound healing process they 
reported that fibroblasts first migrate into the wounded region and then differentiate into 
myofibroblasts with SMaA expression.88 In this study Movat, Masson, and hemotoxylin 
and eosin stains were used to analyze the changes in the tissue during the wound healing 
process, along with immunohistochemistry for SMaA.88 In a second study Tamura et al. 
looked at the response of the mitral valve to sutures.89 In this study they found thrombi 
covering the atrial surface and a fibrous neointima covering the ventricular surface 
starting at 2 weeks.89 They reported that healing was slow, particularly at the free edge in 
which it took 12-16 weeks for a fibrous sheath to cover the sutures (vs. 4 weeks in the 
basal region.89 Two other studies worth mentioning related to wound healing in the valve 
are studies by Durbin and Lester. Durbin et al. studied valve injury using an in vitro 
model in which they scraped a line through a monolayer of VICs in culture, and then 
measured migration of the different VIC subtypes.90 In this experiment they found that 
the spindle-shaped VICs tended to migrate the most quickly while the cobble-stone 
shaped cells acted to synthesize matrix for the "wound."90 Durbin and others have also 
researched the cell signaling involved in the healing process, including the importance of 
nitric oxide.91 Lester et al. specifically looked at the response of the anterior leaflet of the 
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MV to denudation injury using pieces of valve incubated in a Petri dish for 6 days. In 
this study the authors found that valve cells on the ventricular side of the injured leaflet 
grew into the wound more rapidly than those on the atrial side, for reasons that are 
unknown.92 The role of inflammation and valve injury has also been extensively 
investigated in the context of chronic valve diseases, for instance inflammation has been 
implicated to be important in the development of calcific aortic stenosis.93"95 
E. Changes in Valves with Development and Aging 
/. Histology and Biochemistry 
Aikawa et al. has done the most work on characterizing the human heart valve 
matrix from the fetus to the adult. In their work they studied semilunar valve structure, 
the phenotype of valvular interstitial and endothelial cells, and histology for a number of 
matrix components.96 They documented a transition from a largely amorphous GAG-rich 
matrix to a trilaminar structure at 36 weeks.96 Valves at birth appeared rudimentary 
compared to adult valves, indicating that significant postnatal development occurs. 
Collagen content increased through fetal development, but then was found to remain 
relatively constant during the postnatal period. During postnatal development there was a 
decrease in thin collagen fibers, an increase in thick collagen fibers, and an increase in 
collagen fiber alignment. Elastin content was found to increase postnatally. VIC cell 
density was found to decrease rapidly from fetal to adult valves. The fetal VIC cell 
phenotype was more myofibroblast-like with more activation (seen by expression of 
SMaA and embryonic myosin heavy chain) and expression of proteolytic enzymes 
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(including MMP13) relative to postnatal VICs. Analysis of the neonatal valve showed an 
increase in cell activation of AV cells compared to PV, as the AV adjusted to the higher 
pressures of the postnatal circulatory system.96 
Valve development has been studied in depth in both the mouse and avian animal 
model. Kruithof et al. observed endocardial cushion growth, valve formation, and valve 
condensation in the mouse.97 Changes that were apparent during the perinatal time 
period include a decrease in alcian blue staining mucopolysaccharides and a decrease in 
the PG versican.97 Specifically, versican was observed homogenously throughout the 
leaflet before becoming restricted to the atrialis starting at in the early postnatal period.97 
Collagen I and V staining was diffuse in the embryonic period and became localized to 
the ventricularis after birth.97 In contrast, collagen VI was constant in the entire leaflet 
with age.97 Others have demonstrated that the two most abundant components of 
endocardial cushions are versican and hyaluronan,98, " and in fact that versican is 
necessary for endocardial cushion formation.99 
In the studies of valve development in the avian model by Hinton et al., they 
found elastin appearing late during cusp remodeling, along with collagen in the fibrosa 
and elastic fiber fragments in the ventricularis.100 The PG aggrecan was expressed during 
cushion elongation, and present in the fibrosa and spongiosa during cusp remodeling.100 
Distinction of the fibrosa and spongiosa layers was evident late in the embryonic period 
just before birth.100 
While histology of matrix components has been looked at to some degree in 
human semilunar valves96 they have not been examined in the pig, a common animal 
model for human heart valve biology and disease. Furthermore, the studies in valve 
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development performed in other species concentrated on aspects of valve development 
distinct from the aspects in this proposal. Kruithof et al. concentrated on endocardial 
growth, valve formation and valve condensation, all events very early in valve 
development.97 The mouse studies of Hinton et al. also focused on valve condensation 
along with valve remodeling that occurs later in fetal development.100 Beyond these 
studies in semilunar valves, little has been done in the atrioventricular valves during 
development. 
Early investigations into changes in valves with aging depended on basic histology 
and biochemistry. While the results have not been unanimous, certain age-related 
changes have been agreed upon. Multiple studies have found an increase in collagen 
crosslinking with age, first detected by increased digestion time.101'102 Fibrosity has been 
found to increase with age but so does collagen fiber degeneration.27 Some have 
described aged collagen fibers as more "smudgy," swollen, and disoriented.103 More 
recent studies reported that large diameter collagen fibers become larger with age.96 A 
consensus as to the total amount of collagen changing with age has not been made. 
7 1 100 
Keller and Angrist reported an increase in the total amount of collagen fibers, ' while 
Bashey et al. demonstrated reduced collagen concentration accompanied by a reduction 
in the total amount of protein.101 Elastin content has generally been reported as 
increasing with age,27'96'103 although some have reported this increase to be slight, and 
even negligent in the AV.101 In terms of GAG content, Sell and Scully reported a 
decrease in acid mucopolysaccharides from the 3rd to 5th decade,103 while McDonald et al. 
reported an increase with age, specifically in the spongiosa, especially the distal 
portion.27 
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/#. Mechanical Properties 
Assessment of age-related changes in the mechanical properties of valves has 
largely been overlooked, with the exception of a study by Christie et al. in which failure 
strain was measured for different aged human AV.104 In this study they found that the 
radial failure strain in AV was -80% in the 15 years-old young adult, but that failure 
strain decreased by -4% per year such that at 25 years-old the stretch was 40%.104 From 
there the extensibility remained constant until age 40 years-old at which the stretch began 
to decrease by 1% per year at least until age 58 years-old.104 The authors attributed the 
decrease in stretch from age 16 years-old to 25 years-old to the fact that the area of the 
leaflets is not changing, but there is an increase in the luminal diameter.104 The authors 
reasoned that the leaflets respond by remaining more stretched.104 However, other than 
this study, age-related changes in mechanical properties of valves have not been 
addressed. 
F. Tissue Engineering Heart Valves 
/'. Design Criteria 
The characteristics desired of a tissue engineered valve include: 1) simulate native 
valve motion as closely as possible, most importantly not obstructing blood flow during 
opening and closing quickly after blood entry without leaking; 2) not adversely interact 
with the blood, such as inducing infection or thrombosis, or lysing red blood cells; 3) 
demonstrate structural and material stability, i.e., a durable, long-lasting, chemically inert 
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device that integrates with native tissue; 4) easily implantable; 5) remodel in response to 
changing mechanical demands, including growth for tissue engineered heart valves used 
in pediatric patients.105 In order to accomplish this several general strategies are being 
used. Some have tried using cells that are not cardiac derived and using biological and 
mechanical stimuli to induce proper differentiation and organization into valves. Others 
propose using only the native valve cells in the tissue engineered valve, and speculate 
that by their inherent nature these cells will properly organize themselves. Still others 
propose simply inserting a scaffold and allowing the patient's own cells to seed the 
scaffold and form a valve in vivo. This has been done with acellularized human 
valves.106 Proposals addressing the layered complexity of valves include assembling 
building blocks such as branched collagen, elastin sheets and tubes, and hydrated GAG 
matrix." 
//. Cell Sources 
While some scientists focus on recreating the mechanical environment in which 
valves reside via complex bioreactors, others focus on potential cell sources (Table 1-3). 
As mentioned above, some scientists are proponents for using valve cells, while others 
have searched for other cell types that can be easily manipulated to behave like valve 
cells. A wide variety of cell types have been assessed for their potential use in a tissue 
10*7 1OR 
engineered heart valve and include mesenchymal stem cells, radial artery cells, 
stromal cells,109 bone marrow cells,109 valve cells,110 chorionic villi-derived cells,111 and 
femoral artery myofibroblasts.112 A number of other cell types have been used for 
vascular engineered tissues, and have the potential to be used in a tissue engineered heart 
valve.113 An additional complexity to the cell source problem is the heterogeneity of 
26 
cells within the native valve; the native valve contains VICs (including subpopulations 
that are myofibroblast-like), endothelial cells, as well as smaller populations of smooth 
muscle, cardiac muscle, and nerve cells.114 Methods such as sequential seeding can be 
used to partially re-create the cellular heterogeneity present in native valves. For 
example, Rothenburger seeded myofibroblasts on scaffolds and then added endothelial 
cells.115 
Table 1-2. Pros and Cons of Different Cell Sources Used in Tissue Engineering. 
Cell Sources Pros Cons 
VICs Inherent properties to Autologous VICs couldn't be used in 
create proper matrix CVD patients; difficult to harvest 
Dermal Autologous cells could be Require conditioning to create 
fibroblasts used in CVD patients; easy proper valve matrix; concern long-
to harvest term maintenance of proper 
phenotype 
Stem Cells Autologous cells could be Require conditioning to create 
used in CVD patients proper valve matrix; tumorogenic 
potential; concern long-term 
maintenance of proper phenotype; 
bone marrow stem cell harvest 
painful 
Adapted from J Biomed Mater Res B Appl Biomater 83(1): 16-43. 
Hi. Scaffolds and PEG Hydrogels 
The scaffold in engineered tissues has several functions. First it provides a means 
for transplantation of a large number of cells. This type of cell delivery can be 
considered, in and of itself, a "drug delivery" system,117 but growth factors or other 
biologically active agents can also be attached and/or released from the scaffold. 
Secondly, the scaffold acts as a three dimensional space in which the cells can grow. As 
such it can also provide structural cues for directed growth.117 
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The material composition of the scaffold is particularly important (Table 1-3). 
Some propose an acellular scaffold with or without fixation," however one of the 
challenges with these acellular scaffolds is the complete and non-destructive removal of 
all cells to minimize the immunogenicity of the scaffold. The main disadvantage with 
this approach is that because the result scaffold is acellular, it does not allow for cell-
mediated remodeling or repair."8 Others propose a natural scaffold, such as a scaffold 
constructed from collagen, i.e., a collagen "sponge,"119 or even dura mater120 or small 
intestinal submucosa.121 Others propose using natural components formed into a tissue 
engineered construct; hyaluronan, fibrin, and collagen have been utilized in this 
manner. Some propose a degradable scaffold, made of either natural or synthetic 
components, so that the scaffold is gradually replaced by the patient's own tissue." This 
Table 1-3. Pros and Cons of Different Scaffolds Used in Tissue Engineering. 
Scaffolds Pros Cons 
Natural 3D matrix architecture, Variability, ill-defined, 
Matrices anisotropic material properties, tuning properties difficult, 
bioactive cues immune concerns 
Natural More control over composition, Lack inherent 3D matrix 
Components reproducibility than natural structure, endogenous 
matrices bioactive cues, regional 
heterogeneity, anisotropy, 
difficult to control 
degradation rate 
Synthetic Reproducible; tunable material Lack inherent 3D matrix 
properties, bioactive structure, endogenous 
components, degradation rate; bioactive cues, regional 
can be made responsive to heterogeneity, anisotropy, 
environment potential toxic metabolites 
with degradation 
Adapted from J Biomed Mater Res B Appl Biomater 83(l):16-43 Tnr 
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decreases the time the immune system must battle a foreign object as well as allows for 
growth and remodeling.119 
Hydrogels are an expanding topic in the field of tissue engineered scaffolds with 
numerous advances making them an increasingly more attractive option. Poly(ethylene) 
glycol (PEG) hydrogel scaffolds are extremely hydrophilic, which prevents protein 
adsorption, a critical step in the immunogenicity and degradation of bioprosthetics. 
Furthermore, these scaffolds are also highly permeable allowing the exchange of 
nutrients and waste materials.126 One of the factors that makes these gels particularly 
attractive is the ability to custom tailor them by conjugating various peptides, including 
cell ligands and growth factors, to the PEG backbone. This capability can allow for 
selective adhesion of particular cell types, manipulation of cell phenotype, as well as 
enhancement of various tissue processes such as angiogenesis or tissue remodeling. This 
"biofunctionality" makes PEG hydrogels ideal for the tissue engineering of heart valves. 
In the case of valves, this technology would be optimal if a ligand for VICs was attached 
to these hydrogels, allowing VICs to populate the scaffolds without other proteins or cells 
invading. Different growth factors could also be attached in order to encourage both 
growth and a specific cell phenotype. Furthermore, these hydrogels can be made with 
enzyme degradable sequences in their polymer backbone allowing the scaffold to be 
degraded as the scaffold becomes populated (and as the cells' own secreted enzymes 
degrade the scaffold).127 With careful design the number of degradable sequences within 
the hydrogel could be generated such that the scaffold would only begin to be degraded 
once the seeded cells produced enough matrix to withstand its mechanical environment 
on its own. In that manner a patient would have foreign material in his or her body for a 
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limited amount of time, decreasing any immune response. A recent advance in this area 
is the encapsulation of cells within the PEG scaffold128 utilizing a polymerization method 
that does not damage the cells.129 The key advantage here is the homogeneous 
distribution of cells throughout the scaffold. In the traditional technique of seeding cells 
onto scaffolds, the ultimate cell density throughout the scaffold is highly variable. 
Various techniques, such as serum deprivation130 and bioreactors,131 have been used to 
improve these results, but using encapsulated cells ensures a homogeneous distribution of 
cells. 
Various combinations of cell sources and scaffolds have been tested, both within 
in vitro and in vivo settings, in tissue engineering. A few, with particular attention paid to 
tissue engineered heart valve applications, are outlined in Table 1-4. 
iv. Challenges 
Heart valves are among the most complex connective tissue structures in the 
entire body.16 As the field of tissue engineering works to create valves, it faces the 
difficulties presented by this complexity on multiple levels. At a macroscopic, tissue 
level, it is believed that the spongiosa acts as a buffer zone and enables shearing between 
the ventricularis and fibrosa as the valves open and close.'' In modeling the forces and 
stresses on the valves and the valves mechanical responses, it is clear that the unique 
properties of valves are, in part, due to its multilayered nature and the folded 
configuration of the fibrosa.77 Therefore, it appears including this macroscopic 
heterogeneity in a tissue engineered heart valve would be important for proper valve 
mechanics. 
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Adapted from J Biomed Mater Res B Appl Biomater 83(l):16-43. TEHV=tissue engineered 
heart valve; VICs=valvular interstitial cells; HA=hyaluronan; PV=pulmonic valve; 
PEG=poly(ethylene) glycol; -meth HA=methacrylated HA cross-linked into the PEG hydrogel; 
PVA=poly(vinyl alcohol); PHA=poly(hydroxyalkonoate); PGA=poly(glycolic acid); 
PLGA=polylactide-co-glycolide; OPF=oligo (PEG) fumarate; PEUU=poly(ester urethane) 
urea; BMSC=bone marrow stem cells; SMC=smooth muscle cells. 
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There is also complexity in the valve at the cellular level. Not only are there a 
number of cell types within the valve, but the predominant valve cell type, the VIC, is a 
heterogeneous population. Work is on going to elucidate the VIC subpopulations and 
their roles in valve health and disease. Undoubtedly it will be important to take into 
consideration this heterogeneity in the tissue engineering of a valve. Very few groups 
have included these important VICs in their tissue engineering design, which appears to 
be a major oversight" considering their role in producing and maintaining the 
extracellular matrix of the valve which is essential for proper valve function.69 While 
effort is ongoing in developing a tissue engineered heart valve, the structure, mechanics, 
and pathology of the native valve must be better understood before an adequate tissue 
engineered heart valve can be made. 
G. Summary 
/. Synopsis of Previous Work 
Undoubtedly much has been learned in the last several decades in terms of heart 
valve biology, mechanics, and the pathophysiology of various valve diseases. These 
studies have revealed that the valve is not simply a passive flap at the mercy of the 
changing pressures and flow patterns within the heart, but instead a complex structure 
that actively remodels in response to its environment. These previous studies have shown 
the intricate valve microstructure and how that impacts its mechanical properties, the 
importance of VICs within the leaflet, and the role of the extracellular matrix, among 
other key findings. While these previous studies have laid important groundwork, a 
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number of questions remain unanswered. These studies have primarily been carried out 
in adults, however, valve diseases affect patients of all ages and potentially tissue 
engineered heart valves could be utilized in a wide range of ages. If there are age-
specific considerations, these remain to be explored more thoroughly. Additionally, these 
studies largely have not considered regional valve heterogeneity or heterogeneity within 
the VIC population. Furthermore, while considerable work has been performed in 
creating scaffolds and bioreactors for a tissue engineered heart valve, the effect of 
scaffold mechanical properties on the VICs themselves has not been considered. These 
are some of the unanswered questions to be addressed by this thesis. 
//. Thesis Motivation, Scope, and Structure 
The overarching goal of this body of work was to gain a better understanding of 
heart valves in health and disease for the design of an age-specific tissue engineered heart 
valve. In accordance with this goal, the various studies which compose this body of work 
can be divided into three main categories, those which address 1) the characterization of 
normal valves, especially aspects related to aging and valve heterogeneity; 2) 
characterization of valves in disease states including congenital valve disease, 
myxomatous mitral valve disease, dilated cardiomyopathy and "functional" mitral 
regurgitation, iatrogenic valve wounds, and calcific aortic valve disease; and lastly, 3) 
preliminary attempts at tissue engineering such a valve using PEG hydrogels. 
The motivation for this work largely stemmed from the need for a tissue 
engineered heart valve to replace the current inadequate treatments for pediatric valve 
disease. The literature lacked information required for the development of design criteria 
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for such a tissue engineered heart valve, including material properties and matrix 
composition of different aged heart valves, as well as compositional and cellular 
heterogeneity within valves that may need to be incorporated into a tissue engineered 
heart valve design. This led to Specific Aim 1 of this thesis' proposal, which was the 
characterization of porcine valve throughout development and aging using 
immunohistochemistry, fluorophore-assisted carbohydrate electrophoresis, and 
mechanical testing (Chapters 3, 4, 7). However, since the initial proposal, this original 
specific aim has been expanded to also include studies regarding valve compositional 
changes during the perinatal period (Chapter 5) and heterogeneity in AV regional 
composition in elderly valves (Chapter 6). The specific aim has also been further 
expanded to include studies related to heterogeneity in valve composition and motion 
(Chapters 8, 9) and cellular heterogeneity in the valve (Chapters 10, 11). 
Therefore, in this expanded portion of the thesis addressing normal valve 
mechanobiology, the chapters are grouped into those assessing age-related changes in 
normal valves, those analyzing valve heterogeneity, and finally cell-matrix interactions in 
the normal valve. First among the studies analyzing valve aging are included 
compositional and structural analyses of fetal and postnatal aging (Chapters 3 and 4), 
perinatal changes (Chapter 5), regional compositional heterogeneity of elderly valves 
(Chapter 6), and postnatal aging with respect to material properties and relationship to 
composition and structure (Chapter 7). The studies of normal valve heterogeneity 
include analyses of composition and motion of the mitral annulus (Chapter 8) and mitral 
leaflets (Chapter 9) and studies related to heterogeneity in VICs, specifically the 
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development of a method to isolate the myofibroblast-like VIC subpopulation (Chapter 
10) and functional characterization of that subpopulation (Chapter 11). 
In the process of developing a tissue engineered heart valve, it is important to 
define both positive and negative design criteria. Furthermore, characterization of 
congenitally diseased valves may also lead to insight into pathogenesis and possible 
novel treatment strategies for this debilitating disease. Therefore, Specific Aim 3, as 
originally stated in this thesis' proposal, was to characterize altered matrix composition 
and hyaluronan metabolism in pediatric pathological valves. However, since that time, 
this portion of the thesis has been greatly expanded to include a number of valve diseases 
as well as encompass Specific Aim 4 from the original thesis proposal, which was to 
study valve remodeling in an ovine model of isolated mitral regurgitation. Therefore, this 
portion of the thesis now more broadly studies valve injury and disease and includes 
investigations of congenital valve disease (Chapter 14, as well as a review of congenital 
valve disease in Chapter 13), studies of the mitral valve in dilated cardiomyopathy and 
"functional" mitral regurgitation (Chapters 15-17), studies of valve wound healing 
(Chapter 18), studies of myxomatous mitral valve disease (Chapter 19, as well as Chapter 
24 in the Appendix), and studies of calcific aortic valve disease (Chapters 20, 21). 
The final portion of this thesis brings the knowledge learned in the above studies 
to bear upon a preliminary tissue engineered heart valve construct. Originally stated in 
the thesis proposal as Specific Aim 2 to determine the optimal stiffness of hydrogel 
scaffolds for different aged porcine valvular interstitial cells, this aim has been revised to 
study both age-related effects as well as aspects of valve heterogeneity. This study 
comprises Chapter 22. 
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Chapter 23 reviews the knowledge obtained from the main portion of this body of 
work, highlights its unique contributions to the literature, and discusses possible 
implications and future directions. The appendix includes a study of myxomatous mitral 
valve disease in which I was integrally involved, but was not central to my proposal 
(Chapter 24), as well as two papers on which I was co-first author regarding myocardial 
mechanics (Chapters 25, 26). 
While the studies included in this thesis span a broad range of topics, they are 
unified by several themes including valve heterogeneity, the importance of the 
extracellular matrix, the role of the valvular interstitial cell, the interrelationship between 
structure and function, and the importance of the valve's mechanical environment. The 
knowledge obtained from this body of work can serve as design criteria for a tissue 
engineered heart valve. Furthermore, the studies of diseased valves give insight into the 
various diseases' pathogenesis, and therefore, may allow the development of novel or 
more refined treatment strategies. 
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Chapter 2: The Use of Collagenase III for the Isolation of 
Porcine Aortic Valvular Interstitial Cells: Rationale and 
Optimization 
In this chapter a collagenase Ill-based method for isolating valvular 
interstitial cells (VICs) was optimized. While this study does not directly address 
questions related to valve mechanobiology, this method of enzymatic isolation of 
VICs was used throughout the thesis work. Therefore, the optimization of this 
method was important to performing many other studies contained in this thesis 
work, as well as provides an optimized protocol that can be used by other 
researchers. 
ABSTRACT 
Background: Substantial heart valve research relies on the isolation of valvular 
interstitial cells (VICs). While a wide variety of conditions have been reported for VIC 
isolation, the effectiveness of these methods has rarely been compared. It is also likely 
that the age of the valve donor will influence these valvular tissue dissociation conditions. 
The aim of this study was to increase the efficiency and cost-effectiveness of VIC 
isolation, while taking into account possible differences due to the age of the valve donor. 
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Methods: Aortic valves were obtained from 6-month-old (n=24) and 6-week-old pigs 
(n=45) within 24 hrs of death. After removal of endothelial cells, the tissues were 
minced and subjected to various enzymatic digestions for variable lengths of time. 
Results: The optimal concentration of collagenase III was determined to be 1 mg/ml for 
6-week-old pigs and 2 mg/ml for 6-month-old pigs. The optimal duration of digestion 
was 4 hours for both ages. Addition of neutral protease (2 mg/ml) further increased 
yield, while additional DNase and hyaluronidase had no effect. Yield was not influenced 
by the volume of enzyme solution or the use of previously frozen enzyme solution. 
Conclusions: These findings provide age-specific conditions for improving the yield of 
VIC isolation, which should have utility in experimental evaluations of valvular cell 
biology and tissue engineering investigations. 
The work contained in this chapter was published as: 
Stephens EH, Carroll JL, Grande-Allen KJ. The Use of Collagenase III for the 
Isolation of Porcine Aortic Valvular Interstitial Cells: Rationale and Optimization. 
Journal of Heart Valve Disease. 2007; 16(2): 175-183. 
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INTRODUCTION 
Given the severity and prominence of heart valve disease and problems with 
artificial and bioprosthetic valves, production of tissue engineered heart valves for the 
treatment of heart valve disease is of high importance,' particularly for the treatment of 
pediatric valve disease.2 Not only do artificial replacement valves have higher 
complication rates in children, but pediatric patients must undergo multiple open heart 
surgeries before adulthood alone to replace artificial valves the child has outgrown.2 
While an autologous tissue engineered heart valve is the ultimate goal because of 
immune and coagulation issues, recent research has focused on the basic science of 
valves in order to determine biological design criteria.3'4 This research often relies on 
valvular interstitial cell isolation from valves of a widely investigated animal model, the 
Pig-
Techniques for the isolation of primary cells generally fall into one of three 
categories: enzymatic, mechanical, and primary explant.5 Primary explant, while 
avoiding exposing tissue to harsh enzymes, selects for a mobile cell phenotype and 
therefore is only recommended for use when tissue is extremely limited or fragile.5 
Enzymatic and mechanical disaggregation results in a more representative cell population 
in a shorter amount of time.5 In enzymatic disaggregation, a balance is sought between 
sufficient enzymatic degradation to allow for the release of cells and minimizing the 
damaging effects of the enzymes on the viability of cells. Of the variety of enzymes 
used, the collagenases and neutral protease (a.k.a dispase) are considered gentle enzymes 
but provide incomplete disaggregation.5 Trypsin and pronase, on the other hand, are 
harsher enzymes that produce the most complete dissociation, but are more damaging. 
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The most common enzyme used is trypsin, referring to a mixture of pancreatic enzymes 
(also called pancreatin).6'7 Trypsin is effective and generally well tolerated by a large 
variety of cell types, and has the benefit that any residual activity is neutralized by culture 
media serum.5 However, trypsin is ineffective in fibrous tissues, such as the collagen-
rich heart valves, in which collagenase is preferred.5 There are several classes of 
collagenases; collagenases I and II have high clostripain tryptic activity, collagenase III 
has lower tryptic activity and thus is less harsh, and collagenase IV is recommended for 
specific use in isolation of pancreatic islet cells.7 Additional enzymes are often added to 
the enzymatic solution, such as DNAse, which degrades the DNA from ruptured cells 
since DNA can inhibit proteolysis and cause cellular aggregation.5 Hyaluronidase is 
particularly useful in digesting the glycosaminoglycan (GAG) hyaluronan, which can be 
prevalent in the extracellular matrix surrounding the cells. 
Table 2-1. Reported Enzymatic VIC Isolation Techniques. 
Enzyme 
Collagenase (W) 
Collagenase II (S) 
Collagenase (G) 
Collagenase II (B) 
Collagenase 1 (W) 
















Step 1: 5 min 
Step 2: 30 min 
Overnight 
Step 1: 30 min 










*the unit concentration could not be determined; 
W=Worthington, S=Sigma, G=Gibco, B=Boehringer. 
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For the study of heart valves, reported conditions for cell isolation vary 
dramatically from time durations of 30 minutes4 to 24 hours,8 and include a variety of 
enzymes at different concentrations (Table 2-1); it should be noted that units of enzyme 
activity vary between manufacturers, although these units are less frequently reported by 
investigators. Enzymes used in heart valve digestion tend to be various mixtures of 
collagenases, although no optimization of enzymes and digestion conditions has been 
published. Furthermore, consideration has not been given to how methods should be 
modified for cell isolation from different aged valve donors. Such modification is likely 
necessary and in fact has been reported previously by Angrist et al., who found that valve 
tissues showed reduced susceptibility to collagenase digestion with advancing age 
(geriatric).9 Furthermore, recent research has shown significant changes in valve 
composition with age, including quantity of proteoglycans and glycosaminoglycans 
(GAGs), changes in collagen content and crosslinking,10 and the density of cells.11 Given 
these differences, it is likely that enzymatic degradation of the extracellular matrix of 
aortic valves from different aged donors will require different dissociation conditions, 
whether these donors are human surgical subjects or animal models. 
Although optimization studies have rarely been published for valvular cell 
isolation,12 such experiments have been performed in other tissues. For example, 
optimization experiments with osteoblasts found that enzymatic isolation, rather than the 
primary explant technique, gave the osteogenic differentiation desired.13 In contrast, in 
the optimization of human gingival cells isolation better results were found with the 
direct explant technique rather than enzymatic isolation.14 The effectiveness of different 
enzymatic mixtures has also been compared in other tissues.15 From these works it is 
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clear that the optimum dissociation conditions and enzymes used for cell isolation 
depends on the tissue matrix content and desired cell phenotype. 
Our hypotheses were that valve tissues from different aged donors, given their 
distinct compositions, would require different digestion conditions for optimal yield. We 
also hypothesized that there would be a range of conditions that improves not only yield 
but also cost effectiveness. Therefore, we examined various combinations of enzymatic 
digestion mixtures (with collagenase III as the base enzyme for reasons stated above) and 
incubation conditions to determine the optimal cocktail for the isolation of cells from 
porcine aortic valves. Valves from both 6-week-old and 6-month-old pigs were used to 
determine the need to tailor dissociation conditions to valve donor age. 
METHODS 
General Procedure 
Porcine aortic heart valves were obtained from an abattoir (Fisher Ham and Meat, 
Spring, TX, USA) within 24 hours of death. These valves were dissected and rinsed with 
PBS. For 6-month-old valves (n=24), each aortic valve leaflet was further cut in half, 
each half acting as a sample (total 137 samples), while for the 6-week-old valves (n=45) a 
whole aortic valve leaflet constituted a sample (total 134 samples). In both cases the wet 
weight of the sample was recorded. Next, to remove the endothelial cells, the tissue was 
incubated for 30 minutes in collagenase II (2 mg/ml of 246 U/mg, Worthington 
Scientific, Lakewood, NJ, USA) and 2.5% antibiotic/antimycotic (ABAM, from stock 
concentration of 10,000 IU penicillin, 10,000 ug/ml streptomycin, 25 ug/ml amphotericin 
B, Mediatech, Herndon, VA, USA) in DMEM (Mediatech) in a shaking incubator (160 
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rpm, 37° C). The loosened endothelial cells were then removed by gently brushing the 
leaflet surfaces with a sterile cotton swab; our laboratory has previously shown that this 
treatment removes endothelial cells (the final cell population does not stain for CD31).16 
Table 2-2. Experimental Conditions. 
Duration Concentrations of Enzymes 
(hours) Coll III Hyase* DNAse NP 
Other Factors 















































""concentrations are on top of baseline (0.1 mg/ml HA); Coll = collagenase, NP = neutral 
protease, o/n=overnight. 
The tissue was finely minced and placed into the enzymatic mixture being tested 
(Table 2-2). The tissue in solution was placed in a shaking incubator (160 rpm, 37° C) 
for a variable number of hours (Table 2-2). After that time the mixture was filtered 
through a 70 micron cell strainer (BD Falcon, Bedford, MA, USA). The cells were 
pelleted via centrifugation (1500xg, 5 min) and resuspended in 1 ml DMEM:F12 with 
10% Bovine Growth Serum (Hyclone, Logan, UT, USA), with 1% ABAM and 5.6 
ml/500 ml HEPES buffer (Mediatech). 
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Assessment of Cell Number: MTT Assay and Trypan Blue Exclusion 
To determine cell yield, either an MTT assay or a hemocytometer (trypan blue 
exclusion) was used immediately after cell isolation, as well as 48 hours later to 
determine if the harvested cells maintained cell viability. Trypan blue exclusion was only 
used in the initial experiment; all subsequent experiments used the MTT assay that 
offered more precision and efficiency. Manual counting of cells using the trypan blue 
exclusion method was performed using a hemocytometer according to standard 
techniques. For each MTT test, 130 \x\ aliquots of the resuspended cell mixture were 
seeded in duplicate in sterile 24 well plates; based on initial counts this volume contained 
approximately 100,000 cells. The MTT assay consisted of adding MTT reagent (5 mg/ml 
sterile 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma-Aldrich, St. 
Louis, MO, USA) in PBS), gently mixing by rocking the plate back and forth, and then 
storing in the incubator for 3 hours. Afterwards 1 ml of MTT solvent (IN HC1 in 
isopropyl alcohol) was added and each well triturated thoroughly. Triplicates of the 
assay solution from each well were measured in a 96 well plate. Plates were read by a 
spectrophotometer (SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA) at two 
different wavelengths (A570-A690). The difference of the two wavelengths for each 
well was taken as directly proportional to cell number. Both methods were normalized 
first to tissue weight to obtain cell density. To compare data between different 
experiments, the cell densities resulting from the different collagenase III concentrations 
and digestion durations were normalized to the 1 mg/ml (6-week-old) or 2 mg/ml (6-
month-old)/ 4 hour results from that same experimental group. 
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Experimental Conditions 
The baseline enzymatic cocktail consisted of 2.5% ABAM, 2.5% HEPES buffer, 
and 10 mg/100 ml hyaluronidase (499 USP/NF U/mg, Worthington Scientific) in 
DMEM, as well as collagenase III (149 U/mg, Worthington Scientific) at varying 
concentrations. To test the effect of digestion duration, the minced valve tissues were 
incubated for 2, 3, 4, or 6 hours as well as overnight (Table 2-2). To test the effect of 
collagenase III concentration, 1, 2, 4, 5, 7, and 10 mg/ml solutions were evaluated. 
Under the rationale that increased volume may allow more opportunity for enzyme-tissue 
interaction, the effect of the volume of solution added to the minced tissue was tested by 
using a digestion mixture of 20 ml (instead of our standard 8 ml) in one experiment. To 
test the effect of freezing the enzyme mixture prior to use, one digestion mixture was 
frozen for several days and then thawed before use in an experiment where it was 
compared to a freshly prepared mixture of identical composition. Additionally, various 
concentrations of additional enzymes were tested to determine if they would improve cell 
yield (Table 2-2). These supplemental enzymes included hyaluronidase (an additional 
0.1, 0.2, and 0.5 mg/ml on top of the baseline 0.1 mg/ml), DNAse (0.1, 0.2, and 0.5 
mg/ml), and neutral protease (NP, 0.5, 2, and 5 mg/ml; 0.28 U/mg, Worthington 
Scientific). 
Statistical and Cost Benefit Analyses 
Multifactorial analysis of variance tests were performed using SigmaStat (SPSS, 
Chicago, IL, USA) to determine if concentration and duration effects were significant 
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(p<0.05). Post-hoc Tukey tests were performed as needed to compare subgroups. 
Calculations of cost were based on 2006 Worthington Scientific prices for enzymes and 
assumed equivalent volumes of enzymatic mixtures per sample. 
RESULTS 
Valvular Interstitial Cell Isolation from 6-Month-Old Pig 
Initial studies showed that at low concentrations of collagenase III (1-2 mg/ml) 
the overnight digest gave the most cells compared to the 2 and 4 hour digests, up to 
tenfold higher for 1 mg/ml overnight compared to 2 hour. Cell yield greatly increased 
(average of ~4X) with higher concentrations of collagenase III (5-10 mg/ml). However 
at the high concentrations the overnight digest yielded lower cell densities (-75%) than 2 
or 4 hours. Based on this initial study, the overnight digestion was omitted and only 
shorter digestion times used. This same experiment also showed that most collagenase 
III concentrations on average yielded a higher (1-2X) cell density at 4 hours than after 2 
hours. For that reason, subsequent experiments compared the effectiveness of four hour 
and six hour digestions. 
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Concentration of Collagenase III (mg/ml) 
Fig. 2-1: Optimization of collagenase III concentration for 6-month-old ("adult") 
valves. Above: 4 hour digestion duration, showing MTT cell yield on day 0 and day 2: 
p<0.001; *=p<0.01 vs. 7 mg/ml. Below: cell yields resulting from 6 hour digestion 
duration: p<0.001; A=p<0.005 vs. 7 mg/ml. Relative cell yield = yield for each 
combination of enzyme concentration and digestion duration normalized to the MTT 
result from the 2 mg/ml and 4 hour data. 
Given that the day 2 analysis of cell viability indicated that the 4 hour digestion 
culture consistently contained a higher number of cells than the 6 hour digestion culture, 
4 hours was determined to be the optimum digestion duration (pO.OOl, Fig. 2-1). While 
the greatest yield was obtained with the highest concentration of collagenase III (for 4 
hour digestion pO.OOl; p<0.01 for 7 vs. each of 1, 2, and 4 mg/ml), taking into account 
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the cost (Fig. 2-2), 2 mg/ml was determined to be the optimal collagenase III 
concentration for the 6-month-old valve. 
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F/g. 2-2: Cost benefit analysis showing that the cell yield and cost per sample curves cross at 
approximately 3 mg/ml. Because 4 mg/ml gave poorer yields than 2 mg/ml, the lower 
concentration of collagenases HI was selected as optimal. 
Additional hyaluronidase by itself or in combination with DNAse did not increase 
yield above that of the baseline cocktail (Fig. 2-3). Similarly, the addition of DNAse did 
not result in higher yield compared to baseline at any concentration, but neutral protease 
at a concentration of 2 mg/ml resulted in a significant increase in the number of day 2 
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Fig. 2-3: Optimization of additional enzymes for 6-month-old ("adult") valves. A) 
Optimization ofhyaluronidase. B) Optimization of DNAse. C) Optimization of neutral 
protease, for day 2: p<0.001; *=p<0.001 vs. 2 mg/ml. For all experiments each sample 
(n) consisted of one half of an aortic valve leaflet. Hyase=hyaluronidase. 
Valvular Interstitial Cell Isolation from 6-Week-Old Pig 
Initial studies in 6-week-old valves showed that the yield for the overnight digest was an 
average of approximately 50% less than the 4 hours digest for all concentrations. These studies 
also showed that for most concentrations the yield for the 4 hour digest was higher (-1.2-5X) 
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Suckling Optimization of Digestion Time 
i D Day 0 




Fig. 2-4: Optimization of digestion duration and collagenase III concentration for 6-week-old 
("suckling") valves. A) Optimal collagenase HI concentration for 6 hour digestion duration 
was 1 mg/ml, p=0.038. B) Optimization of collagenase III concentrations in 4 hour digestion 
duration. C) Optimization of digestion time. For all parts of figure each sample (n) consisted 
of one whole aortic valve leaflet. Relative cell yield = yield for each combination of enzyme 
concentration and digestion duration normalized to the MTT result from the I mg/ml and 4 
hour data. 
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Baseline Hyase 0.2 mg/ml Hyase DNAse DNAse + DNAse + 
(0.1mg/ml) (0.1mg/ml) + 0.2mg/ml Hyase 0.5mg/ml Hyase 
0.1 mg/ml Hyase 
Enzyme Combination 
Suckling Optimization of DNAse 
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I I Day 2 
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• Day 2 
0.5 2 
Concentration of Neutral Protease (mg/ml) 
Fig. 2-5: Optimization of additional enzymes for 6 week-old ("suckling") valves. A) 
Optimization of hyaluroniddase concentration, for day 2: p<0.001; *=p<0.001 vs. DNAse 
+ 0.2 mg/ml hyaluronidase. B) Optimization of DNAse, for day 2: p<0.001;*=p<0.001 vs. 
0.1 mg/ml DNAse. DNAse was in addition to 0.2mg/ml hyaluronidase. C) Optimization of 
neutral protease, for day 2: p<0.001; A=p<0.005 vs. 2 mg/ml neutral protease. Neutral 
Protease was in addition to 0.2mg/ml hyaluronidase. For all parts of figure each sample 
(n) consisted of one whole aortic valve leaflet. 
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than the 2 hour digest. Subsequent experiments, therefore, included 3, 4, 5, and 6 hour 
digests. The optimum duration for digestion for 6-week-old valves was found to be 4 
hours because this gave the greatest number of viable cells on day 2 (Fig. 2-4). In 6-
week-old valves the optimal concentration appeared to be, by a small margin, 1 mg/ml 
(p=0.08). Given this result and considering the cost of the enzyme, 1 mg/ml collagenase 
III was determined to be the optimal concentration. Of the additional enzymes used to 
supplement the digestion mixture (hyaluronidase, DNAse, and neutral protease), the 
optimal hyaluronidase concentration was 0.2 mg/ml (for a total of 0.3 mg/ml) (p=0.024; 
p<0.001 for 0.2 vs. 0.1 mg/ml). The optimum DNase concentration was 0.1 mg/ml 
DNAse, which substantially increased yield (pO.OOl; p<0.005 for 0.1 vs. both 0.2 and 
0.5 mg/ml, Fig. 2-5). Neutral protease increased yield at a concentration of 2 mg/ml and 
improved day 2 viability at all concentrations (pO.OOl). 
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Fig. 2-6: A,B) Fresh versus frozen enzymatic cocktail. C) Effect of volume 
(performed in 6-week-old "suckling" valves only). Samples in 6-month-old 
("adult") valve experiments consisted of one half of one aortic valve leaflet. 
Samples in 6-week-old valve experiments consisted of one whole aortic valve leaflet. 
In both age groups, freezing the enzymatic preparation ahead of time did not 
diminish cell yield (Fig. 2-6). Increased volume (tested in 6-week-old valves) also did 
not affect yield (Fig. 2-6). Table 2-3 summarizes the optimal disaggregation conditions 
that were determined for each age group. 
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Table 2-3. Optimized Enzymatic Digestion Mixtures for 
















*Step 1 for both age groups loosens the endothelial cells and the mixture contains collagenase II 
(2 mg/ml of 246 U/mg) and 2.5% antibiotic/antimycotic (from stock concentration of 10,000 IU 
penicillin, 10,000 ug/ml streptomycin, 25 ug/ml amphotericin B) in DMEM. 
DISCUSSION 
A wide range of collagenase III concentrations was found to be effective in the 
isolation of VICs from porcine aortic valves, although with different resulting cell yield. 
This result confirms the notion that in enzymatic disaggregation a balance is sought 
between sufficient enzymatic degradation of the tissue to allow for the release of cells 
and minimizing the damaging effects of the enzymes on the viability of cells. 
Collagenase III was found to be very effective as the main enzyme in valvular 
disaggregation, as expected given that collagenase is reported to be particularly 
appropriate for either delicate tissues or fibrous tissues.5 The collagenases are a family of 
enzymes that are composed of differing proportions of clostridopeptidase A (which 
specifically cleaves Pro-X-Gly-Pro) with other proteases, polysaccharidases, and lipases.7 
In general, crude enzymatic preparations (used in this study) are often more successful in 
cell isolation; since they are less pure, they contain contaminating nonspecific proteases 
that aid in digestion.5 However, higher purity preparations of enzymes are advantageous 
for being less toxic to cells and more specific to distinct types of ECM.5 At different 
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points in the enzymatic digestion process, different preparations of collagenase are more 
appropriate. Within the collagenase family, collagenase II is harsher and has more tryptic 
clostripain activity than collagenase III.7 Therefore, collagenase II can be used briefly to 
loosen the endothelial cells but is likely too harsh for a sustained digestion duration. 
Although DNAse is known to improve yield by degrading DNA from cells that 
have ruptured, since DNA both inhibits proteolysis and causes cellular aggregation 5, this 
enzyme only increased day 2 viability, not yield. While the addition of hyaluronidase did 
not improve 6-month-old valve dissociation, it did improve 6-week-old valve 
dissociation, consistent with increased GAG content in human infant valves compared to 
human adult valves.'' Neutral protease, which is a gentler, less tryptic enzyme (similar to 
the collagenases7), was found to increase yield and 2 day viability for both age groups. 
Based on developmental milestones and growth studies, a 6-week-old pig is 
approximately equivalent to approximately an 8-year-old human; whereas a 6-month-old 
pig is approximately equivalent to a 17-19 year-old human17"19 (Table 2-4). 
Table 2-4. Human and Porcine Age Equivalencies. 
Porcine Age Corresponding Human Age 
5 days infant18 
18 
4 weeks toddler 
5 weeks 4-5 years-old 1? 
6 weeks ~8 yearsA 
4 months adolescent18 
5 months 13.7 years-old 19 
6 months 17 year-old female, 19 year-old maleA 
6 year-old sow oldA 
life span: 10-15 years, but for sows considerably shorter (esp. if reproducing)A 
A
=personal communication with Dr. Gil Costas, DVM, Texas Heart Institute. 
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Valves from the different age groups were shown to require different 
concentrations of collagenases. The need for a higher concentration of collagenase III in 
the older group was not surprising considering numerous researchers have used the 
digestion time of valve tissue as an indication of crosslinking (with an increase in 
digestion time indicating more crosslinking), and reported differences between age 
groups.9 The cell yield from 6-month-old valves also increased with the concentration of 
collagenase, while 6-week-old valve disaggregation was improved with lower 
concentrations and optimal at 1 mg/ml, implying that higher concentrations may be too 
harsh for younger cells. Similarly, the finding that 0.1 mg/ml DNAse improved the 6-
week-old valve disaggregation suggests that these cells are more prone to rupture and 
therefore the DNAse was able to prevent the released DNA from forming sticky cell 
aggregates. 
Cost effectiveness was a major factor in determining the optimal enzymatic 
mixture. In 2006, a bottle of 100 mg of collagenase III cost $29 from Worthington 
Biochemical. Per sample, 1 mg/ml of collagenase III cost $2.32, while 4 mg/ml cost 
$4.64, and 7 mg/ml cost $16.24. The specialized enzymes were also costly; optimizing 
their effectiveness should offer substantial savings. 
Limitations in this study were shown by the day 2 tests, which often showed that a 
small percentage of cells died after seeding; this experimental design also could not 
indicate long-term viability. However, since many valvular cell studies need to expand 
these cells in culture, the MTT test on day 2 indicated which technique produces the 
greatest number of viable, proliferating cells in the short term. Another limitation is that 
we only used collagenase products from the Worthington Biochemical and results may 
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not translate to enzymes from all other manufacturers. To enable comparison between 
manufacturers, the caseinase, clostripain, collagenase, and tryptic assay numbers for a 
given product should be examined. The unit activities of the collagenases that we used 
are given in Table 2-5; these data indicate the tight range of activity present between the 
two different lots of collagenase III that were used in this study. 








148 u/mg dw 
1.85-1.97 u/mg dw 
0.24-0.28 u/mg dw 
dw = dry weight 
CONCLUSIONS 
The optimum enzymatic digest mixtures were determined to be 1 mg/ml of 
collagenase III for 6-week-old pigs, along with 0.3 mg/ml hyaluronidase, 0.1 mg/ml 
DNAse, and 2 mg/ml neutral protease dissolved in DMEM containing 2.5% 
antibiotic/antimycotic solution and 2.5% HEPES buffer. The optimum mixture for 6-
month-old pigs was 2 mg/ml collagenase III and 2 mg/ml neutral protease, dissolved in 
the same DMEM/ABAM/HEPES. The optimized duration of digestion was 4 hours for 
each age of aortic valve. These findings provide age-specific and cost-effective 
conditions for improving the yield of VIC isolation, which should have utility in 
experimental evaluations of valvular cell biology and tissue engineering investigations. 
68 
In this chapter enzymatic valvular interstitial cell (VIC) isolation was 
optimized. This optimization was foundational to the thesis, as it was used in many 
other studies throughout this thesis work. In the next chapter, the first of the 
studies directly examining valve mechanobiology, some of the questions related to 
how normal valves change with age are addressed. Specifically, in the next study 
changes in aortic and mitral valve collagen content and turnover in fetal and 
postnatal aging are analyzed. 
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Chapter 3: Age-Related Changes in Collagen Synthesis and 
Turnover in Porcine Heart Valves 
This chapter is the first of four chapters (Chapters 3-6) examining age-
related changes in matrix composition and structure in normal aortic and mitral 
valves. In this chapter changes in collagen content and turnover in fetal and 
postnatal aging are analyzed. 
ABSTRACT 
Background: The 6-month-old pig is commonly used to study human heart valve 
biology and several age-specific valve diseases. However, correlation of porcine valve 
biology and development with that of humans has not been thoroughly assessed. Given 
the matrix's important role in valve function, we characterized porcine valve matrix 
structure and collagen turnover during development and aging. 
Methods: Porcine aortic (AV) and mitral valves (MV) throughout fetal development and 
at 6-weeks, 6-months, and 6-years, were examined using Movat pentachrome stain and 
immunohistochemistry for collagen III, markers of collagen synthesis [molecular 
chaperone HSP47, hydroxylating enzyme prolyl 4-hydroxylase (P4H), crosslinking 
enzyme lysyl oxidase (LOX)] and collagen degradation (matrix metalloproteinase 
(MMP)-13), and a marker of an "activated" cellular phenotype, smooth muscle alpha-
actin (SMaA). Analysis of variance was used to compare staining intensities. 
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Results: Cell density measurements showed layer differentiation in the 1st trimester 
(p<0.003) and decreased ten-fold from 2nd trimester to 6-year-old (p<0.025). Matrix 
turnover was identified by co-localization of P4H, HSP47, and MMP13 and correlated to 
an "activated" cellular phenotype. SMaA expression was noted on the inflow surface of 
both valves. P4H and LOX were maximally expressed around mature collagen 
(p<0.001). P4H increased during fetal development (p<0.01) and in the 6-year-old AV 
fibrosa (p<0.05). Collagen-related markers were consistently higher in the AV than MV 
(HSP47 in fetal; P4H, Col III, and LOX in 6-year-old). 
Conclusions: Substantial changes occur in porcine valve matrix throughout life. These 
changes should be considered when comparing clinical studies with the porcine model for 
studying age-specific diseases. 
The work contained in this chapter was published as: 
Stephens EH, Grande-Allen KJ, Age-related Changes in Collagen Synthesis and 




Because of anatomic and structural similarities1"3 and convenient availability, the 
6-month-old pig is a widely used animal model for investigating human heart valve 
biology and disease, including age-specific diseases such as calcific aortic stenosis and 
myxomatous mitral valve disease.4 Additionally, much of the work towards developing a 
tissue engineered valve has focused upon thoroughly characterizing valves using the 
tissues and cells from 6-month-old pigs. However, the biology of the porcine valve has 
not been assessed in depth for concurrence with human biology nor has its valve 
development been related to human valve development. A critical component of the 
heart valve is the extracellular matrix (ECM), whose synthesis and degradation enables 
both valve development and maintenance of the mature valve. Once merely thought to 
act as a scaffold, it is now known that the ECM is intimately involved in morphogenesis, 
cell migration, growth factor and other cell regulation, material behavior,5 and 
mechanosensing.6 Although previous studies of the ECM in porcine valve aging have 
been performed, these have largely evaluated histological changes,4 such as those evident 
in Movat pentachrome stained samples, or collagen crosslinking.7'8 In this investigation, 
we characterized porcine valve matrix composition, structure, and turnover during 
development and aging. Our particular focus was on collagen, since it is the primary load 
Q 
bearing component of the valvular ECM. By utilizing immunohistochemistry to stain 
for various enzymes regulating collagen synthesis and degradation, we were able to 
localize sites of active turnover within the intricate structure of the valve, as well as 




Porcine hearts were obtained from an abattoir within 24 hours of death (Fisher 
Ham and Meat, Spring, TX for 6-week-old pigs and 6-month-old pigs, Animal 
Technologies, Tyler, TX for fetal and 6-year-old pigs). The sample set consisted of 
porcine mitral (MV) and aortic valves (AV) aged first fetal trimester, second trimester, 
third trimester, 6-week-old, 6-month-old, and 6-year-old (Table 3-1). One leaflet per AV 
Table 3-1. Sample Size. 
Age 
Fetal 1st trimester 
Fetal 2nd trimester 


















*Each sample represents a heart valve from a different animal. 
Multiple sections of each sample were stained. 
(chosen randomly from the non-coronary, right coronary, and left coronary leaflets) was 
used; for the MV only the anterior leaflet was used. Tissues were fixed overnight in 10% 
formalin and 5 mm wide cross sections of the leaflet were cut from the annulus to the free 
edge. For the aortic valve, cross sections were taken slightly off center thereby avoiding 
the nodule of Arantius. These cross sections were embedded in paraffin, sectioned to a 
thickness of five microns and mounted on slides according to standard procedures. A 
schematic of the sections analyzed for each valve is shown in Fig. 3-1. 
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Histology and Immunohistochemistry 
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Abeam (Cambridge, MA); Chemicon (Temecula, CA); Assay Designs (Ann Arbor, MI); 
dImgenex (San Diego, CA); eDakocytomation (Denmark). 
Each sample was stained histologically with Movat pentachrome and 
immunohistochemically (IHC) for markers involved in the synthesis and turnover of 
collagen (Table 3-2), including collagen III (col III), lysyl oxidase (LOX), prolyl 4-
hydroxylase (P4H), matrix metalloproteinase 13 (MMP13), and heat shock protein 47 
(HSP47). P4H is an enzyme located in the rough endoplasmic reticulum that is required 
for the critical step of proline hydroxylation in collagen synthesis.9 MMP13 is a major 
enzyme responsible for collagen degradation and HSP47 is a molecular chaperone that is 
specific to procollagen biosynthesis.10 In contrast to P4H and HSP47, LOX has two 
major roles in matrix metabolism, namely the initiation and regulation of crosslinking in 
elastic fibers and collagen.'' 
In addition to these collagen-related markers, sections were stained for smooth 
muscle alpha-actin (SMaA) to serve as an indicator of an activated cellular phenotype. 
Recognizing that P4H, MMP13, and HSP47 have common roles in collagen metabolism 
and that these markers were frequently co-localized, we summed their intensities to 
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create a new marker denoted "total P4H, MMP13, HSP47" (tPMH). In addition, several 
representative slides for each age group were stained for MMP1, MMP2, MMP9, and 
Tissue Inhibitor of Matrix Metalloproteinase (TIMP)-l. Negative controls were stained 
with either secondary antibody only or the appropriate isotype control (mouse or rabbit 
IgG) with their corresponding secondary antibody. 
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F/g. J-/ : ^ Diagrams of histological layers of MV and AV. Shaded dashed-line boxes indicate 
approximate portions used in grading. B) Example of grading rubrics. Top: rubric for 
quantification of staining intensity illustrating the range in intensities using several histological 
layers. Intensity was quantified for each histological layer and leaflet portion using this rubric. 
Pictured examples are from the annulus of the MV. Bottom: rubric used for quantification of 
degree delineation in the mid-leaflet. Lower grades indicate less differentiation between 
histological layers. Both contrast in intensity between layers and clarity of the boundary 
between the layers were considered in the quantification. Pictured examples are from the AV. 
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IHC samples were graded on a scale of 0-4 for each characteristic in the different 
portions of the leaflet (annulus, mid-leaflet, and free edge) and in each histological layer 
(ventricularis, atrialis (mitral only), spongiosa, and fibrosa), except for the free edge, 
which was considered one layer. The term "inflow layer" was defined to be the atrialis of 
the MV and ventricularis of the AV. A corresponding "outflow layer" was not compared 
between AV and MV because of their inherent differences in composition. 
Characteristics evaluated included marker intensity, delineation (marker's contrast 
between valve layers), and "fibrosa correlation" (degree of marker co-localization with 
the Movat saffron stained collagen). Quantification was based on a grading rubric for 
each characteristic (Fig. 3-1). Between 1 to 3 sections of a given valve sample were 
stained with a given antibody. Replicates, whether within the same IHC batch or in 
different IHC batches, were averaged. The quantification was performed twice, once by 
an unblinded observer and once by a trained blinded observer. Intra- and inter-observer 
variabilities as well as intra- and inter-IHC batch variabilities were all calculated to be 
less than 15% based on replicated sections. 
Overall collagen content and alignment was analyzed using picrosirius red 
staining. Sections were stained in picrosirius red (0.1% w/v) for 1 hour followed by a 
water wash and dehydration. Sections were visualized using a Nikon Eclipse E600 
microscope and polarization filter (Melville, NY), and Image Pro software (Media 
Cybernetics, Bethesda, MD). Collagen type was inferred based on hue (red=collagen I, 
yellow/green=reticular collagen). 
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Cell Density Assessment 
Cell density was assessed by counting nuclei within specific layers of the annulus 
and mid-leaflet regions of either Movat or IHC slides counterstained with hematoxylin. 
All evaluations were done by a trained individual blinded to the valve identity. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL). When the data for a given characteristic (marker intensity, delineation, and 
fibrosa correlation) was normally distributed (as determined by the software), the 
program continued with a three factor ANOVA for age (factor 1: 6-week-old, 6-month-
old, and 6-year-old), histological layer (factor 2: ventricularis, atrialis, spongiosa, and 
fibrosa), and valve region (factor 3: annulus, mid-leaflet, and free edge). When the data 
set was not normally distributed, a comparison on ranks was used. In both cases the level 
of significance was set at 0.05. The Holm-Sidak all-pairwise multi-comparison method 
was used for post-hoc testing. 
RESULTS 
Cellular Density 
The valvular cell density decreased throughout fetal development and aging 
(p<0.001, Fig. 3-2). First and second trimester fetal valves were approximately 50 and 
10 times more cellular, respectively, than that of the 6-year-old (unless otherwise 
indicated, results refer to both MV and AV and include all layers). This magnitude 
reduction in cell density corroborates research in human13 and chick valves.14 
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Differentiation of cell density between layers was previously reported in chick valves, 
but only for the late gestation stage at which point rudimentary layers are apparent by 
Movat.14 Here, we found that as early as the 1st trimester the spongiosa layer had 65-
67% lower cell density than the other layers (data not shown, p<0.003). 
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Fig. 3-2: Decrease in cell density with aging. Error bars indicate standard 
deviation. f=p<0.001 vs. Is' trimester, *=p<0.025 vs. 2nd trimester fetal, d=p<0.05 
ord 
vs. 3 trimester fetal. v=p<0.05 vs. 6-week-old. 
Movat Tissue Organization 
Early fetal valves appeared as a largely amorphous collection of GAGs that 
became more delineated with trimester, confirming reports in other species.13"15 This 
delineation by Movat staining was accompanied by differential protein expression 
demonstrated immunohistochemically (Fig. 3-3). These findings are consistent with 
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SMocA SMaA Col III 
1st Trimester 
^ -V^y 
2nd Trimester 1st Trimester 2nd Trimester 
Fig. 3-3: Differential protein expression evident in 2" trimester MV as compared to 1M 
trimester MV. Left hand side: SMaA staining; right hand side: collagen III staining. 
Scale bars are 50 /um. 
reports describing fetal human valves as consisting primarily of proteoglycans with 
minor disorganized collagen in the second trimester, a bilaminar structure at 20 weeks, 
and a trilaminar structure at 36 weeks 13 
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& M 
ord , Fig. 3-4: Visualization of picrosirius red stained 3r trimester MV under polarized light 
(middle panel) demonstrates a rudimentary collagen I fibrosa. Bottom panel shows the 
same section visualized without polarization and top panel shows the corresponding 
Movat stain. Scale bar is 100 pm. 
Visualization of picrosirius red stained fetal valve sections demonstrated that 
aligned type I collagen was evident at points of chordal development, and was even 
evident as a rudimentary fibrosa in third trimester mitral valves (Fig. 3-4). The third 
trimester valve was still profoundly less differentiated than the 6-week-old valve and 
the 6-month-old valve was significantly more delineated than the 6-week-old valve 
(Fig. 3-5), implying substantial postnatal valve development as reported by others13'l4 
and as recently documented in mice.15 Paralleling this increase in organization was an 
increase in collagen content demonstrated by Movat. However, even in the 3 rd 
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trimester valve the yellow stained Movat collagen was weakly evident and intermixed 
with GAGs, whereas in the fibrosa of the 6-week-old the Movat collagen formed a 
continuous band, which then appeared more densely collagenous in the 6-month-old. 
Fig. 3-5: Right two panels contain comparison of 6-month-old and 6-week-old AV at each 
region of the leaflet illustrates greater tissue organization in 6-month-old compared to 6-
week-old. Asterisk marks collagen capping the free edge tip. Arrow points to presence of 
collagen in the spongiosa. Scale bars on the right two panels are 200 jxm. Left panel shows 
Movat of 3" trimester AV, which is less differentiated than the 6-week-old AV. Scale bar on 
fetal picture is 100 /xm. Movat pentachrome stains glycosaminoglycans blue, collagen 
yellow, and elastic fibers black. 
In the 6-month-old, some collagen was present within the spongiosa and towards the 
free edge, sometimes even encasing the tip of the free edge (Fig. 3-5). This increase in 
tissue organization from the fetal stage to adulthood was found despite a significant 
age-related reduction in cell density (Fig. 3-2), and confirms other reports of an 
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increase in collagen content and orientation during this age period.13 With advanced 
aging, collagen fiber organization has been documented to decrease4 consistent with the 
decrease in organized collagen III staining found here (p<0.01). 
Fetal Valve Immunohistochemistry 
The abundance of the collagen synthesis enzyme P4H increased with increasing 
fetal age, corresponding to increased Movat collagen (p<0.01). The collagen degrading 
enzyme MMP13 also tended to increase over the trimesters, whereas MMP1 decreased 
during fetal development (p<0.05), and collagen III remained stable. While increased 
MMP13 expression is consistent with findings in humans, the decrease in MMP1 is not. 
This contradiction could simply be a result of different antibody specificity, or may be a 
true species difference. Fetal valves also stained positively for MMP2 and MMP9, with 
TIMP1 staining on the leaflet edge. 
Matrix Turnover and the "Activated" Cell Phenotype 
The markers P4H, MMP13, and HSP47 were frequently found to co-localize in all 
age groups (Fig. 3-6). Considering the specificity of P4H and HSP47 for collagen 
synthesis, and MMP13 for matrix degradation, such areas of co-localization were 
identified as possible regions of active collagen turnover, i.e., areas of ongoing collagen 
synthesis and degradation. Wherever all three proteins were expressed, SMaA staining 
was distinctly apparent. These results build upon previous immunoblotting studies 
showing a correlation between HSP47 and SMaA6 by demonstrating specific spatial 
correspondence between areas of collagen synthesis and the "activated" cell phenotype. 
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Fig. 3-6: Co-localization of P4H, MMP13, HSP47, and SMaA indicate areas of collagen 
turnover and an activated cell phenotype. A) 6-month-old AVfree edge: dashed red circles 
indicate areas of degradation without new synthesis. White circles indicate areas of 
degradation and new synthesis. SMaA co-localizes with both. Scale bars are 200 /xm. B) 
Third trimester fetal MV shows similar co-localization. Scale bars are 100 /um. 
Valvular interstitial cells are thought to transition from a quiescent, fibroblast-like state to 
this "activated" myofibroblast-like state in the context of remodeling,16 pathological 
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states such as myxomatous mitral valve disease, and immature tissue engineered 
constructs.18 In valves, this "activated" cell phenotype is also characterized by positive 
staining for non-muscle myosin (produced by activated mesenchymal cells) and negative 
staining for myosin.17'I8 In this study, P4H, MMP13, and HSP47 were frequently, but 
not always, co-localized suggesting that different stages of active collagen synthesis 
occur throughout the valve. In several fetal valves, localized expression of SMaA was 
especially dramatic, particularly in locations that would later become rich in highly 
aligned collagen, such as the chordae and fibrosa (Fig. 3-7). The activated nature of 
those cells in those regions, and the observation that those regions later demonstrated low 
staining for the collagen synthesis and crosslinking enzymes, may indicate that collagen 
in the fibrosa and chordae matures very early. 
Fig. 3-7: SMaA expression in fetal valves. Upper: Is trimester MV; lower: 3r trimester 
A V. Scale bars are 50 /urn. 
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Common Findings between Aortic and Mitral Valves 
In both valves, staining for P4H and LOX was strongest surrounding the well-
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Fig. 3-8: A) Co-localization of LOX with P4HandMMP13. Note that LOX, P4H, andMMPU 
do not stain where the well-defined, mid-leaflet fibrosa appears in Movat. Top: 2" trimester 
MVwith 50 nm scale bars; bottom: 6-year-old AV with 200 /um scale bars. B) Graph 
illustrating significantly lower collagen-related marker expression in the fibrosa as opposed to 
the ventricularis. Data is taken from mid-leaflet portion of all ages of A V (data was not 
significantly different across age groups, p=0.12). Error bars are standard errors of the mean. 
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Fig. 3-9: Visualization of picrosirius red stained 
6-month-old MV under polarized light shows 
aligned collagen type I corresponding to the 
Movat yellow stained tissue. The upper two 
images show the annulus and the lower two 
images show the mid-leaflet. For each pair of 
images, the top image is the Movat stained 
section and the bottom image is the picrosirius 
red stained section viewed under polarized light. 
Scale bar is 100 /urn. 
networking of collagen III could include i 
least staining for these two markers 
(p<0.001; no statistical effect of age). 
This pattern suggests that active 
collagen synthesis occurs surrounding, 
but not within, the yellow Movat 
staining collagen of the fibrosa, which 
could be considered "mature." In fact, 
other markers, including collagen III, 
MMP13, and the combination tPMH, 
all stained the least in the fibrosa of 
both valves (p<0.001). While 
visualization of picrosirius red stained 
sections under polarized light 
confirmed previous reports that the 
fibrosa mainly consists of load bearing 
type I collagen (Fig. 3-9),19 
localization of the network-forming 
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type III collagen ' to areas outside 
of the fibrosa likely demonstrates the 
need for flexibility and even stress 
transfer within these regions. The 
on with elastic fibers,21 which may be 
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responsible for high LOX expression in the atrialis of the MV and the ventricularis of 
both valves (Table 3-3). 









at > v > sp > f* 
at > sp = v > f* 
at = v > sp > f* 
v = at = sp > f* 
at > sp = v = f* 
at > v > sp > f* 
Aortic Valve 
sp > v » f* 
sp > v > f* 
v > sp > f* 
~ 
v > sp > f* 
v > sp > f* 
v=ventricularis, sp=spongiosa, f=fibrosa, fe=free edge, at=atrialis, 
*p<0.05, "--" indicates no significant difference. 
Differences between Aortic and Mitral Valves 
Overall, the AV demonstrated greater expression of collagen-related markers, 
particularly collagen III, than found in the MV (Table 3-4). The AV spongiosa exhibited 
Table 3-4. Comparison of Protein Expression between Mitral Valve and Aortic Valve. 
Fibrosa, Spongiosa, Free 
Markers All Layers edge Tissue Structure 
tPMH -- sp AV > MV* 
P4H - sp and f AV > MV* fc AoV > MV$, d AV > MV* 
MMP13 - feAV>MV$ 
HSP47 - fAV>MV$ 
Col III AV > MV* sp AV > MV^, fe AV > MVt 
LOX » --
v=ventricularis, sp=spongiosa, f=fibrosa, fe=free edge, at=atrialis; fc=fibrosa correlation, 
d=delineation; *p<0.001, fp<0.01, $p<0.05, "--" indicates no significant difference. 
greater expression of P4H, collagen III, and the combined "turnover" marker tPMH (all 
p<0.05). Similarly, the fibrosa of the AV had more P4H and HSP47 expression, and the 
free edge of the AV had more collagen III and LOX expression. Interestingly, HSP47 
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expression was significantly higher in the fetal AV than in the fetal MV (p<0.035); given 
that these fetal valves do not experience major differences in their mechanical 
environments, this pattern may reflect the inherent differences between the valves' 
embryonic origins.22 Taken together, these patterns may reflect inherent structural and 
load bearing differences, or the differential effects of aging,4 between valves. 
The relative intensities between histological layers also differed between MV and 
AV. In the MV, the marker combination tPMH showed highest expression in the inflow 
elastic layer (atrialis) and decreased progressively in the ventricularis and then spongiosa 
(p<0.001). In the AV, however, tPMH staining was strongest in the spongiosa, and lower 
in the inflow elastic layer (ventricularis, p<0.001). In the MV, P4H was more abundant 
in the inflow (atrialis) and less in the spongiosa and ventricularis, while in the AV, P4H 
was higher in the spongiosa and lower in the inflow (ventricularis, p<0.001). This 
different pattern could be interpreted as the spongiosa playing more of a role in load-
bearing in the AV than in the MV. Furthermore, the AV contained a gradient of P4H 
expression from the annulus (low) to the free edge (high); the P4H staining was also 
more organized (as measured by delineation and fibrosa correlation, p<0.035) in the AV 
compared to the MV. The correlation of this marker with the valve anatomy and layers 
suggests that P4H expression may be related to the valve mechanical behavior, since the 
layered nature of the valve and the interaction between the layers contributes to the 
material properties.23 
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Postnatal Aging Changes in Aortic and Mitral Valves 
While the most marked changes with aging were evident during fetal 
development, the expression of several markers changed significantly with postnatal 
aging. For instance, the metalloproteinases MMP2 and MMP9 and their inhibitor TIMP1 
were only expressed in the 6-year-old valves and even that was very slight. This finding 
is interesting given findings in pigs and humans showing expression of these markers in 
age-related valvular heart disease.24'25 In contrast, slight staining of MMP1 was evident 
in the 6-month-old and 6-year-old porcine valves. Another change noted in both valves 
was a decrease in the delineation of the combination marker tPMH in the 6-year-old 
(p<0.015) that may reflect the presence of collagen in all leaflet layers. Surprisingly, we 
observed MMP13 expression in all age groups in contradiction to previous reports noting 
that either the MV contains MMP1 but not MMP13,26 or that MMP13 was present in 
interstitial cells from younger valves but not adult.18 Such discrepancies could be due to 
differences in antibody, or may be a true species difference that would need to be taken 
into consideration when using the pig as an animal model. 
Changes with aging were also seen in the individual valve types. The AV showed 
significantly greater expression of P4H, LOX, and collagen III in the 6-year-old (all 
p<0.05). In the AV fibrosa both P4H and tPMH were strongest in the 6-year-old (both 
p<0.05), corroborating studies showing increased collagen content and crosslinking in 
aged heart valves. This result may also be explained by aging-related decreases in aortic 
compliance, which results in greater force applied to the AV fibrosa, the main load-
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bearing element.4 Interestingly, the abundance of collagen III in the AV was higher in 
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Fig. 3-10: A) Graph of collagen III intensity in layers of A V (each layer graded on a scale of 
0-4, so maximum intensity is 12), displayed in a stacked format for visual demonstration. 
* total collagen HI different between ages, p<0.024. B) Graph of collagen III intensity in 
layers of MV (each layer graded on a scale of 0-4, so maximum intensity is 16), displayed in a 
stacked format for visual demonstration. 
trend was seen in the MV (Fig. 3-1 OB). We speculate that the increased collagen III in 
the 6-week-old results from the AV adjusting to the higher pressures of the postnatal 
circulatory system27 along with increased demands of growth. In the 6-year-old valve the 
increase in collagen III staining intensity, which was accompanied by less delineation 
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(p<0.02) suggests that the age-related AV fibrosis involves type III collagen becoming 
diffusely abundant throughout the valve. 
Both the 6-week-old and 6-year-old (but not the 6-month-old) AV demonstrated 
more MMP13 staining towards the leaflet free edge (p<0.05), again emphasizing the 
unique mechanical demands of these age valves. An age-related increase in MMP13 
expression at the AV free edge suggests that this location may experience sustained 
remodeling. Slightly different age effects were found in the MV. Collagen III expression 
in the fibrosa was greatest at 6 weeks (p<0.025), which may be due to the MV adjusting 
to higher postnatal pressures.27 In the ventricularis (elastic outflow layer), collagen III 
expression was greatest at 6 years and may aid in withstanding the increased pressures 
resulting from an overall decrease in aortic compliance. 
Novel Finding of SMaA Expression 
SMaA, the marker indicating cell activation, was found in a subendothelial line 
both along the inflow and outflow surfaces of both valve types as well as deeper 
approaching the fibrosa (Fig. 3-11). This pattern was evident in all age groups. These 
findings confirm previously reported expression of SMaA as present in the 
subendothelial outflow layer as well as deeper within the valve interior;13 we have 
additionally noted a second, previously unreported anatomical distribution on the inflow 
surface, and have localized the interior expression to the fibrosa. When SMaA was not in 
these anatomical distributions, it was co-localized with tPMH. This data suggests that 
SMaA expression is both constitutive (with a particular anatomic distribution) as well as 
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Fig. 3-11: Two anatomical distributions ofSMaA (inflow and outflow). Top: 6-year-
old AV, middle: 6-month-old AV, bottom: 3rd trimester MV. Left: SMaA staining, 
right: Movat pentachrome stain. Scale bars are 200 jum. 
DISCUSSION 
In this study we characterized changes in matrix composition and turnover in 
porcine MV and AV with age, concentrating on collagen, the primary component of the 
valve ECM. Our studies both confirm previous studies into changes in collagen 
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crosslinking and stability with age; ' ' as well as expand upon those results by 
addressing active collagen synthesis and degradation. These findings are applicable to 
porcine models for basic and translational studies of heart valve disease relevant to 
different human age groups, and give further insight into the role of matrix turnover of 
the MV and AV during the development and aging processes. 
Significant differences between various ages of human valves have recently been 
described13 - these same differences should be present in the optimal animal model for 
human valves. In the study of valve biology, age is an important consideration because 
valves of different ages likely respond to mechanical or biological stimuli in 
fundamentally different ways. Age-related changes are similarly an important 
consideration in the study of valve pathology and pathogenesis given that a number of 
valve diseases are age-related (i.e., calcific aortic stenosis or congenital defects). 
Furthermore, knowledge of age-related changes in valve composition and turnover is 
essential for attempts to tissue engineer a valve for different aged patients. 
These findings regarding collagen turnover and organization both complement 
and build on previous reports of valvular collagen concentration, degree of crosslinking, 
and fiber morphology. In those investigations, biochemical, enzymatic, microscopic, and 
advanced optical approaches were used to demonstrate an age-related increase in 
collagen concentration,8 crosslinking,7 alignment,13 and fragmentation,4 although the AV 
demonstrates greater collagen crosslink stability with age compared to the MV. 
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Relevance to Human Valves 
The observed differences in matrix organization and turnover between heart 
valves of different aged pigs suggest that specific ages of pigs may be age-appropriate 
models for various human heart valve diseases and for use in engineering a heart valve 
for different age groups. As far as the correlation of these findings to human disease, 
based on developmental milestones and growth studies, a 6-week-old pig is 
approximately equivalent to an 8-year-old human, whereas a 6-month-old pig is 
approximately equivalent to a 17-19 year-old human (see Chapter 2, Table 2-4).29" ' 
However, several caveats should be noted about the pig as an animal model. It appears 
that the MMP profile of porcine valves differs from humans, especially for MMP13 and 
MMP1. If these are true species differences, this altered MMP profile could affect 
studies of calcific aortic stenosis and myxomatous mitral valves. Furthermore, given the 
age correlation for the 6-month-old pig discussed above, the 6-month-old pig may not be 
the appropriately aged pig in which to study aging-related human valve diseases. 
Limitations 
Study limitations included the use of a semi-quantitative grading system and two 
observers; however, we quantified the between-observer, within-observer, and between-
batch variability as 14%, 11%, and 14% respectively, and inter-batch variability as 14%. 
While IHC staining using a collagen I antibody would have been a more specific method 
for demonstrating the location of collagen I, numerous antibodies and pretreatment 
methods were unable to demonstrate the presence of collagen type I within the yellow 
Movat stained fibrosa, likely due to the abundance of mature crosslinks blocking 
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antigenic binding sites. Therefore, picrosirius red allowed us to look at collagen types as 
well as fiber alignment. Also, we analyzed consistent leaflet sections but did not assess 
the variability in leaflet makeup around the entire circumference of the valve. Despite 
these limitations, numerous significant patterns were found between leaflet regions, 
layers, valves, and age groups. Another possible limitation could be that MMP13 is not 
specific for collagen degradation and requires activation, and therefore MMP13 
expression may not directly translate to collagen degradation. That noted, MMP13 is 
considered a major regulator of collagen turnover. Furthermore, the other major MMPs 
involved in the degradation of matrix that were assessed, including MMP1, MMP2, and 
MMP9, as well as the main inhibitor, TIMP1, were negative in all ages of valves except 
the 6-year-old pig. While we recognize that more quantitative methods for assessing 
matrix turnover are available, the use of immunohistochemistry has enabled us to localize 
expression of these synthesis and degradation markers within the heterogeneous leaflet 
microstructure. 
CONCLUSIONS 
In summary, in this novel study of markers of collagen synthesis and degradation 
we have presented data that suggests matrix turnover tends to occur at the edge of 
"mature" collagen, an observation that was evident at all ages tested. Furthermore, we 
have shown that this turnover is associated with an "activated" cell phenotype. The 
difference in MMP profiles between the pig and that reported in humans may need to be 
taken into account when using the pig as an animal model, in particular for studies in 
diseases involving the MMPs. Furthermore, considering that a 6-month-old pig is 
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equivalent to a human young adult, this age pig may not be an appropriate animal model 
for age-related pathologies like calcific aortic stenosis and myxomatous mitral valve 
disease. Future studies into other extracellular matrix components need to be performed 
in order to give a more complete picture of development and aging of the heart valve. 
This chapter, which analyzed changes in collagen content and turnover in 
fetal and postnatal aging, was the first of four chapters (Chapters 3-6) examining 
age-related changes in matrix composition and structure in normal aortic and 
mitral valves. In the next chapter in this series of studies, age-related changes in 
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Chapter 4: Valve Proteoglycan Content and 
Glycosaminoglycan Fine Structure are Unique to Microstructure, 
Mechanical Load, and Age: Relevance to an Age-Specific Tissue 
Engineered Heart Valve 
This chapter is the second of four chapters (Chapters 3-6) examining age-
related changes in matrix composition and structure in normal aortic and mitral 
valves. In this chapter changes in proteoglycan and glycosaminoglycan in fetal and 
postnatal aging are analyzed. 
ABSTRACT 
Background: This study characterized valve proteoglycan and glycosaminoglycan 
composition during development and aging. This knowledge is important for the 
development of age-specific tissue engineered heart valves as well as treatments for age-
specific valvulopathies. 
Methods: Aortic valves and mitral valves from lst-3rd trimester, 6-week, 6-month, and 6-
year-old pigs were examined using immunohistochemistry for versican, biglycan, 
decorin, and hyaluronan, as well as elastin and fibrillin. The fine structure of 
glycosaminoglycans was examined by fluorophore-assisted carbohydrate electrophoresis. 
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Results: Decorin expression was strongest in the 6-year-old valves, particularly in the 
aortic valve spongiosa. The quantity of iduronate was also highest in the 6-year-old. The 
central tensile-loading region of the anterior mitral leaflet demonstrated reduced 
glycosaminoglycan content, chain length, and hydration and a larger fraction of 4-sulfated 
iduronate and lower fraction of 6-sulfation. With age, the anterior leaflet center showed a 
further increase in 4-sulfated iduronate and decrease in 6-sulfation. In contrast, the 
anterior leaflet free edge showed decreased iduronate and 4-sulfated glucuronate content 
with age. The young aortic valve was similar to the mitral valve free edge with a higher 
concentration of glycosaminoglycans and 6 rather than 4-sulfation, but aged to resemble 
the mitral anterior leaflet center, with an increase in 4-sulfated iduronate content and a 
decrease in the 6-sulfation fraction. Elastin and fibrillin often co-localized with the 
proteoglycans studied, but elastin co-localized most specifically with versican. 
Conclusions: Composition and fine structure changes in valve proteoglycans and 
glycosaminoglycans with age are complex and distinct within valve type, histological 
layers, and regions of different mechanical loading. 
The work contained in this chapter was published as: 
Stephens EH, Chu C-K, Grande-Allen KJ. Valve Proteoglycan Content and 
Glycosaminoglycan Fine Structure are Unique to Microstructure, Mechanical Load 
and Age: Relevance to an Age-Specific Tissue-Engineered Heart Valve. Acta 
Biomaterialia. 2008;4(5): 1148-1160. 
103 
INTRODUCTION 
Proteoglycans (PGs) and glycosaminoglycans (GAGs) are critical to the function 
of numerous soft connective tissues, including heart valves, providing material properties 
such as viscoelasticity and resistance to compression and tension.1'2 PGs and GAGs also 
play crucial roles in tissue differentiation, growth factor regulation, and various 
pathologies.2 During fetal development, PGs and GAGs are the predominant components 
of the nascent heart valves.3 In the mature mitral valve (MV), the composition of PGs 
and GAGs has been shown to vary regionally based on the type of mechanical loading 
experienced by these tissues.4 Altered proportions of selected PG and GAGs are found in 
myxomatous MV disease,5 are likely responsible for the altered material properties of 
these swollen tissues,6 and are possibly involved in the disease pathogenesis. The loss of 
the GAG and PG-rich spongiosa layer, which normally provides shear between the outer 
valve layers and thus enables complex valve leaflet movement,7 from porcine 
bioprosthetic aortic valves (AVs) is thought to be instrumental in the failure of these 
devices.8 Overall, knowledge of the composition and distribution of the various GAGs 
and PGs within heart valves appears to be essential information for understanding and 
recapitulating the complex mechanics of the heart valve leaflets. It is unknown, however, 
how the composition and distribution of these PGs and GAGs change throughout 
development and aging, when the heart valves experience significant changes in 
mechanical loading and tissue differentiation. Because these PG and GAG changes are 
likely important to valve function, characterizing them would contribute to the 
understanding of age-specific valve pathologies as well as the design of an age-specific 
tissue engineered heart valve (TEHV). 
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While a limited number of reports have described the GAGs found in valves, "13 
these largely have not considered the complex valvular microstructure, the effect of 
subject age, and GAG fine structure, i.e., the abundance of variously sulfated 
disaccharides. Sulfation patterns on GAG chains are thought to be critical to GAG 
function and cellular signaling.14"16 Although a previous study on GAGs in human MV 
considered age,4 the age-range was limited to the adult years. Moreover, 
characterizations of PGs and GAGs during heart and heart valve development have been 
limited to specific PGs and signaling pathways.17'18 Reports characterizing GAGs in the 
AV are even fewer and largely assess bioprosthetic valves and TEHVs.19"24 
Therefore, it was the aim of this study to characterize the composition and fine 
structure of GAGs and PGs during development and aging of porcine AVs and MVs. As 
described above, this work represents the first such analysis of the AV, and changes in 
GAG composition during development have not been studied in either the AV or MV. In 
this study, a novel combination of two approaches, immunohistochemistry (IHC) and 
fluorophore-assisted carbohydrate electrophoresis (FACE) was used to provide detailed 
information regarding layer and region-specific PG and GAG distribution as well as the 
quantity and fine structure of various GAGs in different regions of the valve. IHC was 
also used to co-localize the specific PGs and GAGs with other matrix components with 
which they are known to interact, such as fibrillin, elastin, and transforming growth factor 
beta (TGF(3). Porcine valves, which commonly serve as an animal model for human 
heart valve biology and pathology,25 were used because they were available in large 
numbers at a wide range of ages. Considering the substantial regional differences in 
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mechanical loading of the MV, the MV leaflets were separated into regions experiencing 
compression (leaflet free edge, MVF) or tension (anterior leaflet center, MVAC). 
METHODS 
General Procedure 
Porcine hearts were obtained within 24 hours of death (Fisher Ham and Meat, 
Spring, TX for 6-week- and 6-month-old pigs, Animal Technologies, Tyler, TX for fetal 
and 6-year-old pigs). Hearts were maintained on ice until processing. The sample set 
consisted of MVs and AVs from first fetal trimester, second trimester, third trimester, 6-
week-, 6-month-, and 6-year-old pigs. Three to five valves from each age group were 
used for IHC, whereas 10-14 valves from each postnatal age group were used for FACE. 
One leaflet per AV was used, chosen randomly from the non-coronary, right coronary, 
and left coronary leaflets; for the MV only the anterior leaflet was used. Tissues used in 
IHC were fixed overnight in 10% formalin before cross sections of the leaflet were cut 
from the annulus to the free edge, embedded in paraffin, and sectioned to 5 urn thickness. 
For the AV, cross sections were taken slightly off center to avoid the nodule of Arantius. 
Histology and Histochemistry 
Each sample was stained histologically with Movat pentachrome to demonstrate 
the overall distribution of collagen (saffron yellow), elastin (hematoxylin black), and 
PGs/GAGs (alcian blue) within the valves. This staining enabled the identification of the 
different leaflet layers.26 Histochemistry was performed to demonstrate the PGs versican 
(clone 2B1, Associates of Cape Cod, Falmouth, MA), decorin (LF-122, gift from Dr. 
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Larry Fisher, NIH), and biglycan (LF-104, gift from Dr. Larry Fisher), since these are the 
predominant extracellular PGs found in valves,4 as well as the GAG hyaluronan (HA) 
using the biotinylated HA binding protein (Associates of Cape Cod). Sections were also 
stained using antibodies against the extracellular matrix components elastin and fibrillin 
(both from Abeam, Cambridge, MA) as well as the growth factor TGF|3 (Biovision, 
Mountain View, CA) since those proteins are known to interact with versican, decorin, 
and biglycan.1, 27~29 Because the PG antibodies' binding site is on the core protein 
obscured by GAG chains, an enzymatic digestion of the GAG chains was used 
(200mU/ml chondroitinase ABC (Associates of Cape Cod, Falmouth, MA) 1 hour, 37 
degrees) before placement of the primary antibody. A citrate-buffer based antigen 
retrieval (30 min, 80 degrees) was used in the staining of elastin, fibrillin, and TGF(3. 
IHC samples were graded on a scale of 0-4 to evaluate marker intensity and delineation 
(marker's contrast between valve layers) in each histological layer (ventricularis, atrialis 
(MV only), spongiosa, and fibrosa). Further details on grading, as well as an example of 
a grading rubric, can be found in Chapter 3. Overall PG intensity was assessed using the 
combination marker "tPG," which was the sum of versican, decorin, and biglycan 
staining for a given region/layer. The term "inflow layer" was defined to be the atrialis 
of the MV and ventricularis of the AV. A corresponding "outflow layer" was not 
compared between AV and MV because of their inherent differences in composition. 
Fluorophore-Assisted Carbohydrate Electrophoresis (FACE) 
Fluorophore-assisted carbohydrate electrophoresis (FACE) was used to analyze 
the quantity and fine structure of the different GAG classes, HA and the 
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chondroitin/dermatan sulfates (CS/DS).4'30 Note on nomenclature: CS is defined as only 
containing glucuronate while DS is defined as containing some quantity of iduronate. 
First, the AV (random leaflet) and MV (anterior leaflet) were dissected from the different 
postnatal aged porcine hearts within 24 hours of death. The mass of tissue obtained from 
fetal valves was insufficient for FACE analysis; therefore FACE was performed on the 
different postnatal valves only. The MV anterior leaflet was trimmed of chordae then 
divided into the "tensile loading" center region (MVAC) and the "compressive loading" 
free edge (MVF). Each sample was weighed before and after lyophilization; hydration 
was calculated as (wet weight - lyophilized weight)/wet weight. The GAGs in the 
lyophilized samples were then analyzed by FACE.4'5 In brief, the lyophilized samples 
were rehydrated with 100 uL of 100 mM ammonium acetate, minced, and digested with 
100 ul of 10 mg/ml proteinase K (EMD Pharmaceutical, Durham, NC) at 60°C, 16-48 
hrs. After boiling 5 min to inactivate the Proteinase K, aliquot volumes containing 
approximately 5 \xg of uronic acid were digested with either chondroitinase ABC and 
chondroitinase ACII (3 \i\ each, Associates of Cape Cod, Falmouth, MA) or ACII alone, 
3 hrs, 37°C. The samples were then vacuum dried and the GAGs fluorescently tagged 
using 2-aminoacridone HC1 (Molecular Probes, Eugene, OR). Samples were resolved on 
20% acrylamide gels. Fluorescently labeled known quantities of maltotriose were mixed 
with the samples and run on the gel to generate a standard curve relating concentration to 
fluorescence intensity. The gels were imaged and the bands analyzed using Gel-Pro 
(Media Cybernetics, Silver Spring, MD). Specific GAGs were identified by 
correspondence to bands in a disaccharide standard lane and quantified using the 
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integrated optical density of the band(s) and the fluorescence standard curve as 
previously described.4 
The resulting GAG profiles were used to calculate several factors specific to 
particular PGs. The ratios of 6-sulfation to 4-sulfation and glucoronate to iduronate 
containing disaccharides were calculated.4 The average CS/DS chain length was 
estimated by calculating on a lane-by-lane basis the total amount of the CS/DS 
Adisaccharides and dividing it by the total amount of saccharides at the nonreducing 
termini of the chains. The measured GAG class contents from each sample were 
normalized to the tissue dry weight to estimate the tissue concentrations and proportions 
of the different classes were calculated relative to the total GAG quantity as measured by 
FACE. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL). When the data for a given characteristic was normally distributed (as 
determined by the software), the program continued with an ANOVA. When the data set 
was not normally distributed, a comparison on ranks was used. In both cases the level of 
significance was set at 0.05. In a few, select cases the p-value for a non-normally 
distributed data set was >0.05 after rank transformation, while the original ANOVA had a 
p-value <0.05; in these instances the p-value from the original ANOVA is listed followed 
by an "R." In all other cases of non-normalized data sets, the p-value from the rank 
transformed ANOVA is shown. The Holm-Sidak all-pairwise multi-comparison method 




During the first fetal trimester, valve leaflets were largely an amorphous mass of 
PG and GAGs, demonstrated by Movat staining as a deep alcian blue present throughout 
Fig. 4-1: A) Is' trimester valves largely consisted of an amorphous mass of proteoglycans (PGs) 
and glycosaminoglycans (GAGs). Over the course of fetal development rudimentary layers became 
apparent. B) In Is' trimester valves, the PG expression was largely ubiquitous. Expression became 
more localized over the course of fetal development. Scale bars indicate 100 pm. C) Movat stain 
showed maximum PGs and GAGs in the spongiosa, but staining for DCN (and VC and BGN) was 
often stronger in other layers. In contrast, staining for hyaluronan (HA) was often strongest in the 
spongiosa. Sections are from the aortic valve and are oriented so that the ventricularis is at the top 
and fibrosa is at the bottom. Scale bars indicate 100 fxm. 
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the leaflet (Fig. 4-1 A). As the trimesters progressed, rudimentary leaflet layers became 
apparent and PG staining became more localized (Fig. 4-IB). Postnatally, there tended to 
be a decrease in alcian blue-staining PG and GAGs intermixed in the annular fibrosa. 
This presence of intermixed PG and GAGs within the fibrosa also tended to be more 
prevalent in the AV compared to the MV, but neither of these trends was statistically 
significant. In the 6-month old valves, however, there was significantly stronger staining 
with alcian blue throughout the AV compared to the MV (p=0.042), a result that was 
predominantly due to the increased abundance of PG and GAGs in the annulus of the 
AV. 
Table 4-1 A. IHC Differential Protein Expression Between Layers of 
Postnatal Valves. 
Marker Mitral Aortic 
tPGA v > sp,f > at* v > sp > f* 
DCN -- v > sp,f* 
BGN - v » s p > f5 
VC v > sp,f > at* sp > v > f* 
HA at,v > sp > f* sp > v > f* 
Elastin at > v,sp > f* v > sp > f* 
Fibrillin at > sp,v > f* sp > v > f* 
v=ventricularis, sp=spongiosa, f=fibrosa, at=atrialis, tPG=sum of intensities of decorin (DCN), 
versican (VC), and biglycan (BGN). HA=hyaluronan.*=p<0.001; *=p<0.01; §=p<0.05. "--" 
indicates that there was no statistically significant difference. 
The combination marker "tPG" (the sum of versican, decorin, and biglycan 
staining) showed significantly different staining intensity between layers as well as 
between the AV and MV. In the MV, tPG was strongest in the ventricularis, less 
abundant in the spongiosa and fibrosa, and least abundant in the atrialis (p<0.001, Table 
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4-1 A). In contrast, in the AV, tPG staining was strongest in the ventricularis and lowest 
in the fibrosa (pO.OOl). In both valves, tPG intensity increased with age, particularly in 
the spongiosa (p<0.01, Table 4-IB). Overall, tPG expression was higher in the AV than 
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in the MV; this difference was again most notable in the spongiosa (p<0.02, Table 4-1C). 
When comparing the elastin-rich inflow layers of the 2 valves, tPG expression was also 
higher in the AV than in the MV (pO.OOl). 
Table 4-1C. IHC Differences in Protein Expression Between Postnatal 
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sp=spongiosa. AV=aortic valve, MV=mitral valve. tPG=sum of intensities of of decorin 
(DCN), versican (VC), and biglycan (BGN). HA=hyaluronan. *=p<0.001; *=p<0.01; §=p<0.05. 
"--" indicates that there was no statistically significant difference. 
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In the AV, decorin was more abundant in the ventricularis than in the spongiosa 
and fibrosa (p<0.005, Table 4-1 A); no such distinction in decorin staining between layers 
was detected in the MV. In both valves (and particularly in the AV spongiosa), decorin 
was most abundant in the 6-year-old leaflets (p<0.005, Table 4-IB). Decorin was evident 
in fetal valves but showed no significant pattern of localization or age. Although decorin 
expression was not strongest in the fibrosa layer, it was the PG that was most often found 
within the collagen-rich fibrosa. 
Biglycan expression was more ubiquitous than the other PGs, confirming other 
reports.31 No difference in biglycan was detected between MV layers, but in the AV the 
expression of biglycan was strongest in the ventricularis, less in the spongiosa, and 
lowest in the fibrosa (p<0.025, Table 4-1 A). Fetal valves showed moderate biglycan 
staining without detectable changes throughout trimesters. With age, biglycan staining in 
the AV both increased and became more diffuse (p<0.035, Table 4-1B). Similar to 
decorin, the expression of biglycan was higher in the AV than in the MV, particularly in 
the spongiosa (p<0.003, Table 4-1C). 
Compared to the other PGs, versican expression in postnatal valves was unusual 
in that its abundance across layers did not increase with age; in fact, versican expression 
on the AV inflow surface decreased from the ages of 6-weeks to 6-months (p<0.009). In 
the MV, versican expression was highest in the ventricularis, lower in the spongiosa and 
fibrosa, and lowest in the atrialis (Table 4-1 A). However, in the AV, versican abundance 
was highest in the spongiosa, with progressively lower amounts in the ventricularis and 
then the fibrosa (p<0.001). Versican was weakly abundant throughout the fetal valves 
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with stronger staining specifically co-localized with elastin. A change in versican 
expression over the trimesters was not detected. 
Hyaluronan Distribution 
The GAG HA was often abundant in the spongiosa, particularly in the AV 
(pO.OOl). Compared to the AV, HA appeared to be more abundant in the MVF; this 
finding may be explained by noting that the MV free edge consists almost exclusively of 
spongiosa, in contrast to the free edge of the AV, which has a more layered structure. 
Interestingly, HA was also abundant in the atrialis and ventricularis of the MV, which are 
rich in elastin (Table 4-1 A). When all layers were considered together, the abundance of 
HA was greater in the MV than in the AV (p<0.05, Table 4-1C), and did not change 
significantly with age. With respect to the fetal valves, the MV showed greater HA 
expression than AV (pO.OOl) and in both fetal MV and AV, the expression of HA 
increased over the trimesters (p=0.004). 
Distribution of Other Matrix Components and Co-localization with PGs 
Prenatally, elastin was present in the first trimester as a heavy outline on the 
ventricularis that moved interiorly over the trimesters, even though elastic fibers were not 
demonstrated by Movat staining during the early trimesters. Indeed, 1st trimester MV 
sections showed marked differentiation of elastin expression, with elastin distinctly 
located in both the atrialis and ventricularis (Fig. 4-2). Elastin expression decreased 
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Fig. 4-2: A) Strong expression ofelastin within both atrialis and ventricularis layers of V 
trimester mitral valve. Scale bar indicates 200 /urn. B) Out of the three proteoglycans 
(PGs) examined, versican (VC) co-localized most closely with elastin, shown here in an 
aortic valve. In this figure the ventricularis is on the left and the fibrosa is on the right. 
Scale bars indicate 200 ym. 
postnatally and was least abundant in the AV ventricularis of 6-year-olds and in the MVF 
(p<0.039, Table 4-IB). Similarly, the amount of elastic fibers detected by Movat 
decreased with age in both valves (both p<0.010). Within the layers of the MV, elastin 
was most abundant in the atrialis, less so in the spongiosa and ventricularis, and least 
abundant in the fibrosa (pO.OOl, Table 4-1A). The AV showed a comparable pattern, 
with elastin intensity highest in the ventricularis, lower in the spongiosa, and lowest in 
the fibrosa (p<0.001). Compared to the MV, elastin in the AV was more abundant both 
across the whole leaflet (Table 4-1C) and in the fibrosa layer, but was less abundant on 
the outflow surface (p<0.01). 
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Unlike elastin, fibrillin staining remained diffuse and weak in the prenatal valves. 
Postnatally, fibrillin abundance within the MV was highest in the atrialis, lower in the 
spongiosa and ventricularis, and negligible in the fibrosa (p<0.01, Table 4-1 A). In the 
AV, fibrillin was strongest in the spongiosa, lower in the ventricularis, and lowest in the 
fibrosa (pO.OOl). Fibrillin expression on the AV inflow surface was high in 6-week old 
pigs but decreased progressively with age (p<0.025, Table 4-IB). Fibrillin was often 
inversely localized with the collagenous fibrosa and was also found independent of 
elastin in locations, such as the free edge, that never develop elastic fibers; the abundance 
of fibrillin was lowest at the annulus, gradually increasing to its greatest abundance at the 
free edge (p=0.008). TGF|3 staining closely followed fibrillin and elastin, but also co-
localized with the regions of "lone" fibrillin expression (without corresponding elastin). 
PGs were frequently co-localized with elastin and fibrillin, particularly in the mid-
leaflet. In 6-week-old and 6-year-old valves, versican was frequently present when 
elastin and fibrillin were found in the same area, e.g., likely present as mature elastic 
fibers (Fig. 4-2). In 2nd and 3rd trimester fetal valves, all of the PGs co-localized with the 
concomitant expression of elastin and fibrillin, with versican expression most closely 
matching elastin expression. TGF|3 was most closely co-localized with decorin out of all 
the PGs examined. 
Hydration 
The MVAC had significantly lower hydration than the MVF and AV (each 
p<0.015, Fig. 4-3A). With increasing age, all regions showed a decrease in hydration 
(each p<0.006). 
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Fig. 4-3: A) Percent hydration examined by valve and age. *=p<0.001 between different 
valves. a=p^0.003 between different ages. Error bars are standard error of the mean. B) 
Percent of total glycosaminoglycan (GAG) composed of hyaluronan (HA) (as measured by 
FACE) examined by valve and age. *=p<0.001 MVF > AV > MVAC. a=p<0.001 between 
different age groups. MVF= mitral valve (MV) free edge; MVAC=MV anterior center; 
A V=aortic valve. Error bars are standard error of the mean. 
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Fig. 4-4: Proportion of glycosaminoglycans (GAGs) in valves of different ages, as calculated 
from FACE data. Statistical differences are marked between different ages of a given valve and 
between the MVAC and MVF regions of the same age. (Differences between AV and the MV 
regions for a given age have not been marked. Differences between MVAC and MVF in 
fractions when considering all ages have not been marked, but are discussed in the text.). 
f=MVAC significantly different than MVF for the 6-week-old, 6-month-old, or 6-year-old. 
*=significant change in a given GAG across ages in a given valve region (MVF, MVAC, and 
AV). All marked differences are p^O.05 except a=p<0.03R. MVF= mitral valve (MV) free 
edge; MVAC=MV anterior center; AV=aortic valve. GOS=unsulfated glucuronate, G4S=4-
sulfated glucuronate, G6S=6-sulfated glucuronate, I4S=4-sulfated iduronate, I6S=6-sulfated 
iduronate, and XS=di- and tri-sulfated glucuronate/iduronate. Only percentages >10% are 
labeled. 
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GAG Compositional Analysis 
The general effects of aging evident across all valve regions included an increase 
in HA (p<0.013 for each valve region, Fig. 4-3B), a decrease in unsulfated glucuronate 
(GOS, p<0.001, Fig. 4-4) and 6-sulfated glucuronate (G6S, p<0.003), and a decrease in 
the ratio of CS to DS (p<0.004, Table 4-2). 
Table 4-2. Ratio of GAG Components. 
















7.79 ± 0.39* 
6.65 ± 0.50** 
4.20 ± 0.19** 
6.85 ± 0.53* 
3.93 ±0.19*" 
4.09 ± 0.30*A 
24.24 ± 3.70** 
8.29 ± 0.95** 
4.97±0.31* t 
AV>MVF>MVAC 




















Data are mean ± the standard error; MVF>MVAC for a given age, differences between AV and 
MVF or MVAC have not been marked; a=p=0.009R; *6-week-old significantly higher than 6-
month-old and 6-year-old; *6-year-old significantly higher than 6-week-old and 6-month-old 
(p=0.013R). *=overall decrease with age. All marked differences have p-values <0.05, except 
otherwise noted. MVF= mitral valve (MV) free edge; MVAC=MV anterior center; AV=aortic 
valve. CS=chondroitin sulfate, defined as only containing glucuronate. DS= dermatan sulfate, 
defined as containing some quantity of iduronate. D4S=dermatan 4-sulfate, C4S=chondroitin 4-
sulfate. CS/DS-6=6-sulfated glucoronate or iduronate. CS/DS-4=4-sulfated glucoronate or 
iduronate. See methods for complete explanation of statistical methods. 
The MVAC, which experiences tension, contained a lower concentration of total 
GAGs than the MVF (pO.OOl), due to reduced concentrations of GOS (p<0.04), 4-
sulfated glucuronate (G4S, p<0.04), G6S, (p<0.04R) and HA (pO.OOl). Compared to 
MVF, MVAC had more 4-sulfated GAGs (pO.OOl, Fig. 4-4, Table 4-3), which were 
predominantly 4-sulfated iduronate (I4S) and less 6-sulfated GAGs (p<0.001). Even 
though the overall concentration of GAGs was greatly reduced in the MVAC compared 
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Table 4-3. Patterns of GAG composition expressed as fraction of total 













AV.MVF > MVAC 
MVAC > AV > MVF 
-
AV.MVF > MVAC 
MVAC > AV.MVF 
MVAC > AV.MVF 
— 
MVF> AV > MVAC 
MVAC > AV.MVF 
AV.MVF > MVAC 
All p<0.05. "--" indicates no statistically significant difference detected. "4 sulfation" includes 
both G4S and I4S; "6 sulfation" includes both G6S and I6S. MVF= mitral valve (MV) free edge; 
MVAC=MV anterior center; AV=aortic valve. GOS, G4S, G6S, I4S, and I6S are all defined in 
the legend for Fig. 4-4. 
to the MVF, the MVAC contained a greater concentration of hypersulfated GAGs (XS, 
pO.OOl). With increasing age, the MVAC demonstrated a further reduction in 6-sulfated 
GAGs (p=0.002, Fig. 4-5) and a further increase in I4S (p<0.026R). 
Conversely, the MVF had greater fractions of HA (pO.OOl), G6S, 6-sulfated 
GAGs, and lower fractions of XS and iduronate, particularly I4S (p-values given above). 
With aging, the MVF showed a decrease in 4-sulfated GAGs (p=0.015) and an increase 
in 6-sulfated GAGs (p=0.014) that was mainly evident between 6-weeks and 6-months. 
The AV showed characteristics that largely resembled the MVF (Table 4-3). Like 
the MVF, the AV contained high concentrations of total GAGs, glucuronate, and HA 
(each pO.OOl) and a high ratio of 6 to 4-sulfation (p<0.025, Table 4-2). However, the 
AV also showed a number of traits that were similar to the MVAC, such as low amounts 
of HA and 6-sulfated GAGs (both pO.OOl). With aging, the AV appeared to become 
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GAG Composition in MVF 
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Fig. 4-5: Glycosaminoglycan (GAG) composition for each valve and each age group, as calculated 
from the FACE analysis. Note that the middle graph has a different scale on the y-axis. Statistically 
significant differences (p^O.05) are marked between different ages of a given valve and between the 
MVAC and MVF regions of the same age. (Differences between AV and MVF as well as AV and 
MVAC for a given age have not been marked. Differences between MVAC and MVF in 
concentrations when considering all ages have not been marked, but are discussed in the text.). 
Error bars are standard error of the mean. a=significant change in a given GAG in a given valve 
across ages, /3=p<0.03R. f= significant difference between MVAC and MVF in the 6-week-old, 6-
month-old, or 6-year-old. MVF= mitral valve (MV) free edge; MVAC=MV anterior center; 
A V=aortic valve. GOS, G4S, G6S, I4S, I6S, and XS are all defined in the legend for Fig. 5-4. 
121 
more like the MVAC in composition, with a decrease in 6-sulfated GAGs (p<0.001), an 
increase in 4-sulfated GAGs (p=0.038), and an increase in I4S (p=0.005). 
Chain Length 
6-week-old 6-month-old 6-year-old 
Fig. 4-6: Chain length of valve regions by age, as calculated from FACE data. Overall 
p=0.059 by ANOVA. MVF= mitral valve (MV) free edge; MVAC=MV anterior center; 
A V=aortic valve. Error bars are standard error of the mean. 
Chain Length 
Overall, the average lengths of the CS/DS chains in the MVAC tissues were 
shorter than those found in the MVF tissues (p<0.002, Fig. 4-6). There was no 
significant change in chain length with age. 
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DISCUSSION 
This study showed that the distribution of PGs and GAGs within porcine AV and 
MV is complex, region and layer-specific, associated with different mechanical 
environments, and strongly age-dependent. The MVF, which experiences compression, 
contains an abundance of water and GAGs, particularly G6S and HA, while the MVAC, 
which experiences tension, contains relatively fewer GAGs but higher proportions of I4S 
and XS. General aging trends included an increase in HA and in iduronate-containing 
GAGs, and a decrease in hydration. This study was also the first to examine the GAG 
profile of porcine AVs, which are important in the production of bioprosthetic 
replacement valves. The younger AVs largely resembled the MVF, but aged to become 
more like the MVAC. In the IHC analysis, it was shown that decorin, important in 
collagen fibrillogenesis, was the PG most often found within the collagen-rich fibrosa 
layer, and the expression of the small leucine-rich PGs decorin and biglycan increased 
with age. In contrast, the GAG HA was strongly expressed in the more loosely organized 
spongiosa layer of the valves. Overall, the expression of PGs in the AV was stronger 
than in the MV. Many regions of distinct PG expression also demonstrated rich 
expression of elastin and fibrillin. 
PGs and GAGs Vary in Distribution Between Layers and Loading Regions 
These results indicate that each PG has a unique distribution within heart valves 
that is likely related to its unique functions. Decorin was the PG most often co-localized 
with collagen, which would support the critical role of decorin in collagen 
fibrillogenesis. In the AV, HA and versican expression was strongest in the spongiosa, 
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consistent with their contribution to compressive resistance. Decorin and biglycan 
expression was strong in the ventricularis layer of the AV, which experiences cyclic 
tension33 and is primarily comprised of elastic fibers, likely reflecting the roles of these 
PGs in tension4'34 and in elastogenesis.35 Interestingly, although the Movat alcian blue 
dye stained most strongly in the spongiosa, IHC did not always demonstrate maximal 
expression of PGs in this layer. This discrepancy could be due to the presence of HA in 
the spongiosa; HA reportedly comprises 60% of all GAGs.31 
The results in this study largely corroborate the previously reported distribution of 
PGs within human valves, which considered all four valves as a group.31 This previous 
study reported PGs, especially decorin, to be abundant on the valve inflow surfaces, 
which agreed with the PG expression in the ventricular layer of the porcine AV, but 
conflicted with the atrialis layer of the porcine MV. In human valves, biglycan and 
versican were ubiquitously distributed. In porcine valves, biglycan expression was 
generally ubiquitous, but the AV demonstrated differential expression of all PGs between 
layers, and the MV showed layer-specific versican expression. 
The characterization of GAGs in the porcine MV largely agrees with our previous 
study of the human MV.4 In both studies, the MVAC had less water, total GAGs, and 
HA, and more iduronate and 4-sulfated GAGs compared to the MVF which contained 
more glucuronate and 6-sulfated GAGs. Both studies found age-associated decreases in 
hydration and the fractions of G6S in the MVAC, decreases in the fractions of G4S and 
G6S in the MVF, and a decrease in CS and increase in DS in the MV as a whole." 
Unlike in human valves, however, the porcine MVAC did not demonstrate age-associated 
decreases in total GAGs, HA, or I4S, and in fact actually showed increases in both HA 
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and I4S with age. In addition, the porcine MVF showed no significant decrease in 
average GAG chain length with age, as found in human valves. Differences between the 
findings of these two studies may be due in part to inter-species differences in valve 
composition, differences in gender makeup (gender of the 6-week and 6-month old pigs 
was unknown), and the distribution of sample ages. 
Valve PG and GAG Composition Reflects Mechanical Requirements 
Given evidence that valvular interstitial cells respond to their mechanical 
environment through altering extracellular matrix synthesis, mechanical loading can 
explain several of the observed layer-specific and age-related patterns of PGs and GAGs. 
The ventricular inflow surface of the AV experiences high shear, laminar flow, and 
tensile forces,37 which would necessitate abundant decorin and biglycan to mediate 
collagen fibrillogenesis.38 Differences in loading patterns, as well as geometry, may also 
explain the differences in composition between the AV and MV. The overall increase in 
valve PG expression with age is consistent with reports of increased GAGs with aging. ' 
39
 Given the general role of PGs and GAGs in providing compressive strength, the 
increase in PGs in the AV may be in response to increased transvalvular pressures, since 
diastolic function and aortic compliance both decrease with age.40' 41 Correspondingly, 
the increase in overall PGs in the MV may be a response to increased left atrial 
pressure.42 The FACE data indicated that with aging, the compressive regions showed a 
decrease in the fraction of 4-sulfated GAGs (associated with tension) and an increase in 
the fraction of 6-sulfated GAGs (associated with compression), whereas the tensile 
regions showed the opposite pattern. Cartilage tissues, which bear compressive loading, 
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also demonstrate an increase in the 6S:4S ratio with aging suggesting that the inherent 
differences in mechanical loading experienced by the MVAC and MVF are associated 
with these age-related changes. Other studies have shown increased GAG sulfation with 
age44 and with mechanical loading.45 However, as shown here in valves, not all types of 
sulfation increased uniformly, and changes in glucuronate sulfation with age were 
distinctly different between valve regions. 
Aging Transforms AV Composition from Compressive to Tensile 
The GAG composition of the 6-week-old AV was largely similar to that of the 
MVF, containing an abundance of total GAGs, high fractions of G6S and HA, and low 
fractions of I4S and XS, consistent with previous findings.46 With age, however, the AV 
GAG composition changed to become more like that of the MVAC. For example, both 
the MVAC and the AV had an aging-related increase in the fraction of I4S and 
demonstrated more 4-sulfation and less 6-sulfation. Whereas for the MVAC these aging-
related changes accentuated the tensile tissue phenotype, these changes reversed the 
compressive tissue phenotype observed in the younger AV. These tensile phenotypic 
changes in the AV may reflect increased tensile loading on the AV leaflet tissues that 
would accompany an age-related decrease in aortic compliance. 
Interplay of PGs with Elastin and Fibrillin 
PGs were frequently co-localized with elastin and fibrillin, particularly in the mid-
leaflet region. These patterns are consistent with previous reports that versican, biglycan, 
and decorin co-localize with fibrillin29'47 and that both versican and decorin are involved 
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in elastogenesis. ' TGFp\ which was most often co-localized with decorin, also 
interacts with various PGs and is reported to upregulate biglycan and versican expression 
but downregulate decorin expression.27 TGF|3 has also been shown to increase the 
expression of elastin.50 The presence of TGFp within these valves is also intriguing 
because this growth factor can induce the "activated" phenotype of valvular interstitial 
cells.51 
The strong expression of elastin in the nascent ventricularis layer of the fetal 
valves may reflect the need for tissue extensibility as early as the 1st trimester as blood 
flows through the fetal heart. With increasing postnatal age, there was a decrease in the 
valvular elastin content, although other studies have found an increase in mature elastic 
fibers with age,26'52 particularly between the 2nd and 5th decades of human life53 and in 
pathological valves.54 Given that elastic fibers, at least of the lung parenchyma, are 
thought to last the lifetime of the animal,55 it may be that the elastin antibodies have 
reduced binding to the more mature elastic fibers in older animals. 
It is intriguing that fibrillin was often found in these heart valves unaccompanied 
by elastin. While fibrillin is primarily found as part of elastic fibers, fibrillin on its own 
is known to demonstrate elastomeric material behavior56 and regulates growth factors, 
such as by binding to TGFp.57 
Implications for Valve Disease and Tissue Engineered Heart Valves 
Altered PG and GAG composition have been shown to play an important role in 
many heart valve diseases. For example, in myxomatous MV disease the valve has 
increased hydration and concentration of GAGs, especially G6S and HA.58 As opposed 
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to the changes associated with myxomatous valves, it was shown here that normally 
aging valves are less hydrated and contain more iduronate, which supports the premise 
that myxomatous MV disease is not caused by aging. Furthermore, studies of 
bioprosthetic valves have implicated loss of PG and GAG content with bioprosthetic 
valve failure.8 Recent evidence also suggests that PG and GAG may act as a key 
component in the development of calcific AV disease.59 
These results also demonstrate the incredible regional and layer-specific 
complexity in the matrix composition of the native valve, which has important 
implications for heart valve tissue engineering. Although some of these compositional 
differences may appear quite subtle, such as the presence and location of sulfation on 
GAG chains, these fine structural distinctions may have important biological roles such 
as serving as binding sites for other matrix components or for signaling cell 
differentiation.14"16 Future studies will need to examine how these components contribute 
to proper valve function and how to recapitulate this complex composition within a tissue 
engineered construct, for example through mechanical stimulation. Lastly, these results 
show that a tissue engineered heart valve should optimally contain age-specific 
components and should take into account the substantial changes that occur throughout 
development and aging. 
Limitations 
In this study, two different techniques (IHC and FACE) were employed in an 
effort to circumvent the inherent limitations of each separate approach. The use of IHC 
permits very specific localization of markers of interest within the different valve layers 
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and anatomic regions. Previous studies using IHC have largely limited the assessment of 
this localization to qualitative observations and if a grading system was used it largely 
discounted such localization. However, in this study we have employed a systematic 
valve layer and region-specific semi-quantitative grading system that allows assessment 
of this localization. The quantitative analysis of region-specific tissue by FACE nicely 
complements the IHC data of this study. FACE allows for specific and truly quantifiable 
measurements of GAG fine structural features, including the presence and location of 
sulfation and epimerization. Although FACE was applied to samples from distinct 
anatomic regions of the MV, those regions were not able to be subdivided into the 
different leaflet layers. In addition, due to the miniscule size of fetal valves, FACE could 
not be performed on tissue from the various trimesters. Another limitation is that, while 
there is evidence that certain PGs tend to contain certain GAG types,4 we have not 
directly correlated GAG composition to particular PGs. In the future, it will be of great 
interest to examine the quantitative differences in GAG fine structure between 
developmental, postnatal, and aged valves and the different valve layers, to confirm the 
presence of different PGs using Western blotting, and to correlate matrix composition, 
age, and material behavior via mechanical testing and selective degradation of matrix 
components. Lastly, this study has found distinct patterns between matrix composition 
and mechanical environment, but showing causality between mechanical stimulation and 
matrix production will require more in vitro experimentation.34 
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CONCLUSIONS 
In this novel study of MV and AV composition during development and aging, 
FACE and IHC were used to localize PGs and GAGs within the individual layers of heart 
valves, to examine the association between mechanical environment and the GAG 
composition and fine structure, and to determine how these characteristics change with 
age. The resulting data revealed that the valvular PGs and GAGs are complex in their 
distributions and age-related changes, but that some patterns are apparent. Regions 
experiencing tension contain fewer GAG overall, with lower fractions of HA, 
glucuronate, 6-sulfation, and water, compared to regions experiencing compression. The 
composition of PGs and GAGs was also different between layers, such as the abundance 
of versican in the spongiosa of the AV. Age-related changes were also frequently unique 
to specific histological layers as well as associated with differences in mechanical 
loading. For example, the increase in decorin that was observed in the aging AV largely 
occurred in the spongiosa layer. Overall, the GAG and PG composition of the AV 
demonstrated a compressive tissue phenotype, but aged to exhibit more of a tensile tissue 
phenotype. In the MV, the differences between the MVAC (tensile) and MVF 
(compressive) became more pronounced with age. Clearly, the inherent complexity 
within valve tissues, due to the histological layers, mechanical forces, matrix 
composition, and effects of aging, impact the function of normal valves and will impose 
challenges on the development of a TEHV. 
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This chapter, which analyzed changes in proteoglycan and 
glycosaminoglycan content in fetal and postnatal aging, was the second of four 
chapters (Chapters 3-6) examining age-related changes in matrix composition and 
structure in normal aortic and mitral valves. In the next chapter in this series of 
studies, changes in aortic and mitral valve matrix composition and structure during 
the perinatal period are analyzed. 
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Chapter 5: Perinatal Changes in Mitral and Aortic Valve 
Structure and Composition 
This chapter is the third of four chapters (Chapters 3-6) examining age-
related changes in matrix composition and structure in normal aortic and mitral 
valves. In this chapter changes in matrix composition and structure during the 
perinatal period are analyzed. 
ABSTRACT 
Background: At birth, the mechanical environment of valves changes radically as fetal 
shunts close and pulmonary and systemic vascular resistances change. Given that valves 
are reported to be mechanosensitive, we investigated remodeling induced by perinatal 
changes by examining compositional and structural differences of aortic and mitral 
valves (AV, MV) between 2-day old and 3 rd fetal trimester porcine valves using 
immunohistochemistry and Movat pentachrome staining. 
Methods: 2-day old and 3rd trimester fetal porcine valves were stained with Movat 
pentachrome to examine leaflet structure, as well as immunohistochemically stained for 
markers of collagen synthesis and turnover pro-collagen I, pro-collagen III, prolyl 4-
hydroxylase, matrix metalloproteinase 13, and periostin. Samples were also stained for 
elastin, hyaluronan, hyaluronan receptor for endocytosis (HARE), and the proteoglycans 
biglycan, versican, and decorin. Staining intensity was quantified using ImageJ software. 
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Results: AV composition changed more with birth than the MV, consistent with a 
greater change in AV hemodynamics. At 2 days, AV demonstrated a trend of greater 
versican and elastin (p=0.055) as well as greater hyaluronan turnover (HARE, p=0.049) 
compared to the 3rd trimester samples. AV also demonstrated decreases in proteins 
related to collagen synthesis and fibrillogenesis with birth including pro-collagen I, prolyl 
4-hydroxylase, biglycan (all p<0.005), and decorin (p=0.059, trend). Both AV and MV 
demonstrated greater delineation between the leaflet layers in 2-day old compared to 3rd 
trimester samples, and AV demonstrated greater saffron-staining collagen intensity 
suggesting more mature collagen in 2-day old compared to 3r trimester samples (each 
p<0.05). The proportion of saffron-staining collagen also increased in AV with birth 
(p<0.05). 
Conclusions: The compositional and structural changes that occur with birth, as noted in 
this study, likely are important to proper neonatal valve function. Furthermore, normal 
perinatal changes in hemodynamics often do not occur in congenital valve disease; the 
corresponding perinatal matrix maturation may also be lacking and could contribute to 
poor function of congenitally malformed valves. 
The work contained in this chapter was published as: 
Stephens EH, Post AD, Laucirica DR, Grande-Allen KJ. Perinatal Changes in 




At birth, the body undergoes a number of profound changes, one of which 
includes a dramatic restructuring of the circulation. No longer able to rely on the 
placenta for oxygenation, circulation in the neonate is redirected: fetal shunts such as the 
ductus venosus, foramen ovale, and ductus arteriosus begin to close and blood flow to the 
nascent lungs greatly increases.1 The systemic vascular resistance also significantly 
increases, along with the pressures of the left side of the heart.1'2 While the right side of 
the heart dominates during fetal life, with greater cardiac output in comparison to the left 
side of the heart,3 with birth the left side of the heart becomes predominant, since it is 
responsible for the blood flow to the rest of the body. Such a substantial and abrupt 
change in hemodynamics undoubtedly affects the heart valves, which are essential 
components of the heart and are responsible for the propagation of blood flow, but this 
topic has not been widely studied. 
Heart valves are essential to proper heart function. Once thought to be passive 
flaps, heart valves are now known to be complex structures, complete with their own 
vasculature4 and nerves,5 that actively participate in heart function and cardiac 
pathologies.6' 7 Additionally, heart valves dynamically respond to their mechanical 
environment. Studies have shown that extracellular matrix production and valve cell 
phenotype in adult valves changes in response to altered mechanical stimulation.8"10 
Although investigation of valve composition and valve cell phenotype in developing 
valves has been limited, it has been demonstrated that valve composition changes during 
fetal development11' 12 and continues to mature after birth.13' 14 Fetal valves also 
demonstrate altered composition that correlates with changes in their mechanical 
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environment.15 However, how this dramatic change in hemodynamics that occurs with 
birth affects valve structure and composition has not been studied in detail. Given the 
mechanosensitive nature of valves that has been extensively studied in adult valves,16"19 
as well as evidence that valve composition changes during fetal and postnatal 
development, we hypothesized that these perinatal events drive changes in mitral and 
aortic valve composition and valve cell phenotype. 
Further understanding of normal valve changes around birth would not only add 
to fundamental knowledge of developmental cardiac physiology, but would also 
contribute to the field of congenital heart disease. Heart valves are malformed in the 
majority of congenital heart disease cases,20 posing a considerable burden for pediatric 
patients. With current valve replacements and repair options inadequate for many 
patients,21,22 research is underway to develop tissue engineered heart valves. Given that 
pediatric heart valves have unique, age-specific tissue and cell phenotypes compared to 
older valves,13'14 tissue engineering heart valves for neonates will require knowledge of 
valve compositional changes surrounding the birth event. Additionally, understanding 
the normal perinatal development of valves could lead to other types of interventions for 
this vulnerable population. 
To this end, aortic and mitral valves from 3 rd trimester pigs and 2-day old pigs 
were analyzed to assess differences in leaflet structure and extracellular matrix 
composition, namely elastin, collagen types I and III, regulatory proteins related to 
collagen synthesis and turnover, proteoglycans, and glycosaminoglycans. 
140 
METHODS 
Tissue Procurement and Sample Preparation 
Hearts from third trimester pigs and 2-day old pigs were obtained within 24 hours 
of death (3rd trimester obtained from Animal Technologies (Tyler, TX) and 2-day old 
obtained from Baylor College of Medicine); all were conventional cross-bred pigs. The 
animal sample set included aortic valves (AV) from four 3 rd trimester pigs and mitral 
valves (MV) from three 3 rd trimester pigs, and AV and MV from four 2-day old pigs. 
The specific time point within the 3 rd trimester from which those valves were taken is 
unknown. Multiple tissue strips were taken from the valve of each animal. The study 
protocol was approved by the Animal Care and Use Committee of Baylor College of 
Medicine and was conducted in accordance with the NIH guidelines. The AV leaflets 
and the anterior leaflet of the MV, along with accompanying myocardium, were dissected 
from the hearts (Fig. 5-1 A). Tissues were fixed overnight in 10% formalin, embedded in 
paraffin, sectioned to a thickness of five urn, and mounted on slides according to standard 
procedures. Samples of human congenitally diseased valves were also obtained at time 
of surgery and similarly prepared. The research use of these tissues was approved by the 
Institutional Review Boards at Rice University and Texas Children's Hospital. 
Histology and Immunohistochemistry 
Each sample was stained histologically with Movat pentachrome to demonstrate 
the relative distribution of collagen, glycosaminoglycans and proteoglycans (PGs), and 
elastic fibers. Each sample was also stained immunohistochemically (IHC) for markers 
involved in the synthesis and turnover of collagen, including pro-collagen I (Col I)23 and 
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pro-collagen III (Col III)23 (antibodies LF-41 and LF-69, gifts of Dr. Larry Fisher, NIH), 
prolyl 4-hydroxylase (P4H, MAB2701, Chemicon, Temecula, CA), matrix 
metalloproteinase 13 (MMP13, MAB3321, Chemicon), and periostin (MAB3548, R&D 
Systems, Minneapolis, MN). Collagen I is the predominant collagen found in adult 
valves24 and is responsible for the valve's tensile strength, while collagen III is a reticular 
collagen. P4H is an enzyme located in the rough endoplasmic reticulum that is required 
for the critical step of proline hydroxylation in collagen fiber synthesis.25 MMP13 is a 
major enzyme responsible for collagen degradation. The quantity of elastin, the major 
component of elastic fibers that are necessary for valve recoil, was also assessed via IHC 
(ab9519, Abeam, Cambridge, MA). Periostin is an adhesion molecule of the fasciclin 
family26 that appears to modulate collagen fibrillogenesis27 and has been shown to play a 
role in valve development, as well as cardiac remodeling. ' IHC was also performed 
for the PGs decorin (DCN) and biglycan (BGN) (antibodies LF-122 and LF-104, gifts of 
Dr. Larry Fisher, NIH), both involved in collagen fibrillogenesis.30 IHC was performed 
for the large PG versican (VC, antibody 2-B-l, Associates of Cape Cod, Falmouth, MA)), 
which is involved in elastic fiber formation31 and is also necessary for several early 
events in valvulogenesis.32 The abundance of the glycosaminoglycan hyaluronan (HA), 
which like VC is necessary for valvulogenesis,33 was assessed using hyaluronan binding 
protein34 (400763-1, Associates of Cape Cod). HA turnover was assessed by IHC for HA 
receptor for endocytosis (HARE)35 (antibody mabl59, gift of Dr. Paul Weigel, University 
Oklahoma Health Science Center, Oklahoma City, OK). Representative sections were 
also stained for CD44 (F10-44-2, Abeam), a cell surface receptor for HA, lysyl oxidase 
(LOX, IMX-5121, Imgenex, San Diego, CA), which is involved in both elastic and 
142 
collagen fiber crosslinking, and transforming growth factor-beta (TGFp, 5559-100, 
Biovision, Mountain View, CA), a growth factor involved in valve cell activation. 
IHC staining intensity was quantified within each histological layer (ventricularis, 
atrialis (MV only), spongiosa, and fibrosa) and leaflet region (annulus and mid-leaflet 
(spongiosa evaluated in mid-leaflet only)) using ImageJ software (NIH, Bethesda, MD). 
Semi-quantitative grading (on a scale from 0 to 4, in which 0 was minimum) was also 
performed on blinded Movat-stained sections to evaluate delineation between leaflet 
layers and intensity of saffron-staining collagen. The fraction of leaflet composed of 
saffron-staining collagen was also estimated from blinded Movat-stained sections. 
Percent change in protein intensity was calculated as the difference in intensities between 
the two groups relative to 3rd trimester intensities. For purposes of comparisons between 
AV and MV, the ventricularis of the AV was considered analogous to the elastin-rich 
atrialis of the MV. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL), as described in Chapter 4. Correlations between staining intensities of 
different proteins within individual leaflet layers, regions, and segments (to assess protein 
co-localization) were calculated using a Pearson rank order test if the data was normally 
distributed and Spearman rank order correlation test if data was not normally distributed. 
For correlations between intensities of different proteins, the level of significance was 
reduced to account for the large number of proteins being considered, and thus p<0.015 
was considered a trend and p<0.0056 considered statistically significant. 
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RESULTS 
Perinatal Changes in Valve Structure 
Movat-stained sections demonstrated, to varying degrees, the layered structure of 
the valve leaflets, namely the collagen-rich fibrosa layer, the GAG-rich spongiosa in the 
middle, and a layer rich in elastic fibers on the leaflets' inflow surface. These sections 
also revealed substantial changes in valve structure with birth (Fig. 5-IB), including 
increases in leaflet layer delineation, the intensity of saffron-staining collagen, and the 
proportion of the valve leaflet thickness comprised of saffron-staining collagen (Fig. 5-2). 
In the AV these structural changes with birth were all statistically significantly different 
(delineation pO.OOl (221% increase), saffron-collagen intensity p=0.029 (106% 
increase), fraction saffron-staining collagen p=0.019 (57% increase)). In the MV, 
however, only the increase in leaflet layer delineation was statistically significant 
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Fig. 5-1: A) Photographs of3r trimester MV anterior leaflet (top) and AV (bottom). 
Scale bar indicates 1 mm. B) Representative Movat-stained 3r trimester fetal and 2-
day old AV and MV. Scale bar indicates 200 nm. 
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Delineation and Saffron-Staining Collagen in AV 
B. 
Delineation Saffron-Collagen Fraction Saffron-
Intensity Collagen 




Delineation Saffron-Collagen Fraction Saffron-
Intensity Collagen 
Fig. 5-2: Delineation and saffron-staining collagen in A V (A) and MV (B), *p<0.05. 
Error bars indicate standard error of the mean. 
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Elastin, VC in AV Mid-Leaflet 
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Fig. 5-3: Elastin and VC in AV mid-leaflet, overall p=0.055. Error bars indicate 
standard error of the mean. 
Perinatal Changes in Valve Composition 
Elastin and VC in the AV mid-leaflet tended to be greater in the 2-day old age 
group compared to the 3r trimester age group (36% and 61% increases, respectively, 
overall p=0.055, Fig. 5-3). There was no significant change in the annular region. 
HARE, involved in HA turnover, was greater in the AV annulus and mid-leaflet of the 3rd 
trimester group compared to that of the 2-day old group (47% decrease, p=0.049, Fig. 5-
4), although no significant difference between age groups was noted for HA. The mid-
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Fig. 5-4: HA and HARE in AV annulus and mid-leaflet, *p<0.05. Error bars 
indicate standard error of the mean. 
collagen-related markers Col I (52% decrease, p<0.001, Fig. 5-5), P4H (33% decrease, 
p=0.005), and the proteoglycans BGN (43% decrease, pO.001) and DCN (36% decrease, 
p=0.059, trend), which are involved in collagen fibrillogenesis among other biological 
and mechanical roles.30 The ratio of Col III to Col I was also found to increase with birth 
for both the mid-leaflet and annular regions of the AV (p=0.037 and p=0.002); however, 
no significant change was found in the MV. However, MMP13 in the mid-leaflet and 
annulus of 2-day old MV was greater than 3rd trimester MV (27% increase, p=0.023). 
Col III displayed no significant difference between age groups for either MV or AV. 
While periostin appeared to increase with birth in both MV and AV, the change was not 
statistically significant. Unlike in the AV, which demonstrated significant perinatal 
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changes in a number of matrix components, in the MV only MMP13 showed evidence of 
significant perinatal change in expression. 
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Collagen-Related Proteins in AV Mid-Leaflet 
Coll P4H BGN 
• 3rd trimester 
• 2-day old 
DCN 
Fig. 5-5: Collagen-related proteins in AV mid-leaflet, *p<0.05, *p=0,059. 
Error bars indicate standard error of the mean. 
Perinatal Changes in Relative Composition of AV and MV 
The degree of expression of multiple matrix components, such as BGN, HARE, 
and elastin, was similar between AV and MV within the 3 rd trimester group, but then 
became different within the 2-day old group (Fig. 5-6). Similarly, while the expression 
of VC in AV and MV were different within the 3 rd trimester age group, the difference 
between VC expression in AV and MV became greater within the 2-day old age group. 
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B. Differences Between AV and MV: HARE 
3rd trimester 2-day old 
-.rd . Fig. 5-6: Differences between AV and MV in the 3 trimester and 2-day old age 
groups for BGN (A) and HARE (B), *p<0.05. Error bars indicate standard error 
of the mean. 
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Location and Co-localization of Matrix Components 
As expected from adult heart valves, the PGs BGN and DCN demonstrated 
similar localization, predominantly to the fibrosa, although BGN staining was generally 
more diffuse. The PG VC was generally enhanced in the spongiosa layer, as well as the 
elastin rich layers (ventricularis and atrialis of MV and ventricularis of AV). Elastin 
showed very distinct, often nearly linear localization to the ventricularis of the AV and 
atrialis of the MV, along with a much thinner line of distribution along the ventricularis 
of the MV and subendothelial outflow (aortic side) of the AV. Elastin distribution was 
spread throughout more of the thickness of the leaflet in the mid-leaflet and free edge. 
Col III demonstrated a similar distribution as Col I, although Col III staining was more 
diffuse. P4H was generally more diffuse than both Col I and Col III. HARE was often 
localized to the fibrosa in both MV and AV (Fig. 5-7A). Periostin, which appeared to co-
localize with Col I, was also concentrated in the fibrosa in both MV and AV (Fig. 5-7A). 
MMP13 expression was also co-localized with Col I (Fig. 5-7B). Although before birth 
HARE tended to be more diffusely expressed throughout the layers of the leaflet, after 
birth HARE expression appeared to be localized to the fibrosa (Fig. 5-8). This increased 
localization of staining with birth was commonly seen with a number of matrix 
components. LOX, which is involved in crosslinking of collagen and elastic fibers, 
demonstrated relatively diffuse staining in both valves and age groups (Fig. 5-7B). In 
both valves and age groups TGFp and CD44 demonstrated diffuse staining, without 
notable layer or region-specific localization (Fig. 5-9). 
Statistical correlations between the intensities of different matrix components 
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A) Localization of both 
periostin and HARE to 
the fibrosa; shown 
here in a 2-day old A V 
sample. Scale bar 
indicates 200 /xm. 
B) Co-localization of 
MMP13 with Col I in 
the fibrosa, while LOX 
staining was diffuse; 
shown here in a 2-day 
old MV sample. Scale 
bar indicates 200 /xm. 
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Mo vat HARE 
2-day old 
•>«/ Fig. 5-8: HARE showed more diffuse expression in 3r' 
trimester valves compared to 2-day old valves, as illustrated 
here with AVsamples. Scale bar indicates 200nm. 
interrelated roles of these components in perinatal valves. For instance, consistent with 
the common functions of BGN and DCN, in the fibrosa of the AV BGN was correlated 
with DCN (annulus: r=0.864, p=0.0057; mid-leaflet: r=0.794, p=0.0038). Similarly, 
consistent with the common roles of BGN and P4H in collagen fibrillogenesis, BGN was 
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Fig. 5-9: CD44 and TGFfi demonstrated diffuse staining in both MV and A V of both 
age groups that did not localize to individual layers or regions. Shown here is a 2-
day old MV sample. Magnification: 5x objective, scale bar indicates 200 yan. 
correlated with P4H in the mid-leaflet fibrosa of the AV (r=0.794, p=0.0038). In the 
ventricularis layer of the AV, Col I was correlated with HARE in the annular region 
(r=0.907, p=0.0019) and with P4H in the mid-leaflet region (r=0.83, p=0.0056). In the 
annular fibrosa of the MV, elastin was correlated with Col III (r=0.894, p=0.0066). 
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DISCUSSION 
This histological and immunohistochemical study showed that the composition 
and structure of the aortic and mitral valves change with birth, although these changes 
were more evident in the AV than in the MV. In general, perinatal changes in valve 
structure included increased delineation of leaflet layers and abundance of saffron-stained 
collagen. Perinatal changes in valve composition, found solely in the AV, included 
increases in proteins related to turnover of elastic fibers and decreases in proteins and 
receptors related to collagen and HA turnover. These changes could have important 
functional consequences as well as clinical implications. 
Perinatal Changes in AV and MV Structure and Composition 
The AV and MV appeared relatively similar before birth and became more 
distinct with birth. While the AV demonstrated numerous structural and compositional 
changes perinatally, including an increase in leaflet layer delineation, an increase in 
intensity of saffron-staining collagen, and an increase in the proportion of leaflet 
thickness comprised of saffron-staining collagen, all were evident in the AV, only an 
increase in delineation with birth was evident in the MV. Additionally, compositional 
changes with birth were almost exclusively only evident in the AV, not the MV. This 
greater change in AV composition and structure with birth compared to the MV could 
relate to greater change in the hemodynamic environment of the AV as opposed to the 
MV with birth. The hemodynamic environments (i.e., blood flow velocities, afterload 
pressures) of the two valves are relatively similar in the fetal circulation.1'36 At birth, 
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however, the diastolic pressure borne by the AV increases by 51%, whereas the MV must 
bear a 23% greater diastolic pressure.2 Thus, the mechanosensitive valves may be 
demonstrating levels of remodeling that are consistent with their changing mechanical 
environments. 
Indeed, a large body of research in adult valves has examined the roles of specific 
mechanical factors in valve biology and remodeling. The role of pressure in AV 
composition has been studied in the ex vivo setting, where it was demonstrated that 
1 8 
elevated static pressure caused an increase in collagen synthesis whereas cyclic pressure 
evoked a magnitude and frequency dependent response in valve composition.17 The 
effect of pressure on valve cells has also been implicated in modulation of cell phenotype 
and matrix synthesis based on differences in transvalvular pressures across the AV and 
pulmonic valve. AV valvular interstitial cells (VICs) were found to be stiffer and contain 
more smooth muscle alpha-actin and heat shock protein 47 (a marker of collagen 
synthesis) than VICs from the pulmonic valve.8 In addition, Piatt et al.19 found that the 
application of shear stress to intact AV leaflets decreased the expression of cathepsins but 
increased the expression of MMPs. The effect of strain on adult AV leaflets and VICs 
has been extensively studied and found to affect collagen, MMP, and GAG production in 
a magnitude and frequency dependent manner.16'37"41 
Although collagen synthesis (as shown by P4H expression) and pro-collagen I 
content decreased in the AV mid-leaflet with birth, it is interesting to note that the 
collagen in the fibrosa of 2-day old valves appeared more aligned and mature, as 
evidenced by greater intensity and proportion of Movat saffron-staining collagen. 
Additionally, the collagen remodeling enzyme MMP 13 increased with birth in the MV, 
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and was localized to the fibrosa layer. Taken together, these results suggest that while 
less collagen is being produced immediately after birth, the collagen undergoes 
significant remodeling with birth as it becomes more mature and aligned. Ex vivo studies 
in which the AV was subjected to mechanical stimulation have demonstrated greater 
MMP expression with cyclic strain,39 as well as thicker, more aligned collagen fibers.9 
Alterations in the ratio of Col III to Col I have also been noted in cardiac remodeling, 
such as dilated cardiomyopathy,42"44 although a consensus has not been reached as to the 
exact nature of these changes and their implications. 
Regional Heterogeneity in Perinatal Changes in Valve Composition 
Perinatal changes in valve composition were predominantly found in the mid-
leaflet as opposed to in the annular region of the valve. This regional heterogeneity could 
be attributed to the greater impact of the perinatal hemodynamic changes on the mid-
leaflet region. More specifically, the myocardial anchorage of the annular region of the 
leaflet may partly shield that region from hemodynamic changes. In addition, the annular 
region can transduce forces to the myocardium, whereas the mid-leaflet does not have 
this anchorage. Greater compositional changes in the mid-leaflet as opposed to the 
annular region of the leaflet have also been observed in other animal models of altered 
hemodynamics.7 
Localization of Matrix Components within AV and MV 
The hyaluronan receptor for endocytosis (HARE), also known as stabilin-2, was 
localized to the fibrosa of the 2-day old valves. Although HARE has been previously 
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demonstrated in adult mouse valves ' and human adult normal and myxomatous mitral 
valves,47 its function in valves remains enigmatic. In one relevant study in mice, HARE 
was reported to be absent during development but present in the postnatal murine heart; 
in these murine valves, HARE was found limited to the valvular endothelium.46 Another 
study, however, demonstrated HARE throughout the valve thickness in adult mice. 5 In 
general, the predominant role of HARE is considered to be HA metabolism, i.e., the 
removal of HA from the bloodstream or extracellular space. Given the involvement of 
HA in valvulogenesis,33 and the observed decrease in HA during atrioventricular 
endocardial cushion development in chicks,15 it is not surprising that HA metabolism 
would change during valve development and that the abundance of HARE would 
decrease with birth. However, the localization of HARE to the fibrosa layer and its co-
localization with collagen in postnatal valves may be more related to other binding sites 
within the HARE molecule; HARE is known to bind to pro-collagen,48 although the 
purpose of this binding in the context of valves is unclear. HARE can also mediate both 
heterophilic49 and homophilic cell-cell interactions,50 and HA binding to HARE triggers 
intracellular extracellular signal-regulated kinase (ERK) activation;51 these results 
suggest that HARE enables cells to sense matrix turnover. Furthermore, considering the 
many binding sites for diverse molecules along its length, HARE could potentially act 
as a scaffolding protein providing structure for and promoting interaction between these 
molecules. Clearly, the roles of HARE are diverse, meaning broader than HA 
metabolism alone, and many of these roles have yet to be elucidated, especially in the 
context of heart valves. Although CD44, one of the cellular receptors for HA, did not 
demonstrate a change in abundance with birth, the receptor activity of CD44 could have 
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changed while expression levels remained relatively constant. There are also a number of 
other cell surface receptors for HA and other proteins involved in HA metabolism that 
could be changing during this time period. 
The co-localization of periostin with collagen in the fibrosa seen in this study is 
consistent with studies demonstrating that periostin directly binds collagen I and is 
involved in collagen fibrillogenesis.27 Several other studies have also demonstrated the 
location of periostin in the AV and MV, both during development and in mature valves. 
In a report of murine embryological development, periostin showed widespread 
expression in the AV, but greater expression in the atrial aspect (elastic layer) of the 
MV.53 In adult mice, however, two studies have demonstrated periostin expression 
localized within the collagenous fibrosa layer of the AV and MV.53' 54 During chick 
embryological development, periostin was found in the ventricular aspect of the MV (the 
fibrosa), but the AV showed lower expression relative to the MV.55 In general, an 
increase in periostin with birth would be consistent with the role of periostin in cardiac 
remodeling in response to increased mechanical stimulation.29 
The localization of collagens and proteoglycans corroborate previous studies of 
different aged human and porcine MV and AV. Col III, a reticular collagen,56 
demonstrated more diffuse staining than Col I, as previously reported in human MV and 
AV.57 The finding that P4H, a marker of collagen synthesis, was more diffusely present 
either collagen, and was even found outside the fibrosa layer, is consistent with previous 
evidence that collagen turnover is not limited to the fibrosa layer in porcine AV and 
MV.13 The enhanced staining of the proteoglycans BGN and DCN in the fibrosa is also 
consistent with previous studies14 and supports the role of these proteoglycans in collagen 
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integrity. ' The change in DCN expression could have affected collagen fiber diameter, 
given the known role that DCN plays in regulating collagen fiber diameter during 
collagen fibrillogenesis.58'60 The localization of VC in the spongiosa and elastin-rich 
regions also corroborates previous reports in porcine valves,14 and supports a role for VC 
in elastic fiber homeostasis.31 LOX staining, which was relatively diffuse in the valves, 
suggested ongoing maturation of nascent matrix throughout the leaflet in both age 
groups. 
Proposed Functional Consequences of Valve Structural and Compositional Changes 
These observed valve compositional and structural changes likely affected the 
leaflet tissue and overall function. The increase in leaflet layer delineation, which is 
consistent with previous studies,13 would reduce flexural stress.61 The increase in elastin 
would aid in valve flexion and elastic recoil, as well as maintaining proper collagen fiber 
configuration. The increase in collagen maturation would result in greater tensile 
strength, allowing the valve to withstand the perinatal increase in pressures. A recent 
study by Balguid et al.63 elegantly demonstrated a positive correlation between collagen 
crosslinking and tensile elastic modulus in the adult AV. Additionally, our lab has 
recently demonstrated that an increase in AV and MV tensile strength with postnatal age 
was associated with an increase in the amount of Movat saffron-staining collagen.64 The 
role of decreased HA turnover with birth, as suggested by HARE expression, is less clear. 
HA has numerous roles, both biological and mechanical,65'66 and the derangement of its 
regulation has been implicated in several pathologies in a variety of tissues including 
valves.47 Therefore, alterations in HA metabolism observed with birth could have 
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important biological and mechanical consequences, although the exact nature of those 
remain to be determined. Similarly, perinatal changes in abundance and localization of 
proteoglycans could affect tissue mechanics, collagen homeostasis, cell signaling, growth 
factor regulation, and cell phenotype regulation. For example, DCN sequesters 
transforming growth factor-beta (TGFP),30 a growth factor that modulates valve cell 
phenotype,67 and is implicated in a number of valve diseases including myxomatous 
mitral valve disease.68 Indeed, previous studies have demonstrated the co-localization of 
DCN with TGFJ3 in porcine valves,14 although in this set of valves TGF(3 staining was 
found to be relatively diffuse. The proteoglycan VC is commonly found to be up-
regulated in disease states as well as development,30 and given its role in elastic 
fibrillogenesis the perinatal increase in VC could directly relate to the increase in elastin 
content with birth found in this study. Greater elastin could result in functional changes 
in leaflet bending properties as the leaflet adapts to the altered hemodynamics. Clearly, 
further study is required to better understand the functional consequences of these 
perinatal compositional and structural changes. 
Implications 
These data regarding the perinatal development of heart valves have several 
implications. First, as work continues to develop tissue engineered heart valves, a broad 
characterization of valve composition will be necessary to provide design criteria for 
valves for neonates. This age group is of particular interest given the large number of 
congenital heart disease (CHD) patients, who often undergo neonatal surgical repair 
procedures. Additionally, if the perinatal hemodynamic changes do not occur normally, 
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such as is the case in CHD, valve composition may be affected, which could in turn 
impact valvular cell phenotype and subsequent valvular maturation. Therefore, the 
results of this study suggest a potential mechanism for causing or contributing to the 
compositional and structural abnormalities observed in congenital valve disease. As 
illustrated by a representative example in Fig. 5-10, these congenitally diseased valves 
typically lack a layered leaflet structure and a mature collagenous fibrosa layer, and tend 
to be enriched in GAGs. Further characterization of these compositional abnormalities in 
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congenitally diseased valves is currently underway in this laboratory. Lastly, these 
results could also have implications for the timing of surgical intervention in this patient 
population, in that early restoration of normal neonatal hemodynamics may promote 
normal development of valve composition and function. 
Limitations 
Although there were numerous statistically significant findings within this work, 
certain limitations must be mentioned. Samples were analyzed using 
immunohistochemistry, a powerful and appropriate method for examining both the 
abundance and localization of valve matrix components. However, this method is limited 
by some inherent variability in the staining technique, which in our hands has been 
quantified to be approximately 14%.7 To diminish the effect of this variability on our 
results, multiple samples were taken from each valve, and multiple sections cut from each 
sample were stained; the results were averaged. In addition, there are numerous other 
aspects of extracellular matrix maturation that should be addressed in future studies, such 
as collagen crosslinking and fiber diameter, that will further elucidate the nature of 
remodeling within the perinatal period. Furthermore, it will also be important to translate 
experimental mechanobiology studies, examining the effect of specific mechanical 
factors on the observed valve remodeling, from the time frame of adult valves to the 
perinatal and pediatric periods. This study also used an animal model; however, porcine 
valves are considered to be anatomically excellent animal models for human valves,69 
and indeed are commonly used as animal models for human valve biology and 
mechanics. Lastly, some of the observed perinatal changes in the tissues may have 
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been due to changes in the biological milieu, such as circulating growth factors, 
cytokines, and even inflammatory mediators. Further study is warranted to understand 
the contribution of these other factors on valve remodeling with birth. In the future, it 
will also be important to elucidate the functional consequences of this perinatal valve 
remodeling and investigate how altered hemodynamics may relate to the altered valve 
structure and composition observed in congenital valve disease. 
CONCLUSIONS 
This study demonstrated that the AV and MV undergo significant remodeling 
with birth, including increased leaflet layer delineation and alignment of collagen, as well 
as changes in the amount of collagen turnover, hyaluronan metabolism, elastin, and 
proteoglycans. These perinatal changes were more pronounced in the AV than in the 
MV, consistent with greater hemodynamic changes experienced by the AV. These 
results contribute to a growing body of evidence that the valve dynamically adapts to its 
mechanical environment. Future study is warranted to examine the functional 
consequences of these changes, especially for patients with congenital valve disease. 
This chapter, which analyzed changes in matrix composition and structure 
during the perinatal period, was the third of four chapters (Chapters 3-6) examining 
age-related changes in matrix composition and structure in normal aortic and 
mitral valves. In the next chapter in this series of studies, preliminary data is 
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presented analyzing regional heterogeneity in glycosaminoglycan composition in the 
aged aortic valve. 
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Chapter 6: Regional Heterogeneity in Aortic Valve GAG 
Composition 
This chapter is the fourth of four chapters (Chapters 3-6) examining age-
related changes in matrix composition and structure in normal aortic and mitral 
valves. The work contained in this chapter follows upon a question that arose in the 
analysis of glycosaminoglycan fine structure composition in Chapter 4, namely 
whether the aortic valve displayed regional heterogeneity in glycosaminoglycan fine 
structure, regions that may age distinctly, similar to that observed within the mitral 
valve. The first step to address this question was to see if regional heterogeneity in 
glycosaminoglycan fine structure in the aortic valve existed. Aged aortic valves 
were chosen for the preliminary studies in this chapter with the rationale that older 
valves would have been exposed to heterogeneous loading longer, allowing more 
time for regional compositional heterogeneity to develop; therefore, if there were 
such heterogeneity, it was most likely to be evident in these valves. Given that the 
work contained in this chapter represents a preliminary study, it has been included 
at the end of the series on age-related changes in matrix composition and structure. 
ABSTRACT 
Background: While the need for a tissue engineered heart valve (TEHV) is well 
established, there has been only limited characterization of valvular extracellular matrix 
composition, such as glycosaminoglycans (GAGs), that will need to be recapitulated 
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within the TEHV. GAGs are known to be critical to tissue differentiation, structure, and 
mechanics. Furthermore, GAG fine structure, meaning GAG chain length and sulfation 
pattern, is thought to be important to biological function. While recent studies have 
shown differences in GAG fine structure between regions of the mitral valve that 
experience different mechanical loading, and even that the GAG compositions of these 
regions demonstrate distinct changes with age, such patterns of regional complexity and 
correlation with mechanical loading have not been examined in the aortic valve (AV). 
Methods; Fluorophore-assisted carbohydrate electrophoresis (FACE) was used to 
analyze GAG composition in different regions of the 6-year-old porcine AV (coaptation, 
attachment, nodule, and belly) and interpreted this data in light of known patterns of 
mechanical loading. 
Results: The relative abundances of hyaluronan (HA), chondroitin 6-sulfate (C6S), and 
4-sulfated N-acetylgalactosamine (galNAc4) were significantly different between regions 
(each p<0.05), with the nodule region containing the most HA, C6S, and galNAc4 per dry 
weight. Overall GAG content was also significantly different between regions (p<0.001) 
with the nodule region containing the greatest amount, followed by the attachment region, 
belly region, and then coaptation region. Percent hydration was not significantly different 
among the regions analyzed. 
Conclusions: This study provides promising preliminary information regarding regional 
heterogeneity of GAG distribution within the AV. Further study in this area should yield 
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insight into the role of mechanical loading in AV tissue composition as well as inform the 
design of TEHVs for the aortic position. Assessment of the regional GAG composition 
of different aged AVs will be important to determine whether these regions undergo 
distinct aging processes in terms of GAG content, similar to that observed in MV regions; 
this AV aging data could then be applied to age-specific tissue engineered AV design. 




Glycosaminoglycans (GAGs) play key roles in valve structure and function that 
vary from the cellular level, such as their involvement in the sequestration of growth 
factors and cell signaling,1 to the micro structural level, such as regulating collagen 
fibrillogenesis,2 to the tissue as a whole, such as providing lubrication between layers and 
resistance against compression.3 GAGs also play a role in valvulopathies, such as in 
myxomatous mitral valve disease4 and likely in calcific aortic valve disease.5 A recent 
study of GAG composition of different aged mitral and aortic valves (MV, AV) 
demonstrated significant differences in hydration, GAG types and sulfation patterns, and 
GAG chain length between the center and free edge regions of the MV anterior leaflet, 
which undergo distinct loading patterns.6 However, it is unknown whether this manner 
of regional heterogeneity in GAG content and hydration also exists within the AV. 
Evidence suggests that regions of the AV, like the MV, experience significantly different 
mechanical environments. Finite element modeling of human AV and aortic roots 
suggested that the peak stresses within the AV leaflet were in the belly region, with 
relatively low stresses in the coaptation and attachment regions.7 In another 
computational model of the AV leaflet, regional heterogeneity in stresses and strains 
were also observed. In this model, the annular attachment region experienced low stress, 
whereas maximum stresses were found at the commissures and slightly lower stresses 
were present in the belly region.8 A recent study utilizing porcine AVs in a physiologic 
left-heart simulator found that radial strain was greatest near the tip of the leaflet, while 
circumferential strain was greatest at the base of the leaflet.9 Within this left-heart 
simulator, the basal portion of the leaflet was also found to be substantially stiffer than 
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the tip of the leaflet.9 A number of studies have similarly shown regional heterogeneity 
in terms of collagen composition and structure within the AV.8'10' " Given evidence that 
the differently loaded regions of the MV demonstrate altered GAG content, ' as well as 
additional evidence that valve cells in the in vitro setting respond to mechanical 
stimulation by altered GAG synthesis,13 it was the hypothesis of this study that GAG 
composition would vary among the different regions of the AV that experience different 
mechanical environments. Characterization of such regional heterogeneity in GAG 
composition would not only allow better understanding of the interaction of AV structure 
and its mechanical environment, and how that might be similar to or distinct from that of 
the MV, but also provide design criteria for a tissue engineered AV. 
Therefore, the experiments contained in this chapter were designed as a pilot 
study to provide an initial overview of GAG content within different regions of the AV. 
The abundance of specific GAG classes (using fluorophore-assisted carbohydrate 
electrophoresis (FACE)) and percent hydration were examined within the attachment, 
coaptation, belly, and nodule regions of the AV (Fig. 6-1). It was hypothesized that if 
regional differences in GAG content within the AV existed, they would be most 
pronounced in an elderly animal, such as the 6-year-old pig, given that those leaflets 
hypothetically had been exposed to regional differences in mechanical environment for 





Hearts from 6-year-old pigs were obtained within 24 hours of death (n=3, Animal 
Technologies, Tyler, TX). Hearts were maintained on ice until processing. One leaflet 
per AV was used, chosen randomly from the non-coronary, right coronary, and left 
coronary leaflets. The attachment, coaptation, nodule, and belly regions were dissected 
from the leaflets (Fig. 6-1), and hydration and GAG content was analyzed as described 
below. 
Fig. 6-1: Diagram illustrating regions analyzed. 
A=attachment, B=belly, C=coaptation, N=nodule. 
Fluorophore-Assisted Carbohydrate Electrophoresis (FACE) 
Fluorophore-assisted carbohydrate electrophoresis (FACE) was used to analyze 
the quantity and fine structure of the different GAG classes, HA and the 
chondroitin/dermatan sulfates (CS/DS).12'14 Note on nomenclature: CS is defined as only 
containing glucuronate while DS is defined as containing some quantity of iduronate. 
First, the AV was dissected from porcine hearts within 24 hours of death. Each sample 
was weighed before and after lyophilization; hydration was calculated as (wet weight -
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lyophilized weight)/wet weight. The GAGs in the lyophilized samples were then 
analyzed by FACE,12' 15 as described in detail in Chapter 4. Each sample was run and 
analyzed at least 2 times and the results were averaged. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL), as described in Chapter 4. 
RESULTS 
The results for the wet and drive weights for samples from the different regions 
are listed in Table 6-1. 















Average weight (mg) ± standard error of the mean; 
A=attachment, B=belly, C=coaptation, N=nodule. 
The amounts of hyaluronan (HA), chondroitin 6-sulfate (C6S), and 4-sulfated N-
acetylgalactosamine (galNAc4) were significantly different between regions (Fig. 6-2). 
Among these regions, the nodule region had the highest HA, C6S, and galNAc4 per dry 
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Fig. 6-2: Amount of various GAGs, normalized to mg of dry tissue weight, in 
different regions of the AV leaflet as determined by FACE. *=p<0.05R vs. nodule 
for a given GAG; Ap<0.05R vs. attachment for a given GAG. Error bars indicate 
standard error of the mean. 
weight. The attachment region had lower HA content than the nodule region, but higher 
content than the coaptation regions (each p<0.007R). Dermatan 4-sulfate (D4S) was 
higher in the attachment region relative to the coaptation region, although there was no 
statistically significant difference between regions for D4S and a substantially larger 
number of samples would need to be analyzed to verify that such a difference exists. 
Overall within this pilot study, chondroitin 0-sulfate (COS) and chondroitin 4-sulfate 
(C4S) appeared relatively constant across regions. In terms of the relative amounts of the 
different GAG classes, HA and C6S content were significantly higher than each of the 
other GAG classes (each pO.OOl). 
I i L 




































Fig. 6-3: GAG composition, normalized to mg of dry tissue weight, in different regions of the A V leaflet as 
determined by FACE. Overall regions were significantly different (p<0.001). *=p<0.001 vs. nodule 
region; A=p<0.003 vs. coaptation region. Error bars indicate standard error of the mean. 
The average GAG content was also significantly different between regions (Fig. 
6-3, p<0.001), with the content of the nodule region the highest, followed by the 
attachment region, belly region, and then coaptation region. 
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C6S D4S D6S galNAC4 
Fig. 6-4: Proportion of various GAGs relative to total GAG content in different regions of 
the A V leaflet as determined by FACE. *=p<0.05 regions significantly different for a given 
GAG; A=p<0.05 vs. coaptation region for that GAG; f=p<0.05 vs. attachment region for 
that GAG. Error bars indicate standard error of the mean. 
Analysis of proportional GAG content (i.e., amount of a given GAG relative to 
total GAG content in that region) revealed that the proportional COS content of the belly 
region was greater than the coaptation region (p=0.002, Fig. 6-4), proportional galNAc4 
content of the coaptation region was greater than the other regions (each p<0.005), 
proportional C4S content of the belly region was greater than the nodule region 
(p=0.006), and proportional C6S content of the belly and nodule regions were greater 
than the attachment region (each p<0.009R). 
Overall, across regions the proportional content of C6S was substantially higher 
than each of the other GAG classes except HA (each p<0.001) and HA content was 
greater than D4S and D6S (each p<0.004). 
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Fig. 6-5: Percent hydration in different regions of the A V leaflet. Percent hydration 
was not statistically significant different between regions. Error bars indicate standard 
error of the mean. 
Percent hydration was not significantly different between the regions analyzed 
(Fig. 6-5). 
DISCUSSION 
Although these experiments were designed as a pilot study with a small number 
of samples, and clearly a much larger number of samples would need to be analyzed to 
verify and further demonstrate potential differences between the regions, the results of 
this study provide insight regarding differences in overall GAG content and in specific 
GAG types between regions of the AV. Given that significant differences were observed, 
this pilot study also provides motivation for further study in this area, both in terms of a 
larger number of samples, as well as different aged AV given evidence for age-related 
changes in AV regional stresses.16 
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Regional Heterogeneity in AV Composition 
The results of this pilot study indicate that regional differences in GAG 
composition exist in the AV. While further work needs to be done in this regard, from 
these initial findings the nodule region stood out as being distinct from the other regions 
both in terms of individual GAG classes, especially HA and C6S, as well as overall GAG 
content. The regional GAG composition heterogeneity evident in this study builds upon 
other studies that have demonstrated regional AV heterogeneity in collagen content and 
structure.8' 10' " Of particular note, Balguid et al.8 found that collagen fiber bundle 
diameters were highest in the commissural regions, somewhat smaller in the belly, and 
smallest in the annular attachment region. Decorin and biglycan, two proteoglycans rich 
in dermatan sulfate,12'17 are integrally associated with collagen fibrillogenesis as well as 
collagen fiber bundle formation.17'18 Decorin has been shown in vitro and in knock-out 
animal models to decrease collagen fiber diameter by preventing lateral fusion of 
collagen fibers.17"19 It is worth noting that the attachment region in this study did appear 
to have increased dermatan 4-sulfate, which would correlate to the region of low fiber 
bundle diameter in the study by Balguid et al. It would be interesting in future studies to 
investigate the relative distributions of dermatan sulfate and these two proteoglycans with 
respect to this reported regional heterogeneity in collagen fiber bundles, as has been done 
in other connective tissues.2 
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Potential Relationship between Regional Heterogeneity in AV Mechanics and GAG 
Composition 
Studies examining heterogeneity in GAG composition among differently loaded 
regions of the MV demonstrated that regions that undergo tension contain more dermatan 
and 4-sulfated GAG, less hydration, less chondroitin sulfate, and less 6-sulfation 
compared to regions undergoing compression.6'12 In this study the nodular region, which 
would undergo compression, demonstrated greater HA and C6S compared to the other 
regions. Hydration also was higher in this region, although that difference was not 
statistically significant. Theoretically, this greater HA and C6S (the C6S is likely 
associated with the proteoglycan versican12) would aid in the compressive strength of this 
thickened valve region, and thus serve to prevent regurgitation. Dermatan 4-sulfate 
(D4S) was higher in the attachment region relative to the other regions. This increased 
D4S content may relate to the observed greater stiffness in this region,9 and would be 
consistent with similar correlations between D4S and stiffness in the MV.6'12'20 In terms 
of correlations to the loading pattern experienced by that region, some computational 
studies have suggested high stresses in that region,16 although other computational 
models disagree.7'8 
While the relationship between regional GAG compositional heterogeneity and 
function within the AV is still being elucidated, previous studies demonstrating AV 
regional heterogeneity in collagen structure have correlated these compositional 
differences to functional roles. For instance, Balguid et al. found that the regions of 
higher stress within their computational model correlated to regions with larger diameter 
collagen fiber bundles.8 Sacks et al. demonstrated that the different regions of the AV 
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with varying degrees of collagen fiber alignment responded uniquely to increasing trans-
valvular pressure.11 In fact, given the role of decorin and biglycan in binding and 
organizing collagen fibers, these proteoglycans and their GAG chains may play an 
important part in the ability of different regions of the AV to reorganize their collagen 
fibers observed in the study by Sacks et al. Clearly more is to be learned regarding the 
particular role played by regional heterogeneity in GAG composition plays in AV 
function, but these roles are likely to be important based on these previous studies of 
GAG composition and correlations to function in the MV and studies of collagen regional 
heterogeneity and their relation to function in the AV. 
Nodule of Arantius: Structure and Function 
The nodule of Arantius is a grossly apparent thickening in the center of the AV 
free edge. This nodule is so clearly distinct from the adjacent thin, transparent regions of 
coaptation that it has been described by anatomists for centuries. Despite the grossly 
apparent distinct nature of this region, other studies that have examined AV regional 
heterogeneity in terms of collagen content and structure have largely not addressed the 
nodule of Arantius.8'10' " Only one of these studies comments on structural differences 
in this nodule region, which was found to have lower degrees of collagen fiber 
orientation compared to adjacent regions." 
Examination of the potential functional role of the nodule of Arantius has been 
made in terms of its geometric effect on leaflet stress.21 It has been postulated that the 
localized thickening of the nodule divides the leaflet into two abutting curved segments 
each with its own radius of curvature.21 Based on the law of Laplace, this configuration 
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should reduce leaflet stress relative to a cusp without a nodule of Arantius. 
Bioprosthetic valves made from pericardium do not have a nodule of Arantius, which 
could lead to increased leaflet stress at the free edge of these valves relative to native 
valves, and potentially could relate to deterioration of this free edge known to occur in 
such bioprosthetic valves.21 One could hypothesize that these localized thickenings, 
shown in this study to be enriched in elements associated with compressive strength, 
could aid in preventing regurgitation. 
Limitations and Future Studies 
The major limitation to this study was the small number of samples, as it was 
designed to be a pilot study. However, given that despite such a small number of samples 
and their small dry weights, regional differences in GAG composition were found to be 
statistically significant, this study can act as motivation for further study in this area. 
Additionally, given previous studies demonstrating that different regions of the MV age 
differently in terms of GAG content,20 as well as studies demonstrating that regional 
stresses in the AV vary with age,16 subsequent studies should examine GAG composition 
in various aged AVs. Future studies examining particular PGs in relation to regional AV 
GAG composition and mechanics would provide added insight into the role of GAGs and 
PGs in AV function. Furthermore, although FACE allows for quantification of GAG fine 
structure, the role of the AV layered structure and layer-specific composition was not 
addressed using this technique. In the future, manual dissection of the layers followed by 
FACE analysis or immunohistochemistry on tissue cross-sections could allow 
examination of the role of the layered structure of the valve in regional compositional 
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heterogeneity. Mechanical testing of distinct leaflet regions should also be performed to 
relate regional compositional heterogeneity to material properties. Additionally, it would 
be very informative if future experiments (perhaps in vitro) are able to demonstrate a 
direct, as opposed to associative, relationship between composition and loading patterns. 
CONCLUSIONS 
This study provides a preliminary characterization of the regional heterogeneity in 
GAG composition within the AV. The significant heterogeneity in GAG content that was 
evident from the results provides motivation for further study in this area. Understanding 
such heterogeneity in relation to the different loading of the various regions of the AV 
will yield insight into the relationship between structure and function within the AV, as 
well as inform the design of TEHV for the aortic position. Subsequent studies assessing 
whether these regions undergo distinct aging processes in terms of GAG content will be 
important to age-specific tissue engineered AV design. 
This chapter, which analyzed regional heterogeneity in glycosaminoglycan 
fine structure in the aged aortic valve, was the fourth of four chapters (Chapters 3-
6) examining age-related changes in matrix composition and structure in normal 
aortic and mitral valves. As stated in the preface to this chapter, this work follows 
upon the work in Chapter 4 that demonstrated regions in the mitral valve contained 
distinct glycosaminoglycan fine structure profiles that aged differently. In the 
present chapter preliminary work suggested that distinct regions may also exist in 
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the aortic valve, although it remains to be determined if these regions also age 
differently. 
The next chapter continues within the broad category of studies examining 
normal aging, but moves from the topic of age-related changes in matrix 
composition and structure addressed in Chapter 3-6, to the topic of age-related 
changes in material properties. Specifically, in the next chapter changes in aortic 
and mitral valve material properties during postnatal aging, and the relationship of 
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Chapter 7: Age-Related Changes in Material Behavior of 
Porcine Mitral and Aortic Valves and Correlation to Matrix 
Composition 
This chapter continues within the broad category of studies examining 
normal aging, but moves from the topic of age-related changes in matrix 
composition and structure addressed in Chapter 3-6, to the topic of age-related 
changes in material properties. Specifically in this chapter changes in aortic and 
mitral valve material properties during postnatal aging, and the relationship of 
those changes to alterations in matrix compositional and structural changes, are 
addressed. 
ABSTRACT 
Background; Recent studies showing significant changes in valvular matrix 
composition with age offer design criteria for age-specific tissue engineered heart valves 
(TEHV). However, knowledge regarding aging-related changes in valvular material 
properties is limited. 
Methods: 6-week, 6-month, and 6-year-old porcine aortic (AV) and mitral valves (MV) 
were subjected to uniaxial tensile testing. In addition to standard material parameters, the 
radius of transition curvature (RTC) was measured to assess the acuteness of the 
transition region of the tension-strain curve. 
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Results: Radially, the MV had greater stiffness and a smaller RTC compared to the AV. 
Circumferentially, the center of the MV anterior leaflet (MVAC) had the highest stiffness 
(MVAOAV>MV free edge (MVF)), greater stress relaxation (MVAOMVF/AV), 
lowest extensibility (MVAC<AV<MVF), and smaller RTC compared to MVF 
(AV<MVAC<MVF). AV and MV radial strips had a larger RTC compared to 
circumferential strips. Aging elevated stiffness for MV and AV radial and 
circumferential strips, elevated stress relaxation in AV and MVF circumferential strips, 
and increased RTC for MV radial and MVF circumferential strips. 
Conclusions: There are significant age-related differences in the material properties of 
heart valves, which parallel differences in tissue composition and structure, likely impact 
valve function, and highlight the need for age-specific design goals for TEHVs. 
The work contained in this chapter was published as: 
Stephens EH, De Jonge N, McNeill MP, Durst CA, Grande-Allen KJ. Age-Related 
Changes in Material Behavior of Porcine Mitral and Aortic Valves and Correlation 
to Matrix Composition. Tissue Engineering, 2010;16(3):867-78. 
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INTRODUCTION 
Although heart valve composition and microstructure are known to change with 
aging,1"6 and a number of valve diseases show increase incidence with aging,7' the 
effects of aging on valvular material properties remain largely unknown, with the 
exception of one study of radial failure strain of aortic valves (AV).9 It is likely that 
valve material behavior varies with age given age-related changes in valve composition, 
including increased collagen content1'2 and crosslinking,2' 4 as well as changes in the 
abundance and turnover of specific extracellular matrix (ECM) components.3' 10' " 
Potential age-related changes in the material behavior of valves likely contribute to 
proper physiologic function as cardiac hemodynamics change during the normal aging 
process.12 Ultimately, a properly designed tissue engineered heart valve would similarly 
need specific material properties allowing it to withstand these different hemodynamics 
depending on the patient age. 
Valves are considered to be quasi-viscoelastic,13'14 highly anisotropic tissues,15"20 
that demonstrate stress relaxation14' 17' 20"24 but low hysteresis13' 14 and no creep.13' I4 
Tensile testing of valves results in a characteristic load-elongation curve with a low slope 
pre-transition region in which the collagen fibers are crimped and the elastic fibers are 
bearing load, followed by a transition region during which loading is transferred to the 
collagen fibers, and then a post-transition region whose high slope reflects load-bearing 
by the collagen fibers.21' 22' 25 Valve anisotropy, in which valves are stiffer and less 
extensible in the circumferential direction compared to the radial direction,15"20 is 
attributed to collagen fiber alignment in the circumferential direction.15'26 Stiffness also 
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varies regionally within the mitral valve (i.e., between the anterior center (MVAC) and 
the free edge (MVF)),15 as does ECM composition in these regions.27 
Therefore, the primary objective of this study was to assess age-related 
differences in the material properties of porcine mitral valve (MV) and AV and to 
consider these differences in the context of valve micro structure and ECM composition. 
In addition to standard material parameters, we developed a novel parameter termed 
"radius of transition curvature" (RTC) to quantify the acuteness of the transition from the 
pre-transition to post-transition region of the tension-strain curve. 
METHODS 
Tissue Sample Procurement 
Based on comparable anatomy between porcine and human valves,28"30 valves 
from 6-week, 6-month, and 6-year-old pigs were used (corresponding to child, young 
adult, and older adult ages in humans11). Porcine hearts were obtained from abattoirs 
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MV=mitral valve, AV=aortic valve, MVAC=MV anterior center, MVF=MV 
free edge, NC=AV non-coronary leaflet, RC=AV right coronary leaflet, 
LC=AV left coronary leaflet. 
(Fisher Ham and Meat, Spring, TX, for 6-week-old and 6-month-old pigs; Animal 
Technologies, Tyler, TX, for 6-year-old pigs) and measured to normalize leaflet thickness 
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to heart size (maximum circumference and longitudinal length from the origin of the 
pulmonary artery to heart apex). MVs and AVs were dissected from the hearts, chordae 
were removed from the MV, and circumferential and radial strips of 5 mm diameter were 
cut from both MV and AV (Table 7-1). Given known differences between the material 
properties of the MVAC (defined as the central region without chordal attachments) and 
MVF,15 circumferential strips were taken from both of these regions (Fig. 7-1A). MV 
radial strips spanned the entire leaflet height from annulus to free edge. Tissues were 
stored in phosphate buffered saline (PBS) at 4 degrees until testing and tissues were 
tested within 4 days of harvesting (based on studies showing material properties of valves 







Fig. 7-1: A) Orientation of tissue strips cut from the MV (indicated by dashed boxes). 
Curved solid line indicates the border between the center (MVAC) and free edge (MVF) of the 
anterior leaflet. Rad=radial, circ=circumferential. B) Diagram illustrating the placement of 
glued balsa/valve tissue sample construct within grips of materials testing system. 
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Mechanical Testing 
The thickness of the tissue was measured at 4 locations using a displacement 
gauge (Mitutoyo, Japan). Tissue samples were glued to balsa wood with cyanoacrylate 
and clamped within an EnduraTec ELF 3200 (Bose, Minnetonka, MN) such that the edge 
of the balsa wood aligned with the end of the grips (Fig. 7-IB). The balsa wood 
improved traction of the tissue within the grips, thereby preventing slippage during 
testing. Mechanical testing was performed within a 37°C PBS bath as described 
previously.33 Briefly, mechanical testing began with the tissue in an unloaded state and 
consisted of 25 cycles of pre-conditioning at 1 Hz followed by one load-elongation cycle 
(0.5 Hz). The tissue was then allowed to rest for 15 seconds before another 3 cycles of 
pre-conditioning and a stress relaxation test (duration 100 seconds). 
Data Analysis 
Gauge length, defined as the length at which the tissue first starts bearing load, 
was calculated by fitting a cubic function to the pre-transition region of the load-
elongation curve and then determining the tissue length corresponding to the local 
minimum, similar to the method used by Carew and Vesely.34 Recorded displacement 
values were then divided by gauge length to calculate strains and load converted to 
tension by dividing by tissue width. The slope of the post-transition portion of the 
tension-strain curve (post-transition "stiffness") was calculated by first fitting a straight 
line to the maximum load and the preceding four points. Additional preceding points 
were added and the slope of the linear least squares fit line was re-calculated until its 
value changed by more than 1%. The pre-transition stiffness was determined as the slope 
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of the linear least squares fit between zero strain to one half of "end-transition" strain 
(where the "end-transition" point was the closest point to the origin that was used in the 
post-transition slope calculation). Extensibility was defined as the intersection of the 
linear least-squares fit of the post-transition region with the x-axis (strain). The stress 
relaxation data was fit to the following two-phase decay equation: 
y = y 0 + A0e~Kfas,x + Axe~KslowX 
The Kfast and Ks|0w values were calculated iteratively using Graphpad Prism (GraphPad 
Software, La Jolla, CA). The percentage relaxation (%SR) was calculated as the 
difference between the initial load and the load remaining at 100 seconds as a percent of 
the initial load. The yo value refers to the plateau stress in the tissue (where t is 
approaching 100 seconds). Ao and Ai are best-fit values from a nonlinear regression 
referring to the span of the fast and slow portions of the curve. The radius of transition 
curvature (RTC) was calculated by first dividing the y-axis of the tension-strain curve by 
100 N/m to make both axes dimensionless, and then rotating the tension-strain curve 
clockwise so that pre-transition and post-transition lines were at equal angles from the 
vertical (which converted the vertex of the transition region to a global minimum). A 
hyperbola was then fit to the points in the transition region (from 0 to 1.5* end-transition 
strain) and the RTC was calculated as the inverse of the second derivative of this global 
minimum. 
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Histology and Immunohistochemistry 
To evaluate the valvular material behavior in context of the ECM composition, 
representative tissue strips equivalent to those used for mechanical testing were fixed in 
10% formalin overnight, dehydrated, paraffin embedded, and sectioned for histological 
examination. Movat pentachrome was used to visualize the different ECM components 
and leaflet layers. Immunohistochemistry was also performed as previously described11' 
35
 to identify and localize the PGs decorin, biglycan, and versican (decorin (LF122) and 
biglycan (LF104) from Larry Fisher, NIH, Bethesda, MD; 36 versican (2B1) from 
Associates of Cape Cod, East Falmouth, MA), the GAG hyaluronan (HA, using 
hyaluronan binding protein, Associates of Cape Cod), and collagen type III (Col III, 
which has been shown to change with age," LF69, from Larry Fisher37). Based on 
T O 
studies showing that valve cell contractility can affect valvular material behavior, 
staining was also performed for the myofibroblast marker non-muscle myosin heavy 
chain-IIB (NMM, Covance, Berkeley, CA) as previously described.39 Briefly, 
immunohistochemical staining consisted of antigen retrieval (citrate buffer, Biocare 
Medical, Concord, CA), except for PGs in which chondroitinase ABC was used36 
(Associates of Cape Cod)), followed by quenching of endogenous peroxidases. Non-
specific staining was blocked using goat serum buffer, followed by application of 
primary antibody. Rinses in PBS were performed before application of the appropriate 
species-specific secondary antibody. Positive staining was visualized using Vectastain 
Elite ABC and diaminobenzidine kits (Vector laboratories, Burlingame, CA), followed 
by hematoxylin counter staining. Radially oriented strips of the MV and AV, which were 
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10, 11 previously stained in this same manner as described in a previous publication, ' were 
also used to provide context. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL), as described in Chapter 4. 
RESULTS 
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Fig. 7-2: A) Thickness of circumferential valve strips with age. Results for radial strips were 
comparable (data not shown). B) Thickness of circumferential valve strips with age 
normalized to heart size (maximum circumference of heart). *, A=significantly different 
between ages within a given valve region. a,fl=valve regions significantly different for a 
given direction (radial or circumferential). 
Thickness 
All test strips cut from the MV were thicker than in the AV (p<0.001), whether in 
the circumferential direction (Fig. 7-2) or radial direction. For all valve strips, thickness 
increased with age (each pO.OOl), as reported previously for human valves.40 The 
normalized thickness of circumferential and radial strips (whether normalized to the 
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circumferential or longitudinal dimension of the heart) of 6-month-olds was greater than 
for other age groups (p<0.035 for each valve or leaflet region; thickness normalized to 
circumference). 
Post-Transition and Pre-Transition Stiffnesses 
In the post-transition region of the tension-strain curves, MV and AV radial 
stiffness was less than circumferential (pO.OOl), consistent with previously published 
studies.15"20 The radial stiffness of MV was greater than for AV (p<0.001, Fig. 7-3). 
Post-Transition Stiffness of Circumferential 
Sections 
Post-Transition Stiffness of Radial Sections 
D 6 week-old g 
Q 6 month-old g 
• 6 year-old 
MVAC 
Fig. 7-3: Slope of post-transition region of tension-strain curves for A) Circumferential strips 
and B) Radial strips. *, *=significantly different between ages within a given valve region by 
post-hoc ofANOVA comparing all ages. a=A V, MV significantly different for a given direction 
(radial or circumferential). f=A V radial significantly different from AV circumferential; 
f=MVAC circumferential, MVF circumferential, and MV radial strips each significantly 
different from one another. 
Among circumferential strips, the stiffness of MVAC was greatest, followed by AV, and 
then MVF (p=0.005). With increasing age, MV and AV radial stiffness increased (each 
p<0.003), as did MV and AV circumferential stiffness (each p<0.010). 
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In the pre-transition region of the curves, there were no significant differences 
between circumferential and radial stiffnesses in either the AV or MV. Amongst MV and 
AV circumferential samples, MVF pre-transition stiffness was greater than MVAC, 
followed by AV (Fig. 7-4, p<0.001). With increasing age, the pre-transition stiffness of 
MV samples (both circumferential and radial) and AV radial samples increased (each 
pO.001). 
A . Pre-Transition Stiffness of Circumferential B . 
Sections 
Pre-Transition Stiffness of Radial Sections 
D 6 week-old 
{ H 6 month-old 
16 year-old 
Fig. 7-4: Slope of the pre-transition region of tension-strain curves for A) Circumferential 
strips and B) Radial strips. *, A=significantly different between ages within a given valve 
region by post-hoc ofANOVA comparing all ages. a,p=A V, MV significantly different for a 
given direction (radial or circumferential). 
Stress Relaxation 
In the AV, radial sections showed a higher Kfast but a lower Ksiow than 
circumferential strips (Table 7-2, each p<0.001). In the MV, however, the Kfast and KS|0W 
of MVAC circumferential strips were higher than for MV radial (each p<0.005). Among 
radially oriented sections, the AV Kfast and KS|0W were both greater than for the MV (each 
p<0.002). Among circumferential sections, Kfast of MVAC was greater than AV, 
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followed by MVF (pO.OOl), but Ksiow was greatest in AV (AV>MVAOMVF, 
p<0.001). With increasing age, AV circumferential Kfast was reduced (p=0.006), as was 
MVF circumferential KS|0W (p=0.046). With respect to the relative magnitudes of 
relaxation, %SR was greater for AV circumferential than for AV radial (Fig. 7-5, 
Table 7-2. Stress Relaxation Time Constants. 
Valve 
Valve region Direction Age Kfast Ksiow 
AV total rad1'2 6wk 0.545±0.025 0.0295±0.0010 
6 mo 0.596±0.030 0.0321±0.0013 
6y r 0.543±0.023 0.0312±0.0010 
circ2'5'6 6wk 0.548±0.023* 0.036U0.0010 
6 mo 0.445±0.030* 0.0329±0.0013 
6 y r 0.485±0.023 0.0352±0.0010 
MV total rad1'3 6wk 0.493±0.046 0.0270±0.0013 
6 mo 0.477±0.056 0.0264±0.0015 
6yr 0.463±0.056 0.0240±0.0015 
MVF circ4'6 6 wk 0.457±0.069 0.0307±0.0019* 
6 mo 0.468±0.069 0.0270±0.0019 
6yr 0.499±0.044 0.0263±0.0012* 
MVAC circ3'4'5 6 wk 0.545±0.052 0.0299±0.0014 
6 mo 0.566±0.069 0.0330±0.0019 
6yr 0.707±0.046 0.0285±0.0013 
Units for Kfast and Ksiow are N/sec. Data represents mean ± SEM. 
*=significant difference between indicated ages within a given valve region/direction. 
Samples with the same numeric superscripts indicate significant differences between 
Kfast as well as KS]0W values for those samples across ages, except 4 in which Kfast was 
only significantly different between samples and 6 in which only Ksiow was 
significantly different between samples. All differences marked represent p<0.05. 
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Fig. 7-5: Total percent SR for A) Circumferential strips and B) Radial strips. *, A=significantly 
different between ages within a given valve region by post-hoc ofANOVA comparing all ages. 
a=valve regions significantly different for a given direction (radial or circumferential). f= 
MVAC circumferential, MVF circumferential, and MV radial strips each significantly different 
from one another. 
p<0.001) and greater for MVAC circumferential, followed by MVF circumferential, then 
MV radial (p<0.001). Among circumferential strips, %SR of MVAC was greater than 
for either AV or MVF (p=0.014). With increasing age, %SR was increased in AV 
circumferential strips (p=0.009) and in MVF circumferential sections (p^O.005). 
Extensibility 
In both the AV and MV, circumferential strips were less extensible than radial 
strips (Fig. 7-6, p<0.001). There were no differences between extensibilities of AV and 
MV strips. In both MV and AV radial strips, as well as in MVAC circumferential strips, 
extensibility was reduced with age (each p<0.010). There was no effect of age on the 
extensibility of MVF circumferential strips. Among AV circumferential strips, the 6-
month-old samples were the least extensible (pO.OOl). 
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Extensibility of Circumferential Sections B. Extensibility of Radial Sections 
6 week-old 
A # 136 month-old 
6 year-old ~ 3 5 
MVAC 
Fig. 7-6: Extensibility for A) Circumferential strips and B) Radial strips. *, A,#=signifwantly 
different between ages within a given valve region by post-hoc ofANOVA comparing all ages. 
}=AV radial significantly different from AV circumferential; f= MVradial strips are significantly 
different from both MVAC and MVF circumferential strips. 
Radius of Transition Curvature (RTC) 
AV circumferential RTC was less than AV radial RTC (Fig. 7-7, pO.OOl). 
MVAC circumferential RTC was less than MVF circumferential RTC, and then MV 
radial RTC (pO.OOl). Among circumferential strips, AV RTC was less than MVAC 
RTC, which was less than MVF RTC (pO.OOl). With age MVF circumferential and MV 
radial RTC increased (p=0.003 and p=0.033), but no age-associated changes were evident 
in AV strips. 
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Radius of Transition Curvature for 
Circumferential Sections a 6 week-old 
S 6 month-old 
• 6 year-old 
B. Radius of Transition Curvature for Radial Sections 
% 15 
MVAC 
Fig. 7-7: Radius of transition curvature. A) Circumferential strips and B) Radial strips. 
*=significantly different between ages within a given valve region by post-hoc ofANOVA 
comparing all ages. a,j5=A V, MV significantly different for a given direction (radial or 
circumferential). f=AV radial significantly different from AV circumferential; f=MVAC 
circumferential, MVF circumferential, and MV radial strips each significantly different from 
one another. 
Differences between AV Leaflets 
In 6-year-old AVs, the non-coronary leaflet was thicker than the left or right 
coronary leaflets (p=0.007), as previously reported for human valves.40'41 However, there 
was no significant difference in thickness between AV leaflets in the other age groups. 
For both radially and circumferentially oriented strips, Kfast of the non-coronary leaflet 
was greater than for the other two leaflets (each p<0.037). However, the circumferential 
%SR for the non-coronary leaflet was less than for the other two leaflets (p—0.039). RTC 
of AV non-coronary leaflets was less than the coronary leaflets (p=0.031). 
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Differences in Valve Matrix Composition 
6 week-old 6 year-old 
annulus mid-leaflet annulus mid-leaflet 
Fig. 7-8: Representative Movat stained tissue sample sections for 6-week-old and 6-year-old 
radial strips. In Movatpentachrome stained tissue yellow=aligned collagen, black=elastic fibers, 
and green/blue=PGs/GAGs. To facilitate comparison between AV and MV, valves are all 
oriented with the fibrosa at the bottom of the image and sized to show the complete leaflet 
thickness allowing visualization of all leaflet layers. Because of differences in leaflet thickness 
(see Fig. 7-2), magnifications differ between images. Scale bars indicate 200 yon. Note that the 
MV radial annulus is almost exclusively fibrosa (corresponding to the MVAC), while A V radial 
annulus shows a considerably smaller proportion of the leaflet thickness composed of fibrosa. 
Also of note is the marbling of PG/GAG with collagen in the fibrosa of 6-year-old MV radial 
annular strips (see inset close-up) and MVAC circumferential strips compared to 6-week-old 
strips. This marbling may, in part, account for the increase in SR seen with age (see Discussion). 
By Movat staining, it was evident that the annulus portion of MV radial strips 
(corresponding to the MVAC) contained a higher proportion of the collagen-rich fibrosa 
layer compared to AV radial strips (Fig. 7-8). MVAC circumferential strips contained a 
much thicker fibrosa than found in MVF (Fig. 7-9). With age, the fibrosa thickened and 
collagen content increased throughout the valve layers, but this increase was particularly 
evident in the fibrosa layer and in the ventricularis layer, where collagen surrounded 
elastic fibers. Interestingly, there also was a marbling of PG/GAGs (see inset in Fig. 7-8) 
206 
in the fibrosa of the 6-year-old MV radial annulus and MVAC circumferential section, 
which was not evident in the younger ages. Immunohistochemistry revealed that the PGs 
versican, biglycan, and decorin, as well as the GAG hyaluronan, were present within this 
marbling. Circumferential strips also contained more Col III with age (Fig. 7-10), as 
6 week-old (High Mag) 6 week-old 6 month-old 6 year-old 
Fig. 7-9: Representative Movat stained tissue sample sections for 6-week-old, 6-month-old, and 
6-year-old circumferential. In Movat pentachrome stained tissue yellow =aligned collagen, 
black=elastic fibers, and green/blue=PGs/GAGs. To facilitate comparison between A V and 
MV, valves are all oriented with the fibrosa at the bottom of the image. Images in column I 
show high magnification of 6-week-old valves (all images in column I are the same 
magnification). Images in columns 2-4 are lower magnification to demonstrate the differences 
in leaflet thickness (all images in columns 2-4 are the same magnification). Scale bars indicate 
200 ymi. Compared to MVF, MVAC circumferential sections contain much higher proportion of 
fibrosa. For all valve regions an increase in collagen is noted throughout the valve layers with 
age, but most particularly in the fibrosa and ventricular is. 
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found previously for radial strips.11 The myofibroblast marker NMM was more strongly 
expressed in 6-year-old strips of MVAC than in younger valves. 
6 month-old 6 year-old 
Fig. 7-10: MVAC circumferential sections showing increased Col III and NMM in 6-
year-old sections compared to 6-month-old sections. Similar differences were noted 
for the staining of Col III for other valve regions between the 6-year-old aged sections 
and the younger ages. Scale bar indicates 200 pm. Insets in NMM images are 1.5x 
higher magnification for improved visualization of cells. 
DISCUSSION 
This study showed, for the first time, that there are significant age-related 
differences in numerous material properties of mitral and aortic valves. At each age, the 
valves were more extensible and less stiff radially than circumferentially, as is well 
known.15"20 All valves, however, demonstrated age-associated increases in post-transition 
stiffness and most also showed increased pre-transition stiffness. In general, extensibility 
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was reduced with age, especially radially. Stress relaxation parameters also varied with 
age, particularly circumferentially. The overall shape of the tension-strain curves also 
changed with age, as demonstrated by the novel parameter RTC, which generally 
increased with age in the MV and was larger radially than circumferentially. These age-
related changes in material properties paralleled an increase in collagen content, 
particularly in the fibrosa and ventricularis (which is normally rich in elastic fibers), and 
a marbling appearance of the fibrosa, in which PG/GAGs were interspersed throughout 
the collagen. Because this study tested mitral and aortic valves from the same hearts, it 
was also possible to demonstrate differences in material properties between mitral and 
aortic valves. 
With increasing age, the leaflets showed greater post-transition stiffness both 
radially and circumferentially. This finding is consistent with age-related stiffening of 
other connective tissues such as cartilage42 and tendon,43 which are mainly attributed to 
increased collagen crosslinking.43 Leaflet composition explains much of the differences 
in stiffness among sample groups. For example, the preponderance of the collagenous 
fibrosa layer within the MV annulus likely contributes to the greater radial stiffness of 
MV compared to AV and the greater circumferential stiffness of MVAC compared to 
MVF. Age-related increases in fibrosa thickness and collagen content shown here for 
numerous valve regions, as well as previously reported increases in collagen1'2 and in 
crosslinking2'4 in aging valves, could explain the increased stiffness with age. A greater 
proportion of cells in the 6-year-old MVAC expressed the activated myofibroblast 
phenotype, which has been linked with increased leaflet stiffness.38 In addition, collagen 
crosslinking has been directly correlated with the stiffness of circumferential strips of 
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human AV, although no such correlation was found for radial strips. Combined with 
evidence suggesting that the ventricularis is a key contributor to valvular material 
behavior in the radial direction,22' 44 the age-related increase in radial stiffness could be 
due to increased collagen in the ventricularis, as observed in the Movat-stained sections. 
Interestingly, the pre-transition stiffness was also significantly increased with age. 
This parameter may be due in part to the stiffness of the elastic fibers,45 but is not often 
reported15' 16' 18' 46 and has never previously been studied with respect to age. The 
increase in pre-transition stiffness with age could reflect the stiffening of aging elastic 
fibers,43 as well as increased collagenous reinforcement of the elastic fibers, which was 
observed in Movat-stained sections. It was also noteworthy that the age-related increases 
in the thickness of the valve leaflets40 were not proportional to the increase in heart size, 
possibly due to the ventricular hypertrophy found in older animals.47'48 
Accompanying the age-related increase in the post-transition stiffness was a 
pronounced reduction in radial extensibility of older valves. Extensibility assesses the 
amount of tissue can stretch before the collagen fibers are fully uncrimped and able to 
bear load;21 its magnitude reflects both collagen fiber crimp and alignment. The finding 
1 f\ 1 R 
that extensibility is greater radially than circumferentially confirms previous reports; " ' 
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 this anisotropy permits the leaflets to stretch radially during valve closure. These 
findings are also consistent with a previous report on an age-related reduction in maximal 
radial stretch of human cryopreserved valves. A reduction in extensibility with age 
could be attributed to factors that impact collagen uncrimping, such as increased collagen 
crosslinking2' 4 or elastic fiber fragmentation,43 which can lead to gradual permanent 
tissue stretch and less crimped collagen fibers. Indeed, in tendon collagen, crimp 
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amplitude decreases and crimp wavelength increases with age; these extensibility 
changes motivate future study of collagen crimp in aging heart valves. Similarly, heart 
valves subjected to glutaraldehyde fixation (crosslinking) under pressure demonstrated 
reduced collagen crimp and extensibility.50 
The novel finding of an increase in the percentage of circumferential stress 
relaxation (in AV and MVF) with age could be due to many factors. First, there is more 
hyaluronan with age10 as well as marbling of PGs/GAGs in the collagenous fibrosa, 
which would allow more sliding of collagen bundles relative to one another. 
Alternatively, the greater numbers of PGs decorin and biglycan,10 which bind to the 
surface of collagen fibrils,52 could be transferring more load from collagen to other 
matrix components, resulting in greater %SR. Indeed, age-related changes in %SR were 
most evident in the circumferential direction, the predominant collagen fiber direction.53 
Reductions in the functionality43 and content10 of elastic fibers could also increase stress 
relaxation, according to studies in pericardium.54 Lastly, the greater abundance of Col III, 
which dissipates more energy than does Col I,55 could have contributed to the greater 
%SR with age. There is some disagreement in the heart valve literature regarding 
anisotropy in stress relaxation.14'17'20'23'24 Our finding of greater %SR in circumferential 
strips compared to radial strips corroborates work by Lee et al., who measured the %SR 
of fresh leaflets over 1000 seconds using uniaxial testing. 
The viscoelasticity of valve tissues has been examined using a wide variety of 
constitutive models, 17' 19, 33' 56"59 but the effects of age have not been previously 
investigated. In particular, the QLV model developed by Fung et al.60 has been applied to 
fresh and fixed valve tissues, 19' 33' 56 analysis using this technique, however, is 
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computationally intense. In this study, a Maxwell-Weichert model with 3 elements was 
used to examine biphasic decay behavior of the stress relaxation curve.61' 62 The age-
related decreases in Kfast of AV circumferential samples and in KS|0W of MVF samples 
both indicate more viscous behavior, which could relate to the increased abundance of 
PGs and GAGs.10 The Kfast and Ksiow values reported in this study also serve as baseline 
parameters for evaluating mechanical properties of tissue engineered heart valves. While 
current tissue engineered heart valve studies have focused primarily on linear material 
properties, understanding viscoelastic properties will continue to be of significant value, 
especially as more advanced materials are developed. 
The novel parameter RTC, which quantifies the acuteness of the transition region 
of the tension-strain curve, can be compared across samples for any soft tissues that 
display bi-linear tension-strain or stress-strain curves. Collagen fibers that are highly 
aligned and uniformly crimped will have a very acute transfer of load-bearing from 
elastic fibers to the straightened collagen fibers, and hence a very small RTC. If collagen 
fibers are not uniformly crimped, their transition to load-bearing would be more gradual, 
resulting in a greater RTC. A larger RTC would also result from a random fiber 
alignment, in which some fibers would be initially aligned with the applied load and 
begin bearing load at low strains, but the remaining collagen bundles would require 
varying amounts of additional strain and/or rotational realignment before bearing load. 
Indeed, the angular distribution of collagen fibers significantly changes within this 
transition region.21 The smaller RTC of MVAC circumferential strips compared to MVF 
likely indicates greater alignment53 and homogeneity of collagen fiber crimping in 
MVAC compared to the other valve regions. In the valve, collagen bundles are 
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predominantly oriented circumferentially, therefore RTC would be lower 
circumferentially than radially, as found here. The age-related increase in RTC of MVF 
and MV radial strips could be due to greater collagen crosslinking2, 4 and a greater 
abundance of network-forming collagen type III. In the future, it will be important to 
relate this parameter to changes in the soft tissue microstructure during this transition 
region of loading. 
This study is also the first to show differences in material properties between non-
coronary (NC) and coronary AV leaflets, such as lower %SR and RTC in the NC leaflet. 
These differences may be due to the lack of coronary blood flow within the NC sinus; 
simulations of human AVs have shown that NC experiences higher stress63 and greater 
diastolic pressure loading than the other leaflets.64 The NC leaflet also contains smaller 
diameter collagen fiber bundles,65 which may permit easier rotation of collagen fibers as 
they align in the direction of loading, and hence contribute to a lower RTC. An 
additional subset of valves was frozen at -20°C for 2 months before testing; as previously 
18 
demonstrated by Clark, significant differences were found between fresh AV and 
previously frozen AV (data not shown). 
CONCLUSIONS 
In this study, aortic and mitral valves from the same porcine hearts were subjected 
to tensile testing. In the analysis of the tensile testing data, we developed a novel 
parameter, radius of transition curvature, which may be useful in quantifying the dynamic 
stress-strain behavior of biological tissues. Overall, our results showed that between 
aortic and mitral valves, and within each valve, there are profound heterogeneities and 
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age-related changes that reflect the ECM and microstructural composition. In addition, 
the effects of age on the heart valve tissues differ between valves, valve regions, and 
material testing orientations. Given the documented similarities between porcine and 
human valves, these results provide further justification (as well as baseline data) for the 
development of age-specific tissue engineered heart valves. These age-related changes in 
valve material properties likely contribute to proper physiologic function of valves at 
different ages. For instance, the age-related increase in leaflet stiffness likely allows the 
aortic and mitral valves to withstand the increase in cardiac pressures and concomitant 
decrease in aortic compliance with age.12 Clearly, considerable work remains in 
understanding the structural and mechanical complexity of heart valves, their 
extracellular matrix and cell composition, and the contributions of these characteristics to 
valve function. 
This chapter concludes the studies addressing the topic of normal aortic and 
mitral valve aging; this topic included studies analyzing age-related changes in 
matrix composition and structure (Chapter 3-6), as well as analysis of changes in 
material properties contained in this chapter. The next series of chapters, which 
open Volume 2 of this thesis, addresses heterogeneity in the normal valve. These 
chapters are subdivided into those related to heterogeneity in mitral valve 
composition and motion (Chapters 8 and 9) and those related to heterogeneity in the 
valvular interstitial cell population (Chapters 10 and 11). Specifically in the next 
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chapter, analysis of regional mitral valve leaflet composition in relationship to in 
vivo leaflet length changes is presented. 
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VOLUME II 
Chapter 8: Cellular and Extracellular Matrix Basis for 
Heterogeneity in Mitral Annular Contraction 
Having addressed normal valve aging in the preceding chapters (Chapters 3-
7) contained in Volume 1 of this thesis, the next series of chapters that opens Volume 
2 of this thesis addresses heterogeneity in the normal valve. These chapters are 
subdivided into those related to heterogeneity in mitral valve composition and 
motion (Chapters 8 and 9) and those related to heterogeneity in the valvular 
interstitial cell population (Chapters 10 and 11). Specifically in this chapter, 
analysis of regional mitral valve leaflet composition in relationship to in vivo leaflet 
length changes is presented. 
ABSTRACT 
Background: Regional heterogeneity of mitral annular contraction, generally ascribed to 
the fibrous vs. muscular annular composition, has been well described in the mammalian 
mitral valve. It is unknown, however, whether the cells in the annulus, and the 
extracellular matrix that they produce, contribute to this heterogeneity. We set out to 
investigate the relationship between ultrastructure and regional geometry of the normal 
ovine mitral annulus. 
Methods: Fourteen sheep underwent implantation of 8 radiopaque markers around the 
mitral annulus defining four segments: septal (SEPT), lateral (LAT), and anterior (ANT-
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C) and posterior (POST-C) commissures. Maximum and minimum annular segmental 
lengths during the cardiac cycle were calculated using biplane videofluoroscopy. 
Immunohistochemistry of annular cross sections assessed regional matrix content, matrix 
turnover, and cell phenotype, as well as degree of fibrosa insertion. 
Results: Regional annular contraction was inversely related to the degree of fibrosa 
insertion into annular muscle. Whereas SEPT contained more collagen I and III 
(pO.OOl), LAT demonstrated more collagen and elastin turnover as shown by greater 
decorin, lysyl oxidase, and matrix metalloprotease (MMP)-13 (p<0.033) and smooth 
muscle alpha-actin (SMaA, indicating myofibroblastic valve cell activation, pO.OOl). 
This greater matrix turnover was consistent with greater annular contraction in LAT 
compared to SEPT (18.1±4.4% vs. 3.9±2.6%, pO.OOl). Similarly, POST-C had more 
SMaA and MMP13 than ANT-C (p<0.02), consistent with greater annular contraction in 
POST-C (15.4±5.7% vs. 9.9±3.5%, pO.OOl). Correlations between intensities of matrix 
turnover-related proteins and proteins indicating the activation of valvular interstitial cells 
(VICs) strengthen the presumed role of myofibroblasts in the observed compositional 
heterogeneity. 
Conclusions: These data illustrate that matrix turnover and expression of activated VICs 
correlate with regional annular length change, and could be therapeutic targets when 
annular motion is impaired. Conversely, alterations in this heterogeneous annular 
contraction, whether through disease or secondary to ring annuloplasty, could disrupt this 
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normal pattern of cell-mediated matrix remodeling and further adversely impact mitral 
valve function. 
The work contained in this chapter is in preparation for submission to Journal of 
Heart Valve Disease. 
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INTRODUCTION 
The mitral valve (MV) annulus demonstrates heterogeneity in both structure and 
motion. Structurally, the MV annulus is an asymmetric, hyperbolic paraboloid or 
saddle-shaped oval ring.1 Annular deformation during the cardiac cycle is complex and 
diverse, involving tilting around multiple axes,2'3 translation,2 and contraction,4" each 
occurring to varying degrees throughout the different regions of the annulus. In general, 
lateral annular contraction is substantially greater than that of the septal annulus during 
the cardiac cycle.4"6 Elimination of this dynamic movement of the MV annulus in vivo 
may be deleterious to cardiac function.7"9 This heterogeneity has been primarily 
attributed to the fibrous vs. muscular composition of the septal and lateral annulus, 
respectively,4"6' 10 but the role of the MV annular cells and the extracellular matrix that 
they produce in the observed heterogeneous annular contraction has not been previously 
investigated. 
Cells from a wide range of tissues,11 including valves,12' 13 both respond to and 
influence their mechanical environment via phenotypic modulation and synthesis of 
extracellular matrix. The relationship between the highly dynamic in vivo mechanics 
and composition of the valve annulus, however, remains unknown. Establishing such a 
link between annular geometry and composition would have important implications 
regarding the ultrastructural mechanisms of annular dilation in valve diseases, the 
potential for preventative treatments, and the design of better annular repair strategies and 
annuloplasty rings. Therefore, the aim of this study was to correlate the regional 
heterogeneity of normal MV annular length change during the cardiac cycle with regional 
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extracellular matrix composition and valve cell activation using immunohistochemistry 
(IHC). IHC was performed for a number of proteins related to cell activation as well as 
the abundance, synthesis, and degradation of extracellular matrix. 
METHODS 
All animals received humane care in accordance with the guidelines of the US 
Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The use of 
animals in this study was approved by the Stanford Medical Center Laboratory Research 
Animal Review Committee. 
Animal Protocol 
Eight (8) radiopaque markers were implanted into 14 sheep to delineate four 
annular segments (Fig. 8-1): septal (SEPT, the distance of segments between markers 2 
and 4) and lateral (LAT, markers 6-8) annulus, and anterior (ANT-C, markers 4-6) and 
posterior (POST-C, the distance of segments between markers 1 and 2 and markers 2 and 
8) commissures. Procedures for marker implantation and biplane video fluoroscopy have 
been described previously.14 Annular segment contraction was calculated as the 
percentage change from maximum to minimum segment length during the cardiac cycle 
both at baseline and during inotropic augmentation with calcium infusion5 in open-chest 
animals. The hearts were then harvested and stored in formalin. 
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Fig. 8-1: Location of the different annular segments from which tissue sections were taken. 
In the case of septal segment (SEPT) and lateral segment (LAT) 2 tissue sections were 
analyzed, in the case of the anterior and posterior commissures (ANT-C, POST-C), one tissue 
section was taken from either side of the tantalum marker based on quality of the leaflet on 
each side. For calculation of annular contraction, the distance between the segments between 
markers 2 and 4 was defined as SEPT, markers 6-8 as LAT, markers 4-6 as ANT-C, and the 
distance of segments between markers 1 and 2 and markers 2 and 8 as POST-C. 
Histology and Immunohistochemistry 
For each segment of the MV annulus a 3-5 mm wide strip was cut from the 
myocardium to the leaflet free edge (Fig. 8-1, locations #1, 3, 5, 7). Cross sections were 
embedded in paraffin and sectioned to a thickness of five microns. Each sample was 
stained with Movat pentachrome as well as IHC to demonstrate specific extracellular 
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Table 8-1. Panel of Antibodies Used in IHC. 
Protein Function 
Collaqens and Collagen-Turnover Proteins 
Collagen I (Col l)a Predominant collagen in valve, provides tensile strength 
Collagen III (Col III)a Reticular collagen 
Matrix Metalloproteinase (MMP)-13b Collagen degradation 
Elastic Fiber-Related Proteins 
Matrix Metalloproteinase (MMP)-9C Elastin degradation 
Lysyl oxidase (LOX)d Involved in collagen and elastin crosslinking 
Elastin e Predominant component of elastic fibers 
Proteoglycans (PG) and Glvcosaminoglvcans (GAG) 
Hyaluronan (HA) f GAG providing compressibility 
Decorin (DCN)a PG involved in collagen fibrillogenesis 
Valve Cell Activation 
Smooth muscle alpha-actin (SMaA)9 Indicates an "activated" myofibroblast-like phenotype 
Non-muscle Myosin Heavy Chain (NMM)h Indicates an "activated" myofibroblast-like phenotype 
a
 gift of Dr. Larry Fisher, NIH (Bethesda, MD); Chemicon (Temecula, CA); cAssay Designs 
(Ann Arbor, MI); d Imgenex (San Diego, CA); eAbcam (Cambridge, MA); 'Associates of Cape 
Cod (Falmouth, MA);9 Dakocytomation (Denmark);h Covance (Berkeley, CA). 
matrix components, enzymes involved in matrix turnover, and cell phenotype (Table 8-
1). Staining intensity in each layer (fibrosa, atrialis, and muscle, Fig. 8-2A) of the four 
MV annulus segments of blinded samples was quantified using ImageJ software (NIH, 
Bethesda, MD). Semiquantitative grading of blinded samples was also performed to 
evaluate the degree of fibrosa insertion into annular muscle using a pre-determined rubric 
(Fig. 8-2B, see legend for specific criteria for each grade). 
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Insertion Grading Rubric 
Fig. 8-2: A) Right image shows location of layer of annulus analyzed in tissue section relative to 
leaflet below and annular fluoroscopy marker seen in left photograph of gross specimen. Arrows 
point to layers of the MV annulus (atrialis, fibrosa, and muscle). Scale bar represents 2 mm. B) 
Semi-quantitative grading scale for degree of insertion: l=insertion either appears spongy, does not 
contain collagen, or insertion fibrosa remains superficial (does not penetrate muscle); 2=insertion 
is either not collagen, or poorly aligned collagen, or is a combination of collagen and spongy 
material; 3=mostly collagen, but thinner or does not insert as far into the muscle. 4=collagen-rich, 
substantial (thick) fibrosa that continues well into muscle. LA=left atrium, LV=left ventricle. 
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Statistical Analysis 
Multifactorial analysis of variance (ANOVA) was performed using SigmaStat 
(SPSS, Chicago, IL), as described in Chapter 4. Because of the multiple segments and 
layers analyzed, data is reported as mean ± standard error of the mean, unless otherwise 
indicated. Paired t-tests were used to compare annular contraction with and without 
calcium infusion. Correlations between staining intensities of different proteins within 
individual annular layers and segments were used to assess protein co-localization related 
to matrix turnover and cell phenotype. Correlations between protein intensities and 
annular contraction were analyzed to investigate the mechanobiology of compositional 
differences. These correlations were calculated using Pearson and Spearman tests, as 
described in Chapter 5. For correlations between intensities of different proteins p<0.02 
was considered a trend and p<0.00625 considered significant (since 8 proteins were being 
compared); for correlations between intensities of proteins and annular contraction each 
protein was considered individually, therefore p<0.05 was considered significant, but 
only the most significant of these correlations with p<0.03 are listed. 
RESULTS 
Heterogeneity of Annular Segment Contraction 
Without calcium infusion, annular contraction was greatest in LAT, followed by 
POST-C, ANT-C, and lastly SEPT (Table 8-2, p<0.001). With calcium infusion, annular 
contraction was greatest in LAT and POST-C, followed by ANT-C, and lastly SEPT 
(Table 8-2, pO.OOl). The contraction of each annular segment except SEPT increased 
with calcium infusion compared to baseline (each p<0.036). 
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Table 8-2. Percent Contraction of Annular Segments 















*p<0.05 v. Baseline; fp<0.05 v. SEPT; tp<0.05 v. ANT-C; 
data presented as mean ± standard deviation. 
Differences in Leaflet Insertion Structure 
The degree to which the fibrosa inserted into the musculature was greatest in 
SEPT followed by ANT-C, POST-C, and lastly LAT (mean grades of 4.0, 2.3, 2.0, and 
1.75 respectively, overall ANOVA comparing all segments p<0.001). These grades were 
inversely correlated with the relative percent contraction in the annular segments (Table 
8-2). The degree of insertion grades indicate that the fibrosa in SEPT continued deep into 
the musculature as a substantial, collagen-rich band, whereas in LAT the fibrosa 
remained more superficial to the annular musculature. Additionally, in LAT the leaflet 
appeared to be a continuation of the muscular tissue (Fig. 8-3), as opposed to an 
independent structure into which the muscle inserted. In contrast, in both ANT-C and 
POST-C the leaflet was more structurally distinct from the adjacent musculature. 
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Fig. 8-3: Examples of differences in insertion structure in different MV annular segments. In the left 
panel is an image representing the typical insertion of the LAT leaflet with the large base, middle 
panel represents the commissural segments, and right panel represents the SEPT leaflet. Scale bars 
represent 2 mm. LA-left atrium, LV=left ventricle. 
Compositional Heterogeneity between Septal and Lateral Segments and between 
Commissures 
Compared to the LAT annulus, the SEPT annulus contained more Col I and III 
both across layers (Fig. 8-4, each p<0.001) and in the muscle layer individually (each 
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Collagen Content in Annular Segments 
• Coll 
• Col III 
140
 n 
LAT SEPT ANT-C POST-C 
Fig. 8-4: Relative amounts of Col I and HI across the different annular segments. Overall 
ANOVA comparison between segments for Col I and Col HI each p<0.001. *p<0.001 vs. LAT 
for a given protein (Col I or Col III). Ap<0.01 vs. SEPT for a given protein (Col I or Col III). 
For all graphs, error bars indicate standard error of the mean. 
pO.OOl). In contrast, LAT showed greater expression of proteins related to collagen and 
elastic fiber turnover including the collagen-degrading enzyme MMP13 (Fig. 8-5, 
pO.OOl); the proteoglycan DCN, which is involved in collagen fibrillogenesis (LAT 
152.6±2.7, SEPT 144.8±2.7, p=0.033); LOX, an enzyme involved in both elastin and 
collagen crosslinking (LAT 130.8±5.2, SEPT 117.9±3.9, p=0.006); and elastin (Fig. 8-6, 
p<0.005). LAT also demonstrated greater expression of two indicators of cell activation, 
SMaA (Fig. 8-5, pO.OOl) and NMM (LAT 69.0±2.6, SEPT 64.7±2.4, p=0.012). 
Interestingly, LAT also displayed greater expression of the glycosaminoglycan HA (LAT 
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LAT SEPT ANT-C POST-C 
Fig. 8-5: Relative amounts of MMP13 and SMaA across the different annular segments. 
Overall ANOVA comparison between segments for MMP13 and SMaA each p<0.001. All 
comparisons between annular segments were significant for MMP13, therefore those are not 
indicated on the graph. *p<0.001 vs. SEPT for SMaA. Ap<0.001 vs. POST-C for SMaA. 
105.3±4.4 vs. SEPT 94.2±3.0, p<0.006) compared to SEPT. These results of greater 
collagen and elastic fiber turnover in LAT compared to SEPT parallel the contractile 
patterns of these regions (baseline contraction: LAT 18.1±4.4% vs. SEPT 3.9±2.6%, 
p<0.001, Table 8-2). In addition, MMP13 expression in the LAT fibrosa and muscle 
layers was correlated with the magnitude of annular contraction at baseline (r=0.780-
0.823, p<0.023). Compared to ANT-C, the POST-C annulus contained significantly 
more Col III (p<0.015), as well as MMP13 (p<0.02) and SMaA (p=0.006), which may be 
consistent with the greater annular contraction in the POST-C annular segment (baseline 
contraction: POST-C 15.4±5.7% vs. ANT-C 9.9±3.5%, p<0.001, Table 8-2). 
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Elastin in Annular Segments 
Elastin 
LAT SEPT ANT-C POST-C 
Fig. 8-6: Relative amounts of elastin across the different annular segments. Overall 
ANOVA comparison between segmentsp<0.001. *p<0.005 vs. SEPT. 
Compositional Heterogeneity among Septal, Lateral, and Commissural Segments 
In the comparison of all the different annular segments, POST-C showed the 
greatest Col I and III of all the segments (Fig. 8-4, both overall pO.001). Col I and III in 
ANT-C were both greater than LAT (both pO.001). Both commissures also had greater 
expression of MMP13 (Fig. 8-5, pO.001), LOX (POST-C 139.7±5.5, ANT-C 136.5±5.0, 
LAT 130.8±5.2, SEPT 117.9±3.9, p=0.005), and elastin (Fig. 8-6, pO.001). Consistent 
with the greater expression of matrix turnover proteins, ANT-C and POST-C showed the 
greatest expression of SMaA (Fig. 8-5, p<0.001). Lastly, ANT-C and POST-C showed 
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the greatest expression of the glycosaminoglycan HA among the segments (POST-C 
114.0±5.7, ANT-C 110.4±7.3, LAT 105.3±4.4, SEPT 94.2±3.0, overall p=0.001). 
Across annular segments, several strong correlations were noted between proteins 
indicating either cell activation or matrix turnover with magnitudes of annular 
contraction. In the muscle and fibrosa layers, SMaA was strongly correlated with annular 
contraction with and without calcium infusion (muscle: 0.687-0.718, each p<0.00001; 
fibrosa: 0.587-0.611, each p<0.00035), as was MMP13 expression (muscle: 0.622-0.626, 
each p<0.0012; fibrosa: 0.675-0.732, each p<0.0002). 
Correlations between Expressions of Different Proteins 
The presence of the myofibroblast cell phenotype was suggested by several 
correlations between the two proteins indicating cell activation, NMM and SMaA, and 
collagen or MMPs. These correlations included NMM and Col III in the SEPT fibrosa 
(r-0.88, pO.OOl), NMM and MMP9 in the POST-C atrialis (r=0.89, p=0.018), and 
SMaA and MMP13 in the fibrosa and muscle layers of ANT-C and POST-C (r=0.764, 
p=0.006). Across all annular segments, strong correlations were evident between 
MMP13 and SMaA throughout the layers (atrialis 0.875, pO.OOOOl, fibrosa 0.687, 
p<0.00008, muscle 0.88, pO.OOOOOl), and MMP9 with NMM in the fibrosa (0.556, 
p=0.0013). MMP9 also correlated with elastin (0.590, p=0.0025), which further suggests 
elastic fiber turnover. 
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DISCUSSION 
This study provides evidence documenting a novel relationship between the in 
vivo length change of various segments of the mitral annulus and the matrix composition, 
layered structure, and valvular cell phenotype within that segment. Annular contraction 
was inversely related to the degree of fibrous insertion into the muscle, but was directly 
related to matrix turnover and cell activation. The LAT portion of the annulus 
demonstrated greater collagen and elastic fiber turnover, as well as cell activation, 
compared to the SEPT annulus, paralleling greater contraction in LAT compared to 
SEPT. Similarly, collagen turnover and cell activation was high in the POST-C annulus, 
paralleling greater annular contraction in POST-C compared to ANT-C. Overall, the 
commissural annular segments had the highest collagen content as well as most 
pronounced collagen and elastic fiber turnover. Strong correlations between the 
expression of matrix synthesis and turnover-related proteins and myofibroblast proteins 
within individual layers of the different annular segments suggest the involvement of 
myofibroblasts in annular compositional and contractile heterogeneity. 
Functional Implication of Heterogeneous Valve Insertion Structure 
Differences in the insertion of the heavily collagenous fibrosa within the annular 
musculature relate to the mechanical behavior of the different portions of the mitral 
annulus. Although this contractile nature of the mitral annulus has been widely 
investigated,4"6 the microstructural aspects of the mitral leaflets' anchorage within the 
annulus, and how these vary across annular segments, have been largely overlooked. 
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Across the different segments of the MV annulus, the degree of fibrosa insertion was 
inversely related to the magnitude of contraction. Regarding the insertion of the SEPT 
leaflet, the substantial bands of collagen demonstrated here could greatly reduce 
contraction of the SEPT annular segment relative to remainder of the annulus, as 
observed in this and other studies.4'5'15'16 Differences in insertion structure between the 
annular segments could potentially affect the flexibility of this leaflet region. The thick 
annular insertion base anchoring the LAT and commissural leaflets would reduce 
flexibility compared to the thin, narrow base anchoring the SEPT leaflet. Indeed, 
compared to LAT, the SEPT leaflet displays greater excursion3 and closure rate.6 
Annular Compositional Heterogeneity and Relation to Contraction 
The overall abundance of collagen within the various annular segments was 
consistent with the data patterns regarding degree of insertion. For example, the greater 
collagen content in SEPT vs. LAT reflected the collagen-rich fibrosa inserting into the 
muscle of SEPT. However, collagen was not limited to the fibrosa layer; the muscle 
layer of SEPT also contained more collagen that did LAT. This finding suggests that the 
frequently described "fibrous" nature of the SEPT annulus is characterized by collagen 
that is highly organized within the fibrosa layer and diffusely abundant throughout the 
muscular layer. 
Both within the LAT and SEPT annular and the commissural annular 
comparisons, the relative magnitudes of annular contraction paralleled those of matrix 
turnover and cell activation proteins. These results, combined with strong statistical 
correlations between these same variables within individual annular segments, suggest a 
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relationship between annular contraction and matrix turnover/cell activation. 
Correlations were predominantly found between annular contraction and proteins of 
matrix turnover and cell activation in the muscle and fibrosa layers, which is consistent 
with the structural and functional roles of these layers. Interestingly, when all four 
annular segments were compared, the commissures demonstrated not only the greatest 
collagen content but also the greatest collagen turnover and level of cell activation. The 
commissures as a group, however, did not undergo significantly greater annular 
contraction compared to LAT, which would have been expected given their greater 
collagen turnover and cell activation (although this contraction-turnover relationship was 
demonstrated in the POST-C/ANT-C comparison). Reasons for this inconsistency might 
include the density of collagen within the fibrosa layer (very high in commissures but 
admixed with PGs and GAGs in LAT) or the influence of other mechanical stimuli, in 
addition to contraction, that could affect the annulus in a heterogeneous manner. 
Potential Functional Contributions of Myofibroblasts 
Given the known roles of myofibroblasts in matrix remodeling,17'18 correlations 
in the fibrosa layer between proteins associated with myofibroblasts and those indicating 
matrix degradation imply that myofibroblasts contribute to the annular compositional 
heterogeneity. Moreover, myofibroblasts respond to their mechanical environment.19 
Therefore, we speculate that these cells provide an important link between annular 
cell/matrix composition and function by sensing annular contraction and responding by 
synthesizing extracellular matrix. Consequently, the altered matrix composition would 
affect the material behavior of the annular tissue and in turn influence the capacity for 
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contraction. In addition, myofibroblasts also demonstrate contractile properties, which 
have been shown to alter valve stiffness,21 and thus may also affect annular contraction, 
even though the muscular layer is certainly the major effector of contraction. Taken 
together, these results suggest a link between myofibroblasts and annular length change. 
As such, the myofibroblast may be a therapeutic target for diseases in which annular 
composition and contraction is altered. 
Implications 
The link between annular contraction and composition evident in this study 
implies that altered annular contraction, such as occurs with annuloplasty ring 
placement,22'23 as well as in disease processes such as ischemic and functional mitral 
regurgitation,14' 24 may lead to alterations in valve cell phenotype and mitral annular 
composition, which could lead to further deterioration in MV function. Therefore, this 
study provides further motivation for the ongoing refinement of annuloplasty ring designs 
to maintain physiologic, heterogeneous annular contraction. In addition, the 
heterogeneity of the insertions of the mitral valve leaflets into the annulus, which are 
essential mechanical linkages connecting the leaflets to the mitral annular/left ventricular 
complex, will need to be carefully replicated in the design of a tissue engineered mitral 
valve to ensure proper function. In the future, it will be important to understand and 
account for the numerous forces acting on the mitral annulus and how those forces 
interplay with annular composition to provide a more complete picture of the complex 
structure-function relationship in the mitral annulus. 
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Limitations 
One of the limitations in this study is the inherent variability of IHC, which was 
quantified to be 13.7% within batches and 16.5% between batches. In order to limit this 
variability, duplicate sections were cut from the SEPT and LAT annular segments, and 
the staining results were averaged. Furthermore, all samples from a given annular 
segment were stained for a given protein in one batch. Despite any remaining variability, 
we have found significant results. Additionally, there are some anatomic differences 
between the annuli of ovine and humans.25 Therefore, significant caution should be 
practiced before applying the results of this study to human patients. 
CONCLUSIONS 
This study reveals heterogeneity in MV annular composition in terms of 
individual matrix components, matrix turnover, presence of myofibroblasts, and structure 
of leaflet insertion. Furthermore, this study provides the first evidence of a direct 
correlation between the heterogeneity in mitral valve annular matrix composition and 
heterogeneity of annular contraction. Such a link could prove instrumental both in 
clinical strategies to treat valves with altered matrix composition as well as in strategies 
for designing a heterogeneous tissue engineered heart valve. 
This chapter, in which regional mitral valve leaflet composition was analyzed 
in relationship to in vivo leaflet length changes, opens the series of four chapters 
addressing normal valve heterogeneity. This series of chapters is subdivided into 
those related to heterogeneity in mitral valve composition and motion (Chapters 8 
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and 9) and those related to heterogeneity in the valvular interstitial cell population 
(Chapters 10 and 11). In the next chapter, analysis of the composition of the mitral 
annular leaflet attachment region in relationship to in vivo changes in annular 
segment length will be presented. 
242 
REFERENCES 
1. Levine R, Hung J, Otsuji Y, Messas E, Liel-Cohen N, Nathan N, Handschumacher M, 
Guerrero J, He S, Yoganathan A, Vlahakes G. Mechanistic insights into functional mitral 
regurgitation. Curr Cardiol Rep. 2002;4(2):125-129. 
2. Komoda T, Hetzer R, Oellinger J, Sinlawski H, Hofmeister J, Hubler M, Felix R, Uyama 
C, MaetaH. Mitral annular flexibility. J Card Surg. 1997;12(2):102-109. 
3. Karlsson M, Glasson J, Bolger A, Daughters G, Komeda M, Foppiano L, Miller D, Ingels 
N, Jr. Mitral valve opening in the ovine heart. Am J Physiol. 1998;274(2 Pt 2):H552-563. 
4. Glasson J, Komeda M, Daughters G, Niczyporuk M, Bolger A, Ingels N, Miller D. 
Three-dimensional regional dynamics of the normal mitral annulus during left ventricular 
ejection. J Thorac Cardiovasc Surg. 1996;111(3):574-585. 
5. Timek TA, Green GR, Tibayan FA, Lai DT, Rodriguez F, Liang D, Daughters GT, Ingels 
NB, Jr., Miller DC. Aorto-mitral annular dynamics. Ann Thorac Surg. 2003;76(6):1944-
1950. 
6. Tsakiris A, Von Bernuth G, Rastelli G, Bourgeois M, Titus J, Wood E. Size and motion 
of the mitral valve annulus in anesthetized intact dogs. J Appl Physiol. 1971;30(5):611-
618. 
7. Okada Y, Shomura T, Yamaura Y, Yoshikawa J. Comparison of the Carpentier and 
Duran prosthetic rings used in mitral reconstruction. Ann Thorac Surg. 1995;59(3):658-
662; discussion 662-653. 
8. David TE, Komeda M, Pollick C, Burns RJ. Mitral valve annuloplasty: the effect of the 
type on left ventricular function. Ann Thorac Surg. 1989;47(4):524-527; discussion 527-
528. 
9. van Rijk-Zwikker G, Delemarre B, Huysmans HA. Mitral valve anatomy and 
morphology: Relevance to Mitral Valve Replacement and Valve Reconstruction. J Card 
Surg. 1994;9[Suppl]:255-261. 
10. Anderson R, Wilcox B. The anatomy of the mitral valve. In: Shapiro L, ed. Mitral Valve 
Disease. Oxford: Butterworth-Heinemann; 1996:4. 
11. Peyton SR, Ghajar CM, Khatiwala CB, Putnam AJ. The emergence of ECM mechanics 
and cytoskeletal tension as important regulators of cell function. Cell Biochem Biophys. 
2007;47(2):300-320. 
12. Merryman WD, Youn I, Lukoff HD, Krueger PM, Guilak F, Hopkins RA, Sacks MS. 
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: 
implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol. 
2006;290(1):H224-231. 
243 
13. Balachandran K, Konduri S, Sucosky P, Jo H, Yoganathan A. An ex vivo study of the 
biological properties of porcine aortic valves in response to circumferential cyclic stretch. 
Annals of biomedical engineering. 2006;34(11): 165 5-1665. 
14. Timek TA, Dagum P, Lai DT, Liang D, Daughters GT, Tibayan F, Ingels NB, Jr, Miller 
DC. Tachycardia-induced cardiomyopathy in the ovine heart: Mitral annular dynamic 
three-dimensional geometry. J Thorac Cardiovasc Surg. 2003; 125(2):315-324. 
15. Lansac E, Lim K, Shomura Y, Goetz W, Lim H, Rice N, Saber H, Duran C. Dynamic 
balance of the aortomitral junction. J Thorac Cardiovasc Surg. 2002;123(5):911-918. 
16. Parish L, Jackson B, Enomoto Y, Gorman R, Gorman J, 3rd. The dynamic anterior mitral 
annulus.^wz Thorac Surg. 2004;78(4):1248-1255. 
17. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of 
interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis. 
2004;13(5):841-847. 
18. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and 
mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 
2002;3(5):349-363. 
19. Wang J, Chen H, Seth A, McCulloch CA. Mechanical force regulation of myofibroblast 
differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 
2003;285(5):H1871-1881. 
20. Messier RH, Jr., Bass BL, Aly HM, Jones JL, Domkowski PW, Wallace RB, Hopkins 
RA. Dual structural and functional phenotypes of the porcine aortic valve interstitial 
population: characteristics of the leaflet myofibroblast. J Surg Res. 1994;57(1):1-21. 
21. Merryman W, Huang H, Schoen F, Sacks M. The effects of cellular contraction on aortic 
valve leaflet flexural stiffness. JBiomech. 2006;39(l):88-96. 
22. Glasson JR, Green GR, Nistal JF, Dagum P, Komeda M, Daughters GT, Bolger AF, 
Foppiano LE, Ingels NB, Jr., Miller DC. Mitral annular size and shape in sheep with 
annuloplasty rings. J Thorac Cardiovasc Surg. 1999;117(2):302-309. 
23. Green GR, Dagum P, Glasson JR, Nistal JF, Daughters GT, 2nd, Ingels NB, Jr., Miller 
DC. Restricted posterior leaflet motion after mitral ring annuloplasty. Ann Thorac Surg. 
1999;68(6):2100-2106. 
24. Kaplan SR, Bashein G, Sheehan FH, Legget ME, Munt B, Li XN, Sivarajan M, Bolson 
EL, Zeppa M, Arch MZ, Martin RW. Three-dimensional echocardiographic assessment 
of annular shape changes in the normal and regurgitant mitral valve. Am Heart J. 
2000;139(3):378-387. 
25. Walmsley R. Anatomy of human mitral valve in adult cadaver and comparative anatomy 
of the valve. Br Heart J. 1978;40(4):351-366. 
244 
Chapter 9: Relationship of Mitral Leaflet Compositional 
Heterogeneity to Leaflet Deformation 
The work contained in this chapter continues the topic of normal valve 
heterogeneity, and specifically the topic of mitral valve composition in relationship 
to in vivo strains addressed in the previous chapter. In this chapter analysis of 
mitral annular composition in relationship to in vivo changes in annular segment 
length is presented. 
ABSTRACT 
Background: Mitral valve (MV) leaflets must undergo regionally heterogeneous 
dynamics to ensure proper valve closure. The compositional and cellular basis for this 
regional heterogeneity, however, is incompletely understood. We studied regional leaflet 
matrix composition, matrix turnover, and cell phenotype as it relates to regional 
deformation. 
Methods: Matrix composition and cell phenotypes were immunohistochemically 
evaluated in three regions (basal leaflet (BL), mid-leaflet (ML), and free edge) within the 
septal (SEPT), lateral (LAT), and anterior and posterior commissural leaflets (ANT-C, 
POST-C) of 14 sheep. Videofluoroscopy imaging of radiopaque markers implanted in 
the septal and lateral leaflet of the same sheep was used to calculate maximum radial and 
circumferential lengths during the cardiac cycle, and related to regional composition. 
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Results: Collagens I and III in SEPT were greater than in LAT (p<0.025 for ML, BL). 
LAT, however, showed greater collagen turnover (matrix metalloprotease (MMP)-13 
p<0.005 in each region, lysyl oxidase p<0.008 in ML) and cell activation (smooth muscle 
alpha-actin, SMaA, pO.OOl in each region and non-muscle myosin (NMM) pO.OOl in 
ML, BL). SMaA and MMP13 in POST-C ML were greater than ANT-C (each p<0.008). 
Correlations between MMP13, MMP9, NMM, and SMaA suggested the role of 
myofibroblasts in this compositional heterogeneity. MMP13, NMM, and SMaA were 
strongly correlated with length changes in both SEPT and LAT. 
Conclusions: This work demonstrates significant heterogeneity in MV leaflet 
composition and suggests a link between MV deformation and matrix turnover. 
Additionally, these results suggest that myofibroblasts, given their contractility and 
synthetic capability, contribute to the heterogeneity in both leaflet composition and 
deformation. This information should guide new approaches to MV repair techniques 
and ring design to preserve this normal coupling between leaflet composition and motion. 
The work contained in this chapter is in preparation for submission to Journal of 
Heart Valve Disease. 
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INTRODUCTION 
Mitral valve (MV) competence is critical to cardiac function. Indeed, mitral 
regurgitation portends a significantly higher morbidity and mortality to patients with 
myocardial infarction independent of left ventricular function.1 MV competence relies on 
adequate, timely coaptation between the leaflets. For this to be accomplished, the 
different segments of the MV undergo complex, heterogeneous motion2'3 culminating in 
the distal leaflet regions of the various segments forcefully joining in a precise alignment 
to prevent blood backflow. Recent studies have shown that the degree of coaptation is 
critical to mitral regurgitation in diseases such as dilated cardiomyopathy.4 Numerous 
studies have characterized leaflet motion and found it to be heterogeneous, with the 
anterior or septal leaflet motion being substantially further and its closure rate more 
rapid than for the posterior or lateral leaflet.5 Strains were even found to be 
heterogeneous within the septal leaflet.6 The underlying basis for this heterogeneity, 
however, remains unknown. 
Although relationships between in vivo leaflet strain and composition have not 
been previously reported, differences in material behavior between regions of the septal 
leaflet and between the septal and lateral leaflets ' have been generally attributed to 
differential thickness of the collagen-rich fibrosa layer across the leaflet anatomy.7' 9 
However, these previous studies performed materials testing on strips of excised leaflets, 
and did not address in vivo strains and hemodynamics, the valve environment, or the 
commissural leaflets. In addition, these explanations omit the possible contributions of 
heart valve cells to tissue mechanics, even though valve cells are known to be 
contractile10 and to produce extracellular matrix in response to mechanical stimulation.11' 
247 
It was the hypothesis of this study that valvular cell-mediated differences in 
extracellular matrix composition and turnover underlie the observed heterogeneity in 
leaflet deformation. Therefore, immunohistochemistry (IHC) was performed to 
characterize valve cell phenotype, matrix composition, and matrix turnover within the 
different segments of the mitral leaflets, and in the septal and lateral leaflets related to in 
vivo regional leaflet length changes. 
METHODS 
All animals received humane care in accordance with the guidelines of the US 
Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The use of 
animals in this study was approved by the Stanford Medical Center Laboratory Research 
Animal Review Committee. 
Animal Protocol 
Radiopaque markers were implanted into fourteen sheep delineating the septal 
(SEPT) and lateral (LAT) MV leaflets (Fig. 9-1). Procedures for marker implantation 
and biplane video fluoroscopy have been described previously.14 Leaflet segment length 
change, defined as the percent change from minimum to maximum dimensions 
throughout the cardiac cycle, was calculated. It was not possible to calculate radial or 
circumferential leaflet length change for ANT-C and POST-C due to limitations on 




Fig. 9-1: Circles indicate the location of the implanted radiopaque markers. Dark gray 
rectangles indicate tissue section location (sections did not include markers or their sutures). 
Two tissue sections were analyzed and the results averaged for the septal (SEPT) and lateral 
(LAT) segments, respectively; one tissue section was used for each of the commissures (ANT-C, 
POST-C). BL=basal leaflet, ML=mid-leaflet. Double-headed arrows indicate leaflet segment 
length measurements; rad=radial, circ=circumferential. For SEPT, BL rad + ML rad=total rad. 
Histology and Immunohistochemistry 
For each MV segment a 3-5 mm wide strip was cut from insertion region to free 
edge (Fig. 9-1), embedded in paraffin, and sectioned to a thickness of five microns. Each 
sample was stained with Movat pentachrome as well as IHC to demonstrate the 
myofibroblast valve cell phenotype, extracellular matrix components, and matrix 
turnover. Components stained for included collagen I (Col I), collagen III (Col III), 
matrix metalloproteinase (MMP)-13, MMP9, lysyl oxidase (LOX), elastin, hyaluronan 
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(HA), decorin (DCN), smooth muscle alpha-actin (SMaA), and non-muscle myosin 
(NMM) (for list of matrix components, their roles, and antibodies used, see Chapter 8, 
Table 8-1). Staining intensity was quantified on blinded IHC sections using ImageJ 
software (NIH, Bethesda, MD) for three regions of the valve, (BL, ML, and free edge 
(Fig. 9-2)) and for each histological layer (fibrosa, atrialis, and spongiosa (spongiosa was 
only quantified in the ML)). Analysis of blinded Movat-stained sections included 
measurement of the distance of muscle insertion relative to total leaflet length using 
Image Pro software (Media Cybernetics, Bethesda, MD). Semi-quantitative grading was 
performed to evaluate delineation between leaflet layers using a pre-determined grading 
rubric ranging from 0 (minimum) to 4 (maximum) as previously described.15 
Free Edge Mid-leaflet Basal Leaflet, , 
Fig. 9-2: Locations of leaflet regions and histological layers. Bracket in upper right corner 
indicates measurement for calculating proportion of muscle insertion into leaflet. Scale bar 
represents 2 mm. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, 
Chicago, IL), as described in Chapter 4. Because of the multiple segments, regions, and 
layers analyzed, data is reported as mean ± standard error of the mean, unless otherwise 
indicated. Paired t-tests were used to compare leaflet length changes between segments. 
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Correlations between staining intensities of different proteins within individual leaflet 
layers of specific regions and segments were used to assess protein co-localization and 
correlations between protein intensities and leaflet length change were analyzed to assess 
further relationships between deformation and composition. These correlations were 
calculated using Pearson and Spearman tests, as described in Chapter 5. For correlations 
between intensities of different proteins, p<0.02 was considered a trend and p<0.00625 
was considered significant since 8 proteins were compared. For correlations between 
intensities of proteins and regional leaflet length changes, each protein was considered 
individually, therefore p<0.05 was considered significant, but only highly significant 
correlations with p<0.03 are reported. 
RESULTS 
Differences in Leaflet Length Changes across Annular Segments 
Over the cardiac cycle, the change in the radial length of LAT was greater than in 
SEPT (p=0.004, Table 9-2). Within SEPT, the radial and circumferential leaflet length 
changes in ML were greater than in BL (p=0.001). 
























Data presented as mean ± standard deviation. 
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Differences in Leaflet Structure across Annular Segments 
Delineation between leaflet layers was greatest in SEPT, then in ANT-C/POST-C, 
and lastly in LAT (Fig. 9-3, p=0.011). The length of the muscle insertion into the leaflet 
region relative to total leaflet length was highest in ANT-C (0.32), much less in LAT 
(0.13) and POST-C (0.10), and minimal in SEPT (0.02, p<0.001). Analysis of Movat-
stained sections revealed further structural differences between the leaflets. In the ML 
region of LAT where the chordae tendineae insert, the leaflet fibrosa contained collagen, 
PGs, and other matrix components, and the chordae tendineae insertions were apparent as 
branches coming off of fibrosa. In contrast, in the commissural leaflets the collagen-rich 
chordae tendinae often appeared as continuous with the fibrosa. Therefore, the leaflet 
fibrosa of the commissures contained proportionately more collagen than LAT (Fig 9-4). 
Delineation Between Leaflet Layers 
SEPT LAT ANT-C POST-C 
Fig. 9-3: A) Degree of delineation between layers. *=p<0.001. For all bar graphs error bars 
indicate the standard error of the mean. 
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Fig. 9-4: The two left sections represent examples of commissure sections in which the collagen 
core of the chordae tendinae is continuous with the fibrosa of the leaflet resulting in a particularly 
collagen-rich fibrosa in this section of the leaflet. That pattern contrasts with the chordal origins 
in LAT (far right), in which chordae has branched off of the existing fibrosa. Arrows in left two 
images point to chordae continuous with leaflet fibrosa; arrow in right image points to chordae 
branching off fibrosa. Scale bars represent 2 mm. 
Compositional Heterogeneity between Septal and Lateral Segments and between 
Commissures 
The expression of Col I in SEPT was greater than in LAT across all leaflet 
regions (Fig. 9-5; SEPT BL: 95.1±4.0 vs. LAT BL: 76.3±6.8; BL, ML each p<0.025; 
SEPT free edge: 89.6±7.7 vs. LAT free edge: 61.1±7.9, free edge p=0.06 (trend)), as was 
Col III (Fig. 9-5; SEPT BL: 109.2±4.1 vs. LAT BL: 85.8±6.6; SEPT free edge: 122.5±3.6 
vs. LAT free edge: 72.8±11.0, BL, ML, free edge each p<0.005). In contrast, the 
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expression of collagen-degrading enzyme MMP13 was greater in LAT than in SEPT 
(Fig. 9-6; LAT BL: 71.1±5.0 vs. SEPT BL: 50.5±4.8; BL, ML each p<0.005). LOX, an 
enzyme involved in collagen and elastin crosslinking, was similarly greater in LAT ML 
compared to SEPT ML (LAT 114.0±5.5 vs. SEPT 94.8±4.4, p<0.008). The proteoglycan 
DCN, which mediates collagen fibrillogenesis, was greater in LAT BL than in SEPT BL 
(LAT 160.5±3.5 vs. SEPT 146.2±3.5, p<0.007). Two indicators of valve cell activation, 
SMaA and NMM, were greater in LAT (both BL and ML) than in SEPT (SMaA: Fig. 9-
6; LAT BL: 73.3±3.9 vs. SEPT BL 50.9±3.8; BL, ML each p<0.0002; NMM: LAT BL 
77.6±2.9 vs. SEPT BL 64.9±2.5, LAT ML 71.6±2.5 vs. SEPT ML 64.6±2.5; BL, ML 
pO.0001). 
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Collagen Content in Mid-Leaflet 
• Coll 
• Collll 
LAT SEPT ANT-C POST-C 
Fig. 9-5: Relative amounts of Col I and III in the mid-leaflet. Overall Col I and Col III 
each p<0.001. *p<0.008 vs. LAT and Ap<0.011 vs. ANT-C for a given protein (Col I or 
Col III). 
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These patterns of collagen turnover and cell activation paralleled those of radial 
and circumferential segmental leaflet length changes. For example, MMP13 abundance 
correlated with the change in radial change in SEPT BL (r=0.99, p=0.001). SMaA 
expression correlated with circumferential length change in the atrialis layer of SEPT BL 
(0.935, pO.OOl) and with radial length change in SEPT ML (r=0.700, p=0.03). In LAT 
ML, NMM correlated with changes in radial lengths (r=0.857, p=0.006). Furthermore, 
consistent with greater leaflet length change in SEPT ML compared to BL, the abundance 
Collagen Turnover and Cell Activation in Mid-Leaflet 




Fig. 9-6: Relative amounts of MMPJ3 and SMaA in the mid-leaflet. Overall MMP13 
and SMaA each p<0.001. *p<0.001 vs. SEPT and Ap<0.015 vs. POST-C for a given 
protein (MMP13 or SMaA). 
255 
of NMM, SMaA, and MMP13 was greater in the SEPT ML fibrosa than in the BL fibrosa 
(p=0.037). 
Compared to ANT-C, POST-C demonstrated greater expression of Col I and Col 
III in BL and ML (Fig. 9-5; Col I: POST-C BL 120.6±5.0 vs. ANT-C BL 87.4±5.0, Col 
III: POST-C BL 145.4±5.2 vs. ANT-C BL 111.7±4.9, each p<0.0005), SMaA in ML 
(Fig. 9-6, p<0.008), and MMP13 in ML (Fig. 9-6, p<0.003). 
Compositional Heterogeneity across MV Segments 
When comparing all segments, Col I and Col III in both ML and BL were greatest 
in POST-C, followed by SEPT, then ANT-C, and lastly LAT (overall pO.OOl for each of 
Elastin in Mid-Leaflet 
Elastin 
LAT SEPT ANT-C POST-C 
Fig. 9-7: Relative amounts of elastin in the mid-leaflet. Overall p<0.001. *p<0.001 vs. SEPT. 
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ML and BL). MMP13 was greatest in POST-C, followed by ANT-C, then LAT, and 
lastly SEPT (each region overall p<0.007). In BL, LOX was greatest in ANT-C/POST-C 
and LAT, followed by SEPT (ANT-C: 132.2±5.5, LAT: 130.7±6.2, POST-C: 128.6±5.5, 
SEPT: 112.6±4.5, overall p=0.022), whereas in ML, LOX was greatest in ANT-C/POST-
C, followed by LAT, and then SEPT (POST-C: 120.2±5.6, ANT-C: 120.1±5.1, LAT: 
114.0±5.5, SEPT: 94.8±4.4, overall pO.001). In BL, DCN was greatest in LAT, 
followed by ANT-C/POST-C, and then SEPT (LAT: 160.5±3.5, ANT-C: 162.5±4.6, 
POST-C: 158.8±4.7, SEPT: 146.2±3.5, overall p=0.019). 
With regards to cell activation, SMaA in BL and ML was greatest in POST-C, 
followed by ANT-C and LAT, and then SEPT (Fig. 9-6; POST-C BL: 85.9±4.9, ANT-C 
BL: 77.6±5.7, LAT BL: 73.3±3.9, SEPT BL: 50.9±3.8; BL and ML each overall pO.001 
for each of BL and ML). In BL, NMM was greatest in LAT, followed by POST-C/ANT-
C, and then SEPT (LAT: 77.6±2.9, POST-C: 71.9±3.4, ANT-C: 68.2±4.1, SEPT: 
64.9±2.5, overall p=0.016). 
For proteins related to elastic fibers, elastin in ML was greatest in ANT-C/POST-
C, followed by SEPT and LAT (Fig. 9-7, overall pO.001) and MMP9 in ML was 
greatest in ANT-C/POST-C, followed by SEPT and LAT (ANT-C: 65.9±3.4, POST-C: 
64.6±3.2, SEPT: 56.5±2.6, LAT: 55.9±2.5, overall p=0.032). The glycosaminoglycan 
HA was greatest in POST-C ML, followed by ANT-C and LAT, and then SEPT (POST-
C: 135.5±5.5, ANT-C: 125.4±5.5, LAT: 121.9±4.3, SEPT: 111.3±3.9, p=0.005). 
257 
Correlations between Proteins within Leaflet Regions 
Within specific leaflet regions and layers, strong correlations between proteins 
associated with cell activation and proteins involved in matrix synthesis and degradation 
suggested the presence of myofibroblasts. These correlations were between MMP13 and 
SMaA in the ML across all layers (0.764, p<0.00001), as well as in the BL fibrosa 
(0.810, pO.00001) and free edge (0.656, p=0.003); MMP9 and each of SMaA and NMM 
in the BL fibrosa (0.576, p<0.0022 and 0.578, p<0.0014, respectively); and SMaA and 
Col III in the BL fibrosa (0.578, p<0.0008). 
DISCUSSION 
This study demonstrates significant compositional and cellular heterogeneity 
across the segments of the MV. While collagen content in SEPT was greater than LAT, 
collagen turnover was greater in LAT, consistent with greater leaflet length changes in 
that leaflet. The presence of myofibroblast-like valve cells paralleled this greater 
deformation and collagen turnover in LAT. Comparison between regions of the valve 
revealed that the commissures had the highest collagen content, as well as the highest 
collagen and elastic fiber turnover and valve cell activation. Strong correlations between 
cell activation and matrix turnover markers suggest the role of myofibroblasts in the 
observed compositional heterogeneity. Additionally, leaflet length changes in SEPT and 
LAT paralleled compositional differences, suggesting a relationship between leaflet 
deformation and composition for the first time in the in vivo MV. 
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Characterization of Commissural Leaflets 
This work also provided novel information regarding the structure and dynamic 
matrix composition of the commissural leaflets. The composition of these leaflets has 
been largely overlooked for decades, with one exception describing their collagen fiber 
alignment.16 In an extensive study of MV histology from 1956, it was noted that the 
"junctional" tissues of the normal MV are "anatomically and histologically not different 
from the rest of the valvular tissue."17 In contrast, this study demonstrated that the 
commissures have significantly different structure and composition compared to the other 
MV segments. As a result, ANT-C and POST-C defy easy classification as resembling 
either SEPT or LAT, or even as resembling each other. In terms of collagen content, 
delineation of leaflet layers, and extent of muscle insertion, ANT-C resembled LAT and 
POST-C resembled SEPT. In terms of collagen turnover and cell activation, however, 
ANT-C more closely resembled SEPT (lower MMP13 and SMaA), and POST-C more 
resembled LAT. Significant differences in protein expression between ANT-C and 
POST-C (Col I, Col III, SMaA, and MMP13) suggest inherent differences between the 
two commissures. It is also noteworthy that MMP13, LOX, elastin, and SMaA were all 
greater in the commissures than in SEPT/LAT, which suggests that the commissural 
leaflets undergo some of the highest rates of remodeling across the entire MV. This 
finding could reflect differences between ANT-C/POST-C and SEPT/LAT in leaflet 
deformation; in the future, it will be important to attach markers to the valve in a manner 
that permits direct comparison of percent leaflet length change between ANT-C/POST-C 
and SEPT/LAT. 
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Differences in Leaflet Structure 
Significant heterogeneity in composition between the different MV leaflets 
reflects their differences in structure as well as function. For instance, the SEPT leaflet 
showed greater abundance of Col I and III compared to LAT throughout the layers, but 
less collagen remodeling than in LAT. The amount of cardiac muscle present atop the 
proximal leaflet has not been previously reported, even though the general nature of the 
muscular and fibrous portions of the mitral annulus has been widely observed. Compared 
to SEPT, muscle was found to extend much further into the leaflets of LAT, ANT-C, and 
POST-C. This muscle tissue would likely impart significant contractility to these 
regions, and is consistent with greater changes in leaflet lengths across the cardiac cycle 
in LAT compared to SEPT. It is interesting to note that SEPT had significantly greater 
delineation of leaflet layers compared to LAT. Since a layered leaflet structure decreases 
the resistance to bending,9 this greater delineation of SEPT may functionally allow the 
SEPT leaflet to bend further compared to LAT, as previously reported.2 Bending of 
SEPT is also likely aided by the thinness of the BL within the center "clear zone" of the 
anterior leaflet. 
Relation between Leaflet Composition, Leaflet Deformation, and the Role of the 
Myofibroblast 
While future work is required to further verify the relationship between leaflet 
deformation and composition, overall, these results suggest that there is a relationship 
between leaflet deformation during the cardiac cycle, levels of matrix turnover proteins, 
and valve cell activation towards the myofibroblast phenotype, as demonstrated by 
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comparisons between MV segments and regions, as well as direct statistical correlations. 
The finding of greater deformation in the mid-leaflet compared to the basal leaflet of 
SEPT is consistent with more rigorous modeling of in vivo marker data from similar such 
experiments,18 and was found to correlate to composition of these regions across animals. 
This work provides an important, initial in vivo validation for previous ex vivo aortic 
valve studies showing that leaflet strain leads to altered leaflet composition, such as 
increased collagen content and SMaA expression19 and altered MMP expression,20 as 
well as multiple in vitro studies that have demonstrated altered matrix synthesis11"13 and 
increased SMaA11 by valve cells exposed to different strains or residing in valves 
experiencing different transvalvular pressures. The myofibroblast cell phenotype may 
contribute to the observed heterogeneity in composition. Myofibroblasts can sense and 
respond to their mechanical environment.21 These cells are also synthetic in nature, 
express abundant MMPs,22 and are contractile.10 Although this contractility does not 
occur at the time scale of the valve opening and closing, it does affect leaflet stiffness in 
vitro, and could affect deformation. Therefore, this cell type may, at least in part, act as 
the link between the deformation experienced by a leaflet region and the composition of 
that region, as evident in this study. Taken together, these results suggest that the normal 
MV continually undergoes matrix remodeling in response to its mechanical environment, 




The potential relationships between leaflet deformation and composition, while 
only partially characterized in this study, emphasize the need to restore normal leaflet 
deformation in valve repair procedures, such as through judicious design of annuloplasty 
rings. Restoring normal leaflet deformation could be important not only for preventing 
mitral regurgitation by proper leaflet coaptation, but also for maintaining normal leaflet 
composition, which in turn effects both leaflet material properties and could be important 
to the progression of various valve diseases. Indeed, the results from this study suggests 
that the myofibroblast could be key to this link between deformation and composition, 
and the myofibroblast is thought to be critical to the progression of myxomatous mitral 
valve disease.22 Furthermore, these results provide a more complete picture of the 
complexity of MV composition and structure. In particular there is growing interest in 
the commissural leaflets,24'25 which have been far less characterized, yet may be relevant 
to the design of a tissue engineered mitral valve and in commissural repair procedures. 
Future studies are warranted to determine causative mechanisms of the relationship 
between in vivo deformation, cell phenotype, and matrix composition. It will also be 
important to investigate other aspects of the in vivo mechanical activity of the valve, such 
as flexure, shear, and coaptation, on regional leaflet composition and structure. 
Limitations 
While IHC is a powerful tool in determining localization and abundance of 
specific proteins, one of its limitations is the inherent variability of the technique, which 
was quantified to be 13.7% within batches and 16.5% between batches. Averaging of 
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duplicate sections and batch staining methods were performed to limit this variability. 
Similarly, while radiopaque markers allow precise determination of in vivo leaflet 
motion, limitations in the number and locations of marker placement did not allow 
measurement of commissural leaflet length changes or fully account for leaflet curvature. 
However, these leaflet length measurements did allow assessment of relative length 
changes necessary to examine the relationship between deformation and composition. 
While further work remains to better characterize this relationship between composition 
and deformation in the in vivo setting, this study represents an important step forward in 
that regard. Additionally, slight anatomic differences between the ovine and human MV26 
could affect translation of these data to human patients. 
CONCLUSIONS 
This study demonstrates significant compositional and cellular heterogeneity 
across the MV, and suggests a relationship between in vivo valve deformation, collagen 
turnover, and cell activation. Myofibroblast-like valve cells, which demonstrate 
contractile and synthetic capabilities, may contribute to both the observed compositional 
heterogeneity as well as the heterogeneity in leaflet deformation important for proper 
leaflet coaptation. In the future, the myofibroblast may be an important therapeutic target 
for diseases in which leaflet motion and composition are altered. Furthermore, it will be 
important for vale repair techniques and annuloplasty ring design to preserve this 
heterogeneity in leaflet strain and thereby attempt to prevent any further deterioration in 
leaflet composition that accompanies these disease processes. 
263 
This chapter, in which mitral annular composition was analyzed in 
relationship to in vivo changes in annular segment length, concludes the portion of 
normal valve heterogeneity studies addressing the relationship between normal 
valve composition and in vivo strains. The next two chapters (Chapters 10 and 11) 
address heterogeneity in the valvular interstitial cell (VIC) population. Specifically, 
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Chapter 10: Fibronectin-Based Isolation of Valvular 
Interstitial Cell Subpopulations: Relevance to Valve Disease 
The work contained in this chapter continues the topic of normal valve 
heterogeneity and specifically addresses heterogeneity in the valvular interstitial cell 
(VIC) population. In this chapter a method for separating the myofibroblast VIC 
subpopulation is presented. 
ABSTRACT 
Background: Myxomatous mitral valves (MVs) contain elevated proportions of unique 
cell populations such as myofibroblasts. Without a reliable technique to isolate such cell 
populations, however, it has been difficult to study the role of these cells. The goal of 
this study was to use fibronectin (FN) to isolate distinct cell subpopulations from normal 
porcine MVs. 
Methods: Cells from porcine posterior MV leaflets were separated based on time-
dependent adhesion to either tissue culture plastic (TCP) flasks or FN-coated flasks. The 
resultant "FAST" and "SLOW" adhering subpopulations from each technique were 
phenotyped using flow cytometry and immunocytochemistry to detect expression of 
myofibroblast markers, enzymes for collagen synthesis, and mitogen-activated protein 
kinases. 
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Results: Compared to FN SLOW, FN FAST showed significantly higher expression of 
prolyl 4-hydroxylase, heat shock protein-47 (HSP47), smooth muscle alpha-actin 
(SMaA), non-muscle myosin (Smem), extracellular-related signaling kinase (ERK) 1, 
ERK2, and phosphorylated-ERK. In contrast, TCP FAST showed higher expression of 
only HSP47, SMaA, and Smem compared to TCP SLOW. 
Conclusions: Differential adhesion to FN successfully separated a myofibroblast-like 
subpopulation from the posterior leaflet of the MV. This subpopulation may be useful in 
studying myxomatous MV disease, although additional studies remain to verify that this 
myofibroblast-like population resembles that observed in myxomatous MV disease. 
The work contained in this chapter was published as: 
Stephens EH, Huynh TN, Cieluch JD, Grande-Allen KJ. Fibronectin-Based Isolation of 
Valve Interstitial Cell Subpopulations: Relevance to Valve Disease. Journal of 
Biomedical Materials Research A. 2010;92(l):340-9. 
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INTRODUCTION 
While myofibroblasts are known to be involved in disease processes in multiple 
tissues including the kidney,1'2 lung,3 pancreas,4 and heart valves,5 it has been difficult to 
isolate these cell subpopulations from valves to allow their systematic study. In order to 
develop novel medical treatments for these diseases, it will be important to understand 
the phenotypic regulation of the cells involved and how these cells contribute to disease 
progression. The myofibroblast-like valve cell phenotype in particular is common to a 
number of valve diseases and thought to be influential in the development and 
progression of diseases such as myxomatous degeneration.5' 6 Numerous publications 
have described the valvular interstitial cells as a heterogeneous population with some 
fibroblastic-like cells and others that appear more myofibroblastic-like. " The 
myofibroblast-like valve cell, when characterized in situ or induced via treatment with 
transforming growth factor-(3, is marked by greater production of matrix, expression of 
matrix metalloproteases, expression of muscle related markers, and contractility.5' 6' 10 
Furthermore, many of the valve diseases that are characterized by altered proportions of 
distinct cell phenotypes also contain altered composition of valvular extracellular 
matrix.5,'' It was therefore hypothesized that matrix components could be used to isolate 
specific valvular interstitial cell (VIC) subpopulations, which are critical for further 
studies regarding the etiology and treatment of valve diseases. It was the general goal of 
this study to develop a matrix-based technique for the isolation of this myofibroblast-like 
cell phenotype. 
Previous studies from our laboratory explored the utility of two related methods to 
isolate the myofibroblast subpopulation from aortic valve cells:12 differential detachment 
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(trypsinization) from tissue culture plastic (TCP) and differential adhesion to TCP. 
Although it was observed that these two methods yielded similar cell subpopulations, it 
was speculated that the detachment method could cause the loss of the very proteins that 
make this adhesive population unique. It was further speculated that differences in 
adhesiveness could be the basis for phenotypic differences among VICs;12 therefore, this 
study was developed to investigate the nature of differentially adherent cells. In addition, 
our previous study used only one phenotypic marker, smooth muscle alpha-actin 
(SMaA), whereas this study involved a much more comprehensive assessment of cell 
phenotypes. Furthermore, the present study utilized VICs harvested from the posterior 
leaflet of the mitral valve, since these cells will be more relevant to future studies of the 
mechanisms of myxomatous mitral valve disease (which primarily affects the posterior 
leaflet). 
Most importantly, this study investigated the phenotypes of cell subpopulations 
resulting from differential adhesion to fibronectin, a protein that is relevant to both 
normal and diseased cell-matrix interactions and is present in both normal and 
myxomatous valves.10'13'14 Fibronectin was evaluated for this matrix-based technique to 
isolate myofibroblasts for several reasons. Myofibroblasts are known to exert force on 
their adhesive substrates through fibronectin-linked, enlarged focal adhesions (also 
known as the fibronexus).15' 16 It was thus hypothesized that the myofibroblast 
subpopulation within a mixture of primary cultured VICs would adhere to fibronectin 
more strongly than other VIC phenotypes. Fibronectin is also more abundant in injured 
and regenerating tissues.17"22 In renal fibroblasts, for example, differentiation to the 
myofibroblast phenotype results in extracellular fibronectin accumulation.23 In heart 
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valves, it has been shown that activated VICs remodel the orientation of fibronectin fibers 
in the matrix.6 Furthermore, fibronectin has been associated with valve cell "injury" in 
that VICs that migrate into a region devoid of cells (using a scrape wounding in vitro 
model) then secrete fibronectin.24 For these reasons, fibronectin may be an appropriate 
matrix component to serve as the basis for isolating myofibroblastic VICs associated with 
valve injury. 
Therefore, the purpose of this investigation was to compare the utility of 
fibronectin-coated vs. uncoated tissue culture plastic for differential adhesion-based 
isolation of the myofibroblast-like subpopulation of VICs. Following cell separation on 
these two substrates, flow cytometry and immunocytochemistry were used to assess a 
number of phenotypic characteristics relevant to myofibroblasts. 
METHODS 
Isolation of Valvular Interstitial Cells 
This investigation utilized cultured VICs, which have been previously reported to 
demonstrate phenotypes largely representative of valve cells in v/vo8 and to maintain 
aspects of this phenotype over multiple passages.25"27 These VICs were cultured from 
porcine valves, a widely used, anatomically comparable model for human heart valves.10' 
Porcine hearts from healthy 6-month-old pigs were purchased from Fisher Ham and 
Meats, Spring Cypress, TX, USA; valves from several hearts were pooled together 
(between 3-10 hearts per cell harvest) were harvested for primary culture according to 
standard methods.32"34 Valve tissues were pooled to limit potential effects of inherent 
variability between animals. The isolation of primary cells from pooled valve tissues was 
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performed on at least six different occasions. The posterior leaflets of the mitral valves 
were dissected from the hearts, trimmed of attached chordae, placed in 2 mg/mL 
collagenase II (Worthington Biochemical Corp., Worthington, VA) in serum-free 
Dulbecco's modified Eagle's medium (Mediatech, Herndon, VA) containing 1% 
antibiotic/antimycotic/antifungal solution (Mediatech), and incubated in a shaker for 20 
min (37°C, 140 rpm).34 Afterwards, the loosened endothelial cells were removed by 
wiping the leaflet surfaces with sterile cotton swabs. The tissues were then finely minced 
and dissociated in a solution of collagenase II and hyaluronidase (1 mg/ml and 0.1 
mg/mL, respectively in serum-free medium) in an incubated shaker for 4 hours. The 
resulting VICs were counted, seeded in tissue culture flasks at a density of 10,000 
cells/cm2, and maintained at 37°C, 95% humidity, and 5% CO2. Cells were grown in 
medium containing 10% bovine growth serum (BGS, HyClone, Logan, UT) and 1% 
antibiotic/antimycotic/antifungal solution and passaged after reaching 90% confluence. 
Experiments were performed on cells between their first and third passages. 
Isolation of Subpopulations 
VICs were separated into subpopulations based on adhesion time to either 
uncoated or fibronectin-coated tissue culture plastic (TCP). Primary cultures of VICs 
were removed from culture plates using trypsin, pelleted, and resuspended in 10 ml of 
media. These VICs were then seeded into an uncoated TCP T-75 flask (Fig. 10-1, flask 
#1) and incubated. After 30 minutes approximately 20% of the cells had adhered to the 
flask. The media and unattached cells were then removed from flask #1 and placed into a 
new T-75 flask (flask #2) while fresh media was added to flask #1. After 2 more hours, 
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F/g. 70-i: Schematic illustrating the process of isolating subpopulations from plastic flasks. 
The same method was used for subpopulations isolated from fibronectin-coated flasks, except 
with different time increments. 
the unattached cells and media from flask #2 were removed and seeded into a new T-75 
flask (flask #3). The subpopulation that adhered within 30 min (in flask #1) was called 
TCP FAST, while the population that had not adhered after 2.5 hours (grown in flask #3) 
was called TCP SLOW. While the TCP SLOW population may have been exposed to an 
increased number of dead cells, previous studies of viability and phenotype of valve cells 
after various durations of ischemia suggest that it would be unlikely for the presence of 
non-viable cells to alter the phenotype and viability of the surviving cells.35 The same 
procedure was repeated with VICs on fibronectin (FN)-coated TCP flasks (Becton 
Dickinson, Franklin, NJ) but the time intervals were shortened because VICs adhered to 
FN-coated flasks faster than to normal TCP flasks. Therefore, in the case of FN-coated 
flasks the subpopulation that adhered within the first 15 minutes was called FN FAST 
and the subpopulation that adhered after 1.5 hours was called FN SLOW. To 
demonstrate repeatability, this adhesion-based separation process was performed on six 
separate groups of primary cell cultures. Cells attached to the #2 flasks were considered 
to have an intermediate rate of adhesion and a mixed phenotype (neither distinctly FAST 
nor SLOW), and were discarded. 
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Adhesion of Subpopulations to TCP 
Each of the separated VIC subpopulations (FN FAST, FN SLOW, TCP FAST, 
TCP SLOW) was seeded within quadruplicate wells of a TCP 6-well plate at a density of 
4.0x104 cells/cm2. Control cells, which were primary cells (harvested as described above 
from the pooled valve tissues) that had not been subjected to the separation process, were 
seeded in identical conditions. After 30 min, 90 min, 150 min, and 24 hours, the medium 
containing the unadhered cells were removed and the adherent cells were trypsinsized 
and counted using trypan blue staining and a hemocytometer. 
Flow Cytometry 
The various adhesive VIC subpopulations (FN FAST, FN SLOW, TCP FAST, 
TCP SLOW) were evaluated using flow cytometry to assess their expression of several 
phenotypic characteristics. These markers included prolyl 4-hydroxylase (P4H, 
Chemicon, Temecula, CA) and heat shock protein-47 (HSP47, Abeam, Cambridge, MA), 
both markers of active collagen synthesis; smooth muscle alpha-actin (SMaA, 
Dakocytomation, Denmark), non-muscle myosin heavy chain (Smem, GeneTex, San 
Antonio, TX and Covance, Berkeley, CA), which are markers of VIC activation and the 
myofibroblast phenotype; smooth muscle myosin (SMM, Sigma, St. Louis, MO), which 
differentiates myofibroblasts from smooth muscle cells; and extracellular signal-regulated 
kinase (ERK)-l, ERK2, and p-MAP kinasel/2 (pERK, Chemicon). ERK1, ERK2, and 
pERK are all signaling proteins in the mitogen-activated protein (MAP) kinase pathway 
that are involved in fibroblast activation to myofibroblast in a number of tissues,23'36~38 
and have been shown to be responsive to tension such as that the cell experiences during 
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adhesion. ' These proteins are also related to the production of matrix 
metalloproteases, which are abundant in myxomatous mitral valves.41 
In preparation for flow cytometry, after 2-4 days, the separated VIC 
subpopulations were trypsinized, counted, washed twice with 10 ml of PBS, and placed 
in fixative (1% paraformadehylde in PBS) at 2.00xl06 cells/ml. After 1 hour, the fixed 
cells were incubated in permeability buffer (0.1% Triton-X 100 in PBS; 1 ml per lxlO6 
cells) for 10 minutes. Separate tubes containing lxlO6 cells were prepared for each 
antibody and for a negative isotype control (to be treated with IgG and secondary 
antibody only). An additional tube of cells, which would remained untreated, was 
prepared for a "blank" control and used for gating purposes. The cells were mixed with 1 
mL of flow cytometry (FC) buffer (PBS containing 0.5% BSA, 0.05% sodium azide), 
then pelleted by centrifuging for 1 minute at 13,200 rpm. The cells were then incubated 
in 100 \iL of primary antibody (or IgG for controls) for 1 hour on ice, then mixed with 1 
mL of FC buffer and pelleted by centrifuging for 1 minute at 13,200 rpm. Next, the cells 
were mixed with 100 uL of FITC-conjugated secondary antibody and stored in the dark. 
After 1 hour, 500 i^L of FC buffer was added, samples were spun for 1 minute at 13,200 
rpm, and the supernatant was decanted. The pellet was resuspended in 250 \iL of FC 
buffer and transferred to 5 ml tubes. 
A FACScan flow cytometer with Cell Quest Pro software (Becton Dickinson) was 
used for data acquisition and analysis. Data was gated based on size (forward scatter), 
complexity (side scatter), and non-specific fluorescence following calibration with the 
isotype control samples and unstained samples. The fluorescence-based gate was set 
such that less than 1% of the non-specific fluorescence fell within the gate. Data reported 
275 
includes only that located within the above gates. Each sample was analyzed at least 
twice to confirm the mean fluorescence values, which has been shown to be proportional 
to the number of proteins on the cells.42 Flow cytometry measurements were performed 
three times on VIC subpopulations from 3 different adhesion-based separations. Data 
was reported as an average of all 3 measurements. 
Lmmunocytochemistry 
Cells from the 4 different adhesive subpopulations were seeded at a density of 
5,000 cells/cm2 on glass microscope slides and maintained in medium/10% serum/1% 
antibiotic solution in an incubator. After 2 days, the cells were rinsed with PBS and fixed 
in 100% acetone at room temperature. The slides were incubated in a solution containing 
5% goat serum in PBS for 1 hour to block non-specific binding. The slides were then 
incubated in primary antibodies that were diluted in PBS containing 1% bovine serum 
albumin and 0.1% TritonX-100 (Roche Diagnostics, Mannheim, Germany). Antibodies 
used were the same as those in the flow cytometry assessment as well as vimentin 
(Dako). All primary antibodies were diluted 1:100 except for vimentin (1:200). After 
washing three times in PBS, the slides were incubated in appropriate secondary 
antibodies for 1 hour (goat anti-mouse and anti-rabbit IgG FITC, Jackson 
ImmunoResearch, West Grove, PA, 1:100 dilution). Negative controls were prepared 
without primary antibodies but with secondary antibodies. The slides were washed three 
times with PBS, drained, mounted with Vectashield with DAPI (Vector Laboratories, 
Burlingame, CA), coverslipped, and sealed. This staining procedures and the imaging 
described below were repeated three times on three different batches of subpopulations. 
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The stained slides used for quantification of fluorescence were imaged using the 
10X and 20X objectives of an Axioplan fluorescent microscope (Zeiss, Thornwood, NY) 
and Metamorph software (Molecular Devices, Sunnyvale, CA). Three 20X images were 
taken from non-overlapping, randomly chosen regions of each slide. The total number of 
cells in each image was manually and automatically counted using the DAPI nucleic acid 
marker. The results of manual and automatic counting were comparable (data not 
shown), therefore, the automatic count was applied to all samples. All images for the 
same marker were obtained using identical acquisition parameters in one imaging 
session. Cells staining positive were evaluated to obtain the fluorescence intensity per 
pixel (from 0 to 4025, where 4025 was the highest fluorescence.) The background 
intensity, due to non-specific binding, was eliminated by establishing a threshold of 700-
800. Once the threshold had been applied, the integrated intensity of an area was divided 
by the number of nuclei in that same area to give the average intensity per cell. 
Preliminary Analysis of Human Myxomatous Valves and VICs 
In a preliminary translation of these methods to human valve studies, these FN 
and TCP-based subpopulation isolation techniques were also performed on VICs isolated 
from 4 human myxomatous mitral valves. Myxomatous mitral valve specimens were 
obtained from 4 patients after surgery to correct severe mitral regurgitation due to a 
prolapsing valve. These four patients (3 females aged 50, 61, and 69 years old and one 
59 year-old male) underwent quadrilateral resection of the posterior leaflet and 
implantation of an annuloplasty ring. These tissues were obtained from the Cooperative 
Human Tissue Network and their use was authorized by the Institutional Review Board. 
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Following the adhesive separation process on passage 4-5 cells, the 4 human VIC 
subpopulations were subjected to flow cytometry analysis for SMaA, Smem, pERK, and 
ERK2. 
We also performed immunohistochemistry to confirm the presence of fibronectin 
in human normal and myxomatous mitral valve leaflets. Posterior leaflets from four 
myxomatous mitral valves (mean patient age 65.0±10.5) removed during valve repair 
surgery and three normal valves (no history of cardiac disease, mean subject age 
64.7±14.5) removed at autopsy were formalin-fixed, paraffin-embedded, and sectioned to 
a thickness of 5 ^m. Slides were stained using an antibody to fibronectin (Chemicon, 
Temecula, CA) after citrate-based antigen retrieval, visualized using Vectastain Elite 
ABC and diaminobenzidine kits (Vector Laboratories, Burlingame, CA), and 
counterstained with hemotoxylin (Richard-Allan Scientific, Kalamazoo, MI)). The use of 
these valve tissues for research was approved by the Institional Review Board. 
Statistical Analysis 
Multifactorial analysis of variance was performed using SigmaStat software 
(SPSS, Chicago, IL), as described in Chapter 4. The Holm-Sidak all-pairwise multi-
comparison method was used for post-hoc testing. Statistical comparisons of 
immunocytochemical data, as well as the myxomatous cell flow cytometry data because 
of the limited nature of that data set, were performed using a student's paired t-test and 
the same level of significance (0.05). 
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RESULTS 
Confirmation of FAST and SLOW Subpopulations Adhesion Rate 
A. 
TCP Separated Subpopulations: 
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Fig. 10-2: A) Adhesion to TCP over time using subpopulations previously separated using 
TCP. B) Adhesion to TCP over time using subpopulations previously separated using FN-
coated flasks. Our laboratory has previously reported that such VIC subpopulations retain 
their adhesive properties over multiple passages. 
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After the TCP and FN separation techniques were performed, the resulting 
subpopulations' adhesion rates to TCP were evaluated to confirm that distinctly adherent 
FAST and SLOW subpopulations had been generated (Fig. 10-2A, B). For both the FN 
and TCP separation techniques, the FAST cells adhered more rapidly than did the SLOW 
cells, and both were different from the control (unseparated cells). Furthermore, the final 
percentage of cells adhered in the FAST subpopulations was higher than the SLOW 
subpopulation for both surfaces. Lastly, the final percentage of adhered cells for FN 
FAST was higher than TCP FAST and similarly the final percentage of adhered cells for 
FN SLOW was higher than TCP SLOW. 
Flow Cytometry - Porcine VICs 
Compared with the cells that adhered slowly to fibronectin (FN SLOW), the cells 
that adhered quickly to fibronectin (FN FAST) showed significantly higher expression of 
the markers of collagen synthesis P4H (pO.OOl) and HSP47 (p=0.043), markers of the 
myofibroblast phenotype SMaA (pO.OOl) and Smem (p=0.002), and proteins in the 
MAP kinase pathway ERK1 (p=0.005), ERK2 (p-0.011), and pERK (p<0.001)(Fig. 10-
3A). In contrast, following differential adhesion to tissue culture plastic, only ERK1 was 
significantly different between the fast and SLOW subpopulations (pO.OOl), and in fact 
was lower in the TCP FAST group (Fig. 10-3B). There were also trends of increased 
ERK2 and pERK expression in the TCP FAST cells compared to the TCP SLOW cells 
(p=0.074 and p=0.064 respectively). SMM expression was negligible in all groups, 
confirming that these isolated cells were not smooth muscle cells.5'43' 44 These same 
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expression patterns were found in all replicate flow cytometry measurements, regardless 
of whether the cells had been cultured for 2 or 4 days following the subpopulation 
separation procedure. 
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Fig. 10-3: A) Flow cytometry marker fluorescence of TCP differential adhesion 
subpopulations. Error bars indicate standard error of the mean, as the graph includes data 
from 3 independent experiments. *=p<0.05. B) Flow cytometry marker fluorescence of FN 
differential adhesion subpopulations. Error bars indicate standard error of the mean, as the 
graph includes data from 3 independent experiments. *=p<0.05, A=p<0.075. 
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When comparing the FN FAST group to the TCP FAST, both of which were the 
-20% most adhesive VICs isolated from the posterior leaflet, the FN FAST cells showed 
higher expression of two markers, ERK1 (p=0.0002) and Smem (p=0.0001). In contrast, 
when comparing the two least adherent VIC subpopulations, those separated using 
fibronectin had lower expression of ERK1, pERK, and SMaA than the TCP SLOW 
(p<0.002). 
Flow Cytometry and Immunohistochemistry - Human Myxomatous Valves 
In the small group of human VIC subpopulations, FN FAST tended to show 
greater expression of the markers SMaA, NMM, pERK, and ERK2 compared to FN 
A . Differential Marker Expression in Human Myxomatous 
Valve Cell Subpopulations 
Smem pERK SMaA ERK2 
Fig. 10-4A: Ratio of FN FAST to FN SLOW flow cytometry marker mean fluorescence for 
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^ig. 10-4B: Immunohistochemical staining illustrates the presence offibronectin in both 
normal (left, 79year-old male) and myxomatous heart valves (right, 70 year-old male). Scale 
bar represents 200 nm. 
SLOW (Fig. 10-4A, p=0.064 by paired t-test). However, no difference was detected 
between TCP FAST and TCP SLOW (p=0.452). Immunohistochemical staining of a 
representative set of myxomatous and normal posterior mitral valve leaflets demonstrated 
positive staining for FN in all samples (Fig. 10-4B). 
Immunocytochemistry 
Immunocytochemical results were similar to the flow cytometry results. In 
immunocytochemistry FN FAST showed higher expression of ERK2 (p<0.001), pERK 
(pO.OOl), HSP47 (p<0.006), SMaA (pO.Ol), and Smem (pO.OOl) compared to FN 
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Fig. 10-5: A) Immunocytochemistry marker integrated optical density per cell of TCP 
differential adhesion subpopulations. Error bars indicate standard deviation, as the graph 
includes data from one representative experiment. Data between experiments showed the same 
differences between cell subpopulations, but varied in integrated optical density. *=p<0.05. B) 
Immunocytochemistry marker integrated optical density per cell of FN differential adhesion 
subpopulations. Error bars indicate standard deviation, as the graph includes data from one 
representative experiment. Data between experiments showed the same differences between cell 
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Fig. 70-6: Representative images of immunocytochemistry for given markers on TCP 
differential adhesion subpopulations. Images were captured using 10X objective. Scale bar 
represents 100 urn and applies to all images. 
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TCP FAST only having higher expression of HSP47 (p=0.021), SMaA (pO.OOl), and 
Smem (pO.OOl) in TCP FAST compared to TCP SLOW (Figs. 10-5B and 10-6). 
Although the immunocytochemical data from different cell labeling preparations and 
different cell subpopulation separations could not be averaged because of possible 
variations in staining and imaging parameters, the statistically significant differences 
between subpopulations were consistent across experiments. 
DISCUSSION 
Differential adhesion to fibronectin was successful in isolating VICs with an 
activated, myofibroblast-like phenotype as evidenced by greater expression of 
myofibroblast-related markers by the FN FAST subpopulation compared to FN SLOW. 
Although the phenotyping presented in this paper was performed on freshly isolated 
subpopulations, our previous studies have shown that subpopulations retain their 
1 9 
adhesive and phenotypic properties over multiple passages. Therefore, this method may 
be an effective means of isolating the myofibroblast-like valve cell population for further 
study. Overall, these results confirmed and extended the results of our previous 
subculturing study.12 These cells that adhered the most rapidly to fibronectin 
demonstrated stronger expression of Smem as well as other proteins associated with the 
myofibroblast phenotype including markers of collagen synthesis10' 45 and the MAP 
kinase pathway.46"48 While the mechanism behind the differential adhesive properties 
these VIC subpopulations is still under investigation, myofibroblasts expressing SMaA 
have been shown to exert stronger forces than their SMaA-negative counterparts,49'50 a 
feature that is attributed to more abundant cell-matrix contacts,51 isoform-specific 
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terminal peptide adhesions, and specialized, enlarged focal adhesions incorporating 
unique proteins such as tensin. 
The findings that the VICs that were more adhesive to fibronectin showed the 
greatest expression of the myofibroblast markers, compared to tissue culture plastic, 
suggests that the fibronectin aids in promoting the myofibroblast phenotype. Fibronectin 
was utilized in this study because it is present throughout mitral valve leaflets (Fig. 10-4) 
and chordae14 and because it is involved in myofibroblast adhesion.15' 16 Others have 
shown that adhesion to fibronectin causes fibroblasts to differentiate towards the 
myofibroblast phenotype21 and that VICs cultured on fibronectin-coated plates had 
significantly higher SMaA expression compared to VICs cultured on TCP.53 Therefore, 
it is possible that the fibronectin coating both enables the separation of cell 
subpopulations and manipulates the cell phenotype of the cells that adhere. Given that 
the FN SLOW cells did not become myofibroblast-like, we speculate that the ability of 
fibronectin to potentiate activation of the myofibroblast phenotype is specific to certain 
cell types. The slow to adhere cells may represent a more true fibroblastic phenotype. 
Our demonstration that the abundance of unphosphorylated and phosphorylated 
ERK was more abundant in the FN FAST cells is promising given that the activation of 
valve cells to myofibroblasts is thought to occur via the MAP kinase pathway. 
Correspondingly, it was recently shown that the use of heparin to prevent the activation 
of the FGF2 receptor complex, which inhibits MAP kinase, resulted in an increase in the 
myofibroblast phenotype of VICs.54 The link between MAP kinase pathway activation 
and SMaA has been shown in VICs46"48 as well as cardiac fibroblasts,36 and the role of 
the MAP kinase pathway in fibroblast activation to myofibroblasts has been shown in 
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cells derived from a number of tissues including vascular adventitia, liver, and 
kidney among others. 
Both immunocytochemistry and flow cytometry showed that differential adhesion 
to fibronectin (vs. TCP) resulted in a more definitive isolation of the myofibroblast 
phenotype. However, there were some differences between the results of these two 
assessment methods. The difference in SMaA expression between TCP FAST and TCP 
SLOW was detected by immunocytochemistry, but not by flow cytometry. On the other 
hand, the greater expression of ERK1, ERK2, and pERK by the TCP FAST cells (vs. 
TCP SLOW) was only detected by flow cytometry, as was the greater ERK1 expression 
in FN FAST compared to FN SLOW. Some differences are to be expected between the 
results of these two methods given that in each technique the cells are in different 
adhesive states. In immunocytochemistry the cells are actively attached to a surface, 
while in flow cytometry the cells have been removed from their surface. The process of 
the cells removal and the cells' adhesive state may affect the states of signaling. It should 
also be noted that in immunocytochemistry, the tested cells had been cultured on glass for 
several days, rather than TCP or FN-coated flasks as in the case of the cells tested by 
flow cytometry. This difference in cell substrate could have also contributed between 
differences in results between flow cytometry and immunocytochemistry, as substrate 
stiffness has been shown to alter fibroblast55 and valve cell phenotype,27and given that 
glass is significantly stiffer than TCP.56 Interestingly, in the present study the TCP FAST 
cells did not show significantly higher expression of SMaA by flow cytometry as was 
found in the previous study. This discrepancy may be because mean fluorescence after 
gating was used to assess marker expression in flow cytometry rather than the median 
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fluorescence as was done in the last study. For both immunocytochemistry and flow 
cytometry, it would be beneficial to use a multi-labeling/imaging technique to determine 
which markers are expressed together on a given cell. 
Fibronectin often serves as a substrate in a number of cell-matrix adhesions 
including focal adhesions and fibrillar adhesions. These two types of adhesions are quite 
different structurally. Focal adhesions are large rod-shaped complexes and contain a 
number of cytoplasmic plaque proteins.57'58 In contrast, fibrillar adhesions are smaller 
consisting mainly of as (31 integrins and tensin, lacking the cytoplasmic plaque proteins 
found in focal adhesions.57'58 Based on these structural differences it is likely that these 
two types of adhesions have significant differences in function. Fayet et al. have recently 
shown that VICs growing in monolayers form fibrillar adhesions at the edges of a scrape 
wound "injury."24 Future studies into this FN-based separation technique could involve 
using antibodies unique to fibrillar adhesions to determine if this differential adhesion 
method is separating the cell population principally based on focal adhesions or fibrillar 
adhesions, or both. Characterizing the specific method of isolation in relation to these 
two types of adhesions could have important implications for normal and diseased VIC-
matrix interactions. Indeed, given that fibrillar adhesions form in response to VIC 
injury,24 investigating proteins specific to fibrillar adhesions, such as tensin, may be 
useful in characterizing this myofibroblastic, injury-related VIC population. Clearly, 
much research remains to be done in this area. 
While this paper has provided a means for separating the myofibroblast-like VIC 
phenotype from the mitral posterior leaflet, and preliminary results suggest that the 
method is also effective for human myxomatous valve cells, it will be important to 
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substantiate the utility of this method in the study of myxomatous mitral valve disease 
with a larger sample number of diseased valves. While myxomatous valves contain 
greater numbers of myofibroblasts,5 myxomatous valve cells may secrete excess GAGs 
and PGs into their pericellular matrix, which may make them less adhesive, but this 
remains to be shown. Elucidating the basis, mechanism, and optimal substrate for 
differential adherence of these cells will be essential in isolating the myofibroblast-like 
cells from a pool of myxomatous mitral valve cells. It is possible that further study will 
show that the myofibroblast-like population from myxomatous valves shares expression 
of many of the same markers as the myofibroblast-like cells isolated in this study. 
CONCLUSIONS 
This study demonstrated the successful separation of VIC subpopulations using 
differential adhesion. Differential adhesion to fibronectin produced a larger difference 
between subpopulations and moreover the FN FAST subpopulation demonstrated the 
phenotype associated with the VIC myofibroblast. This study demonstrated that an 
extracellular matrix component, fibronectin, which is abundant in tissues undergoing 
remodeling, can be used to isolate a unique cell population that is also commonly found 
in remodeling and diseased valves. Developing and validating such techniques for 
isolating specific cell subpopulations will be crucial in enabling the study of these 
subpopulations in diseased heart valves. 
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This chapter, in which a method for separating the myofibroblast valvular 
interstitial cell (VIC) population was presented, continued the theme of 
heterogeneity in the normal valve. In the next chapter this series of chapters related 
to valve heterogeneity (Chapters 8-11) is concluded with a study characterizing this 
fibronectin-separated myofibroblast VIC subpopulation. 
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Chapter 11: Functional Characterization of Fibronectin-
Separated Valvular Interstitial Cell Subpopulations: Application 
to Study of Valve Disease 
This chapter concludes the series of chapters addressing normal valve 
heterogeneity, and specifically heterogeneity in the valvular interstitial cell (VIC) 
population, with a study characterizing the myofibroblast VIC subpopulation 
isolated using the method detailed in the previous chapter. 
ABSTRACT 
Background: Myxomatous mitral valves (MVs) contain elevated proportions of 
myofibroblasts, a valvular interstitial cell (VIC) subpopulation likely important in disease 
pathogenesis. We recently developed a novel technique for the isolation of VIC 
myofibroblasts using time dependent adhesion to fibronectin (FN). Cells that quickly 
adhere to FN ("FAST") demonstrate myofibroblast cell phenotype markers, in contrast to 
cells that fail to adhere after a longer time ("SLOW"). The aim of this study was to 
characterize the functionality of these subpopulations using 3D collagen constructs. 
Methods: VICs were harvested from porcine mitral valve posterior leaflets. FAST and 
SLOW subpopulations, as well as unseparated VIC populations grown on FN and TCP 
(UNSEP TCP, UNSEP FN) were seeded within 3D collagen gels and cultured for 3 
weeks. Collagen gel contraction was assessed throughout the culture duration and 
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mechanical properties of the resulting collagen constructs were assessed using uniaxial 
tensile testing. 
Results: FAST cells demonstrated greater contraction of collagen gels compared with 
SLOW cells, particularly after 10 days (p<0.05). Interestingly, the collagen gel 
contraction by both FN-separated VIC subpopulations (FAST and SLOW) was greater 
than for gels seeded with UNSEP TCP VICs (p<0.05). Further, the contraction of 
UNSEP FN gels was greater than UNSEP TCP throughout culture duration (p<0.002), 
suggesting that the subculture of VICs on FN potentiated these phenotypic changes. 
Finally, the collagen constructs seeded with FAST cells were stiffer than those seeded 
with SLOW, followed by UNSEP TCP (pO.OOl). The same pattern was found for 
failure stress (p=0.006). 
Conclusions: Time dependent adhesion to FN produced a VIC subpopulation (FAST) 
whose function in 3D culture was consistent with that of myofibroblasts; FN exposure 
alone also caused VICs to function more like myofibroblasts. This novel isolation 
method may prove valuable in future studies of myofibroblasts in valve disease. 
The work contained in this chapter was published as: 
Stephens EH, Caroll JL, Post AD, Kuo JJ, Grande-Allen KJ. Functional 
Characterization of Fibronectin-Separated Valve Interstitial Cell Subpopulations: 
Application to Study of Valve Disease. Journal of Heart Valve Disease, in press. 
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INTRODUCTION 
Myxomatous mitral valves (MVs) contain elevated proportions of 
myofibroblasts,1 a valvular interstitial cell (VIC) subpopulation proposed to play an 
important role in disease pathogenesis. However, study of this cell type and its potential 
role in valve disease pathogenesis has been limited by difficulties in isolating this cell 
type. Recently we developed a novel isolation technique utilizing fibronectin (FN), an 
extracellular matrix component known to be involved in myofibroblast adhesion.3' 4 In 
this isolation technique VICs are seeded onto FN-coated tissue culture flasks and sorted 
into "FAST" to adhere and "SLOW" to adhere subpopulations.2 Previously, we used 
immunocytochemistry and flow cytometry to show that the FAST subpopulation of VICs 
demonstrate a more myofibroblast-like cell phenotype relative to the SLOW population.2 
While these results were promising, suggesting that this technique may be an effective 
method for the isolation of the VIC myofibroblast subpopulation, that study was limited 
to expression of phenotypic markers. To assess whether this FAST subpopulation also 
behaved functionally like myofibroblasts, this study was performed to characterize the 
behavior of the FAST and SLOW VIC populations using 3D collagen gel constructs. 
While much can be learned by study of cell behavior and function in the 2D in 
vitro culture environment, cells in vivo function in a 3D environment. Indeed numerous 
studies have shown that cell morphology and basic behaviors such as cell migration5 and 
the composition of cellular adhesions6 are different when cells are cultured in a 3D 
environment. Cell-seeded collagen gels, first developed by Bell,7 are widely used for the 
study of cells in a controlled, ex vivo 3D environment. Among the several types of 
collagen contraction models (free floating, constrained, and attached and delayed 
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release ), in this study we chose to use a constrained collagen gel model, which was 
considered to be more representative of the in vivo mechanical environment that VICs 
experience. Thus, FAST and SLOW VIC subpopulations, along with primary 
unseparated VICs cultured on FN-coated and uncoated tissue culture plastic (TCP), were 
seeded into collagen gel constructs. Functionality of the cells was evaluated as their 
ability to contract the collagen gel over a 3 week period, as well as the mechanical 
behavior of the resulting collagen construct. 
METHODS 
VIC Isolation 
The specific approaches employed for the isolation of VICs and the separation of 
VIC subpopulations using differential adhesion to fibronectin (FN) have been described 
in detail previously,2 and are summarized here. Mitral valves were dissected from fresh 
6-month-old pig hearts obtained from an abattoir (Fisher Ham and Meat, Spring, TX). 
VICs were isolated from the posterior leaflet using a two-stage collagenase digestion as 
previously described.9 Cells were cultured on tissue culture plastic (TCP) in DMEM 
containing 10% bovine growth serum (HyClone, Logan, UT) and 2% 
antibiotic/antimycotic (Mediatech, Herndon, VA) with changes of medium every 48 
hours. Cells were passaged after reaching 80-90% confluence. Experiments were 
performed on VICs between their second and fourth passages. 
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Isolation of VIC Subpopulations 
VIC subpopulations (FN FAST, FN SLOW) were generated utilizing differential 
adhesion to FN, as described in Chapter 10. The resultant FN FAST and FN SLOW 
subpopulations were grown in their respective FN-coated TCP flasks for 4 days until 
being seeded into the collagen constructs, described below. An additional population of 
unseparated VICs was grown on FN-coated TCP for 4 days (UNSEP FN). To serve as 
controls, unseparated VICs were grown only on TCP (UNSEP TCP). 
Collagen Constructs 
The methods for the formation and culture of cell-seeded collagen constructs have 
been described in detail previously.10 Briefly, 6-8 collagen constructs of each of the four 
groups of VICs (FN FAST, FN SLOW, UNSEP FN, and UNSEP TCP) were grown to 
approximately 80% confluence, trypsinized, and then added to a solution containing rat 
tail collagen type I (BD Biosciences, Franklin Lakes, NJ) and DMEM (Mediatech) to 
obtain a final collagen concentration of 2.0 mg/ml and final VIC concentration of 1.0x106 
cells/ml. The collagen-VIC solution for each of the four VIC populations was pipetted 
into dog-bone shaped wells within a custom-made silicone rubber Petri dish insert (60 
mm x 5 mm x 5 mm). The rounded ends of each well were equipped with a stainless 
steel wire post covered in porous polyurethane (Sawbones, Inc., Vashon, WA) in order to 
anchor the gels in static tension as the VICs contracted the collagen during the culture 
duration. Collagen gels were incubated for 3 weeks at 37 °C and 5% CO2 and media was 
changed every 48 hours. 
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Images of the collagen gels were collected throughout the culture period and 
analyzed using ImagePro Software (Fig. 11-1, Media Cybernetics, Silver Spring, MD). 
Gel contraction was calculated as 100% minus the percent of well width occupied by the 
collagen construct. Measurements of gel contraction were made at 5 points along the 
A 
^mm 
o in IS polyurethane foam 
surrounding posts 
collagen gel width 
well width 
Fig. 11-1: Collagen constructs shown within silicone rubber wells. Stainless steel posts 
surrounded by porous polyurethane foam provided anchors for the constructs to 
develop uniaxial tension during the culture period. Contraction was calculated as the 
width of the collagen construct relative to the silicone rubber well width measured at 
five locations along the construct length. 
length of the collagen construct, and the percentages averaged. Percentage gel 
contraction for all VIC populations was normalized to the average percentage contraction 
of UNSEP TCP at the first time point. 
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Mechanical Testing 
At the end of the culture duration, each construct was dissected away from the 
wire posts, and divided in half yielding two constructs of approximately equal length. 
Each half was mechanically tested in uniaxial tension using an EnduraTec ELF 3200 
(Bose, Framingham, MA). The construct was inserted into the grips for a final grip-to-
grip distance of 10 mm. Before tension was applied, the grip-to-grip distance was 
decreased by 1 mm to ensure no pre-tension was applied to the construct before the 
application of strain. Based on previous studies showing the potential for creep during 
pre-conditioning,11 samples were not pre-conditioned prior to testing. Constructs were 
then stretched at a rate of 3 mm/sec until failure. Data collected was plotted as a load-
displacement curve and used to determine the gauge length, the length of the stretched 
construct at which load rose above 0. By normalizing displacement and load, 
respectively, by the gauge length and the cross-sectional area of the construct, the data 
was converted to a stress-strain curve (strain was defined as (gauge length-
displacement)/gauge length). The modulus was defined as the slope of the best least-
squares mean fit to the linear portion of the stress-strain curve. The failure stress was 
defined as the stress at which the collagen construct broke; failure strain was similarly 
defined. Failure stress and strain was only calculated for samples that broke in the 
middle of the construct. 
Statistical Analysis 
Multifactorial analysis of variance to compare differences between 
subpopulations was performed using SigmaStat (SPSS, Chicago, IL), as described in 
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Chapter 4. Post-hoc testing was performed using the Holm-Sidak method for all pairwise 
multiple comparisons. 
RESULTS 
Collagen Construct Contraction 
Overall, collagen gels containing FAST cells and SLOW cells demonstrated 
comparable patterns of contraction throughout the culture duration. After 240 hours (10 
days) the percentage of contraction of FAST was consistently greater than that of SLOW 
(Fig. 11-2A). This difference, however, was not apparent during the first 100 hours, and 
at several early time points the rate of contraction of SLOW was actually greater than 
FAST (Fig. 11-2B). Throughout the collagen gel culture period, gels seeded with FAST 
or SLOW cells both demonstrated significantly greater contraction compared to gels 
seeded with UNSEP TCP cells (p<0.05 at each time point). Interestingly, the collagen 
gels containing unseparated cells exposed FN (FN UNSEP) contracted more at each time 
point than did the gels containing UNSEP TCP cells (p<0.002). The gels containing the 
UNSEP FN cells also demonstrated rapid early contraction towards a relatively stable 
plateau, while collagen gels containing the other VIC populations (FAST, SLOW, and 
UNSEP TCP) all demonstrated more gradual increases in contraction over the culture 
duration. 
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A. Contraction of Collagen Constructs by VIC Subpopulations 
- o - FAST 
—•—SLOW 
- •*- • UNSEP TCP 
- - • - • U N S E P FN 
600 
Fig. 11-2A: Normalized contraction of collagen constructs populated by the different 
VIC subpopulations. For all subpopulations, percentage contraction at each time point 
was normalized to the percentage contraction of the first time point of UNSEP TCP. 
*p<0.05 FAST vs. SLOW for a given time point (only marked on the time points >100 
hours for this graph, for time points <100 hours see part B). FAST and SLOW were each 
significantly different compared to UNSEP TCP at each time point (p<0.05) and UNSEP 
FN was significantly different compared to UNSEP TCP at each time point (p<0.002). 
Error bars indicate standard deviation. 
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B. 
Early Contraction of Collagen Constructs by VIC Subpopulations 
- o - FAST 
—•—SLOW 
- * - - UNSEP TCP 
- - • - • U N S E P FN 
Fig. 11-2B: Contraction of collagen constructs populated by the different VIC 
subpopulations over the first 100 hours. *p<0.05 FAST vs. SLOW for a given time point. 
FAST and SLOW were each significantly different compared to UNSEP TCP at each time 
point (p<0.05) and UNSEP FN was significantly different compared to UNSEP TCP at each 
time point (p<0.002). Error bars indicate standard deviation. 
Material Properties of Collagen Constructs 
The elastic moduli of the collagen gels were greatest for those seeded with FAST 
cells and lowest for those seeded with UNSEP TCP (Fig. 11-3, pO.OOl). Failure stress 
measurements showed the same pattern of differences between groups (Fig. 11-4, 
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Fig. 11-3: Elastic modulus of collagen constructs populated by the different VIC 
subpopulations. Overall p<0.001. *,A,f indicate p<0.05 between bars with 
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Fig. 11-4: Failure stress of collagen constructs populated by the different VIC 
subpopulations. Overall p=0.006. *p<0.05 between FAST and UNSEP TCP. 
Error bars indicate standard deviation. 
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DISCUSSION 
The first major finding of this study was that the myofibroblast-like VIC 
subpopulation that adhered quickly to FN demonstrated greater collagen gel contraction 
and remodeled the gels to produce stronger constructs, when compared to the less 
adhesive VIC subpopulation (SLOW). This finding is consistent with connective tissue 
and wound healing literature showing that myofibroblasts exert more force than 
fibroblasts12"14 and have been shown to contract collagen gels more than their fibroblast 
counterparts.13' 15 Therefore, this work extends our previous report that this FAST 
subpopulation of VICs expresses many myofibroblast phenotypic markers 2 by showing 
that they also function like myofibroblasts. Differential adhesion to FN was chosen as 
the means for isolating the VIC myofibroblast subpopulation based on the role of FN in 
myofibroblast adhesion3'16 as well as its presence in normal and myxomatous valves and 
chordae tendinae.2'1? FN has also been shown to be secreted by VICs exposed to injury-
1 Q 
like conditions, during which time the myofibroblast phenotype might also be 
expressed.19 Additionally, the expression of FN was increased in the mitral valves of 
dogs with chronic valve disease similar to human myxomatous mitral valve disease.20 
Based on these studies documenting enriched FN content in conjunction with elevated 
numbers of myofibroblasts, it was hypothesized that the myofibroblast VIC 
subpopulation may display greater affinity for FN relative to other VIC subpopulations, 
and therefore FN could be a useful tool for isolating this subpopulation. The mechanism 
underlying the VIC myofibroblasts' faster adhesion to FN is still under investigation, but 
may be due in part to greater adhesive strength. Although the adhesive strength of VIC 
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myofibroblasts has not been assessed, studies of other cell populations have shown that 
myofibroblasts exert stronger forces than their fibroblast counterparts12"14 and are better 
at contracting collagen gels.13' 15 This enhanced adhesion has been attributed to more 
extensive cell-matrix contacts,21 isoform-specific terminal peptide adhesions,2 and 
differences in focal adhesion structure and composition.3 Indeed, our previous work on 
these cell populations revealed that compared to the SLOW subpopulation, the FAST 
subpopulation expressed greater amounts of smooth muscle alpha-actin, which has been 
shown to correlate to contraction strength of myofibroblasts in other connective tissues.13 
It is interesting to note that both FAST and SLOW subpopulations show similar 
contraction early, perhaps due to the potentiation effect of FN (as discussed below), 
although at later time points the FAST subpopulation started to contract the gels 
significantly more than the SLOW subpopulation. This late difference could have been 
because the FAST subpopulation created more stress within the gel, which further 
enhanced the myofibroblast phenotype and led to further contraction. The mechanical 
environment of fibroblasts/myofibroblasts, especially the stress that these cells 
experience, has been well documented to drive myofibroblast differentiation and 
contraction in other connective tissues.16 
The second major finding was that exposure of unseparated VICs to FN resulted 
in a greater ability to contract collagen gels, compared to unseparated VICs grown on 
TCP, which suggests a potentiation effect of FN adhesion. Unexpectedly, this effect was 
greater than the difference between FAST and SLOW. This effect was examined when it 
was noted that the FAST and SLOW cells, which were isolated by culture on FN, were 
both better able to contract collagen gels more than the UNSEP TCP cells, which were 
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never exposed to FN. After unseparated VICs were exposed to FN for an equivalent 
amount of time as the FAST and SLOW cells, their overall contraction of collagen gels 
was comparable to FAST and SLOW, and in fact was more rapid. These results suggest 
that adhesion to FN potentiates the myofibroblast phenotype in VICs, which is consistent 
with our previous finding that the VIC subpopulation that quickly adhered to FN 
demonstrated greater myofibroblast phenotypic marker expression than the VIC 
subpopulation that quickly adhered to TCP.2 This interpretation that FN potentiates the 
myofibroblast phenotype in VICs is also supported by studies demonstrating increased 
SMaA expression of VICs plated on FN-coated 2D surfaces, as well as studies of 
fibroblasts from a range of other tissues.24 
Although several reports have described the culture of VICs within collagen gels, 
the mechanisms of VIC-collagen interactions are less understood. Generally collagen gel 
contraction by fibroblasts/myofibroblasts is thought to occur by the contraction of cells 
seeded within collagen gels (principally seen with myofibroblasts), the tractional forces 
that develop as the cells translocate and bundle collagen fibers, and the elongation and 
spreading of the initially spherical cells when they are seeded within the collagen gel 
(during the first 4 hours of cell-collagen gel culture).8 The relative contributions of these 
various mechanisms depend on the specific types of cells seeded within the collagen gel 
as well as the boundary conditions imposed on the collagen gel (i.e., free-floating versus 
constrained). In cell-populated constrained collagen gels, the local applied forces of 
fibroblasts on collagen are transmitted to effect global changes.16 As the collagen is 
reorganized by the seeded fibroblasts, matrix stiffening occurs, and cells align in the 
direction of tension and develop stress fibers.16 In an elegant study embedded beads and 
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collagen fibers within cell-seeded collagen gels were visualized to demonstrate that as 
fibroblasts apply traction to adjacent collagen fibers, small, local translocations of these 
fibers were apparent within minutes, and the cells continued to reorganize the collagen 
fibers into bundles, which became visually apparent by 3 hours.25 The interconnected 
mesh-like nature of the collagen gel allowed the simultaneous transmission of these 
localized processes to large-scale global construct contraction. While the basic 
mechanisms by which VICs remodel collagen gels have only started to be 
characterized,26 based on the similarities between VICs and fibroblasts/myofibroblasts, 
the process of collagen gel contraction by VICs likely involves a similar series of events. 
Ongoing progress to characterize the phenotype and function of VIC 
myofibroblasts has implications for a number of valve diseases, including myxomatous 
mitral valve disease1 and calcific aortic stenosis.27 VICs demonstrating the myofibroblast 
phenotype have also been demonstrated in other instances of valve injury19 as well as in 
cardiac diseases28 and ex vivo experiments in which valves experience increased stress.29 
Given the speculated roles of this cell type in clinical valve disease, novel approaches to 
isolate these cells offer promise for future investigations of these diseases, especially 
since there is no single marker that can definitively distinguish this cell type. 
Additionally, adhesion of VICs to FN may prove to be a useful tool for manipulating VIC 
phenotype,30 which could aid in regulating the material properties and calcification 
potential of tissue engineered heart valves. 
While collagen gel studies are a useful ex vivo tool for studying cell function, the 
method was limited in only measuring these cells' interaction with collagen (as opposed 
to other extracellular matrix components) over a relatively short time course. As with 
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many ex vivo experimental studies, this method also did not incorporate in vivo factors 
that undoubtedly affect VIC function, such as hemodynamics, growth factor and cytokine 
signals, and dynamic strain during each cardiac cycle. Another limitation was that 
porcine VICs were used. While porcine valves are commonly and appropriately used as 
models for human valves,31' 32 future studies will need to expand on the approach 
described in this work by utilizing human VICs from both healthy and diseased valves. 
Although, further investigation of this FAST VIC subpopulation is clearly needed, this 
study represents an important first step in functionally characterizing this subpopulation. 
CONCLUSIONS 
In summary, rapid adhesion to FN produces a VIC subpopulation that behaves in 
a manner consistent with myofibroblasts, and generates collagen gels constructs that are 
stronger and stiffer than collagen constructs grown from less adhesive or non-FN treated 
VICs. Additionally, treatment with FN appeared to potentiate myofibroblast behavior in 
unseparated VICs. These results, taken together with previous results demonstrating 
strong expression of myofibroblast phenotype markers in the FAST VIC subpopulation, 
emphasize the promise of this approach for the isolation and study of the VIC 
myofibroblast subpopulation in valve biology and disease pathogenesis. 
This chapter, which characterized the myofibroblast valvular interstitial cell 
(VIC) subpopulation isolated using the method detailed in the previous chapter, 
concludes the series of chapters addressing normal valve heterogeneity, and 
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specifically heterogeneity in the VIC population. In the next chapter the topic of 
VlC-matrix coupling is addressed with a study demonstrating the functional 
interaction of VICs and collagen in the mitral leaflet. 
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Chapter 12: Functional Coupling of Valvular Interstitial Cells 
and Collagen in the Mitral Leaflet 
This chapter continues the topic of understanding normal valve 
mechanobiology by addressing cell-matrix interactions in the normal mitral valve. 
Specifically the study in this chapter demonstrates the functional interaction of 
valvular interstitial cells (VICs) and collagen. 
ABSTRACT 
Background: Recent studies have demonstrated that the anterior mitral leaflet (AML) in 
vivo exhibits a much higher stiffness than observed ex vivo. Such studies have also 
demonstrated dynamic in vivo leaflet stiffness modulation that cannot be accounted for by 
synthetic collagen remodeling or the cardiac muscle that extends into the AML. While 
valvular interstitial cells (VICs) could contribute to such apparent discrepancies between 
in vivo and ex vivo stiffness, as well as dynamic stiffness modulation, the exact 
mechanisms for VICs in AML force generation are not understood. This study tested the 
hypothesis that actin-mediated VIC force generation coupled to collagen via alpb^betai 
integrins is necessary for force generation in the AML. 
Methods: In order to test this hypothesis, the central bare area of the AML was dissected 
from fresh porcine hearts, obtained from a local abattoir, and stained to visualize the VIC 
cytoplasm, nucleus, actin, and alpha2betai integrins. Second harmonic generated signal 
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was used to visualize collagen within the leaflets. Small (~1 cm x 5 mm) strips, with 
long axis in the AML circumferential direction, were sutured into a custom-designed 
strain-load device attached to a Zeiss Leica 510 LSM confocal microscope stage. 
Potassium chloride (KC1, 95 mM) was added to control samples (n=10), as well as 
samples incubated with either alpha2betai monoclonal blocking antibody (n=5) or 25 uM 
cytochalasin (n=4), and the resultant isometric force recorded using custom designed 
software. 
Results: Fluorescent imaging revealed that VIC cell bodies were highly aligned in 
parallel with collagen fibers and their cytoplasm and nuclei were elongated in line with 
the collagen axis. High magnification microscopy revealed VIC cytoplasm tightly 
conforming to collagen fibers, with actin within VIC filopodia appearing to attach to the 
collagen fibers. Alpha2betai integrins were demonstrated to co-localize with VIC 
cytoplasmic staining as well as on the edge of collagen fibers. Functional studies of 
isometric force development demonstrated that while control samples developed force in 
response to KC1, either blocking alpha2betai integrins or blocking actin polymerization 
via cytochalasin abolished KCl-induced force development (pO.OOl). 
Conclusions: The imaging results from this study combined with the functional blocking 
experiments strongly suggest that VIC-collagen coupling, mediated by alpha2betai 
integrins, is necessary for KCl-induced force generation in the AML. This functional 
coupling between collagen and VICs via alpha2betai integrins is a good candidate for 
leaflet stiffness modulation in vivo. 
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The work contained in this chapter is under review by the journal Cellular and 
Molecular Bioengineering: 
Stephens EH, Durst CA, Swanson JC, Grande-Allen KJ, Ingels NB, Jr., Miller DC. 
Functional Coupling of Valvular Interstitial Cells and Collagen in the Mitral 
Leaflet. Journal of Cellular and Molecular Bioengineering, under review. 
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INTRODUCTION 
Recent studies indicate that in vivo mitral leaflet stiffness substantially exceeds 
what has been observed ex vivo. Further studies suggest that dynamic, beat-to-beat 
modulation of leaflet stiffness occurs within the living heart on time scales much shorter 
than can be accounted for by synthetic remodeling of collagen or other extracellular 
matrix components.2 While contraction of cardiac muscle extending from the left atrium 
into the leaflet accounts for some of these dynamic leaflet stiffness changes, 
pharmacologic blocking of contraction of this cardiac muscle revealed that there must be 
additional contractile elements contributing to the observed beat-to-beat leaflet stiffness 
modulation.2'3 This growing body of evidence continues to revise the traditional view 
that mitral leaflets were passive flaps, suggesting, instead, a paradigm involving multiple 
contractile systems within the leaflets. 
The role of valvular interstitial cells (VICs) in this unfolding paradigm remains 
unclear. While it is well known that VICs are fundamental to leaflet extracellular matrix 
synthesis and remodeling on longer time scales in both healthy and disease states,4"7 their 
role in the dynamic modulation of leaflet stiffness remains largely unknown. VICs are 
contractile8' 9 and, based on similarities to fibroblasts and myofibroblasts,10 VIC 
contraction is thought to occur via actin polymerization. Furthermore, studies have 
shown that vasoactive agents that cause VIC contraction also cause increased force 
generation in ex vivo viable valve leaflets9' u"17 and increased aortic cusp flexural 
stiffness,18 suggesting that VIC contraction may play a role in leaflet stiffness 
modulation. The mechanisms underlying this modulation, however, have yet to be 
elucidated. 
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Transmission electron micrographs show VICs closely associated with collagen 
fibers,9' 19 suggesting an interaction between VICs and collagen in the leaflet, perhaps 
even acting together as a functional unit. Given that integrins are the primary proteins 
attaching cells to the surrounding matrix,20 a potential interaction between VICs and 
collagen likely occurs through one of the integrins. Of the known collagen binding 
integrins, only alpha2betaiand alphanbetai show higher affinity for type I collagen (the 
predominant collagen in heart valves21) than type IV.22 Based on fibroblast-collagen gel 
contraction23 and fibroblast collagen fiber transport24 studies, we hypothesized that 
alpha2betai integrins may be a mechanism by which VICs attach to collagen within the 
mitral valve leaflet. While a variety of integrins have been shown to be present on 
enzymatically isolated VICs, including alpha2betai,25'26 the potential functional role of 
integrins in valves, however, has not been studied. 
Based on the hypothesized roles of actin and alph^betai integrins in this proposed 
VIC-collagen mechanotransduction within the mitral valve, the aim of this study was to 
test the specific hypothesis that actin-mediated VIC force generation coupled to collagen 
via alpha2betai integrins was necessary for force generation in mitral leaflets. 
METHODS 
Immunofluorescence 
Porcine hearts (Yosemite Meat, Modesto, CA) were obtained within one hour of 
animal slaughter and transported in cold saline (0.9% sodium chloride, Hospira, Lake 
Forest, IL). The central bare area of each mitral anterior leaflet was dissected within 4 
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hours of animal slaughter and stained to visualize VIC cytoplasm, nucleus, actin, and/or 
alpha2betai integrins. VIC cytoplasm was stained using calcein AM (Invitrogen 
Molecular Probes, Eugene, OR), VIC nuclei were stained using Syto85 (Invitrogen 
Molecular Probes), and alpb^betai integrins were stained using a monoclonal antibody 
(MAB1998, Chemicon, Temecula, CA) conjugated to an AlexaFluor 684 fluorescent 
probe (Molecular Probes). Actin was stained using AlexaFluor 488 phalloidin 
(Invitrogen Molecular Probes) in tissues fixed in 10% formalin for 30 minutes and 
permeabilized with 0.5% Triton-XlOO (Sigma-Aldrich, St. Louis, MO). Tissue was only 
fixed for actin staining; all other staining and force generation experiments utilized fresh 
tissues without fixation or permeabilization. 
Confocal Microscopy 
A Zeiss Leica 510 LSM confocal microscope (Zeiss, Oberkochen, Germany) with 
a Mira tunable Ti:Sa laser (Coherent, Santa Clara, CA) was used to visualize the 
fluorescent probes and the second-harmonic generated collagen signal (excitation at 820 
nm, maximum emission at 410 nm). Specifically, calcein was visualized using a 488 nm 
Ar laser and 500-530 nm band pass (BP) filter, Syto85 was visualized using a 543 nm 
HeNe laser and 565-615 BP filter, AlexaFluor 684 conjugated alpha2betai integrins were 
visualized using a 633 nm HeNe laser and 650 low pass filter, and AlexaFluor 488 
phalloidin was visualized using a 488 nm Ar laser and 500-530 nm BP filter. Second-
harmonic generated collagen signal was obtained using an 820nm wavelength on the 
tunable Ti:Sa laser, and emission captured using a 390-465 nm BP filter. A key 







Fig. 12-1 (previous page): Custom-built strain-load device. A) Diagram illustrating strain-
load device built to fit into a motorized confocal stage. Adjustable screw is shown at left; this 
screw, coupled with a block (labeled "A ") that could freely slide in cut-out channel, allowed 
manipulation of strain on tissue as indicated by red arrow. Chamber glass, which held tissue 
sample in buffer, appears ghosted in on this diagram. The chamber glass was held above 
objective by virtue of a small metal lip. Placement of tissue sample within the set-up is 
indicated by the beige rectangle and load cell is labeled. B) Photo illustrating custom-built 
strain-load device diagrammed in (A) set in place on confocal stage. Edges of strain load 
device are outlined in red, tissue sample and load cell are labeled. Microscope objectives are 
located under the black stage (hidden from view) and microscope eye piece is evident in 
foreground of photo. Signal output from load cell is carried by silver cable to electronics not 
pictured. C) Close-up photo of in situ strain-load device. Note valve tissue sutured to plastic 
mesh between green wire struts. Microscope objective can be seen beneath cover glass. Tissue 
sample and load cell are labeled. Inset: view of tissue sample from above (microscope head 
piece removed) demonstrating tissue sutured in place within the chamber. Microscope objective 
can be seen below. 
visualization of collagen without interfering with the potential VIC-collagen interaction, 
such as may have occurred with a fluorescent probe conjugated collagen antibody. Time-
lapse images were taken with the 20x objective lens, while higher magnification images 
used 25x, 40x, 63x, and lOOx oil immersion objective lenses. Images were processed 
using Zeiss LSM Image Browser software (Zeiss). 
Custom-Built Strain-Load Device 
Using computer assisted design software (SolidWorks, Dassault Systemes, 
Lowell, MA), a strain-load device (Fig. 12-1) was built to fit, spring-loaded, into a 
motorized Zeiss Leica 510 LSM confocal microscope stage replacing the standard 
microscope slide holder. The device was fabricated from 6061 aluminum that was 
anodized for corrosion resistance. Tissue samples were placed in a 4-well cover glass 
chamber (LabTek II, Nalgene Nunc International, Naperville, IL) and sutured to plastic 
mesh attached to wire struts. These wire struts were secured with set screws in blocks on 
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either side of the wells. The blocks slid freely in one dimension in recessed channels. 
The 4-well cover glass chamber was suspended above the microscope objective using a 
small metal lip. An adjustable screw, coupled with the freely-sliding left block, allowed 
manipulation of strain on the tissue. A miniature tension load cell (Omega, Stamford, 
CT) was fit in-line with the sutured tissue. The load cell was powered using a 12 volt 
battery that delivered 10 volt DC to the load cell through the use of a voltage divider. 
Output from the load cell was captured by a USB data acquisition kit (USB 6008, 
National Instruments, Austin, TX), and recorded using a custom-designed virtual 
instrument (Lab View Signal Express, National Instruments). 
Force Generation Studies 
Small (~1 cm x 5 mm) circumferential strips of the central, bare area of the 
anterior mitral leaflet were sutured into the custom-designed strain-load device fit upon 
the microscope stage, as described above. After suturing the tissue in place, the tissue 
was allowed to equilibrate in Kreb's solution for at least 20 minutes (136.9 mM NaCl, 
11.9 mM NaHC03, 2.7 mM KC1, 0.4 mM NaH2P04, 2.5 mM MgC12, 2.5 mM CaC12, 
11.1 mM glucose, 0.04 mM disodium EDTA, pH 7.4). Potassium chloride (95 mM) was 
added to control samples (n=10) and the load-cell output recorded using the custom-
designed software described above. To investigate the roles of alpha2betai integrins and 
actin in VIC-mediated leaflet contraction, VIC cytoplasmic and nuclear staining was 
performed as described above, and tissues were incubated with either 10 |Ag/ml 
alpha2betai monoclonal blocking antibody (n=5) (Chemicon) or 25 \iM cytochalasin 
(n=4) (Sigma Aldrich) before the addition of 95 mM KC1. 
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Fig. 12-2: A). Image demonstrating VIC alignment with respect to collagen fibers. Blue 
(upper left panel) indicates the VIC cytoplasm, green (upper right panel) indicates collagen 
fibers, red (lower left panel) indicates VIC nuclei, and lower right panel is the merged image 
of the 3 other panels. The yellow arrow in the upper right panel indicates the orientation of 
collagen ridges, and correlates to the yellow arrow in the schematic in part B. The white 
arrow in the upper right panel indicates the orientation of collagen fibers, and is analogous to 
the white arrow in the schematic of part B (note: in all remaining figures collagen fiber 
alignment is indicated by a white arrow). Scale bar indicates 50 pim. B). Schematic 
illustrating how undulating collagen fibers at this magnification appear as lines 
perpendicular to the direction of collagen fibers. White portions of undulating fibers above 
green plane represent portions of fibers in focus. The yellow arrow indicates the ridges 
visualized in the upper right panel of part A (and corresponds to the yellow arrow in part A), 
whereas the white arrow indicates the orientation ofcollasen fibers. 
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Statistical Analysis 
Statistical comparisons between groups were made with one-way ANOVAs using 
SigmaStat software (SPSS, Chicago, IL), as described in Chapter 4. Post-hoc pair-wise 
comparisons were performed using Dunn's method. Data is presented as mean ± 
standard error of the mean. 
RESULTS 
VICs Aligned and Integrated with Collagen Fibers 
Fluorescent imaging of VICs revealed that VIC cell bodies were highly aligned in 
parallel with collagen fibers (Fig. 12-2). VIC cytoplasm and nuclei were elongated, with 
their long axis coinciding with that of the collagen fibers. High magnification images 
demonstrated the VIC cytoplasm tightly conforming to the undulating contour of the 
crimped collagen fibers (Fig. 12-3). Fluorescent imaging of VIC cytoskeletal actin 
revealed VIC actin similarly aligned with collagen fibers, and actin within VIC filopodia 
appeared to grasp collagen fibers (Fig. 12-4). Where collagen fibers were not highly 
aligned, VIC morphology and actin configuration were substantially different: VICs were 
less elongated and VIC filopodia extended in disparate directions, although still 
appearing to follow and potentially to attach to collagen fibers (Fig. 12-5). 
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Fig. 12-3: Image demonstrating VICs nestled into the curves of the collagen fibers. 
Green indicates collagen fibers, blue indicates VIC cytoplasm, and pink indicates VIC 
nuclei. White arrow indicates the direction of collagen fibers. Scale bar indicates 10 ji/m. 
VIC Alpha2Betai Integrins Localized to Collagen Fibers 
VIC alpha2betai integrins, demonstrated on the edges of the VIC cytoplasm stain 
(Fig. 12-6), were found at high magnification to co-localize to the borders of collagen 
fibers (Fig. 12-7). VICs in alphaabetai integrin-blocked samples tended to show less 
alignment relative to collagen fibers compared to control samples taken from the same 
region of the same leaflet (Fig. 12-8). 
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Fig. 12-4: Left panel demonstrates alignment of VIC actin with collagen fibers at lower 
magnification. Green indicates collagen fibers, blue indicates VIC actin, and pink indicates 
VIC nuclei. Scale bar indicates 50 fJm. Right panel demonstrates VIC actin processes 
"grasping" collagen fibers at higher magnification. Scale bar indicates 10 fJm. White 
arrow in both portions of the figure indicates orientation of collagen fibers. 
329 
Fig. 12-5: VIC actin in a region in which collagen was not highly aligned. Note 
differences in actin configuration and VIC morphology. To facilitate visualization of actin, 
in this image green indicates VIC actin and blue indicates collagen fibers. Scale bar 
indicates 10 jLOn. 
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Fig. 12-6: Alpha2betai integrins located on VIC cell membrane. Green indicates alpha2betai 
integrins, blue indicates VIC cytoplasm, and pink indicates VIC nuclei. Scale bar indicates 
10 urn. 
Fig. 12-7: Alpha2betai integrins located on collagen fibers. Blue indicates collagen 
fibers, green indicates alpha2betat integrins, and red indicates VIC nuclei. Scale bar 
indicates 20 jUm. White arrow indicates direction of collagen fibers within the image. 
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Control Sample Integrin-Blocked Sample 
Fig. 12-8: VICs after blocking alpha2betai integrins tended to show less alignment with 
collagen fibers. Left panel demonstrates control sample, right panel demonstrates sample from 
adjacent region of the same leaflet in which alpha2betai integrins were blocked. The upper 
panels are merged images in which green indicates collagen fibers, blue indicates VIC 
cytoplasm, and pink indicates VIC nuclei. Lower images are identical to merged images above, 
but illustrate cytoplasm staining alone to better visualize VIC alignment relative to collagen 
fiber orientation (indicated by white arrows), demonstrating less alignment of VICs in 
alphaibetai integrin-blocked samples relative to collagen fibers. Scale bar indicates 20 pn. 
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Blocking Alpha2Betai Integrins or Actin Polymerization Prevented Force 
Generation 
Consistent with previous studies,9' ""17 the addition of 95 mM KC1 resulted in 
force generation (Fig. 12-9) in the circumferential strip of mitral valve tissue. Blocking 
of either alpha2betai integrins or actin polymerization (via cytochalasin) was sufficient to 
prevent force generation in response to 95 mM KC1 (control: 3.30±0.23 mN, integrin-
blocked: 0.04±0.09 mN, cytochalasin 0.20±0.06 mN, pO.OOl, p<0.001, Fig. 12-9). 





Fig. 12-9: Force generated by mitral valve anterior leaflets exposed to various treatments in 
response to 95 mM KCl after 10 minutes. Overall comparison between groups by one-way 
ANOVA: p<0.001; pair-wise comparison (Dunn's method): *p<0.05 vs. control. Error bars 
indicate standard error of the mean. 
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DISCUSSION 
The imaging results of this study, taken together with the leaflet force data, 
support the hypothesis that VIC-collagen coupling, mediated by alpha2betai integrins, 
contributes to the leaflet stiffness modulation that has been observed in the in vivo leaflet. 
Confocal microscopy imaging, used to investigate the structural relationship of 
VICs, collagen fibers, and alpb^betai integrins demonstrated VICs closely conformed to 
crimped collagen fibers and appeared to grasp collagen fibers with their filopodia. 
Alpha2betai integrins localized to the VIC borders adjacent to collagen fibers. When 
these integrins were blocked, VICs appeared less aligned with the collagen fibers. These 
results provide a structural foundation for a proposed VIC/collagen functional unit. 
Functional studies, utilizing KC1 to elicit VIC contraction, built on this 
foundation, and demonstrated the necessary components of this functional unit for mitral 
valve force generation: VIC actin polymerization, collagen fibers, and alpha2betai 
integrins. Blocking either alphaabetai integrin (the hypothesized means by which VICs 
attach to collagen) or actin polymerization (the hypothesized means of VIC contraction) 
abolished leaflet force generation. These results suggest that contraction of VICs and 
their adherence to collagen are both necessary for force generation in the mitral leaflet. 
Structural Interaction between VICs, Integrins, and Collagen Fibers 
The second harmonic-generated collagen signal allowed visualization of the 
structural relationship between collagen fibers and viable VICs in freshly excised leaflets 
without altering their spatial arrangement with tissue fixation and processing, or 
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disrupting potential interactions between VICs and collagen fibers, as can occur with 
antibodies or other probes. This method of visualizing viable cells in freshly excised 
tissues is in contrast to the limited number of previous studies in which transmission 
electron microscopy demonstrated VICs abutting collagen fibers.9' 19 While these 
previous studies were important to our understanding of VICs within the valve matrix, 
such imaging modalities have significant limitations related to specimen preparation, 
which make interpretation of their results in the context of in vivo leaflets difficult. Our 
imaging modality enabled us to make inferences about functional implications of the 
structural interactions observed in the in vivo leaflet, and thereby relate the imaging 
results to the functional studies. 
Of particular note was the parallel alignment of VICs relative to collagen fibers. 
While leaflet anisotropy has largely been attributed to collagen fiber alignment in the 
past,27 the observed alignment of VICs in conjunction with the functional findings of this 
study and studies demonstrating that VIC contraction caused greater circumferential as 
opposed to radial force generation in aortic cusps,15 suggests that VIC alignment may 
contribute to the anisotropic material properties of valves. 
VIC cytoplasm was not only observed to closely follow the contours of the 
crimped collagen fibers, in what could be considered a space-filling manner, but apparent 
direct attachments were observed between filopodia and collagen fibers, suggesting a 
structural link between VICs and collagen fibers. Furthermore, even in regions in which 
collagen fibers were not aligned, VIC filopodia appeared to reach out and grasp collagen 
fibers, further suggesting that VICs were directly interacting with the collagen as opposed 
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to simply possessing the same alignment as a result of space effects. These images could 
even suggest a role for VICs in aligning collagen fibers as the leaflet undergoes strain. 
Confocal imaging demonstrated alpha2betai integrins on VICs within viable tissue 
strips, consistent with previously reported findings using enzymatically isolated VICs. ' 
26
 Imaging in this study, however, also suggested a potential functional role for these 
alpha2betai integrins: attaching VICs to adjacent collagen fibers. When alpha2betai 
integrins were blocked, VICs were less aligned with collagen fibers as compared with 
VICs in control samples taken from the same leaflet region. 
VIC-Integrin-Collagen Functional Unit 
This study demonstrated that blocking alpha2betai integrins abolished leaflet force 
development; this result suggests that VICs are functionally coupled with collagen via 
alpha2betai integrins allowing the force generated by VIC contraction to be transmitted to 
collagen, and thereby the mitral leaflet (Fig. 12-10). Similarly, when actin 
polymerization was blocked via cytochalasin,28'29 leaflet force generation did not occur. 
This result suggests that leaflet force is developed by actin-dependent VIC contraction. 
Therefore, when either the actin portion of the functional unit or the integrin portion of 
the functional unit is blocked, force is not generated in the leaflet. 
VIC-Integrin-Collagen in Stiffness Modulation 
The proposed VIC-integrin-collagen functional unit and the force it can produce 
is likely dynamic, and may contribute to the leaflet stiffness modulation that has been 
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observed in vivo.2'3 Integrin binding is a dynamic process during which time the amount 
of force that is transduced also changes. Beginning with punctate integrin "focal 
Fig. 12-10: Diagram illustrating the proposed VIC-integrin-collagen functional unit 
suggested by the results of this study. Inset on right displays an alpha2betai integrin 
with its external domain attaching to a collagen fiber and cytosolic domain attaching 
to the actin cytoskeleton via linking proteins. 
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complexes," ' integrin binding proceeds with the recruitment of additional proteins to 
form large supramolecular structures, "focal adhesions," that enable greater force to be 
transmitted through the binding site.31 The actin microfilament portion of this contractile 
system, to which focal adhesions attach, also dynamically polymerize and 
depolymerize.31 These two constantly changing processes of integrin binding and actin 
microfilament polymerization affect each other in real time.30 Even the strength of 
integrin binding is not static, but rather continually changing depending on a number of 
factors.32 The magnitude of the force that the integrin-actin complex exerts also changes 
depending upon the state of maturation of the integrin adhesion, as described above, as 
well as the number of binding sites and adhesive strength of the integrins. Similarly, the 
magnitude of actin force development is modulated by a number of factors, including 
signaling events such as those initiated by transforming growth factor beta, the ratio of 
polymerization to depolymerization, and expression of certain actin isoforms like smooth 
muscle alpha-actin.33 Some of these changes, such as the transition from initial low 
affinity integrin binding to high affinity binding, occur on the order of 10 seconds. 
Taken together, this proposed VIC-integrin-collagen functional unit has the potential to 
dynamically alter the force it exerts, and therefore could contribute to leaflet stiffness 
modulation in vivo. 
The supposition that VICs can modulate leaflet stiffness is supported by the work 
of Merryman et al., who showed an increase in aortic valve leaflet flexural stiffness with 
VIC contraction induced by KG.18 Furthermore, treatment of valves tissues with 
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thapsigargin, which prevents VIC contraction via inhibiting ATPase, led to a dramatic 
decrease in leaflet flexural stiffness, suggesting that VICs are responsible for a basal level 
of valve tonus. 
Valve Force Generation in an Isometric Setting 
While force generation in valves is commonly reported in the context of uniaxial 
or biaxial tensile testing, in which case collagen strain is occurring, the force generation 
demonstrated in this study occurred within an isometric set-up without collagen strain. 
The mechanism, therefore, of force generation in this study must be an increase in 
stiffness. This is conceptualized in Figure 12-11. If the yellow stars represent 
hypothetical force measurements of a valve tissue (in the context of this experiment #1 
represents the force measured before addition of KC1 and #2 represents the force 
measured after addition of KC1), then the observed increased in force could be due to an 
increase in strain (as in a traditional uniaxial or biaxial mechanical testing set-up) in 
which the stiffness of the tissue remains constant (path "A"), or by a change in tissue 
stiffness (elastic modulus (E)) from Ei to E2 (path "B"). Examination of force 
development in an isometric setting has a number of advantages including isolating 
variables. While in vivo the leaflet clearly is not an isometric system (rather, collagen 
strain occurs as the valve is hemodynamically loaded), the VIC-collagen interactions 
demonstrated in this study are likely fundamental and therefore would occur in the setting 
of collagen strain as well. In fact, the VIC-collagen interaction may even have a greater 
role to play in the setting of collagen fiber strain, although that remains to be determined. 
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Conceptualizing Means of Force Generation in Valves 
Fig. 12-11: Diagram conceptualizing different means by which force may be generated in valve 
leaflets. E=elastic modulus (tissue "stiffness "), Ei=initial elastic modulus; E2=modified elastic 
modulus. The stars on the y-axis represent two hypothetical measurements of force of a valve 
tissue (i.e., in the context of these studies #1 would represent a measurement of force before 
addition ofKCl and #2 after addition ofKCl). This difference in force could be explained by 
either an increase in strain within the tissue (the path marked by the dashed line "A ") in which 
the elastic modulus does not change (therefore the path follows along the Ej line), or by a 
change in elastic modulus of the valve tissue from E\to E2 (the path marked by the dashed line 
"B "). In the case of path "B, " no change in tissue strain would occur. 
Implications 
The results from this study confirm and build upon a currently proposed working 
hypothesis of contractile systems within the MV. Itoh et al.2 proposed a model of the 
MV that included 3 potential contractile elements including cardiac muscle, smooth 
muscle, and VICs to explain the dynamic stiffness changes that take place in the mitral 
valve in the beating heart. The results of this study confirm that VICs are a contractile 
element in the MV, and add to this proposed model by demonstrating how VICs generate 
force in concert with collagen via integrin coupling. The VIC-collagen coupling 
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demonstrated in this study was demonstrated isometrically, however it is likely that these 
are fundamental interactions that occur in the context of collagen strain in the in vivo 
valve as well. 
A number of factors could affect the proposed VIC-integrin-collagen unit and 
potentially affect leaflet stiffness modulation as well as valve function in 
pathophysiological conditions. For example, changes in collagen fiber crosslinking and 
packing, as well as collagen turnover, could affect the ability of VICs to bind to collagen 
and transduce force. Circulating factors, including cytokines, inflammatory mediators, 
vasoactive agents, and pharmaceutical agents, could affect both the contractile and 
adhesive capabilities of VICs. Changes in VIC cell phenotype, as occur via alterations in 
the mechanoenvironment and chemical mediators, would also likely affect the ability of 
VICs to produce and transduce force. Lastly, sympathetic and parasympathetic 
innervation could affect this functional unit either directly or through paracrine 
mechanisms. 
In fact, valve diseases demonstrate alterations in these factors. Changes in MV 
collagen content, collagen turnover, and matrix metalloproteinase expression have been 
documented in diseases such as dilated cardiomyopathy and functional mitral 
regurgitation.6'7'34 VICs in a number of valve diseases, such as myxomatous mitral valve 
disease, also demonstrate a more myofibroblastic cell phenotype including greater 
smooth muscle alpha-actin expression,4 which directly relates to force generation in 
myofibroblasts.35 Changes in integrins expression and activation, has been demonstrated 
in the myocardium of a number of cardiac diseases,36 and may be altered in valve 
341 
diseases as well. Therefore, the proposed functional unit may be impacted by, or even 
contribute to valve pathologies, although considerable work in this area is needed. 
The results of this study may also have implications for the design of a tissue 
engineered heart valve (TEHV). Creating a TEHV complete with living VICs may be 
necessary not only for the TEHV to successfully adapt (via matrix remodeling) to 
changes in valve stresses, for example as the patient grows, or as cardiac pressures 
change with age, but living VICs within a TEHV will be important at a more fundamental 
level to provide these VIC-collagen functional units and their fundamental contributions 
to tonus, anisotropy, and dynamic modulation of stiffness. This study further 
demonstrates that an acellular elastomeric scaffold whose motion is determined by 
passive response to pressure gradients, would likely fall significantly short of the gold 
standard in TEHV: emulating the native valve. 
Limitations and Future Studies 
While this study represents an important step forward in examining the 
relationship between structure and function in the mitral leaflet, a number of limitations 
should be noted. Tighter control of temperature and carbon dioxide, such as with a 
closed chamber system more analogous to an organ bath set-up, would be ideal, however 
this was not feasible in the present set-up. More precise control of pre-load and of strain, 
perhaps using a micropositioner, would also enhance this set-up. Regardless, given the 
dramatic change in force generation with blocking agents, these limitations did not affect 
the ultimate interpretation of the study. 
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While the isometric set-up used in these experiments had a number of advantages, 
insight could also be gained by examining isotonic contraction, as well as utilizing other 
vasoconstrictive reagents. Exploring changes in mitral leaflet stiffness caused by 
different agents would also add to our understanding of VlC/leaflet contractility and how 
it relates to function. While much remains to be done in this area, including further 
characterization of VICs and collagen as a functional unit, this study is an important step 
in furthering our understanding of the roles played by VICs and collagen in mitral valve 
force generation. 
CONCLUSIONS 
This study demonstrated that VIC-collagen coupling via integrins contributes to 
force generation in mitral valves and supports the concept of multiple contractile systems 
in the mitral valve. Together with other studies demonstrating that the mitral valve 
possesses its own vasculature and innervation, and remodels in response to a variety of 
stimuli, this study adds to a growing body of evidence that the mitral valve is an active, 
dynamic entity as opposed to a passive flap. VICs, in concert with the extracellular 
matrix in which they are not only embedded, but also interact with and regulate the 
composition of, are a key component to this revised notion of the valve. As our concept 
of the valve continues to be refined, so too will our definition of valve diseases and 
therapeutic approaches to them. 
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This chapter, which demonstrated the functional interaction of valvular 
interstitial cells (VICs) and collagen in the mitral leaflet, concludes the series of 
chapters addressing normal valve mechanobiology (Chapters 3-12). In these 
chapters a variety of topics have been covered including age-related changes in 
matrix composition and structure (Chapters 3-6) and material properties (Chapter 
7), as well as valve heterogeneity in terms of composition and motion (Chapters 8 
and 9) and related to the VIC population (Chapters 10 and 11). 
The next portion of the thesis (Chapters 13-21) address valves in the contexts 
of various diseased states including congenital valve disease (Chapters 13 and 14), 
dilated cardiomyopathy and "functional" mitral regurgitation (Chapters 15-17), 
valve wound healing (Chapter 18), myxomatous mitral valve disease (Chapter 19, as 
well as Chapter 24 in the Appendix), and calcific aortic valve disease (Chapters 20 
and 21). This portion of the thesis addressing valves in diseased states opens with a 
review of congenital valve disease contained in the next chapter. 
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Chapter 13: Insight into Histoiogical and Pathological 
Abnormalities in Congenitally Diseased Valves Based on 
Advances in Understanding Normal Valve Microstructure and 
Extracellular Matrix 
Having addressed normal valve mechanobiology, including the topics of 
valve aging and heterogeneity in Chapters 3-12, this next portion of the thesis 
(Chapters 13-21) addresses how valves are altered in various diseased states, 
including congenital valve disease (Chapters 13 and 14), dilated cardiomyopathy 
and "functional" mitral regurgitation (Chapters 15-17), valve wound healing 
(Chapter 18), myxomatous mitral valve disease (Chapter 19, as well as Chapter 24 
in the Appendix), and calcific aortic valve disease (Chapters 20 and 21). This 
portion of the thesis opens with the topic of congenital valve disease, which is 
reviewed in this chapter. 
ABSTRACT 
Congenitally diseased valves are relatively frequent causes of significant 
morbidity and mortality. Pathology descriptions of such valves have primarily focused 
on gross structural features including the number of leaflets or commissures 
(bicuspid/bicommissural valve) and alterations in the contour, thickness and consistency 
of the leaflets (dysplastic valve). Functional correlates of these pathologic alterations are 
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valvar stenosis, insufficiency or both. Further characterization of the microstructural 
abnormalities seen in these malformed valves may not only provide insight into the 
correlation of distinct pathologies with their respective pathogenesis and clinical 
sequelae, but also may prove pivotal in uncovering new avenues for therapeutic 
interventions and prevention regimens. This review summarizes microstructural findings 
in congenital semilunar valve disease (CSVD) and discusses their relevance in light of 
recent advances in knowledge of normal valve microstructure, biology, and function. 
Specifically, the biological and mechanical roles of various matrix components and their 
interactions and the role of mechanical stimulation in valve health are discussed in the 
context of CSVD. Indeed, recent research in normal valves adds significant insight into 
CSVD, and raises many hypotheses that will need to be addressed by future studies. 




Congenitally diseased valves are relatively frequent causes of morbidity and 
mortality,1"3 including valvar stenosis and/or insufficiency, ventricular dysfunction, 
cardiac chamber and/or arterial dilation, substrates for infection and thrombus formation, 
arrhythmias, and sudden death. Pathology descriptions of such valves have primarily 
focused on gross structural features such as the number of leaflets or commissures 
(bicuspid/bicommissural valve) and alterations in the contour, thickness and consistency 
of the leaflets (dysplastic valve). The nature of these abnormalities at the microstructural 
level has received limited detailed study. Instead, published reports on malformed valves 
have focused on associations with other cardiac and systemic anomalies, clinical 
diagnosis and evaluation, potential genetic and developmental causes, and the risks, 
benefits, and long-term outcomes of various surgical repairs. However, more in depth 
characterization of congenitally diseased semilunar valves (CSVD) may aid in their 
classification into more distinct pathologies, correlating with their respective 
pathogenesis and clinical sequelae. Further characterization of the congenital 
abnormalities, as well as the superimposed acquired hemodynamic alterations that 
contribute to disease progression, may prove pivotal in uncovering new avenues for 
therapeutic intervention and prevention regimens. This review provides a brief 
background on normal valve macrostructure and microstructure pertinent to CSVD, 
describes what is known regarding CSVD macrostructure, microstructure, and matrix 
composition and discusses their relevance in light of recent advances in knowledge of 
normal valve microstructure, biology, and function. Specifically, the role of valvular 
interstitial cells, the biological and mechanical roles of various matrix components, the 
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interaction of these components with each other and bioactive molecules such as growth 
factors, and the role of mechanical stimulation in valve health will be discussed in the 
context of CSVD. Indeed, recent research in normal valve microstructure, developmental 
maturational changes and mechanisms of acquired hemodynamic effects on valve 
structure adds significant insight into CSVD, and raises many hypotheses that will need 




Fig. 13-1: Atretic PV from 2 year-old demonstrating a domed valve 
and fused cusps. 
SPECTRUM OF CONGENITAL SEMILUNAR VALVE DISEASE (CSVD) 
CSVD can involve any of the valve's components, including the cusps, annulus, 
commissures and sinuses. Many diseases involve multiple structures either as a primary 
defect or secondary acquired hemodynamic abnormality. The two extremes of CSVD are 
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an atretic valve and absent valve. An atretic valve implies no luminal continuity from the 
ventricle to the great artery, often reflected by an outflow tract that ends blindly in a 
dimple with no valvular tissue, typical of aortic valve atresia (Fig. 13-1). Other forms of 
semilunar valve atresia include an imperforate small membrane or a dome-shaped, 
imperforate, unicuspid valve as seen in some cases of pulmonary valve atresia. Absent 
semilunar valve results in an unguarded valve orifice with either no valve tissue, a slight 
ridge, or very small nubbins of valve tissue at the annulus. A single semilunar valve is 
also seen with a persistent truncal valve in truncus arteriosus. In contrast to the absent or 
atretic valve where there are separate annuli for the aortic and pulmonary valves (albeit 
represented by a blind ending dimple), a persistent truncal valve indicates that there is a 
single, common valve annulus that never divided into aortic and pulmonary valves 
orifices. Truncal valves most often have 3 cusps; however bicuspid and quadricuspid 
valves are not uncommon. 
The most common valve malformation is an abnormal number of cusps, usually a 
bicuspid valve. The two cusps may be of similar or unequal size, and one sinus will 
contain the abortive commissure or raphe. Unicuspid or quadricuspid valves may also 
occur. The unicuspid valve with its single commissure is inherently stenotic with a 
variably hypoplastic annulus and is usually part of a more complex constellation of 
lesions. Bicuspid or quadricuspid valves, with otherwise well formed cusps, are 
functionally normal at birth and may occur as isolated lesions. However long-term 
altered hemodynamics, particularly for the bicuspid aortic valve, often lead to acquired 
stenosis requiring surgical intervention in adulthood. The quadricuspid valve may remain 
asymptomatic or develop valvar regurgitation.4 Quantitative and qualitative 
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abnormalities can coexist, as in a bicuspid, dysplastic aortic valve. Position, alignment or 
connection of each component of a valve may be abnormal as in over-riding or straddling 
valves. 
The valve abnormality most likely to require surgical intervention in childhood is 
a dysplastic semilunar valve. Valvar dysplasia is characterized by variably thickened 
cusps with altered contours resulting in valvar stenosis or, less commonly, regurgitation. 
The dysplastic aortic or pulmonary valve may occur as an isolated lesion, with multiple 
involved valves (polyvalvular dysplasia) or as part of a more complex constellation of 
cardiac lesions such as tetralogy of Fallot or Shone syndrome. It is not uncommon to 
have a combined dysplastic and bicuspid or unicuspid semilunar valve. The dysplastic 
quadricuspid valve is a feature of truncus arteriosus. A regurgitant, dysplastic valve is 
also more commonly seen with truncus arteriosus. 
There are a number of differences between aortic and pulmonic congenital valvular 
disease. The most common form of isolated congenital pulmonary valvular stenosis is 
the domed deformity with fusion of the valve cusps around a central fixed orifice.5 In the 
aortic valve, the bicuspid, dysplastic valve is more common. Differences have also been 
noted between "absent" aortic valve and "absent" pulmonic valve. While in "absent" 
pulmonic valve there is usually a remnant of dysplastic valve-like tissue,6'7 in the 
syndrome of "absent" aortic valve there is usually only an endothelial ridge at the level of 
the valve annulus.7 Even within polyvalvular dysplasia, out of the four valves the aortic 
Q 
valve is the least involved. 
CSVD affecting multiple valves is often a manifestation of a syndrome (Marfan's 
syndrome, polyvalvular dysplasia associated with Noonan syndrome or certain trisomies) 
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or a systemic metabolic storage disease (Mucopolysaccharidoses). This review largely 
focuses on cases of CSVD not associated with more extensive extracardiac disease, with 
particular attention to the most common CSVD requiring therapeutic interventions: 
dysplastic semilunar valves and the bicuspid aortic valve (BAV). 
• * * * r 
t\ 




Fig. 13-2B: Aerial view of a normal A Vfrom a 13 year-old demonstrating 
thin, delicate cusps. 
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NORMAL SEMILUNAR VALVE STRUCTURE 
Valve Macrostructure 
The major components of the semilunar valves include the three half-moon 
shaped cusps, three commissures, sinuses, the annulus, and surrounding supporting 
structures (Fig. 13-2A, B). Each cusp is anchored in place by an undulating ring of 
fibrous tissue (the valve annulus) that separates the ventricle below from the arterial wall 
above. The part of the annulus that separates two immediately adjacent cusps is the 
commissure. The annulus for each valve is continuous with, and supported by, the 
fibrous skeleton of the heart. The higher pressures generated on the left side of the heart 
require a more sturdy annulus for the aortic valve. This valve is centrally located at the 
base of heart and its' annulus shares fibrous continuity with the annuli of the other three 
cardiac valves. Accentuated areas of fibrous tissue connect the aortic valve with the 
mitral and tricuspid valves and are known as the left and right fibrous trigones 
respectively. The pulmonary valve has a more tenuous fibrous annulus and is connected 
to the aortic valve by a thin fibrous (conal) ligament. In addition to the essential role of 
the valve annuli and cardiac fibrous skeleton in anchoring the valve cusps during the 
billions of times the valve opens and closes over an individual's lifespan, the integrity of 
the adjacent ventricular and arterial wall support will impact valve function. 
For each semilunar valve the sinuses of Valsalva are created by the pockets 
formed between the valve cusps and the adjacent arterial wall. Blood filling these sinuses 
during diastole of the cardiac cycle causes the cusps to centrally coapt against one 
another, closing the lumen. The cusps overlap one another for a distance extending 
several millimeters below the free edge, ensuring valve closure. The area of overlap, or 
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lunula, is demarcated at its lower margin by a ridge that becomes more accentuated with 
increasing age, and is more prominent on the aortic than pulmonary valve. The center of 
the lunula has a localized area of fibrous thickening forming a discrete nodule (nodule of 
Arantius) that further ensures a tight seal of the closed valve. With systolic opening of 
the valve, the cusps collapse against the wall of the valve sinus. The integral relationship 
between valve cusps, commissures, sinuses, annulus and supporting structures is essential 
for normal valve function. Abnormalities in the valves due to any of these components 
may cause valvular dysfunction and may impact cardiac physiology as a whole. 
[For a description of normal valve tissue microstructure and valve cells, please see 
Chapter 1, Background] 
Valve Changes with Age and Altered Hemodynamics 
Recent studies have demonstrated that valve composition and accompanying 
mechanical properties normally change with age.9"11 Not only does collagen content and 
crosslinking increase, as previously well established,12"14 but specific glycosaminoglycan 
(GAG) sulfation patterns change with age and these age-related changes appear to be 
valve and valve-region specific." Mechanically, valves become stiffer and less 
extensible with age.10 These normal valve changes associated with the aging process 
complicates the study of congenital valve disease where normal aging is superimposed 
onto valves with structural and biological abnormalities. Additionally, altered 
hemodynamics and mechanical strains are known to stimulate certain compositional 
changes in normal valves, including increased collagen synthesis, matrix 
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metalloproteases (MMPs), and myofibroblast marker expression, 15~17 but how a 
structurally and biologically abnormal valve responds to the altered hemodynamics and 
loading patterns commonly present in congenitally diseased valves remains largely 
unknown. 
MACROSCOPIC CHARACTERIZATION OF CONGENITAL SEMILUNAR 
VALVE DISEASE (CSVD) 
The bulk of the CSVD pathology literature focuses on constellations of anatomical 
formations examined at the macroscopic level. This review will address bicuspid aortic 
valves and dysplastic semilunar valves. 
Fig. 13-3: Bicuspid stenotic A Vfrom a 40 year-old demonstrating diffuse fibrosis. 
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Bicuspid Aortic Valve 
The two cusps of the bicuspid valve are supported by two commissures; therefore 
the valve may be described as bicuspid/bicommissural (Fig. 13-3). A third abortive 
commissure or "raphe" is frequently present evidenced by a ridge within one sinus, either 
confined to the aortic wall or extending a variable distance onto the base of the cusp. The 
raphe should not be confused with a fused commissure between conjoined cusps in a 
tricuspid aortic valve. A raphe does not extend to the free margin of the cusp and its 
aortic attachment sits beneath the horizontal level of the cusp.85 Although histologically 
the raphe often contains abundant elastic fibers similar to adjacent aortic wall, this is not 
a reliable distinguishing feature.85 The two cusps of the bicuspid valve may be of similar 
or unequal size; however the raphe typically partitions the cusp into similarly sized 
85 
components. 
At birth, the valve cusps are most often thin and delicate, similar to the normal 
tricuspid valve and the valve is functionally asymptomatic. However, the alterered 
physiology of a bicuspid valve results in progressive fibrous thickening, often apparent 
by the second decade of life, with increasing rigidity of the cusps.103 Calcification is also 
common, within the cusp and forming nodular masses within the sinus, often involving 
the raphe.18 Calcification is a later manifestation of the dysfunctional bicuspid aortic 
valve, becoming increasing more apparent in the fourth and subsequent decades.103 
Bicuspid valves that become symptomatic earlier in childhood are often both bicuspid 
and dysplastic.19 
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Fig. 13-4: Severely dysplastic A V (arrow) with associated left ventricular hypertrophy 
from a 2-3 month-old. 
Dysplastic Semilunar Valves 
Semilunar valve dysplasia implies congenital abnormalities in the valve 
morphology reflected by alterations in the size, thickness, contour and/or consistency of 
the cusps. In severe dysplasia the cusps appear as nodularly thickened, myxoid warty 
protrusions (Fig. 13-4). The spectrum of changes in milder forms of valve dysplasia 
includes more localized areas of myxoid nodularity (Fig. 13-5). Alternatively, the valve 
may be diffusely, uniformly thickened with redundancy at the free margins providing for 
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F/g. i J-5: Mildly dysplastic A Vfrom an 8 month-old demonstrating localized areas of 
nodular thickening (arrow). 
an irregular contour. The dysplastic valve may have 1, 2, 3 or 4 cusps and some degree 
of commissural thickening may be present. 
While such macroscopic characterization is perfectly adequate for making the 
clinical diagnosis of dysplastic CSVD, with additional knowledge of matrix components 
and microstructure abnormalities, avenues for possible treatments and prevention may 
become evident. 
Acquired Macroscopic Valve Changes 
When assessing CSVD, particularly in older children and young adults, it may be 
difficult to distinguish some milder forms of underlying valve dysplasia from 
360 
superimposed pathological changes due to altered hemodynamics. These acquired 
alterations may include focal or diffuse thickening of the cusps in an environment of 
valvar stenosis and rolled, everted margins caused by the regurgitant stream on an 
insufficient valve. Other acquired changes to be considered include post-inflammatory 
effects of infective endocarditis and iatrogenic effects of interventional 
commissurotomies and balloon dilations. 
MICROSCOPIC CHARACTERIZATION OF CONGENITAL SEMILUNAR 
VALVE DISEASE (CSVD) 
CSVD Microstructure 
Despite the variation in the macroscopic appearance of dysplastic semilunar valves, 
there is a unifying theme to the valve microstructure. The normal trilaminar valve 
structure is distorted by increased GAGs, reflected by an expanded spongiosa that is 
poorly demarcated from the fibrosa and associated with decreased to absent valvar elastic 
tissue (Fig. 13-6).8'20'21 Bharati and Lev also reported that compared to age-matched 
normal valves and normal valves exposed to altered hemodynamics, dysplastic valves 
showed an increase in the spongiosa layer with vacuolar and lacunar degeneration.8'20'21 
Similarly, Hyams' study of a broad group of dysplastic valves, including both isolated 
and polyvalvular cases taken from fetuses to young adults, reported myxomatous nodules 
devoid of elastic tissue with pockets of collagenous tissue. Multiple other authors 
studying various types of congenitally diseased aortic and pulmonic valves report the 
same essential findings.5'23'24 More recently Hinton, in studying 6 explanted, bicuspid, 
stenotic aortic valves from infants and children aged 1 month to 14 years of age, 
361 
specifically reported finding loss of the trilaminar architecture with disorganized collagen 
and PGs in all layers and disorganized, decreased elastin. Thickening of the cusps was 
correlated with increased collagen, and PGs. VICs were also disorganized, focally 
forming clusters, although there was no increase in cell proliferation.23 
Ongoing studies demonstrate that VICs derived from CSVD valves, including 
isolated dysplastic valves, also demonstrate phenotypic differences compared to age-
matched controls. These differences suggest that abnormal VIC function in dysplastic 
valves contribute to the altered extracellular matrix. It remains to be determined whether 
these VIC abnormalities are a primary or secondary phenomenon, and what in utero 
and/or postnatal factors modulate their effects on the valve architecture and composition. 
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Fig. 13-6: Movat pentachrome of a dysplastic PVfrom a 2 year-old (top) 
compared to a normal PVfrom a 2 year-old (bottom). Staining demonstrates loss 
of layered leaflet structure in dysplastic valve compared to control. Scale bar in 
upper panel indicates 1 mm; scale bar in lower panel indicates 500 pcm. 
Mechanical Implications of CSVD Microstructure 
The observed microstructural changes seen in CSVD have important mechanical, 
and therefore functional implications. According to Bharati and Lev, the preponderance 
of the changes seen in CPVD was in the spongiosa layer,21 which based on the 
contribution the spongiosa makes to leaflet mechanics could effect leaflet bending 
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stress and the ability of the leaflet to bear compression. Computational modeling 
indicates that the layered nature of the valve decreases the stress of bending,26 therefore 
the decreased leaflet layer delineation seen in many types of CSVD could decrease valve 
mobility, as well as increase stress on the leaflet. Furthermore, the complex interaction 
that exists between the layers of normal valves, which is important to valve mechanical 
properties,27'28 is lost. The increased valve thickness reported in a number of types of 
CSVD8'23 would also result in an increase in bending stress, according to computational 
analysis.29 Increased collagen content, as reported in children with BAV,23 would be 
expected to increase leaflet stiffness as well as leaflet and chordal stress.30 However, the 
valve has a complex, heterogeneous distribution and alignment of collagen that 
contributes to anisotropic, region-specific valve material properties important to proper 
valve function.26'30'31 Therefore, the specific consequences of increased collagen would 
depend on the exact location and orientation of this additional collagen, but would in all 
likelihood also hinder valve function. 
Other changes in CSVD have functional and mechanical implications. The 
nodularity common to many types of CSVD ' would change hemodynamics by 
disturbing fluid flow and altering shear stress on the valve endothelial cells. Valve 
endothelial cells are well known to respond to shear stress32 and endothelial cell injury 
may be a key step in calcification of the aortic valve.33'34 Elastic fibers, which are 
decreased in a variety of congenitally diseased valves, ' ' ' also have important 
mechanical consequences as the elastic fibers in the ventricularis layer provide recoil, 
returning the collagen in the fibrosa to its crimped configuration after each heart beat.35 
Based on studies in which functioning elastic fibers were removed from normal valves, 
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loss of elastic fibers in CSVD likely causes reduced extensibility and increased 
stiffness.36 
Insight into Possible Pathogenesis of CSVD 
Observations on several congenital and acquired valvular disorders may provide 
insight into the pathogenesis of dysplastic valves. Infantile Marfan's syndrome, 
associated with mutations in the fibrillin-1 gene, is associated with macroscopic valvular 
changes similar to those seen in dysplastic valves.37 Fibrillin is a major component of the 
extracellular matrix, essential to normal elastic tissue formation. Its functions include 
interaction with growth factors such as transforming growth factor-beta (TGF(3) that then 
effect VICs.38 The importance of fibrillin's interaction with TGF|3 in these 
valvulopathies is underscored by experiments demonstrating that in mouse models of 
Marfan's with fibrillin-1 mutations and mitral valve abnormalities, perinatal 
administration of neutralizing antibodies to TGFp rescued the normal mitral valve 
phenotype.39 Other extracellular matrix abnormalities have also been noted in Marfan's 
syndrome. Skin fibroblasts from neonatal Marfan's patients produce markedly decreased 
decorin, a PG associated with elastogenesis40 as well as collagen fibrillogenesis,41 both of 
which could affect tissue matrix integrity. The known interactions of fibrillin with the 
PG versican would also be expected to be impacted in Marfan's syndrome.42 The full 
spectrum of alterations in matrix composition and functional interactions in Marfan's 
syndrome, particularly in the cardiac valves, remain to be elucidated. However even 
these limited observations suggest an important role for the extracellular matrix in these 
valve pathologies. 
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Alterations in the interaction of VICs with the extracellular matrix may be operative 
in other forms of myxoid valvular heart disease. Mutations in filamins have been 
associated with familial mitral valve prolapse,38 whose macrostructure and microstructure 
also resembles dysplastic valves. Filamin has also been postulated to interact with the 
TGF(3 pathway.38 The effects of these varied genotypic matrix alterations leading to 
heart valves with similar microstructure, suggest that valvar dysplasia, as currently 
defined, may reflect a final common morphologic pathway resulting from alterations of 
components of the extracellular matrix. The potential central role of TGF(3 and its 
interaction with VICs and matrix components remain to be defined. 
Others have noted that the microstructure of dysplastic valves, including increased 
GAG content, lack of differentiation between the valve layers, and decreased elastic 
tissue, are features of immature valves during normal development.20'61 Recent studies 
characterizing changes in specific valve matrix components and structure during fetal and 
postnatal valve development demonstrated that many of the matrix components in the 
first trimester were ubiquitous throughout the valve layers, but became localized to 
specific layers in later trimesters, with increasing elastic fiber content, paralleling 
delineation of layers evident in Movat.9' n ' 7 3 This has led some investigators to postulate 
that dysplastic valves represent an arrested step in development.43 While there is 
evidence to support this, the pathogenesis of valvar dysplasia is likely more complex, 
resulting from a spectrum of genetic alterations in a matrix component, VICs, or one of 
the many factors operative in valve remodeling whose impact may first become apparent 
at a variety of time points during development. The in utero and postnatal effects of this 
genetic alteration would interfere with assembly of the normal valve architecture. 
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Further investigation of changes in valve composition during normal development may 
prove important representing a potential origin and pathogenesis for a specific valve 
dysplasia. 
Role of Hemodynamics in CSVD 
In the past it was hypothesized that generally congenitally diseased valves were 
secondary to other structural cardiac anomalies altering normal blood flow during 
development.44 Studies show that indeed mechanical stimulation is a necessary part of 
valve development. For example, decreasing wall shear stress in zebrafish leads to the 
development of dysmorphic valves45 and decreasing zebrafish heart contractility and 
blood flow before endocardial cushion development leads to failed valve development. 
A study in mice found a correspondence between the hyaluronan and collagen 
composition of developing atrioventricular valve cushions, the cushions' biomechanics, 
and blood flow.47 Although the mechanical environment contributes to normal valve 
development, there are other factors that contribute to valve dysplasia. Bharati and Lev 
specifically noted abnormalities in CPVD compared to both normal and 
hemodynamically altered aged-matched controls,8 suggesting altered hemodynamics 
alone cannot explain CPVD. The issue of mechanical stimulation becomes complex in 
the case of congenitally diseased valves because these valves often occur in the context of 
"structural" cardiac defects that alter the hemodynamics and forces that the valves 
experience. One could speculate that the effects from this mechanical environment then 
interact with altered biological processes within valves, such as dysfunctional collagen 
367 
turnover, to create the pathological microstructure that we see in congenitally diseased 
valves. The complexities of this process remain to be determined. 
Not only are hemodynamics important in valve development and could contribute 
to congenital valve pathogenesis, but over the years altered hemodynamics construed by 
malformed valves and the frequently accompanying other congenital heart structural 
deformities, impose secondary changes on the valves, including greater collagen content 
and loss of the spongiosa layer (Fig. 13-7).21 Therefore, evaluation of congenital valves 
from older patients is complicated by secondary hemodynamic changes. 
Fig. 13-7: Movatpentachrome stained PVfrom a 14 year-old with insufficiency 
demonstrates increased collagen content and loss of spongiosa layer. Scale bar 
represents 200 \xm. 
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A frequently related scenario encountered in congenital heart disease is the Ross 
procedure in which the normal PV is placed in the AV position to replace a malformed or 
otherwise deficient AV. Although in this case the PV is not malformed, it does expose 
the PV to increased pressures. A recent study has shown that these valves remodel in 
response to this altered mechanical environment,48 with increased MMPs and VICs 
activation particularly early after the Ross procedure. 
MICROSTRUCTURAL CHARACTERIZATION OF BICUSPID AORTIC 
VALVE (BAV) AND ITS IMPLICATIONS 
Like many different types of CSVD, BAV can range from valves that appear 
normal microscopically, except for the macroscopic configuration of the cusps, to 
dysplastic leaflets complete with loss of the internal layered structure. Typically patients 
that present as symptomatic early in life have more dysplastic valves, while the valves 
from patients that present later in life demonstrate more normal microstructure with 
superimposed calcific changes. 
Possible Pathogenesis of BAV 
While some have argued that BAV is simply a fusion between two of the leaflets, 
recent evidence suggests that the pathogenesis may be more complex.49"52 The "raphe," or 
portion of the valve that appears fused, does not contain valve tissue, but instead elastic 
fibers that can become fibrotic.53"55 Some believe the increased incidence of valvular 
stenosis in BAV is purely due to the altered hemodynamics,56 but as the following studies 
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show the BAV microstructure has alterations that could contribute to the development of 
stenosis in BAV. 
Proteoglycans (PGs) and Glycosaminoglycans (GAGs) in BAV 
Studies assessing specific matrix components and their structure in BAV are 
limited. Baig's 1979 study found less GAG content in BAV adults compared to age-
matched controls.57 In terms of particular GAGs, there was more dermatan sulfate in the 
21-40 year-olds, and less hyaluronan and more chondroitin sulfate in the 41-60 year-olds 
in BAV compared to age-matched controls.57 However, it is difficult to discern how 
much of these differences were secondary to years of altered hemodynamics created by 
the BAV. Nevertheless, altered GAG content has been implicated in the calcification of 
congenitally normal aortic valves58 and could contribute to increased calcification seen in 
BAV. The altered chondroitin sulfate content reported by Baig in BAV likely mostly 
represents versican,59 a PG critical to valvulogenesis60 and therefore suspect to being 
altered in congenitally diseased valves. Versican is important to elastic fibrillogenesis,61 
and alterations in versican could relate to abnormal elastic content23 and fibrillar 
proteins62 observed in BAV. Baig's study also showed altered hyaluronan in BAV;57 this 
could not only alter the tissue's mechanical properties, but affect other processes in which 
hyaluronan is involved, such as cell proliferation 3 and potentially valve calcification.58 
Baig also reports an alteration of dermatan sulfate in BAV,57 which largely reflects 
decorin content.59 Altered decorin content could affect collagen fibrillogenesis,41 
regulation of TGF|364 and fibrillin-1,65 and even wound healing in these valves.66 In fact, 
abnormal collagen content and configuration has been reported in pediatric cases of 
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BAV. In the future it will be important to examine growth factor expression, collagen 
fibril abnormalities, and expression of GAGs and PGs that may shed light on the role of 
altered matrix in BAV. Of course, it is difficult to tell whether the matrix abnormalities 
are the cause or the result of BAV, and most likely is a little of both. 
Dysregulation of Fibrillar-Related Proteins in BAV 
In terms of individual proteins, a more recent study in BAV from children revealed 
a deficiency in fibrillin-1.62 Interestingly, expression of fibulin and fibrillin correlate 
with the transition from immature mesenchymal tissue to mature valve, suggesting BAV 
could involve a suspension of development.49 Furthermore, as mentioned earlier, fibrillin 
is integrally involved in TGF(3 regulation,67 a growth factor essential to major signaling 
pathways including the endocardial-mesenchymal transition in atrioventricular valves 
development.68 TGF|3 expression is associated with the pathogenesis of a number of 
valve diseases in adults without congenital diseases,69'70 and the myxomatous-like valve 
changes seen in Marfan's syndrome, as discussed earlier. Potentially the deficiency of 
fibrillin-1 observed in BAV,62 could result in altered growth factor regulation and matrix 
abnormalities in BAV. 
Another study showed that BAV, compared both to normal and diseased tricuspid 
aortic valves, showed increased MMP2 and MMP9 expression.71 MMP2 and 9 are both 
gelatinases that degrade elastic fibers; indeed, BAV from pediatric patients reported 
fragmented elastic fibers and a decrease in overall abundance.23 As discussed earlier, this 
decrease in elastic fibers could have important implications for valvular mechanics. 
Increased MMP expression in BAV is particularly interesting in light of increased MMPs 
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evident in normal valves experiencing altered hemodynamics, ' undergoing valve 
remodeling,48' 74 and demonstrating other valve pathologies.69' 75 In other words, 
increased MMP expression in valves may be a common pathway for various stresses, as 
others have postulated.74 
Associated Aortic Wall Abnormalities in BAV 
The association of the BAV with a number of aortic wall abnormalities, including 
aortic aneurysm and dissection, led to speculation that matrix abnormalities in these 
patients are not limited to the aortic valve. Approximately 20-50% of patients with BAV 
have an associated cardiovascular complication,22 the most common being coarctation of 
the aorta, interrupted aortic arch, and aortic dissection.76 In the past it was thought that 
these related pathologies of the aorta were secondary to the altered hemodynamics caused 
by BAV, (i.e. post-stenotic dilatation), however, multiple studies suggest there is an 
underlying structural defect in the aortas of BAV patients. A study showed BAV patients 
have significant dilation of the aorta even as children, independent of whether or not the 
valve was stenotic or regurgitant.77 Furthermore, after valve replacement for aortic 
stenosis, patients with a tricuspid valve show a decrease in dilation of the aorta, while 
patients with bicuspid aortic stenosis show an increase in dilation of the aorta.50 
Microscopic analysis reveals elastic fiber fragmentation,78 decreased number and wider 
spacing of elastic lamellae79 in the aorta of BAV patients compared to controls. Indeed 
further analysis has shown that cystic media necrosis, an increase in MMPs, and smooth 
muscle cell apoptosis underlie these aortic wall pathologies. An increase in MMPs is 
consistent with reports of decreased collagen I and III in the aortas of patients with 
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BAV. Just as fibrillin-1 has been found to be decreased in the BAV, fibrillin-1 has also 
been reported to be decreased in the aortas of BAV adults compared to controls.4 Some 
postulate that the BAV and aortic complications occur by a common mechanism of 
cellular apoptosis81 based on increased apoptosis of smooth muscle cells and higher 
expression of pro-apoptic markers found in the aortas of BAV patients.82 Others suggest 
that dysregulation of MMPs lead to both BAV and its aortic complications.83 
Interestingly, the elastic content of the BAV raphe53"55 appears like the media of the 
aorta.53 This accumulation of elastic fibers in the BAV raphe, increased MMP2 and 
MMP9 in BAV, and concomitant elastic degradation in the aortic wall suggest wide-
spread elastic fiber dysregulation. 
Insight BAV Provides into other Congenital Valve Diseases 
Characterizations of matrix composition abnormalities in BAV certainly add 
considerable insight into BAV, but they also may provide insight into other types of 
congenital valve diseases. For instance, given that BAV matrix abnormalities are more 
widespread than just the valve, it could be hypothesized that for some congenital valve 
diseases there are matrix abnormalities in other portions of the heart and aorta. Indeed 
there is some evidence to support this hypothesis. For instance, a review of 
atrioventricular valve dysplasia reports concomitant myxomatous areas of the interatrial 
septum.84 Another study reports both aortic and pulmonic valve atresia to be associated 
with myocardial disarray in the interventricular septum.85 The preponderance of 
concomitant cardiac anomalies for congenital valve diseases could also be considered an 
argument for a broader, underlying pathological mechanism. 
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IMPORTANCE OF VALVES IN BROADER DISEASES' PATHOGENESIS AND 
PROGRESSION 
Studies in diseases largely thought not to involve the heart valve have 
increasingly pointed to an important role played by the valves. For instance, a study has 
shown that in heart failure, a complex disease often thought not to organically involve the 
valve in its pathogenesis, apparently normal mitral valves were shown to have significant 
differences in composition including GAG content.86 Similarly, in "functional" mitral 
regurgitation it has been assumed that the regurgitation was the result of structural 
changes in the annulus and left ventricle. While structural changes certainly contribute to 
the mitral regurgitation, recent studies have shown that the valve is intimately involved in 
the disease and may even be an independent factor contributing to the progression of 
regurgitation.72 In the future it will be important to look for the valves playing important 
roles in broader congenital heart diseases thought not to organically involve the valve. 
CONCLUSIONS 
This review has summarized the microstructural findings of CSVD, and in the 
light of recent advances in the knowledge of normal valve biology, microstructure, and 
mechanics, explored the implications of the aforementioned CSVD microstructure 
findings. This discussion not only yields further insight into CSVD, but presents 
important questions to be addressed in future CSVD research. Clearly, much work still 
remains in elucidating the pathogenesis of CSVD, and this review provides potential 
direction for doing so. 
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This chapter opens the portion of the thesis addressing valve alterations in 
diseased states (Chapters 13-21) with a review of congenital valve disease. In the 
following chapter, a study analyzing matrix remodeling and valvular interstitial cell 
(VIC) phenotypic changes in congenitally diseased semilunar valves is presented. 
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Chapter 14: Extracellular Matrix Remodeling and Cell 
Phenotypic Changes in Dysplastic and Hemodynamically 
Altered Semilunar Heart Valves 
Following upon the context provided by the congenital valve disease review 
presented in the previous chapter, in this chapter a study analyzing matrix 
remodeling and valvular interstitial cell (VIC) phenotypic changes in congenitally 
diseased semilunar valves is presented. The topic of congenital valve disease 
addressed in these two chapters is the first of a series of diseased states in which 
valve alterations are analyzed. 
ABSTRACT 
Background; While congenital cardiac valve disease is a common condition with 
substantial morbidity and mortality and suboptimal treatment options, little is known 
regarding the specific compositional changes in these valves. Characterization of the 
specific matrix and valve cell phenotypic abnormalities could lend insight into disease 
pathogenesis and potentially pave the way for novel therapies. 
Methods: Aortic and pulmonic valves (AVs, PVs, n=35) were collected and categorized 
based on gross and microscopic assessment and clinical history into CTRL valves 
(n=21); dysplastic valves, valves (CTRL, n=21), dysplastic valves, all except one also 
displaying hemodynamic changes (HEMO/DYSP, n=6); and hemodynamic valves 
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(HEMO, n=8). Samples were subdivided by patient age into < 2 years-old (n=13) and > 
9 years-old (n=21). Samples were immunohistochemically stained for matrix 
components, markers of matrix turnover, and markers of valve cell activation. Staining 
intensity was quantified in the mid-leaflet region, as well as in plaques and regions 
underlying plaques. Valvular interstitial cells (VICs) were also isolated from samples 
and analyzed for cell phenotypic markers and markers of hyaluronan and collagen 
metabolism using flow cytometry. 
Results: CTRL AVs demonstrated decreased proteoglycans and hyaluronan with age, as 
well as decreased collagen turnover and valve cell activation. While both HEMO AVs 
and PVs > 9 years-old demonstrated increased matrix metalloprotease (MMP)-13 and 
non-muscle myosin (NMM), and decreased fibrillin, prolyl 4-hydroxylase (P4H) and 
hyaluronan increased in HEMO AVs and decreased in HEMO PVs relative to CTRLs 
(HEMO v CTRL in AV and PV each pO.OOl, AV v PV pO.OOl). HEMO/DYSP AVs > 
9 years-old demonstrated distinct compositions compared to both HEMO AVs and CTRL 
AVs (each p<0.006), including decreased collagen and elastic fiber synthesis and 
turnover. Plaques, and regions underlying plaques similarly displayed altered 
composition relative to CTRL valves (each pO.OOl), as well as distinctions between 
HEMO and HEMO/DYSP (each p<0.013). Both HEMO and HEMO plaques and 
underlying regions displayed decreased P4H, LOX, Col 3, and hyaluronan in plaques and 
underlying regions, but MMP13 was increased in HEMO plaques and underlying regions, 
while MMP13 was decreased in HEMO/DYSP plaques. Flow cytometry of VICs from 
CTRL AVs and PVs revealed greater cell activation and collagen synthesis in AV VICs 
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than PV VICs (p=0.02). Both VICs from HEMO PVs and HEMO/DYSP PVs > 9 years-
old showed significantly different expression in the cell phenotype markers assayed 
compared to VICs from CTRL PVs (each p<0.032), especially increased NMM. 
Furthermore, VICs from HEMO PVs and from HEMO/DYSP AVs and PVs displayed 
greater size and complexity compared to VICs from CTRL valves (each p<0.05). 
Conclusions: HEMO and HEMO/DYSP AVs and PVs demonstrated significant 
alterations in matrix composition and VIC phenotype compared to CTRL valves. 
Changes were distinct depending on valve and pathology. Furthermore, VICs isolated 
from these pathological valves displayed alterations in collagen synthesis, cell phenotype, 
and cell morphology. These results add to our understanding of dysplastic valves, 
namely that dysplastic valves are not simply valves with gross changes or a loss of 
layered leaflet structure microscopically, but these valves contain complex changes in 
matrix turnover, composition, and valve cell phenotype. Key processes, such as collagen 
and elastic fiber turnover, that appear to be dysregulated could be promising for novel 
therapeutics. 
The work contained in this chapter is under review by the journal Cardiovascular 
Pathology: 
Stephens EH, Shangkuan J, Kuo JJ, Carroll JL, Kearney DL, Carberry KA, Fraser CD, 
Grande-Allen KJ. Extracellular Matrix Remodeling and Cell Phenotypic Changes in 
Dysplastic and Hemodynamically Altered Semilunar Cardiac Valves. 
Cardiovascular Pathology, under review. 
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INTRODUCTION 
Congenital valve disease imposes a heavy burden on our society, with a 
prevalence of approximately 1%' and high associated morbidity and mortality. In 2000 
alone 213,000 life years were lost before age 65 because of congenital heart disease, 
nearly equal to the sum of leukemia, prostate cancer, and Alzheimer's disease.2 The 
majority of congenital heart disease cases involve the valves and/or septa.3 Treatment 
options for patients with congenitally diseased valves are suboptimal at best. While 
mechanical valves and bioprosthetic valves perform relatively well in adults, they are 
wrought with complications in pediatrics. Bioprosthetic valves quickly calcify and 
mechanical valves require anti-coagulation, which is not compatible with a child's active 
lifestyle. Even if these issues could be solved, neither of these valve replacements grows 
with the child; therefore, these children must undergo multiple open-heart surgeries to 
replace valve replacements that the children have outgrown. In light of the heavy burden 
of congenital valve disease, there is a compelling need to better understand the pathology 
of this disease, as a foundation for the development of improved treatment options. 
Prior research on congenital valve disease has largely focused on gross structural 
and epidemiological aspects. Pathological studies have examined the incidence of 
congenital valve disease, its association with other anatomic cardiac anomalies, and its 
gross anatomical features. While these valves are known to be histologically abnormal, 
the specific matrix changes that occur within these congenitally diseased valves remain 
largely unknown. The goal of this study was to characterize the matrix composition, 





The research use of this tissue was approved by the institutional review boards at 
each institution. Patients were enrolled in the study after informed consent was obtained. 
A total of 32 surgically excised semilunar valves were collected from Texas Children's 
Hospital including 17 aortic valves (AVs) and 15 pulmonic valves (PVs). Three 
additional autopsy semilunar valves were obtained from Texas Children's Hospital (2 
PVs) and Ben Taub General Hospital, Houston, TX (1 AV). Valves were surgically 
excised for valvar stenosis and/or regurgitation, or were received with cardiac explants. 
Valves were grouped into 3 categories based on gross structural and histologic 
architecture. Valves with thin, delicate cusps and 3 clearly delineated, properly oriented 
histologic layers of normal thickness were designated controls (CTRL, n=21, 12 AVs, 9 
PVs). Hemodynamically altered valves (HEMO, n=8, 3 AVs, 5 PVs) appeared thickened 
and fibrotic with 3 identifiable, but variably thickened layers, with or without fibrous 
plaques on the surface. Valves that were variably thickened and deformed and lacked 
delineated layers with increased myxoid matrix were defined as dysplastic. All except 
the youngest of these samples also displayed hemodynamic changes and were designated 
(HEMO/DYSP, n= 6, 3 AVs, 3 PVs). The one isolated dysplastic PV from 2 year-old 
was evaluated but not included in statistical analyses. Samples were subdivided into 
valves from patients < 2 years-old (n=13) and > 9 years-old (n=21); with one outlying 
HEMO/DYSP AV from a 5 year-old. Additionally a sub-group analysis was performed 
on valvular interstitial cells (VICs) from pulmonary autografts in the aortic position for > 
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3 years as part of the Ross procedure valves4 in which the PVs had been placed in the AV 
position for at least 3 years. The research use of this tissue was approved by the 
institutional review boards at each institution. 
Histology and Immunohistochemistry 
Samples were fixed in 10% formalin, paraffin embedded, and sectioned according 
Table 14-1. Antibodies Used in Immunohistochemistry (IHC) and Flow Cytometry (FC) 
Protein 
Collaoen Turnover Proteins 
Collagen III (Col III) ' 
Matrix Metalloproteinase-13 
(MMP13)+ 
Prolyl 4-Hydroxylase (P4H)f 
Heat Shock Protein-47 (HSP47)11 
Elastic Fiber-Related Proteins 
Lysyl oxidase (LOX)§ 
Fibrillin11 










Proteoglycans (PG). Glvcosaminoqlvcans (GAG), and 
Hyaluronan (HA)# 







Valve Cell Activation/Cell Phenotvoe 
Vimentin** 
Non-muscle myosin (NMM)AA 














Marker of collagen synthesis 
Marker of collagen synthesis 
Involved in collagen and elastin crosslinking 
Component of elastic fibers 
Elastic fiber degradation 
Glycoproteins 
GAG providing compressibility 
Protein involved in HA turnover 
Cellular receptor for HA 
Extracellular glycoprotein 
PG involved in collagen fibrillogenesis 
PG involved in collagen fibrillogenesis 
PG involved elastic fibrillogenesis and compressibility 
Intermediate filament of mesenchymal cells 
Marker of an "activated" myofibroblast-like phenotype 
Marker of an "activated" myofibroblast-like phenotype 
FC=flow cytometry, IHC=immunohistochemistry; "Abeam (Cambridge, MA); TChemicon 
(Temecula, CA); §Imgenex (San Diego, CA); * Assay Designs (Ann Arbor, MI); #detected using 
hyaluronan binding protein, Associates of Cape Cod (Falmouth, MA); *gift of Dr. Larry Fisher 
(NIH, Bethesda, MD); ** Associates of Cape Cod; Agift of Dr. Paul Weigel (University of 
Oklahoma, Oklahoma City, OK); Dakocytomation (Denmark); AACovance (Berkeley, CA). 
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to standard procedures. Each sample was stained histologically with Movat pentachrome 
and immunohistochemically (IHC) for extracellular matrix components and valve cell 
phenotype (Table 14-1). IHC staining intensity of the mid-leaflet region of each section 
was quantified using ImageJ software (NIH, Bethesda, MD). Additionally IHC intensity 
in plaques and the underlying leaflet region was quantified. 
Flow Cytometry 
Valvular interstitial cells (VICs) were isolated from samples procured within 24 
hours of surgery and cultured as previously described.5 VICs from a total of 26 surgical 
samples were analyzed using flow cytometry (13 AVs, 13 PVs). For each cell line, an 
unstained sample and a negative control (mouse or rabbit IgG) were run alongside 
specific antibody samples (Table 14-1). Cells were fixed and stained as described 
previously,6 with the exception of the following modifications: fixation time was > 1 
hour, permeabilization time was 10 minutes, antibody incubation steps times 1 hour and 
the final resuspension volume was 250 uL. Samples were run on a FACScan flow 
cytometer and data analyzed with Cellquest Pro software (both BD, Franklin Lakes, NJ). 
Each sample was run three times and the median fluorescence recorded. Using the 
isotype control sample, the cell population was identified and gated based on size (FSC) 
and complexity (SSC). This population was then further gated based on fluorescence 
such that less than 1% fluorescence fell within the gate. This gate was then used to 
compare changes in fluorescence between cells stained with different markers. 
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Statistical Analysis 
Multifactorial analysis of variance (ANOVA) was performed using SigmaStat 
(SPSS, Chicago, IL), as described in Chapter 4. For comparisons between IHC intensity 
within plaques and the underlying leaflet, paired t-tests were performed. In all cases the 
level of significance was set at 0.05. Pearson and Spearman tests were used to calculate 
correlations between staining intensities, as described in Chapter 5. Significance was set 
at p<0.0042 for correlations in IHC (12 proteins compared) and p<0.0071 for flow 
cytometry (7 proteins compared). 
Expression of PGs, HA in CTRL AV from 
Different Aged Patients 
120 
VC DCN BGN HA 
Fig. 14-1: Expression of PGs and HA in different aged CTRL A Vs. Overall 
p=0.002. Error bars in all graphs indicate the standard error of the mean. 
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RESULTS 
Age-Related Changes in Matrix Composition of Semilunar Valves 
Analysis of CTRL AVs revealed decreased hyaluronan and proteoglycans 
versican and biglycan, but not decorin, with age (Fig. 14-1, p=0.002). Markers of 
collagen turnover (MMP13, P4H, HSP47), Col 3, and SMaA also decreased in CTRL 
AVs with age (Fig. 14-2, pO.OOl). Analysis of CTRL PVs revealed similar age-related 
changes, with decreased markers of collagen turnover (MMP13, P4H, HSP47) and 
markers of VIC activation (NMM and SMaA) (p=0.02, data not shown). Expression of 
proteoglycans and hyaluronan in CTRL PVs of different ages showed similar tendencies 
as AVs, with decreased versican, biglycan, and hyaluronan and no change in decorin, but 
the age-related changes in versican and hyaluronan were smaller than in AVs. 
Expression of Matrix Components in 











• age <2 
• age >9 
Col 3 HSP47 MMP13 P4H SMaA 
Fig. 14-2: Expression of markers of collagen turnover and activated VICs in different 
aged CTRL A Vs. Overall p<0.001, *p<0.05 between age groups for a given marker. 
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Expression of Matrix in HEMO AV, HEMO 















• CTRL AV 
• HEMO AV 
• CTRL PV 
• HEMO PV 
Fibrillin HA MMP13 P4H 
Fig. 14-3: Expression of matrix components in HEMO A Vs and PVsfrom patients >9 
years-old compared to CTRL A Vs and PVsfrom patients > 9 years-old. Overall p<0.001 
for HEMO vs. CTRL for each A V and PV; AVvs. PV within each HEMO and CTRL 
p<0.001. HEMO vs. CTRL p<0.05 for P4Hand HA by Holm-Sidakpost-hoc testing. 
Matrix Changes in Pathological Semilunar Valves 
HEMO AVs and PVs > 9 years-old not only demonstrated altered matrix 
compared to CTRLs (Fig. 14-3, HEMO AV vs. CTRL, HEMO PV vs. CTRL each 
p<0.001), but changes were distinct between AV and PV (pO.OOl). While both HEMO 
AVs and PVs demonstrated increased MMP13 and NMM, and decreased fibrillin, P4H 
and hyaluronan increased in HEMO AVs and decreased in HEMO PVs relative to 
CTRLs. HEMO/DYSP AVs > 9 years-old demonstrated distinct compositions compared 
to both HEMO AVs and CTRL AVs (each p<0.006, Fig. 14-4), including decreased 
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collagen and elastic fiber synthesis and turnover. The Ross valves within this HEMO PV 
group displayed changes consistent with HEMO PVs and distinct from HEMO AVs. 
Collagen and Elastic Fiber Turnover Markers in 
HEMO AV, HEMO/DYSP AV vs CTRLs 




Fig. 14-4: Expression of matrix components in HEMO/DYSP A Vs and HEMO 
A Vsfrom patients > 9 years-old compared to CTRL A Vsfrom patients > 9 years-
old. Overallp<0.001, HEMO, HEMO/DYSP, and CTRL each significantly 
different (each p<0.006). 
Plaques and underlying regions demonstrated altered matrix compositions relative 
to CTRL valves (Fig. 14-5, each pO.OOl), and these alterations were distinct between 
HEMO and HEMO/DYSP (Fig. 14-5, each p<0.013). Both HEMO and HEMO/DYSP 
plaques and underlying regions displayed decreased P4H, LOX, Col 3, and hyaluronan in 
plaques and underlying regions, but MMP13 was increased in HEMO plaques and 
underlying regions, while MMP13 was decreased in HEMO/DYSP plaques. P4H was 
also greater in HEMO plaques relative to HEMO/DYSP and the decrease in hyaluronan 
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Matrix Expression in Plaques and Underlying Regions 
DCTRL 
• HEMO UNDER 
P4HA 'A A MMP13 C o l 3 A LOX HAA-AA DCN 
Fig. 14-5: A) Expression of matrix in HEMO and HEMO/DYSP plaques and the 
regions underlying plaques (UNDER) relative to CTRL valves. Overall plaque vs. 
CTRL p<0.001, underlying regions vs. CTRLp<0.001. Pathology (HEMO, 
HEMO/DYSP, CTRL) was significant for both plaques (p<0.001) and underlying 
regions (p=0.001), and HEMO was significantly different than HEMO/DYSP by post-
hoc testing for both plaques (p<0.013) and underlying regions (p<0.012). *p<0.05 
vs. HEMO or HEMO/DYSP vs. CTRL for a given matrix component. Ap<0.05 CTRL 
vs. plaque and AAp<0.05 CTRL vs. underlying plaques for a given matrix component. 
was greater in HEMO/DYSP plaques and underlying regions compared to HEMO. 
Relative to their respective underlying leaflet regions, plaques in HEMO and 
HEMO/DYSP semilunar valves showed decreased hyaluronan (Fig. 14-6, p<0.001) and 
MMP9 (p<0.05), but increased decorin (p<0.002). Plaques specifically found in HEMO 
semilunar valves demonstrated decreased HSP47 (p=0.013) and decreased NMM 











/ U_ leaflet 
Fig. 14-6: Plaque in a HEMO/DYSP bicuspidAVfrom an 18year-old 
patient demonstrating decreased HA expression in the plaque relative 
to the adjacent, underlying leaflet. Scale bar indicates 1 mm. 
Remodeling of Leaflet Layers in Pathological Semilunar Valves 
While CTRL valves demonstrated clearly delineated trilaminar leaflet structure 
with the Movat stain, accompanied by layer-predominant expression of different matrix 
components (Fig. 14-7), the architectural disruption in HEMO/DYSP valves was 
accompanied by altered localization of matrix components (Fig. 14-8). For instance, in 
CTRL valves hyaluronan was largely expressed in the spongiosa layer, with some 
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^ \ 5 V HA 
PMMP13 
F/g. 74-7: CTRL A Vfrom a 2 year-old demonstrating clearly delineated leaflet 
layers and layer-specific expression of matrix components characteristic of CTRL 
A Vs and PVs. Scale bar indicates 500 /xm and applies to all panels of the figure. 
expression in areas of elastic fibers, but in HEMO/DYSP valves hyaluronan was 
abnormally distributed throughout the valve; hyaluronan in the central region normally 
comprising the spongiosa appeared expanded and hyaluronan did not co-localize with 
elastic fibers (Fig. 14-8). Matrix components such as Col 3, MMP13, and hyaluronan 
also demonstrated marked marbling. Other HEMO/DYSP valves also 
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Col 3 " HA 
Fig. 14-8: HEMO/DYSP A V demonstrating a lack of clearly delineated leaflet layers, 
marbling of Col 3, HA, and MMP13. Arrow points to expansion of HA composition in the 
interior of the leaflet. Scale bar indicates 1 mm and applies to all panels of the figure. 
showed profound abnormalities in marker expression within the central region normally 
comprising the spongiosa. For instance, in the HEMO/DYSP PV shown in Fig. 14-9, 
abnormally high levels of NMM, P4H, LOX, and fibrillin are evident. HEMO/DYSP 
valves also demonstrated variability in degree of loss of leaflet layer delineation 
throughout the length of the leaflet, as illustrated in Fig. 14-10. Also evident in this 
sample are pockets of collagen and elastic fiber remodeling in dysplastic regions. In 
several valves with plaques pockets of strong SMaA expression were noted both within 
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the plaque itself, and at the edge of the plaque (Fig. 14-11). These pockets of SMaA 







Fig. 14-9: HEMO/DYSP PVfrom a 12-year-old patient demonstrating strong expression of 
NMM, P4H, LOX, and fibrillin in the spongiosa (arrow). Note also the expansion of 
hyaluronan staining across the thickness of the leaflet. Scale bar indicates 500 fj,m and 




Fig. 14-10: HEMO/DYSP bicuspid AVfrom a 5 year-old patient demonstrating an 
annular region with relatively intact leaflet layers, indicated by the arrow, and 
nodular region with pockets of collagen (*) and elastic fiber remodeling (**). 
Scale bar indicates 1 mm. 
Correlations between Matrix Components in Pathological Semilunar Valves 
While HSP47 moderately correlated with P4H in CTRL AVs and PVs (r=0.64, 
p<0.002) as expected considering their common roles in collagen synthesis, in diseased 
valves HSP47 showed strong correlations with versican in regions underlying plaques 
(r=0.91, p<0.001). Furthermore, HEMO and HEMO/DYSP valves demonstrated distinct 
correlations related to collagen synthesis and turnover. While HSP47 correlated with 
decorin and versican in HEMO valves (r=0.82, p=0.002 and r=0.80, p=0.003, 
respectively), MMP13 correlated with decorin and versican in HEMO/DYSP valves 
(r=0.91, pO.OOl and r=0.82, p<0.002, respectively) and HSP47 correlated with MMP9 
and fibrillin (r=0.76, p=0.003 and r=0.76, p=0.002, respectively). 
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1 
BGN MMP13 SMaA Movat 
* 
* 
Fig 14-11: HEMO/DYSP bicuspid AVfrom an 18 year-old patient illustrating pockets of 
strong SMaA staining co-localizing with MMP13 and BGN expression (*). Brackets indicate 
location of plaques. Scale bar indicates 1 mm and applies to all panels of the figure. 
Differences between AV and PV VICs 
Flow cytometry analysis of VICs from CTRL AVs and PVs revealed greater cell 
activation and collagen synthesis in AV VICs than PV VICs (p=0.02, Fig. 14-12). 
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A. CTRL AV, PV VICs f r o m Pat ien ts < 2 yo 
5000 
HSP47 SMaA NMM Vimentln 
B. 
CTRL AV, PV V I C s f r o m P a t i e n t s > 9 y o 
AV, age >9 
PV,age >9 
HSP47 SMaA NMM Vimentin 
Fig. 14-12: Expression of cell phenotype markers in VICs from CTRL AV and 
PV from patients < 2 years-old (A) and > 9 years-old (B). Overall AV vs. PV 
p=0.02. 
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A. Cell Morphology of HEMO PV VICs from 
Patients >9 yo 
1200 















I CTRL PV 




B Cell Morphology of HEMO/DYSP and CTRL AV, 





















• HEMO/DYSP AV 
• CTRL PV 
B HEMO/DYSP PV 
FSC SSC 
Fig. 14-13: A) Cell morphology of VICs from HEMO PV of patients > 9 years-old 
compared to VICs from CTRL PV of patients > 9 years-old. *p<0.001 HEMO vs. 
CTRL for a given marker. B) Cell morphology of VICs from HEMO/DYSP AV and 
PV of patients > 9 years-old compared to VICs from CTRL AV and PV of patients > 
9 years-old. HEMO/DYSP vs. CTRL for FSCp=0.041, for SSCp<0.001. 
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Changes in VICs from Pathological Semilunar Valves 
Compared to VICs from CTRL PVs > 9 years-old, VICs from both HEMO PVs 
and HEMO/DYSP PVs > 9 years-old showed significantly different expression in the cell 
phenotype markers assessed (p=0.022 and p=0.031, respectively), especially increased 
NMM. Furthermore, VICs from HEMO PVs demonstrated slightly greater size (FSC, 
p<0.001) and dramatically greater complexity (SSC, pO.OOl) than CTRL PV (Fig. 14-
13A). VICs from HEMO/DYSP AV and PV > 9 years-old similarly displayed greater 
size (FSC, p=0.041) and complexity (SSC, pO.OOl) compared to VICs from CTRL AV 
and PV (Fig. 14-13B). Analysis of the subset of VICs from Ross valves (PV placed in 
A. 
3000 
CTRL AV, PV, and Ross VICs from 
Patients 59 yo 
NMM Vimentin 
Fig. 14-14: A) Expression of cell phenotype markers in VICs from Ross valves (AV 
placed in the PV for > 3 years), CTRL AV, and CTRL PV from patients > 9 years-
old. Overall p=0.016. 
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Fig. 14-14 (cont'd): B) Cell morphology of VICs from Ross valves, CTRL AV, and 
CTRL PV from patients > 9 years-old. For FSC: Ross, AV, PVp=0.013,for SSC: Ross, 
AV, PVp<0.001. *p<0.05 Ross vs. PV for a given marker by Dunn's post-hoc testing. 
the AV for at least 3 years) > 9 years-old compared to VICs from CTRL AVs and PVs > 
9 years-old showed greater NMM and vimentin (p=0.016, Fig. 14-14A) and significantly 
greater size (p=0.013) and complexity (pO.OOl, Fig. 14-14B). 
DISCUSSION 
Previous Studies of Matrix Composition in Congenitally Diseased Valves 
While limited analyses of congenitally diseased valves in terms of general 
structure and composition using basic histological stains have been occasionally reported, 
analyses of specific matrix components are rare. In 1979 Baig reported more dermatan 
sulfate in the 21-40 year-olds BAV, and less hyaluronan and more chondroitin sulfate in 
the 41-60 year-old BAV compared to age-matched controls.7 A more recent study of 
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adult bicuspid AVs demonstrated increased MMP2 and 9, however, given the age of 
these patients in these studies, it is difficult to discern how much of these changes were a 
result of the years of altered hemodynamics.7 Given the patients' ages it also is likely 
that these valves were not highly dysplastic, unlike bicuspid AVs that present early in 
life. 
In terms of basic histological analyses, Hinton reported disorganized collagen and 
elastin, proteoglycans in all layers, decreased elastin, and increased collagen in bicuspid 
AVs from six young patients (ranging from 1-184 months).9 Given the age of these 
patients, these valves may have been less affected by hemodynamic changes and 
potentially more dysplastic than those studied by Baig. In 1973 Bharati and Lev 
analyzed valves in congenital polyvalvular disease (CPVD, a specific congenital valve 
disease in which all four valves are affected) using basic histology.10 CPVD valves 
demonstrated an increase in the spongiosa layer with vacuolar and lacunar degeneration 
compared to age-matched normal valves and normal valves exposed to altered 
hemodynamics.10 These findings sharply contrast with those described in 
hemodynamically altered valves that have increased elastic fibers, and variably increased 
fibrous tissue with distinct, albeit altered trilaminar architecture.10 Koretzky in his study 
of PV dysplasia also reported changes principally in the spongiosa including expansion of 
that layer.11 Hyams' study of a broad group of congenitally diseased valves, including 
both isolated and polyvalvular cases, reported myxomatous nodules devoid of elastic 
tissue with pockets of collagenous tissue.12 However, rarely have alterations in specific 
proteins been studied in congenitally diseased valves and none reported for dysplastic 
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valves. Furthermore, none of the above studies assessed alterations in VIC cell 
phenotype. 
Altered Matrix Composition and VIC Cell Phenotype in Pathological Valves 
In the present study we found that HEMO and HEMO/DYSP valves demonstrated 
significant and distinct alterations in matrix composition compared to CTRL valves. In 
HEMO valves, increased'VIC activation and collagen turnover (MMP13) were seen in 
both AVs and PVs, which are consistent with ex vivo studies in which porcine AVs were 
exposed to increased mechanical stress.13'14 Fibrillin was also decreased in both HEMO 
AVs and PVs, suggesting elastic fiber degradation, as reported in hemodynamically 
altered valves.10 However, hyaluronan and P4H both decreased in HEMO PVs and 
increased in HEMO AVs, suggesting that the AV and PV may respond to altered 
hemodynamics differently. Within the HEMO PV group, Ross valves displayed changes 
consistent with HEMO PVs and distinct from HEMO AVs, suggesting that these Ross 
valves maintain inherent mechanobiological differences in their response to altered 
hemodynamics compared to AVs despite placement in the aortic position. 
HEMO/DYSP AVs demonstrated distinct compositions relative to HEMO AVs, 
including decreased collagen and elastic fiber synthesis and turnover, as compared to 
increased collagen synthesis and turnover in HEMO AVs. Examination of leaflet layer 
remodeling in HEMO/DYSP valves revealed alterations in localization of matrix 
components, particularly in the region normally comprising the spongiosa layer, as well 
as pockets of collagen and elastic fiber remodeling, consistent with previous reports of 
dysplastic valves.10"12 These findings are also consistent with collagen and elastic fiber 
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disarray previously reported in bicuspid (potentially dysplastic) AVs from young 
patients,9 and could suggest impaired ability of the valve to remodel in response to stress, 
which could have functional consequences. Distinct patterns of correlations between 
matrix components related to collagen turnover, elastic fiber turnover, and proteoglycans 
in HEMO valves relative to HEMO/DYSP valves suggest distinct interactions between 
matrix components within these different valves, which may contribute to the distinct 
pathological processes, although much remains to be learned in that regard. 
The plaques and regions underlying plaques in HEMO and HEMO/DYSP valves 
demonstrated distinct matrix compositions relative to CTRL valves, with decreased 
markers of collagen synthesis and hyaluronan. Particularly notable were the differences 
between plaques on HEMO as compared to HEMO/DYSP valves, including increased 
MMP13 in HEMO but decreased MMP13 in HEMO/DYSP plaques relative to CTRLs, 
and a more substantial decrease in P4H and hyaluronan in HEMO/DYSP than HEMO 
plaques relative to CTRLs. Pockets of strong SMaA expression and increased expression 
of matrix components were also noted within and bordering plaques, suggesting 
involvement of VICs with a myofibroblast phenotype in plaque formation. Further work 
understanding the processes occurring in the leaflet regions underlying plaques, and how 
they may relate to plaque formation is warranted. 
Not only did the congenitally diseased valves in this study display altered matrix 
composition, but the VICs contained in these valves displayed alterations in cell 
phenotype relative to VICs from CTRL valves. VICs from HEMO valves particularly 
demonstrated increased NMM, a marker of VIC activation, consistent with the IHC 
results. Both VICs from HEMO/DYSP valves and HEMO valves displayed altered cell 
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morphology, including increased size and complexity, relative to VICs from CTRL 
valves. Analysis of a subset of VICs from Ross valves suggests that these VICs display 
distinct cell phenotypes relative to VICs from CTRL valves. VICs from Ross valves also 
demonstrated increased VIC activation, consistent with the higher mechanical stress the 
PV must experience in the AV position, and consistent with previous analyses of tissues 
from Ross valves.15 As evident in VICs from HEMO and HEMO/DYSP valves, VICs 
from Ross valves also demonstrated increased cell size and complexity compared to 
CTRLs, suggesting these changes in cell morphology may be common to multiple forms 
of congenital valve disease. The differences in VICs from pathological valves relative to 
CTRL valves suggest that inherent abnormalities in the VICs could contribute to the 
documented matrix abnormalities and potentially plaque formation. 
Age-related Changes and Differences between AV and PV among CTRL Samples 
Analysis of CTRL AVs and PVs demonstrated decreased markers of collagen 
synthesis and turnover, VIC activation, proteoglycans (particularly in the AV), and 
hyaluronan with age. Decreased VIC activation and MMP13 is consistent with a 
previous study reporting decreases in these markers from fetal to ~6 year-old and then to 
-50 year-old semilunar valves.16 Previous work examining age-related matrix changes in 
porcine valves and their relationship to changes in material properties'7 among other 
studies, suggests that the changes in composition demonstrated in the present study could 
have important consequences for valve function. 
Greater VIC activation and collagen synthesis in VICs from CTRL AVs 
compared to those from PVs is consistent with previous reports of cell activation and 
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collagen synthesis in VICs from ovine AVs and PVs18 and vimentin in VICs from human 
adult semilunar valves.19 These apparent inherent differences in cell phenotype between 
the valves could relate to differences in composition between the valves. 
Implications 
The results from this study have a number of implications both for our 
understanding of congenitally diseased valves and potential therapeutics, as well as for 
the design of a tissue engineered heart valve. In terms of the results from the analysis of 
CTRL AVs and PVs, the age-related changes in matrix composition demonstrated in AVs 
and PVs corroborate previous studies17'21'22 supporting the need for an age-specific tissue 
engineered heart valve. Previous studies demonstrating altered material properties of 
valves with age, and a correlation between these changes and age-related changes in the 
valve matrix,17 suggest that for ideal function a tissue engineered heart valve optimally 
should have distinct design requirements for different aged patients. Furthermore, the 
results from this study demonstrating inherent differences in cell phenotype between 
VICs from AVs and PVs should be considered in terms of potential cell sources for a 
tissue engineered heart valve. 
With regard to the analysis of congenitally diseased valves contained in this 
study, the differences in VICs from pathological valves relative to CTRL valves suggest 
that inherent abnormalities in the VICs could contribute to the documented matrix 
abnormalities. As such, considerable caution would need to be exercised before utilizing 
autologous VICs in a tissue engineered heart valve for a patient with a congenitally 
diseased valve. The documented abnormalities in elastic and collagen fiber turnover in 
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these congenitally diseased valves provide a potential, novel therapeutic target for the 
treatment of these valves. If proper matrix composition and turnover could be 
encouraged pharmacologically, valve function may improve, which could prevent or 
delay the need for valve replacement. Clearly, however, considerable more work remains 
in this area. 
Limitations and Future Studies 
While this study provides important, foundational knowledge by detailing the 
specific the matrix composition and cell phenotypes within these diseased valves for the 
first time, there is still much research to be done in this nascent area, and a number of 
study limitations should be noted. First, the limited number of samples for each group 
made it difficult to obtain statistical significance for some of the group comparisons. 
Future collection of additional samples, including more age-matched autopsy samples, 
will allow narrower age groupings and more statistical power for group comparisons. 
Additionally, the complex conditions of these patients with congenitally diseased valves 
complicate these analyses. Future in vitro studies assessing signaling pathways that 
could potentially be involved in the observed matrix changes will greatly enhance our 
understanding of the disease and shed light on potential novel treatment strategies. 




In sum, the results contained in this study provide a detailed characterization of 
the matrix changes of congenitally diseased semilunar valves. As such, the study adds to 
our understanding that dysplastic valves are not simply valves with gross changes or a 
loss of layered leaflet structure microscopically, but these valves contain complex 
changes in matrix turnover, composition, and valve cell phenotype. 
This chapter, analyzing matrix remodeling and valvular interstitial cell 
(VIC) phenotype changes in congenitally diseased semilunar valves, combined with 
the review contained in the previous chapter, provides insight into congenital valve 
disease. In the following three chapters (Chapters 15-17), the topic of valve 
alterations in various diseased states is continued with a series of studies analyzing 
the mitral valve in the context of "functional" mitral regurgitation and dilated 
cardiomyopathy. In the next chapter, a study analyzing leaflet changes in response 
to mitral regurgitation is presented. 
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Chapter 15: The Effects of Mitral Regurgitation Aione are 
Sufficient for Leaflet Remodeling 
This chapter continues the topic of valve alterations in various diseased states 
and is the first in a series of three chapters (Chapters 15-17) examining mitral valve 
alterations in the context of "functional" mitral regurgitation and dilated 
cardiomyopathy. Specifically in this chapter a study analyzing leaflet changes in 
response to mitral regurgitation is presented. 
ABSTRACT 
Background: Although chronic mitral regurgitation (MR) results in adverse left 
ventricular remodeling, its effect on the mitral valve leaflets per se is unknown. In a 
chronic ovine model, we tested whether isolated MR alone was sufficient to remodel the 
anterior mitral leaflet (AML). 
Methods: Twenty-nine sheep were randomized to either control (CTRL, n=ll) or 
experimental (HOLE, n=18) groups. In HOLE, a 2.8-4.8mm diameter hole was punched 
in the middle scallop of the posterior mitral leaflet to create "pure" MR. At 12 weeks, the 
AML was analyzed immunohistochemically to assess markers of collagen and elastin 
synthesis as well as matrix metalloproteinases and proteoglycans. A semi-quantitative 
grading scale for characteristics such as intensity and delineation of stain between layers 
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was used to quantify differences between HOLE and CTRL specimens across the 
heterogeneous leaflet structure. 
Results: At 12 weeks, MR grade was greater in HOLE vs. CTRL (3.0±0.8 vs. 0.4±0.4, 
pO.OOl). In HOLE AML, saffron-staining collagen (Movat) decreased, consistent with 
an increase in matrix metalloprotease-13 throughout the leaflet. Type III collagen 
expression was increased in the mid-leaflet and free edge and expression of prolyl-4-
hydroxylase (indicating collagen synthesis) was increased in the spongiosa layer. The 
proteoglycan decorin, also involved in collagen fibrillogenesis, was increased compared 
to CTRL (all p<0.05). 
Conclusions: In HOLE AML, the increased expression of proteins related to collagen 
synthesis and matrix degradation suggests active matrix turnover. These are the first 
observations showing that regurgitation alone can stimulate mitral leaflet remodeling. 
Such leaflet remodeling needs to be considered in reparative surgical techniques. 
The work contained in this chapter was published as: 
Stephens EH, Nguyen TC, Itoh A, Ingels NB, Miller CD, Grande-Allen KJ. The Effects 
of Hemodynamics of Regurgitation Alone are Sufficient for Mitral Valve Leaflet 
Remodeling. Circulation. 2008; 118(1 l):S243-249. 
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INTRODUCTION 
Mitral regurgitation (MR) is associated with a number of chronic heart diseases. 
The prevalence of at least mild severity MR is reported to be approximately 19%, and 
MR in the context of dilated cardiomyopathy (DCM) portends a significantly worse 
prognosis.2"4 It has been hypothesized that the MR in DCM is "functional," i.e., 
primarily due to left ventricular enlargement and annular dilatation resulting in impaired 
leaflet coaptation.5"7 Recent reports of altered leaflet matrix composition in patients with 
heart failure,8 however, suggests that the leaflet itself is involved in the changes 
associated with heart failure, perhaps contributing to MR. Indeed, the severity of MR in 
DCM often increases over time, a phenomenon referred to as "MR begets MR."9 
However, given that many factors contribute to MR in DCM, including ventricular and 
annular remodeling, ischemic damage, and low pressure volume overload,9'10 it is unclear 
which variables drive the worsening regurgitation. The hypothesis of this study was that 
the altered hemodynamics of regurgitation alone could lead to adverse leaflet remodeling, 
thereby providing a possible mechanism for "MR begets MR."9 The goal of this study 
was to investigate the effect of the isolated hemodynamic variable by creating "pure" 
primary MR (independent of left ventricular dysfunction) and examine the anterior leaflet 
for signs of adverse remodeling. The implications of this study would be that of the 
mitral valve during the course of chronic MR could contribute to worsening MR. 
Conversely, this causal relationship would also imply that improvements in valve 
hemodynamics following mitral valve repair surgery could reverse negative remodeling 
of the valvular extracellular matrix. 
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In order to test this hypothesis, an ovine animal model of "pure" regurgitation was 
created by punching a 2.8-4.8 mm hole in the center of the posterior leaflet of the mitral 
valve. MR was monitored for 12 weeks before the animals were sacrificed and the 
anterior mitral leaflet (AML) was analyzed to determine if adverse remodeling had 
occurred. Remodeling was assessed by histological analysis of extracellular matrix 
(ECM) constituents as well as markers of matrix turnover. ECM not only serves as a 
structural scaffold, but also plays an active role in critical processes such as tissue 
differentiation, cell migration, growth factor regulation, mechanical function and disease 
in various tissues including heart valves.1 '•12 In addition, given reports of cell activation 
and proliferation at the site of valve injury,13 these characteristics were examined as well. 
METHODS 
All animals received humane care in accordance with the guidelines of the US 
Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The use of 
animals in this study was approved by the Stanford Medical Center Laboratory Research 
Animal Review Committee. 
Surgical Protocol 
Twenty-nine sheep were randomized to either control (CTRL, n^l l ) or 
experimental (HOLE, n=18) groups. Epicardial echocardiography was used to 
qualitatively grade (0-4) mitral regurgitation (MR) at baseline based on color and width 
of the regurgitant jet.14 A left thoracotomy and atriotomy were employed to access the 
mitral valve, and after establishment of cardiopulmonary bypass a 2.8 mm to 4.8 mm 
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Fig. 15-1: Intraoperative picture of hole-punch made in posterior leaflet of mitral valve. 
hole was created in the central scallop of the posterior mitral leaflet of HOLE animals 
with an aortic hole puncher (Fig. 15-1). CTRL animals underwent the exact same 
operation without the hole-punch. On a weekly basis, a blinded echocardiographer 
performed transthoracic echocardiography and graded the MR on the basis of color 
Doppler regurgitant jet extent and width. The MR grades taken at 6 and 12 weeks were 
combined to determine the "averaged final MR." The end-diastolic volume index 
(EDVI) and end-systolic volume index (ESVI) were calculated based on the sum of 3D 
volumes enclosed by the mitral annular and left ventricular markers, indexed to the body 
surface area. The full explanation of these calculations and the description of additional 
measurements performed using this model has been published previously.15 
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Histology and Immunohistochemistry 
CTRL HOLE 
F/g. 15-2: A) Diagram showing location from which AML cross sections were taken. 
B) Photos of fixed CTRL and HOLE valves before sectioning. 
The anterior leaflet (AML) was isolated and a 5 mm wide strip was cut from 
annulus to free edge (Fig. 15-2A). In order to control for heterogeneity in loading and 
microstructure among different regions of the AML, the strip was taken from the same 
region in all animals. These cross sections were embedded in paraffin and sectioned to a 
thickness of five microns. A cross section was also taken from each posterior leaflet 
(including the region with the hole-punch) and subjected to similar studies as those 
performed here for the AML. Those results are reported in Chapter 18. Each sample was 
stained histologically with Movat pentachrome to demonstrate the general collagen, 
elastic fiber, and proteoglycan/glycosaminoglycan content and to distinguish between the 
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different layers of the mitral valve. Picrosirius red staining was performed to examine 
the collagen content and alignment and infer type of collagen (red=collagen I, 
yellow/green=reticular collagen III16). Samples were also stained 
immunohistochemically to demonstrate specific ECM components and enzymes involved 
in matrix turnover (Table 15-1), including the proteoglycan decorin (DCN), involved in 
Table 15-1. Antibodies Used in Immunohistochemistry. 
Marker Function 
Collagen-related Markers 
PG associated with tension and collagen fiber 
Decorin (DCN)* formation 
Collagen III (Col III)1 Reticular type of collagen 
Prolyl 4-Hydroxylase (P4H) * Hydroxylating enzyme in collagen synthesis 
Heat shock protein 47 (HSP47)f Molecular chaperone in collagen synthesis 
Lysyl Oxidase (LOX)§ Crosslinking enzyme in collagen synthesis 
Elastic fiber-related 
Elastin1 Primary component of elastic fibers 
Fibrillin* Elastic fiber component 
Lysyl Oxidase (LOX)§ Crosslinking enzyme in elastic fiber formation 
Matrix Degradation 
Matrix Metalloprotease (MMP)-1 " Enzyme involved in matrix degradation 
MMP2 " Enzyme involved in matrix degradation 
MMP9 " Enzyme involved in matrix degradation 
MMP13* Enzyme involved in matrix degradation 
Cell Activation/Proliferation 
Proliferating Cell Nuclear Antigen (PCNA)* Marker of cell proliferation 
Non-muscle Myosin (NMM)# Marker of an "activated" cellular phenotype 
*Gift from Dr. Larry Fisher, NIH; * Abeam, Cambridge, MA; JChemicon (Temecula, CA); 
§Imgenex (San Diego, CA); "Assay Designs (Ann Arbor, MI); "Covance (Berkeley, CA). 
PG=proteoglycan. 
collagen fibrillogenesis;17 type III collagen (Col III), which tends to be unregulated in 
remodeling tissues;18 the elastic fiber-related proteins elastin, fibrillin, and lysyl oxidase 
(LOX, involved in crosslinking both collagen and elastin); two markers of collagen 
synthesis, prolyl 4-hydroxylase (P4H) and heat shock protein-47 (HSP47); and markers 
of matrix degradation including the matrix metalloproteases (MMPs)-l, -2, -9, and -13. 
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To determine whether the regurgitation affected the phenotype of the cells within the 
valve, cell proliferation and valve cell activation were evaluated using antibodies against 
proliferating cell nuclear antigen (PCNA) and non-muscle myosin (NMM), respectively. 
In order to limit variability due to staining procedures all leaflets (both HOLE and CTRL) 
were stained for a given marker together in one batch. A semi-quantitative grading scale 
from 0 to 4 was used to assess the intensity of staining and the delineation of stain 
between layers, both throughout the leaflet and in the insertion, annulus, mid-leaflet, and 
free edge regions (Fig. 15-3). In addition, "background elastin staining" was defined as 
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Fig. 15-3: A) Microstructure of a Movat pentachrome-stained mitral valve showing different 
regions and layers. Shaded arrow indicates direction of blood flow from left atrium (LA) to left 
ventricle (LV). Scale bar represents 2 mm. B) Examples of grading rubrics for the characteristics 
staining intensity and delineation. For the characteristic delineation, "1" indicates little 
differentiation in intensity between layers. "4 " indicates maximum. The circle indicates the area 
graded for the characteristic "background elastin intensity. " 
All 
the intensity of staining in the fibrosa and spongiosa layers, i.e. between the strongly 
staining linear fibers found within the atrialis and ventricularis (see circled region in Fig. 
15-3B). All evaluations were performed by a trained individual blinded to the identity of 
the leaflets. 
Statistical Analysis 
Data are presented as mean and standard deviation, unless otherwise noted. 
Multifactorial analysis of variance was performed using SigmaStat (SPSS, Chicago, IL), 
as described in Chapter 4. The Holm-Sidak all-pairwise multi-comparison method was 
used for post-hoc testing. Correlations between factors were calculated using Pearson 
and Spearman tests, as described in Chapter 5. 
RESULTS 
Throughout the study, the MR grade was greater in HOLE than in CTRL (Fig. 15-
4A). At 12 weeks, the grades were 0.4±0.4 vs. 3.0±0.8 for CTRL vs. HOLE, respectively 
(pO.OOl). The regurgitant jet was largely centrally oriented (towards the atrium, Fig. 
15-4B) and did not hit the AML directly. This MR was accompanied by a greater mitral 
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Fig 15-4: A) MR grade of HOLE versus CTRL. B) Sample echo image of 
regurgitant jet (white arrow) in a HOLE animal. 
annulus area, primarily due to an increase in the commissure-to-commissure dimension, 
although there was no evidence of change in the 3D annular shape.15 EDVI and ESVI 
were both significantly greater in HOLE compared to CTRL at 12 weeks (EDVI: 
109.1±30.0 ml/m2 vs. 146.3±30.3 ml/m2 for CTRL vs. HOLE, respectively; ESVI: 
81.7±29.5 ml/m2 vs. 106.3±18.7 ml/m2 for CTRL vs. HOLE, respectively, p<0.004 for 
both). Levels of circulating biochemical markers such as blood natriuretic peptide were 
not significantly different between groups. The full details of cardiac changes observed 
in the HOLE animals have been published previously.15 
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Fig. 15-5: Staining intensity of matrix components in HOLE and CTRL animals. *=p<0.05; 
f=p=0.022R; f=p=0.081. Error bars represent the standard error of the mean (SEM). 
Numerous differences in the staining of several ECM markers within the AML 
were found between HOLE and CTRL animals. Cell proliferation, as detected by PCNA 
staining, tended to be greater in HOLE compared to CTRL (p=0.089), and NMM 
expression in the fibrosa positively correlated with the average final grade of MR 
(r=0.225, p<0.027). With respect to the overall amount of collagen, Movat-stained 
sections showed a significant reduction in saffron-staining collagen in HOLE (p=0.041, 
Fig. 15-5). Picrosirius red staining confirmed that Movat saffron-stained regions were 
composed predominantly of type I, rather than type III, collagen. (When viewed under 
polarized light the large, linear bundles of type I collagen fibers in picrosirius red-stained 
tissue appear red, while the small diameter, networked collagen type III fibers appear 
yellow/green16). HOLE AML showed greater Col III compared to CTRL (p=0.024, Fig. 
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A. MMP9 Expression in Regions of Leaflet 
B. 
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Region of Valve 
Fig. 15-6: A) MMP9 expression in various regions of valve, p=0.021. B) MMP1 staining in 
the fibrosa layer, p—0.024. Error bars represent SEM. 
15-5), particularly in the mid-leaflet and free edge regions. HOLE AML also showed 
elevated P4H expression compared to CTRL (p=0.024), which was most notable in the 
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spongiosa layer (p=0.024). DCN expression was greater in HOLE (p=0.022R), which 
also showed a trend of higher MMP13 intensity compared to CTRL (p=0.081R). MMP9 
staining across all regions of HOLE AML was greater than in CTRL AML (p=0.021, Fig. 
15-6A) and MMP1 staining in the fibrosa of the annulus and mid-leaflet regions was 
greater for HOLE compared to CTRL (p=0.024, Fig. 15-6B). In these same two regions 
the background elastin staining (i.e., staining in the spongiosa and fibrosa) was 
significantly greater in the HOLE AML (p=0.023, Fig. 15-7). In the insertion region of 
AML, there was greater staining for Col III in HOLE compared to CTRL (p=0.048) due 
to an abundance of Col III in the fibrosa layer (p=0.002). The HOLE AML insertion 
region also showed a trend of greater MMP9 abundance (p=0.070) that was significant in 
the fibrosa layer (p=0.022). 
Background Elastin Staining 
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The principal findings of this study were that HOLE AML exhibited collagen 
remodeling, demonstrated by a reduction in collagen type I and elevated expression of 
type III collagen, P4H, DCN, and MMP1. Furthermore, HOLE AML showed evidence 
of elastic fiber remodeling, including greater MMP9 and elastin expression within the 
fibrosa and spongiosa layers. Consistent with valvular matrix remodeling, valve cell 
activation demonstrated by NMM expression was elevated in direct correlation with the 
average final grade of MR. These results suggest that isolated MR was sufficient to 
cause mitral valve leaflet remodeling. 
Anterior Leaflet Remodeling and Functional Consequences 
The finding of collagen remodeling in HOLE AML is demonstrated by the 
elevation in MMPs, reduction in type I collagen, and greater expression of reticular type 
III collagen. Additional evidence was provided by the greater abundance of P4H, which 
is involved in collagen synthesis, and of the proteoglycan DCN, which mediates collagen 
fibrillogenesis.17 These results are consistent with previous reports of DCN upregulation 
in human mitral valve prolapse19 and greater amounts of collagen III in rat mitral valves 
exposed to left ventricular pressure overload.20 Because collagen type III does not have 
the tensile strength of collagen type I, a shift in the proportions of these collagens may 
result in decreased valve stiffness and perhaps an increased susceptibility to leaflet 
prolapse (at least at the 12 week time point). 
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The greater abundance of MMP9 along with the stronger background elastin 
staining demonstrated the remodeling of elastic fibers in HOLE AML. MMP9 can 
degrade elastin, but cannot degrade collagen I and III (the major collagen types in the 
valve, both substrates for MMP 1, 2, and 13).21 Furthermore, MMP9 expression has been 
found to co-localize with elastic fiber degradation in valves.22 The observations of cell 
activation and cell proliferation are also consistent with leaflet remodeling. NMM 
expression by mature valve cells is associated with valve remodeling and disease,2 '2 4 
and cell proliferation is a well-documented (albeit non-specific) response to valve 
injury.13 
The leaflet remodeling was heterogeneous, but in a manner reflecting the normal 
varied distribution of collagen and elastin and their distinct roles in leaflet function. For 
example, stronger background elastin staining was evident in the annulus and mid-leaflet, 
regions where elastin is normally most abundant, albeit in the atrialis and ventricularis as 
opposed to the fibrosa and spongiosa. Given that elastic fibers govern the elastic recoil of 
the tissue, this greater abundance of "background" elastin may indicate altered 
mechanical loading of the AML. With respect to collagen remodeling, the stronger 
MMP1 staining was specifically found in the fibrosa of the mid-leaflet and annulus, 
whereas the stronger type III collagen staining was predominantly found in the mid-
leaflet and free edge. Type I collagen is normally most abundant in the fibrosa layer 
within the annulus and mid-leaflet regions, and is critical to the leaflet's tensile strength. 
Given the specificity of MMP 1 for collagen type I,25 it is logical that MMP1 expression 
would be stronger in the fibrosa layer of these regions. It may be that the nature of the 
regurgitant jet and the altered coaptation patterns caused increased tension on the free 
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edge and mid-leaflet regions, which could explain the greater abundance of type III 
collagen in those regions. It is also interesting to note that the insertion region (annular 
ring) of HOLE AML showed greater abundance of Col III and MMP9. 
We speculate that the MR resulting from the hole-punch led to altered stress on 
HOLE AML, which led to altered collagen turnover throughout the various leaflet 
regions. Functionally, in the mid-leaflet region this altered collagen content would 
reduce tensile strength, leading to leaflet prolapse that could worsen MR. Altered 
collagen turnover in the insertion region (part of the mitral fibrous annulus) would result 
in decreased tensile strength of this region and lead to annular dilation, as evident in 
HOLE. This annular dilation would also then worsen MR.5 Although less annular 
dilation occurs in the anterior as opposed to the posterior mitral annulus in DCM, 
anterior annular dilation has been documented in both animal models26 and human cases 
of DCM.27 
Potential Mechanism for Observed Changes 
The proposed mechanism for the observed dysfunction in the HOLE animals 
involves interrelated changes at three hierarchical levels: cardiac, valve/hemodynamic, 
and leaflet ECM/microstructure. Cardiac changes include annular dilation caused by 
altered strain patterns in the left ventricle due to the HOLE-induced MR; this annular 
dilation would exacerbate MR.5 Considering the level of the valve, computer modeling 
has shown that during normal coaptation, the AML shares the burden of stress with the 
posterior leaflet.5 With regurgitation and annular dilation, however, coaptation is 
reduced, forcing the AML to bear greater stress.5 Indeed, leaflets under increased stress 
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production of new collagen (as suggested by the greater expression of P4H). Other 
findings, however, suggest that this remodeling is "pathological." Elevated MMP9 
expression has been associated with a number of valve pathologies, including non-
rheumatic aortic stenosis.29 Increases in other MMPs have also been reported in diseased 
valves including myxomatous mitral valves23' 30 and stenotic aortic valves.22 
Myxomatous mitral valves also demonstrate a higher ratio of type III to type I collagen, 
as suggested by the results of this study.18 
Potential Mechanism for "MR Begets MR" 
This unique animal model created isolated regurgitation to investigate how the 
valve was affected by low pressure volume overload, and showed that regurgitation alone 
can initiate leaflet remodeling. Several animal models of chronic MR have been created 
previously, but these have all involved the confounding effects of ventricular ischemia 
and remodeling and/or created regurgitation using high pressure volume overload,31 
which is significantly different than the hemodynamics seen in clinical MR. For 
instance, the severance of chordae has been shown to alter left ventricular geometry and 
strain patterns and cause global systolic dysfunction. Many cases of chronic MR 
involve factors other than altered hemodynamics that contribute to increasing 
regurgitation. A paradigm often used to account for chronically increasing MR is that 
ventricular dilation, which frequently accompanies chronic MR, increases ventricular 
wall stress10 and impairs left ventricular ejection performance, which then augments 
regurgitation.10 Others see MR as principally due to annular dilatation that results in 
impaired leaflet coaptation.5"7 In these views the MR is "functional," a result of changes 
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show increased collagen synthesis. At the level of the ECM and individual valve 
layers, the collagen type I-rich fibrosa is responsible for the leaflet's tensile strength. 
Based on the greater staining for non-muscle myosin (a myofibroblastic phenotypic 
marker) in the fibrosa and the positive correlation between this staining and the average 
final MR, it appears that the fibrosa is experiencing increased stress related to MR. It 
also appears that collagen remodeling is occurring with type I collagen being replaced by 
flexible reticular type III collagen. Although this remodeling was likely initiated in 
reaction to the altered stresses, the altered collagen proportions could reduce the tensile 
strength of the AML and worsen MR. 
Pathological versus Adaptive Leaflet Remodeling 
While this study provides the first evidence to date that regurgitation alone is 
sufficient to cause leaflet remodeling, it is difficult to say whether or not these changes in 
the AML should be considered pathological (detrimental) or adaptive (advantageous). 
From a clinical and pathological perspective, these changes would seem to be 
detrimental. Certainly, a decrease in the amount of type I collagen would make the 
leaflet more prone to prolapse, but it is not clear whether other changes such as increased 
expression of P4H and similar markers should be considered detrimental. Increased 
DCN expression has been reported in prolapsed mitral valves,19 but it is not clear whether 
the changes in DCN expression were causing the prolapse or attempting to counteract 
prolapse. It is also important to note that in this study only a single time-point was 
examined. Therefore, the reduction in collagen may have been a transient event in a 
process of adaptive remodeling to restore leaflet integrity that would be followed by the 
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in left ventricular structure and function. However, the findings of the present study 
suggest that MR itself could be an independent factor contributing to chronically 
increasing MR via leaflet remodeling. 
These results have implications for a number of clinical conditions. In this paper 
we have shown that a primarily hemodynamic insult results in secondary organic changes 
with functional consequences. Hemodynamics may similarly affect very different 
conditions, such as myxomatous mitral valves. Leaflets that have undergone organic 
changes (i.e., myxomatous degeneration) may be sensitive to changes in loading that 
could further deteriorate cardiac function. Likewise, myxomatous valves in which 
regurgitation has been surgically corrected would experience improved hemodynamics, 
and may undergo positive remodeling. Overall, changes in left ventricular and annular 
structure and function, organic changes in the mitral valve leaflets, and cardiac and 
valvular hemodynamic changes are interrelated factors that distinctly influence one 
another and trigger further cardiac dysfunction. 
Limitations 
Caution should be exercised in extrapolating the results of this ovine study to 
human hearts. One of the most important limitations was the duration of MR. While in 
patients MR progresses slowly over the course of years, these animals had isolated MR 
for only 12 weeks. Regardless, significant differences were found even within this short 
time period. Another limitation was that increasing MR was not detected over the 12-
week period. This finding was likely due to the short time course and the decrease in the 
posterior leaflet's hole size as it healed (analysis of the posterior leaflet is reported 
432 
separately). Furthermore, although the changes in HOLE were primarily driven by MR, 
there were secondary changes in left ventricular dimensions, such as annular dilation, that 
could have affected leaflet composition. However, all of the effects on leaflet 
composition were either directly or indirectly caused by MR. Another limitation was the 
narrow range of MR in the HOLE animals. A wider range of MR, combined with more 
specific hemodynamic measurements, would have enabled detection of more direct 
correlations between hemodynamics and AML compositional changes. 
Limitations in the leaflet analysis included the subjective nature of histological 
grading. To make this process more objective, a grading rubric was used for each 
characteristic, the grader was blinded to leaflet identity, and all leaflets stained for a given 
marker were evaluated at the same time. In addition, the surgical and histological 
analyses were performed at different institutions, so it was not possible to perform 
materials testing on these tissues or to link material properties directly to matrix changes. 
In the future, it will be important to analyze the remodeling and material behavior of 
other parts of the mitral valve, including the fibrous trigones, the chordae, and the other 
regions of the AML, because loading patterns across the valve are very heterogeneous. 
CONCLUSIONS 
Using a novel animal model of isolated mitral regurgitation, this study provides 
the first evidence that regurgitation alone can result in leaflet remodeling. The HOLE 
AML showed elevated expression of MMPs and reduced expression of type I collagen, 
along with greater abundance of P4H (a marker of active collagen synthesis), DCN (a 
proteoglycan involved in collagen fibrillogenesis), and type III collagen. Taken together, 
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these changes suggest an increase in matrix degradation and in collagen synthesis, 
particularly type III collagen synthesis. Furthermore, greater abundance of elastin in the 
spongiosa and fibrosa layers of the HOLE AML and higher levels of the elastin-
degrading MMP9 suggest that elastin remodeling is also occurring. 
This chapter, analyzing leaflet matrix remodeling in response to mitral 
regurgitation, opens a series of three chapters (Chapters 15-17) analyzing the mitral 
valve in the context of "functional" mitral regurgitation and dilated 
cardiomyopathy. The next two chapters (Chapter 16 and 17) address mitral valve 
changes in dilated cardiomyopathy. Specifically in the next chapter, changes in 
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Chapter 16: Significant Changes in Mitral Valve Leaflet Matrix 
Composition and Turnover with Tachycardia-Induced 
Cardiomyopathy 
In this chapter the topic of mitral valve alterations in the context of 
"functional" mitral regurgitation and dilated cardiomyopathy continues with a 
study of mitral leaflet composition and turnover in an animal model of dilated 
cardiomyopathy. 
ABSTRACT 
Background: Dilated cardiomyopathy (DCM) involves significant remodeling of the 
left ventricular-mitral valve (MV) complex but little is known regarding the remodeling 
of the mitral leaflets. The aim of this study was to assess changes in matrix composition 
and turnover in MV leaflets with DCM. 
Methods: Radiopaque markers were implanted in 24 sheep to delineate the MV; 10 
sheep underwent tachycardia-induced cardiomyopathy (TIC) while 14 sheep remained as 
controls (CTRL). Biplane videofluoroscopy was performed before and after TIC. 
Immunohistochemistry was performed on leaflet cross-sections taken from the septal, 
lateral, and anterior and posterior commissures attachment segments. Staining intensity 
was quantified within each attachment segment and leaflet region (basal, mid-leaflet, and 
free edge). 
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Results: MR increased from 0.2 ± 0.4 before TIC to 2.2 ± 0.9 after TIC (p<0.0002). 
TIC leaflets demonstrated significant remodeling compared to CTRL including greater 
cell density and loss of leaflet layered structure (all p<0.05). Collagen and elastic fiber 
turnover was greater in TIC, as was the myofibroblast phenotype (all p<0.05). 
Compositional differences between TIC and CTRL leaflets were heterogeneous by 
annular segment and leaflet region, and related to regional changes in leaflet segment 
length with TIC. 
Conclusions; This study shows that the MV leaflets are significantly remodeled in DCM 
with changes in leaflet composition, structure, and valve cell phenotype. Understanding 
how alterations in leaflet mechanics, such as those induced by DCM, drive cell-mediated 
remodeling of the extracellular matrix will be important in developing future treatment 
strategies. 
The work contained in this chapter was published as: 
Stephens EH, Timek TA, Daughters GT, Kuo JJ, Patton AM, Baggett LS, Ingels NB, Jr., 
Miller DC, Grande-Allen KJ. Significant Changes in Mitral Valve Leaflet Matrix 




While numerous studies have demonstrated the importance of the mitral valve 
(MV) annulus in proper MV function and in the development of dilated cardiomyopathy 
(DCM),1'2 the MV leaflets have largely been considered bystanders in DCM. A recent 
study, however, demonstrated changes in the MV leaflet geometry following tachycardia-
induced cardiomyopathy (TIC) that were not solely attributable to annular dilation.3 One 
potential explanation for these changes is that TIC altered the mechanical loads applied to 
the valve leaflets, which stimulated the valvular interstitial cells (VICs) to alter their 
phenotype and normal patterns of extracellular matrix synthesis and remodeling.4 
Changes in the composition and arrangement of the extracellular matrix in the valve 
leaflets would, in turn, influence their structure and material behavior. Therefore, the 
objective of this study was to characterize the changes in matrix composition, matrix 
turnover, and VIC phenotype that occurred in mitral leaflets as a result of TIC and to 
relate these to leaflet segment length changes. This information should give insight into 
the pathogenesis of DCM and may help to improve current reparative techniques. 
METHODS 
All animals received humane care in accordance with the guidelines of the US 
Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The use of 
animals in this study was approved by the Stanford Medical Center Laboratory Research 
Animal Review Committee. 
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POST-C 
Fig. 16-1: Circles indicate the location of the implanted radiopaque markers. Gray rectangles 
indicate the locations from which tissue sections were taken (tissue sections were taken to either 
side of markers such that markers or their sutures were not included in the samples). In the 
case of septal segment (SEPT) and lateral segment (LA T) 2 tissue sections were analyzed and 
the results averaged, in the case of the anterior and posterior commissures (ANT-C, POST-C), 
one tissue section was taken from either side of the tantalum marker based on quality of the 
leaflet on each side. BL=basal leaflet, ML=mid-leaflet. 
Animal Protocol 
Radiopaque markers were implanted in 24 sheep to delineate the leaflet and 
annulus of four MV segments (Fig. 16-1): septal (SEPT), lateral (LAT), and anterior 
(ANT-C) and posterior commissures (POST-C). The marker implantation procedure has 
been described in detail previously.5 Ten sheep underwent a rapid-pacing protocol (TIC) 
for an average of 15 ± 6 days,5 while fourteen sheep used for an acute hemodynamic 
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study were utilized as histological controls (CTRL). Biplane video fluoroscopy was 
performed in CTRL and both before and after pacing in TIC animals. TIC-induced 
changes in maximum and minimum septal and lateral leaflet lengths throughout the 
cardiac cycle were measured for basal and mid-leaflet regions (Fig. 16-1: BL and ML, 
respectively). The septal-lateral diameter was measured as the maximum distance 
between the mid-septal and mid-lateral annular markers throughout the cardiac cycle, 
while the commissure-commissure diameter was measured as the maximum distance 
between the two commissural annular markers throughout the cardiac cycle. Although 
animals were not randomly assigned to groups, all animals (CTRL and pre-TIC) 
displayed hemodynamic parameters in the normal range and showed comparable 
percentage changes in annular or leaflet segment distances throughout the cardiac cycle. 
Mitral regurgitation was graded on a scale of 0-4 based on color Doppler regurgitant jet 
extent and width,6 as previously described.5 Left ventricular (LV) end-diastolic and end-
systolic volume (EDV, ESV) were calculated using a space-filling analysis of epicardial 
markers, as described.5 Ejection fraction (EF) was calculated as the difference between 
EDV and ESV divided by EDV. These calculated EF values consistently underestimate 
the true EF because the calculated EDV includes LV myocardial mass, but EF 
calculations were only used to assess potential correlations between LV remodeling and 
leaflet changes amongst the TIC animals. At the end of the study, the hearts were then 
harvested and stored in formalin. CTRL animals were used for histological comparison 
only, while hemodynamic and leaflet segment length analyses compared pre-TIC and 
TIC data. 
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Histology and Immunohistochemistry 
Cross-sections 3-5 mm in width were cut from insertion region (including 
associated myocardium) to free edge (Fig. 16-2), embedded in paraffin, and sectioned to 
a thickness of five microns. Sections were stained with Movat pentachrome to 
demonstrate the layered structure of the leaflet. Immunohistochemistry was performed 
for a number of extracellular matrix components and turnover proteins (Table 16-1). For 
each segment (LAT, SEPT, ANT-C, POST-C, Fig. 16-1), staining intensity was 
quantified within each leaflet region (BL, ML, and free edge) and histological layer 
(fibrosa, atrialis, spongiosa (spongiosa only in ML)) using ImageJ software (NIH, 
Bethesda, MD) (for illustration of leaflet regions and layers analyzed, see Chapter 9, Fig. 
9-2). The free edge was considered a single layer. Cell density was assessed by counting 
Table 16-1. Panel of Antibodies Used in IHC. 
Protein Function 
Collagen Turnover Proteins 
Collagen I (Col I)* Predominant collagen in valve, provides tensile strength 
Collagen III (Col III)* Reticular collagen 
Matrix Metalloproteinase (MMP)-13f Collagen degradation 
Elastic Fiber-Related Proteins 
Lysyl oxidase (LOX)8 Involved in collagen and elastin crosslinking 
Elastin" Predominant component of elastic fibers 
Matrix Metalloproteinase (MMP)-9* Elastic fiber degradation 
Proteoglycans (PG) and Glvcosaminoqlycans (GAG) 
Hyaluronan (HA)* GAG providing compressibility 
Decorin (DCN)* PG involved in collagen fibrillogenesis 
Biglycan (BGN)* PG involved in collagen fibrillogenesis 
Valve Cell Activation 
Smooth muscle alpha-actin (SMaA)** Marker of an "activated" myofibroblast-like phenotype 
Non-muscle Myosin Heavy Chain (NMM)1^ Marker of an "activated" myofibroblast-like phenotype 
'gift of Dr. Larry Fisher, NIH (Bethesda, MD); +Chemicon (Temecula, CA); {Assay Designs 
(Ann Arbor, MI); §Imgenex (San Diego, CA); "Abeam (Cambridge, MA); "Associates of Cape 
Cod (Falmouth, MA); Dakocytomation (Denmark); t1Covance (Berkeley, CA). 
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nuclei within a defined area of the BL and ML fibrosa, as well as the free edge. Semi-
quantitative grading was performed on blinded sections using a pre-determined grading 
rubric ranging from 0 (minimum) to 4 (maximum) for delineation between leaflet layers 
and diffusion of Movat-stained collagen beyond the fibrosa. Percentage differences in 
histological and IHC parameters between TIC and CTRL were calculated by comparing 
each TIC value to the average CTRL value for a given parameter. 
Statistical Analysis 
SigmaStat (SPSS, Chicago, IL) was used for multivariate analysis of variance 
(ANOVA), as described in Chapter 4. Paired t-tests were used for the statistical 
comparison of pre-TIC and post-TIC hemodynamics. Correlations between staining 
intensities of different proteins within individual leaflet layers, regions, and segments (to 
assess co-localization of cell activation and matrix remodeling) were calculated using a 
Pearson rank order test for normally distributed data and Spearman rank order correlation 
test for non-normally distributed data. Correlations between protein intensities and TIC-
induced changes in segment lengths, EDV, ESV, and EF (to relate compositional 
changes, altered strain, and LV remodeling within individual animals) were similarly 
determined. For correlations between intensities of different proteins p<0.015 was 
considered a trend and p<0.00625 considered significant (since the intensities of 8 
proteins were being compared); for correlations between intensities of proteins and TIC-
induced segment length and EDV, ESV, EF changes, each protein was considered 
individually, therefore p<0.05 was considered significant. Data are presented as mean 
and standard deviation, unless otherwise noted. Percentages for IHC are presented as 
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mean and standard error of the mean because of the multiple segments, layers, and/or 
regions involved in the statistical tests. 
RESULTS 
Dynamic Leaflet Changes after the Development of Dilated Cardiomyopathy 
Pre-TIC and Post-TIC MR 
Fig. 16-2: Pre-TIC and post-TIC MR for each animal. Overall p<0.0002. 
Consistent with the development of DCM, the maximum annular septal-lateral 
diameter increased 24±9% (pO.OOOl) in TIC compared to pre-TIC, the commissure-
commissure diameter increased 9±4% (p<0.001), and mitral regurgitation increased from 
0.2±0.4 to 2.2±0.9 (Fig. 16-2, p<0.0002). Further characterization of annular and 
hemodynamic changes with TIC has been previously published.3'5 Leaflet segment 
lengths increased with TIC compared to pre-TIC for both LAT and SEPT (Table 16-2, 
8±12%, each p<0.05). In LAT and SEPT, the TIC-induced increase in the maximum 
mid-leaflet (ML) length was greater than that of the basal leaflet (BL) (13±12% vs. 
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5±10%, p=0.018) and the TIC-induced increase in the maximum ML length of LAT was 
greater than SEPT (14±5% vs. 5±5%, p=0.032). 





















p<0.05 vs. pre-TIC; data expressed as mean +/- standard deviation. 
Structural Changes in TIC Leaflets 
Compared with CTRL, SEPT and LAT of TIC showed greater cell density across 
all leaflet regions (57±17%, p=0.05 and 94±17%, pO.OOl), as did ANT-C/POST-C 
(39±11%, p=0.05). TIC leaflets showed less delineation between valve layers compared 
to CTRL (Fig. 16-3A,B, -20±5%, p=0.014) with collagen more likely to be spread 
beyond the fibrosa layer (37±8%, p=0.002). There was also an increased incidence of 
muscle in TIC leaflets compared to CTRL (9 TIC vs. 2 CTRL samples, Fig. 16-3C). 
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Fig. 16-3: A) Image illustrating the lack of delineation between layers in TIC (top) compared 
to CTRL (bottom). Samples are both LATleaflets stained with Movatpentachrome. Scale 
bars represent 2 mm. B) Graph illustrating decrease in delineation in TIC compared to CTRL 
(p=0.0I4), *=p=0.011. Error bars indicate the standard error of the mean. C) Examples of 
muscle found considerably more often in TIC compared to CTRL (9 TIC, 2 CTRL). Arrows 
point to muscle, which previous studies have shown to be atrial cardiac muscle. Scale bars 
represent 2 mm. 
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Greater Collagen Turnover in TIC Leaflets 
Collagen turnover was examined by staining for collagens I and III (Col I, III) and 
matrix metalloproteinase (MMP)-13. MMP13 in TIC ML was greater than in CTRL 
when all segments were considered (Fig. 16-4, 15±3%, p=0.005) as well as in ANT-C 
MMP13in Basal Leaflet MMP13 in Mid-Leaflet 
120 
^ 100 H 
& «oi 
LAT SEPT ANT-C POST-C LAT SEPT ANT-C POST-C 
Fig. 16-4: MMP13 in basal and mid-leaflet of TIC and CTRL. In all figures, the long 
horizontal line indicates the comparison between groups in the ANOVA, whereas the short 
horizontal line indicates results of the post-hoc comparisons. Error bars indicate the 
standard error of the mean. 
individually (42±10%, p=0.012), while no significant differences were seen in BL. 
MMP13 in the atrialis and fibrosa layers of TIC LAT was also greater than in CTRL 
(12±6%, p=0.002), while SEPT did not show such differences. Col I in TIC ML was 
greater than in CTRL when all segments were considered (Fig. 16-5, 9±3%, p=0.036) as 
well as in ANT-C alone (32±8%, p=0.004), while no significant differences were seen in 
448 
BL when all segments were assessed. Col I in LAT BL (24±7%, p=0.020), the atrialis 
and fibrosa layers of LAT (20±4%, p=0.002), and all regions of ANT-C (46±12%, each 
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Fig. 16-5: Col I in basal and mid-leaflet of TIC and CTRL. Error bars indicate the standard 
error of the mean. 
p<0.008) was greater in TIC compared to CTRL. Col III in LAT BL (14±5%, p=0.035) 
and ANT-C fibrosa (32±7%, p=0.003) was greater in TIC compared to CTRL, but was 
less in SEPT across all regions (-15±6%, each p<0.009). In fact, Col III in SEPT ML 
atrialis negatively correlated with TIC-induced changes in SEPT ML maximum and 
minimum length (r=-0.671, p=0.021 and r=-0.647, p=0.029). Evidence for collagen 
turnover was further suggested by correlations between collagens I and III with MMP13 
in the ML of ANT-C and POST-C (r=0.744-0.779, each p<0.015). Lysyl oxidase (LOX), 
which is involved in both collagen and elastic fiber synthesis, was greater in TIC POST-
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C ML compared to CTRL (16±4%, p=0.012), while no significant differences were noted 
in any of the BL segments. 
Greater Elastic Fiber Turnover in TIC Leaflets 
MMP9 in Basal Leaflet MMP9 in Mid-Leaflet 
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Fig. 16-6: MMP9 in basal and mid-leaflet of TIC and CTRL. Error bars indicate the 
standard error of the mean. 
Elastic fiber turnover was examined by staining for elastin and MMP9, in addition 
to LOX (described above). In TIC, MMP9 in ML of all segments was greater than CTRL 
(Fig. 16-6, 11±3%, p=0.003), but no such differences were seen in BL. MMP9 in LAT 
atrialis and fibrosa was also greater in TIC compared to CTRL (7±4%, p=0.015), while 
SEPT did not show such differences. Elastin in SEPT ML was greater in TIC (40±7%, 
p<0.001), while no significant differences were noted in BL. When examined by layers, 
the atrialis and fibrosa of both SEPT and LAT contained more elastin in TIC (atrialis: 
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28±9%, p<0.001; fibrosa: 25±4%, p=0.032R). This greater abundance of both elastin and 
MMP9 suggests elastic fiber remodeling, especially given that their degree of expression 
correlated with one another in certain leaflet regions (i.e., LAT ML atrialis, r=0.765, 
p<0.0025). Expression of elastin correlated to changes in leaflet segment length. For 
example, elastin in SEPT ML fibrosa positively correlated with TIC-induced changes in 
SEPT minimum ML length (r=0.683, p<0.007). 
Proteoglycans and Glycosaminoglycans in TIC Leaflets 
In TIC, the glycosaminoglycan HA in LAT ML was less than in CTRL (-11±4%, 
p=0.021); no significant differences were noted in any BL segments or for SEPT. The 
abundance of HA in LAT BL atrialis negatively correlated with TIC-induced changes in 
maximum BL length (r=-1.00, p=0.017). Expression of the proteoglycans BGN and 
DCN showed minimal changes with TIC. 
Greater Valve Cell Activation in TIC Leaflets 
Activation of VICs was assessed by staining for smooth muscle alpha-actin 
(SMaA) and non-muscle myosin (NMM), proteins indicating the contractile, highly 
synthetic myofibroblast phenotype.8 In ML, SMaA in TIC was greater than in CTRL for 
all segments except SEPT (Fig. 16-7, 21±3%, each p<0.018); no significant differences 
were evident in BL. SMaA in POST-C free edge in TIC was also greater than in CTRL 
(28±6%, p=0.049). NMM in ML was greater for TIC when all segments were considered 
(7±2%, p=0.046), as well as in POST-C individually (13±3%, p=0.032). NMM in LAT 
BL (13±5%, p=0.049) was also greater in TIC. 
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Fig. 16-7: SMaA in basal and mid-leaflet of TIC and CTRL. Error bars indicate the standard 
error of the mean. 
Cell Activation and Correlations between Proteins within Leaflet Regions and 
Layers 
There were numerous correlations between the phenotypic indicators of valve cell 
activation (NMM, SMaA) and matrix degradation proteins (MMP9, 13) particularly in 
the spongiosa and fibrosa of the different segments (r=0.831-0.874, p<0.002), with strong 
correlation between SMaA and MMP13 in BL fibrosa across segments (r=0.808, 
pO.OOl). 
Relationship of LV Remodeling to Observed Leaflet Changes 
The degree of LV remodeling, as measured by percent changes in EDV, ESV, and 
EF with TIC, was often predictive of leaflet changes. For instance, decreases in EF with 
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TIC were correlated with reductions in expression of Col I in the atrialis and fibrosa 
layers of LAT ML (r=0.973, p<0.001) and greater expression of Col III in ANT-C ML 
and BL (r=-0.765, p=0.0163). As EDV and ESV increased, SMaA and MMP13 in the 
ML fibrosa of ANT-C were increased (SMaA: r=0.921-0.956, psO.0261; MMP13: 
r=0.858-0.861, psO.029). LV remodeling also was predictive of changes in leaflet 
structure. For example, diffusion of collagen in LAT increased with EDV (r=0.911, 
p=0.00115) and cell density in LAT ML increased with both EDV and ESV (r=0.834-
0.835, psO.0388). Different leaflets, however, responded in distinct ways to the LV 
remodeling; some changes in SEPT (i.e., MMP13 in ML fibrosa) were inversely related 
to EDV and ESV. 
DISCUSSION 
TIC leaflets demonstrated significant remodeling compared to CTRL, including 
greater cell density, less delineation between leaflet layers, greater collagen and elastic 
fiber turnover, and evidence of valve cell activation. Compositional differences between 
TIC and CTRL leaflets were heterogeneous by annular segment and leaflet region with 
extracellular matrix changes generally greater in the mid-leaflet than the basal leaflet, 
consistent with the magnitude of leaflet length changes in these regions. Greater 
expression of markers of cell activation in TIC suggests an increase in the myofibroblast 
population; these contractile and synthetic VICs may in part be responsible for these 
changes in leaflet segment length and composition with TIC. Statistical correlations 
provided the first in vivo demonstration of direct relationships between the degree of 
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mechanical strain and the magnitudes of phenotypic changes in VICs and valve matrix 
within individual animals. 
Changes in Matrix Composition are Heterogeneous 
TIC affected the leaflet regions heterogeneously, with greater compositional and 
leaflet length changes in the mid-leaflet than in the basal leaflet region. Decreased 
coaptation could cause the distal mid-leaflet and free edge to experience less of the 
compressive forces associated with coaptation, potentially increasing stresses in those 
regions and directly adjacent regions,1 which could instigate larger compositional 
changes in the mid-leaflet than the basal leaflet. Increased stress on valves9 and valve 
cells4 has been shown to cause increased matrix production and valve cell activation, as 
found in this study. Furthermore, with a decrease in the compressive forces associated 
with coaptation, leaflet segment lengths should increase, particularly in the distal leaflet, 
as noted in this study. 
In terms of layers, changes in composition between TIC and CTRL largely 
consisted of changes in the atrialis and fibrosa layers. Both the atrialis and fibrosa 
normally contain significant amounts of collagen, and given our finding of increased 
collagen turnover, it is logical for changes in composition to be evident in these layers. 
Furthermore, leaflet length changes largely correlated with compositional changes in the 
atrialis and fibrosa, consistent with the role these layers are thought to play in providing 
leaflet tensile strength.10 It is interesting to note that significant changes in elastic fiber 
turnover were found in the fibrosa, a layer not dominated by elastic fiber content; these 
changes may have been induced by increased radial deformation. 
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The various segments also showed significant heterogeneity in response to TIC. 
Compared to CTRL, LAT showed changes in valve cell activation, matrix components, 
and matrix remodeling proteins, such as SMaA, Col I, MMP9, and MMP13, as well as 
mid-leaflet thickening, but SEPT did not show these changes. Greater TIC-related 
changes in matrix composition in LAT compared to SEPT are consistent with greater 
leaflet length changes in LAT. These results corroborate previous studies of both 
computational modeling and animal model experiments. Kunzelman et al., in modeling 
the stresses of various portion of the MV after annular dilation, found that the increased 
stress was mostly on the lateral leaflet.1 While changes in SEPT were less pronounced 
than in LAT, both the fluoroscopy and immunohistochemical results suggest that SEPT 
did remodel in TIC. SEPT showed increased leaflet length, cell density, and elastin in 
TIC compared to CTRL. Interestingly, unlike the other segments, SEPT showed a 
decrease in Col III. This unique remodeling pattern could imply a shift in the balance of 
mechanical loads between the various parts of the MV. In another recent study 
performed by this group, similar results of greater collagen and elastic fiber turnover 
were found in the septal leaflet when that leaflet was exposed to isolated regurgitation for 
12 weeks." Given the MR present in TIC and the results of this previous study, some of 
the changes observed in SEPT of TIC could be attributable to the regurgitation that is a 
partofDCM. 
In terms of the commissural segments, TIC-induced changes in collagen turnover 
in the ANT-C resembled LAT with greater Col I, Col III, and MMP13 compared to 
CTRL. However, neither commissure displayed any alterations in elastic fiber turnover 
proteins (elastin, MMP9, and LOX) while both LAT and SEPT did. While ANT-C and 
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POST-C appeared to show distinct responses to TIC, further work is needed to clarify the 
role of the commissural remodeling in TIC. 
Influence of Mitral Regurgitation and Left Ventricular Remodeling 
Mitral regurgitation imposes altered hemodynamics on all of the mitral valve 
leaflets and commissures, including altered flow patterns,12 in addition to the forces 
secondary to decreased or delayed coaptation,1 all of which could have contributed to the 
changes observed in the TIC leaflets. Indeed, previous studies have documented 
increased collagen content in rat MV under acute increased LV pressure. However, 
TIC animals displayed global LV5, H and even neurohormonal15 changes in addition to 
MR, mimicking the clinical condition of DCM. Therefore, the leaflet changes observed 
with TIC are likely not solely due to MR, but could be secondary to altered forces 
imposed by changes in mitral annular shape and contractility,5 or even circulating 
neurohormones as documented in TIC animals.15 
The predictive relationships between LV remodeling and leaflet changes observed 
in this study highlight how DCM results in alterations in a variety of the normal array of 
forces that comprise the mechanical environment of the MV. These relationships 
confirm that the leaflets are integral to LV structure and function. It is also important to 
note that these predictive relationships were unique to the different leaflets, which is 
consistent with the heterogeneity of the MV leaflets in relationship to LV structure, 
function, and response to DCM. 
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Changes in Phenotype and Matrix Markers Implicate Role of Myofibroblasts 
The correlations between amounts and locations of valve cell activation and 
matrix degradation proteins, along with previous studies demonstrating the capacity of 
these cells for matrix synthesis and remodeling capabilities,8'16 provide strong evidence 
for the involvement of activated myofibroblasts in the matrix changes observed with TIC. 
These findings are consistent with the greater expression of myofibroblast markers in TIC 
leaflets and, more importantly, demonstrate direct relationships between magnitude of 
matrix remodeling, cell activation, and leaflet strain in individual animals. These results 
also strengthen evidence for the presumed role of VIC myofibroblasts in multiple valve 
diseases and remodeling processes.16 Furthermore, considering the contractile properties 
of valvular myofibroblasts,8 which have been shown to modulate leaflet stiffness,4 these 
myofibroblast cells may be responsible in part for the heterogeneous TIC-induced 
changes in valve geometry and strain. We speculate that, in diseases in which leaflet 
motion and composition are altered, the myofibroblast may be a target cell population for 
treatment strategies. 
Implications for Human DCM 
The results of this study corroborate findings in human DCM. Chaput et al. 
recently documented leaflet remodeling, namely increased leaflet area, in patients with 
functional MR17 and Grande-Allen et al. reported increased DNA, collagen, and 
glycosaminoglycans in valves from heart failure patients compared to controls.18 
Consistent with those previous findings, this study found greater cell density and collagen 
in TIC ovine leaflets compared to CTRL. The increase in MMPs demonstrated in this 
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study is also consistent with findings of greater expression of MMPs in the ventricles of 
human patients with DCM.19 
The compositional changes observed in this study could have functional 
consequences. The greater amount of collagen would be expected to make the leaflets 
more stiff, as observed in explanted DCM leaflets.20 Computational studies have shown 
that such increased stiffness leads to delayed and incomplete coaptation and ultimately 
mitral regurgitation.21 Computational modeling has also demonstrated that loss of the 
well-defined layered structure of the leaflets would increase leaflet bending stresses. 
Greater elastic fiber turnover suggests less mature elastic fibers, which could lead to less 
leaflet recoil. Both the changes in stiffness and layered nature of the leaflet could worsen 
mitral regurgitation and lead to further adverse leaflet remodeling.11 Indeed, although the 
study of functional MR by Chaput et al. did not examine leaflet composition, they found 
that remodeling of the leaflet anatomy, specifically the leaflet-to-closure area ratio, 
significantly correlated with MR severity, after adjusting for LV remodeling, function, 
and leaflet tethering.17 Their results are consistent with the speculation that the leaflet 
remodeling demonstrated in this study would lead to functional impairment. In the 
future, it will be important to demonstrate these proposed mechanisms for valve tissue 
dysfunction, perhaps using novel bioengineering approaches. 
Limitations 
One limitation in this study is the short time course. Clinically, DCM occurs over 
a period of years, while in this model the animals experienced DCM for only 15 days. 
Another limitation is the variability of immunohistochemistry, which was quantified to be 
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13.7% within batches. In order to limit this variability two sections were taken for SEPT 
and LAT and the results averaged. Additionally, for a given segment and protein, TIC 
and CTRL sections were stained in the same batch. Despite these limitations of short 
time course and variability in immunohistological analysis, significant results were 
found. Another limitation is that hemodynamic and leaflet length analyses were made 
comparing pre-TIC and TIC animals, while histological analyses compared TIC and 
CTRL animals. While explanted pre-TIC tissue was not available to compare to 
explanted TIC tissue, the authors did verify that there were no significant differences 
between the annular and leaflet radiopaque marker measurements of pre-TIC and CTRL 
animals. Another limitation was that animals were not randomized to groups. In 
addition, there were different numbers of animals in the TIC and CTRL groups, resulting 
in an unbalanced design. These numbers were due to animal loss from the TIC group, 
most commonly due to loss of the animal on anesthetic induction before the second set of 
marker and hemodynamic studies, since the animals were in florid heart failure. With 
respect to the lack of randomization, while each group displayed body weights and 
hemodynamics within a normal range, LVESP of CTRL was found to be higher than TIC 
(p=0.004), while the CTRL animals weighed less (p=0.033); no difference was found 
between CTRL and pre-TIC with respect to LVEDP or EF. The difference in LVEDP 
between groups could be due to a number of factors, including level of anesthetic, 
loading, and adrenergic drive at the time of measurement. However, given that the CTRL 
group in this study was exclusively used for histological comparisons between valves, and 
that there was no comparison of absolute differences in tissue dimensions, the authors 
believe that this difference does not undermine our results. 
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While the ovine MV has dynamics very similar to the human MV ' there are a 
number of anatomic differences including less redundancy in the ovine MV leaflet. ' 
TIC may have subtle differences compared to DCM, although studies have shown that 
the hemodynamics14 and neurohormonal15 changes elicited by TIC match those of human 
DCM. Lastly, the tantalum markers (total mass ~20mg) could have affected leaflet 
motion. However, studies have shown that even when enough markers are added to 
overload the ovine MV (total mass=184mg), MV motion does not change significantly.3 
Furthermore, these markers were present in both TIC and CTRL, therefore they could not 
explain the differences found between TIC and CTRL. Finally, this study found a large 
number of correlations between MV structure, composition, and function, but further 
research will be required to determine causation, delineate the specific role of MR in the 
observed changes, and propose new therapeutic options. 
CONCLUSIONS 
This study shows that the MV leaflets are intimately and differentially involved in 
the DCM disease process, with changes in leaflet composition, structure, and valve cell 
phenotype. These results suggest that the MV leaflets themselves should be considered 
in DCM treatment strategies. Furthermore, the relationship between leaflet composition 
and changes in leaflet segment length suggest that changes in the extracellular matrix 
could be an underlying mechanism for the observed changes in leaflet motion, with the 
myofibroblast potentially playing an important role. The implicated link between altered 
leaflet strain and altered composition also reinforces the need to maintain physiological 
leaflet strains with appropriate annuloplasty design. 
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This chapter is the second of three chapters (Chapters 15-17) analyzing the 
mitral valve in the context of "functional" mitral regurgitation and dilated 
cardiomyopathy. In the next chapter, analysis of the mitral valve in dilated 
cardiomyopathy continues with a study analyzing matrix remodeling in the mitral 
annular region in relationship to changes in annular segment length. 
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Chapter 17: Mitral Annular Region Ultrastructural Changes in 
Dilated Cardiomyopathy Correlate with Regional Remodeling 
In this chapter the topic of mitral valve alterations in the context of 
"functional" mitral regurgitation and dilated cardiomyopathy continues with a 
study of mitral annular matrix remodeling in relation to annular segment length 
changes with dilated cardiomyopathy. 
ABSTRACT 
Background; The mitral annulus enlarges heterogeneously in dilated cardiomyopathy 
(DCM), yet the ultrastructural changes underlying this remodeling remain unknown. We 
studied the relationship between changes in matrix composition and regional geometric 
annular remodeling associated with DCM. 
Methods: Radiopaque markers were inserted into 24 sheep defining four mitral annular 
segments: septal (SEPT), lateral (LAT), and anterior (ANT-C) and posterior commissures 
(POST-C); 10 sheep underwent tachycardia-induced cardiomyopathy (TIC), while 14 
sheep were controls (CTRL). Biplane videofluoroscopy was performed before and after 
rapid pacing. Annular segment lengths were measured as distances between respective 
markers and were related to annular segment composition by immunohistochemistry. 
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Results; MR increased from 0.2 ± 0.4 to 2.2 ± 0.9 after TIC (p<0.0002). For each 
segment, annular lengths increased with TIC (each p<0.001), with the percent change in 
LAT greater than SEPT (pO.OOl). TIC annular segments showed greater collagen 
content overall, greater collagen and elastic fiber turnover, and greater cell activation 
compared to CTRL (each p<0.05). Changes were heterogeneous by annular segment, 
with changes in LAT greater than SEPT, paralleling greater changes in LAT annular 
segment lengths with TIC than SEPT. Strong correlations between proteins of matrix 
turnover and cell activation suggest the myofibroblast phenotype may play an important 
role in the observed heterogeneous changes in annular composition. 
Conclusions: Heterogeneous annular compositional changes with TIC corresponded 
with segment length changes. Matrix changes may be an underlying mechanism for 
annular remodeling seen in DCM. 




The mitral valve (MV) annulus is a major contributor to dilated cardiomyopathy 
(DCM). While annular dilation alone does not appear to cause mitral regurgitation (MR) 
in humans,1 annular dilation and papillary muscle displacement determined regurgitation 
severity in DCM patients.2 The role of annular dilation in MR has been confirmed in 
animal models3 and in vitro experiments.4 While there has been considerable analysis of 
DCM-induced changes in the shape and motion of the mitral annulus,3'5 there is less 
information about the ultrastructural basis for these changes, which are presumably the 
result of cell-mediated remodeling of the annular extracellular matrix (ECM). Recent 
studies have demonstrated mitral leaflet ECM remodeling in animal models of 
"functional" MR6 and DCM,7 but analysis of such changes in the mitral annulus or with 
respect to the geometric annular changes seen in DCM has not been reported to date. 
Characterizing these cell-mediated ECM changes not only gives insight into the 
pathogenesis of the annular structural changes, but may open an avenue for early or 
preventative interventions. 
METHODS 
All animals received humane care in accordance with the guidelines of the US 
Department of Health and Human Services (NIH Publ. 85-23, Revised 1985). The 
animal protocol was approved by the Stanford Medical Center Laboratory Research 




Fig. 17-1: Location of the different annular segments from which tissue sections were taken. 
In the case of septal segment (SEPT) and lateral segment (LAT) 2 tissue sections were 
analyzed, in the case of the anterior and posterior commissures (ANT-C, POST-C), one 
tissue section was taken from either side of the tantalum marker based on quality of the 
leaflet on each side. 
Animal Protocol 
Radiopaque markers were implanted in 24 sheep to delineate four MV annular 
segments (Fig. 17-1): septal (SEPT) and lateral (LAT) annulus, and anterior (ANT-C) 
and posterior (POST-C) commissures, as previously described in detail.5 Ten sheep 
468 
underwent a rapid-pacing protocol (tachycardia-induced cardiomyopathy, TIC) for an 
average of 15±6 days,5 while fourteen sheep remained as controls (CTRL). Biplane 
video fluoroscopy (without pacing) was performed in CTRL and both before and after the 
rapid-pacing intervention in TIC animals. Mitral regurgitation was graded semi-
quantitatively by an experienced echocardiographer on a scale of 0-4 based on size and 
extent of regurgitant jet. Left ventricular (LV) end-diastolic and end-systolic volumes 
(EDV, ESV) were calculated using space-filling analysis of epicardial markers, as 
described previously.5 The hearts were harvested and stored in formalin. CTRL animals 
were used for histological comparison only, while hemodynamic and annular segment 
length analyses compared pre-TIC and TIC data. Annular segment length was measured 
as the sum of the distances from the central marker in each region to the adjacent markers 
on either side of the central marker. TIC-induced changes in maximum (%MAX) and 
minimum (%MIN) annular segment length throughout the cardiac cycle were measured. 
The septal-lateral mitral annular diameter was measured as the maximum distance 
between the mid-septal and mid-lateral annular markers, while the commissure-
commissure diameter was measured as the maximum distance between the two 
commissural annular markers throughout the cardiac cycle. 
Histology and Immunohistochemistry 
Cross-sections 3-5 mm wide were cut from the leaflet-annular insertion or 
"hinge" region at the four sites, including associated myocardium (Fig. 17-2), embedded 
in paraffin, and sectioned to a thickness of five microns. Sections were stained with 
Movat pentachrome to demonstrate the layered structure of the annular region. 
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Fig. 17-2: Middle image of tissue section depicts layers of the annular region analyzed in 
relation to the remainder of the value leaflet, as well as relative to the annular fluoroscopy 
marker demonstrated in photo of gross specimen at left. Right image illustrates 
representative TIC annulus showing greatly increased accumulation of collagen on the 
atrialis compared to control (middle). Scale bar represents 1 mm. 
Immunohistochemistry (IHC) was performed for a number of ECM components and 
turnover proteins, as well as proteins indicating valve cell activation (Table 17-1). For 
each annular segment (LAT, SEPT, ANT-C, POST-C) staining intensity was quantified 
within each histological layer (fibrosa, atrialis, muscle, Fig. 17-2) using ImageJ software 
(NIH, Bethesda, MD). Analysis of blinded Mo vat-stained sections included semi-
quantitative grading (from 0 to 4) of saffron-staining collagen in the atrialis. To 
determine the range of differences in histological and IHC parameters between TIC and 
CTRL, each TIC value was compared to the average CTRL value. The TIC leaflet 
analysis is reported elsewhere,7 see Chapter 16. 
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Table 17-1. Panel of Antibodies Used in IHC. 
Protein Function 
Collagen Turnover Proteins 
Collagen I (Col I)* 
Collagen III (Col III)* 
Matrix Metalloproteinase ( M M P ) - ^ 
Elastic Fiber-Related Proteins 
Lysyl oxidase (LOX)§ 
Elastin11 
Matrix Metalloproteinase (MMP)-9* 
Valve Cell Activation 
Smooth muscle alpha-actin (SMaA)# 
Non-muscle Myosin Heavy Chain (NMM)* 
Predominant collagen in valve, provides tensile strength 
Reticular collagen 
Collagen degradation 
Involved in collagen and elastin crosslinking 
Predominant component of elastic fibers 
Elastic fiber degradation 
Marker of an "activated" myofibroblast-like phenotype 
Marker of an "activated" myofibroblast-like phenotype 
'gift of Dr. Larry Fisher, NIH (Bethesda, MD); ^ hemicon (Temecula, CA); §Imgenex (San 
Diego, CA); "Abeam (Cambridge, MA); * Assay Designs (Ann Arbor, MI); *Dakocytomation 
(Denmark); "Covance (Berkeley, CA). 
Statistical Analysis 
Multifactorial analysis of variance (ANOVA) was performed using SigmaStat 
(SPSS, Chicago, IL), as described in Chapter 4. Paired t-tests were used to compare pre-
TIC and post-TIC hemodynamics and annular segment length changes. Correlations 
between factors were calculated using Pearson and Spearman tests, as described in 
Chapter 5. For correlations between different proteins, p<0.015 was considered a trend 
and p<0.00625 considered significant (since 8 proteins were being compared). For 
correlations between proteins and TIC-induced segment length and EDV/ESV changes, 
each protein was considered individually, therefore p<0.05 was considered significant. 
Data are presented as mean and standard deviation, unless otherwise noted. Percentages 




Development of Dilated Cardiomyopathy and Changes in Annular Dimensions 
Consistent with the development of DCM, the maximum annular septal-lateral 
diameter increased 24±9% (pO.OOOl) in TIC compared to pre-TIC, the commissure-
commissure diameter increased 9±4% (pO.OOl), and mitral regurgitation increased in 
severity from 0.2±0.4 to 2.2±0.9 (p<0.0002). Further characterization of annular and 
hemodynamic changes with TIC has been previously published.5 While the maximum 
and minimum annular lengths of all segments increased with TIC (each p<0.004), POST-
C %MIN was greater than ANT-C %MIN (Table 17-2, p<0.049) and LAT %MAX and 
%MIN were greater than SEPT (each pO.OOl). 





































Data presented as mean ± standard deviation; *p<0.05 v. pre-TIC, **p<0.05 v. SEPT, 
Ap<0.05 v. ANT-C. 
Greater Collagen Turnover in TIC Annular Region 
MMP13, a collagen-degrading enzyme, was greater in TIC LAT and SEPT 
compared to CTRL (22.6±6.2%, p=0.02 and 9.0±4.0%, p=0.048), and MMP13 
expression in SEPT strongly correlated with %MIN (r=0.84, pO.OOl). Col I was greater 
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LAT SEPT ANT-C POST-C 
Fig. 17-3: Col I in annular segments of TIC and CTRL. *p<0.05 TIC vs. CTRL for a given 
annular segment. Error bars indicate the standard error of the mean. 
in TIC LAT (Fig. 17-3, 17.2±4.3%, p=0.042) and ANT-C (21.6±5.2%, p=0.004) 
compared to CTRL, and Col I in the fibrosa of LAT correlated with %MAX and %MIN 
(r=0.85, p=0.033). Compared to CTRL, Col III was greater in TIC ANT-C (14.3±4.2%, 
p=0.013), but was less in TIC SEPT (-11.6±3.0%, p=0.006). Movat-stained sections 
similarly showed greater abundance of saffron-staining collagen in the atrialis layer in 
TIC compared to CTRL (p=0.0001, Fig. 17-2). 
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A . MMP9 in Annular Segments of TIC and CTRL 
LAT SEPT ANT-C POST-C 
B. NMM in Annular Segments of TIC and CTRL 
LAT SEPT ANT-C POST-C 
Fig. 17-4: A) MMP9 in annular segments of TIC and CTRL. B) NMM in annular 
segments of TIC and CTRL. *p<0.05 TIC vs. CTRL for a given annular segment. Error 
bars indicate the standard error of the mean. 
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Greater Elastic Fiber Turnover in TIC Annular Region 
o 
The intensity of MMP9, a gelatinase associated with elastic fiber degradation, 
was significantly greater in TIC LAT, SEPT, and POST-C compared to CTRL (Fig. 17-
4A, 25.4±4.9% p<0.001,15.1±4.0%, p=0.004, and 6.8±3.8%, p=0.049) and strongly 
correlated with %MIN in SEPT (r=0.84, pO.OOl). Compared to CTRL, elastin was 
greater in TIC SEPT (45.3±12.7%, p=0.017R), but was lower in TIC ANT-C (-
11.9±6.9%, p=0.035). LOX, involved both in collagen and elastic fiber synthesis, was 
lower in TIC SEPT compared to CTRL (-11.6±3.9%, p=0.037). 
Greater Cell Activation in TIC Annular Region 
NMM in TIC was greater than CTRL in the annular segments LAT (Fig. 17-4B, 
17.7±5.2%, p=0.024), SEPT (9.5±3.8%, p=0.03), and POST-C (9.3±3.2%, p=0.04). In 
LAT, SMaA was greater in TIC than in CTRL (Fig. 17-5, 16.0±4.1%, p=0.024). 
Relative Changes in Composition between Annular Segments 
Changes in matrix composition, matrix turnover, and cell activation in LAT with 
TIC were consistently greater than those of SEPT. This pattern was shown by increased 
expression of MMP13 (22% vs. 9% in LAT vs. SEPT), Col I (17% vs. no significant 
change), MMP9 (25% vs. 15%), NMM (18% vs. 10%), and SMaA (16% vs. no 
significant change). Greater changes in LAT vs. SEPT paralleled greater changes in 
annular lengths in LAT than SEPT. Similar parallels were found between %MIN in the 
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LAT SEPT ANT-C POST-C 
Fig. 17-5: SMaA in annular segments of TIC and CTRL. *p<0.05 TIC v. CTRL, 
Ap<0.65 TIC vs. CTRL for a given annular segment. Error bars indicate the standard 
error of the mean. 
commissural annular segments and changes in MMP9 and NMM expression, which were 
greater in POST-C with TIC but were not significantly altered in ANT-C. 
Correlations between Expressions of Proteins in Annular Segments 
Correlations were noted between ECM synthesis and turnover proteins and valve 
cell activation, suggesting a role for activated myofibroblasts in the matrix changes 
accompanying TIC. For example, in SEPT, NMM strongly correlated with MMP13 
throughout the segments and layers of the annulus (r=0.94, p=0.006) and with Col III in 
the fibrosa (0.79, pO.OOl). Col I correlated with SMaA in ANT-C fibrosa (r=0.82, 
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p=0.012) and NMM in POST-C atrialis (0.94, pO.OOl). Correlations between SMaA and 
MMP13 were strong across segments in the atrialis (r=0.757, p<0.000001), fibrosa 
(r=0.664, pO.000001) and muscle (r=0.742 p<0.001). 
Relationship between Expression of Proteins and LV Remodeling 
Degree of LV remodeling, as measured by changes in EDV and ESV, often 
strongly correlated with localized changes in protein expression. For instance, Col I in 
the muscle layer of LAT strongly correlated with changes in ESV (r=0.991, p=0.009) and 
SMaA in the fibrosa and muscle layers of ANT-C also strongly correlated with EDV and 
ESV (r=0.992, p=0.009 and r=0.919, p=0.0275). Elastin in the LAT fibrosa negatively 
correlated with EDV and ESV (r=-0.969, p=0.007 and r=-0.961, p=0.009) and elastin 
turnover indicated by MMP9 correlated with EDV in SEPT (r=0.984, p=0.016). 
DISCUSSION 
To further understand the underlying mechanism for annular changes associated 
with DCM, immunohistochemistry was used to assess the changes in matrix composition 
and cell phenotype changes in the annular region that accompany the development of 
tachycardia-induced cardiomyopathy (TIC), an animal model of DCM, and to relate those 
to segmental annular length change. The TIC annular region demonstrated greater 
collagen content overall, greater collagen turnover, greater elastic fiber turnover, and 
greater cell activation than CTRL. These changes were heterogeneous, with greater 
changes in LAT than in SEPT, which paralleled the magnitude of changes in annular 
length in these annular segments. Correlations between ECM synthesis and turnover 
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proteins and valve cell activation implicate valvular myofibroblasts in this heterogeneous 
remodeling. 
Changes in Annular Composition with TIC in Relation to Changes in Annular 
Dimensions 
TIC-induced changes in matrix composition, matrix turnover, and cell activation 
in LAT were consistently greater than those of SEPT, paralleling greater changes in 
annular lengths in LAT than SEPT. While correlations between matrix changes and 
length changes within individual segments were evident suggesting a relationship 
between the annular length change and matrix remodeling within that segment, regional 
heterogeneity was evident. For instance, matrix changes in POST-C were generally not 
as great as in LAT despite similar length changes with TIC, suggesting regional 
differences in relation to similar degrees of annular remodeling. 
Implicated Role of Myofibroblasts 
The strong correlations between markers for valve cell activation and matrix 
degradation within specific annular segments and layers imply that the activated 
myofibroblast phenotype is present and contributing to the heterogeneous compositional 
changes of the mitral annulus that accompany TIC. Indeed, this evidence of 
myofibroblast involvement is consistent with the known role that the myofibroblasts play 
in valve9 and connective tissue remodeling,10 as well as in the pathogenesis of other valve 
diseases." Given that myofibroblasts are known to respond to their mechanical 
environment,12 these cells may be an important link in the structure- function interplay 
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shown in this study, namely through sensing changes in annular geometry and then 
responding by altering matrix synthesis, which would influence local material behavior 
and further modify annular shape. Furthermore, the underlying tone imparted by the 
contractile behavior of these cells,13 which has been shown to alter stiffness of mitral 
leaflets,14 could contribute to the heterogeneity of annular segment length changes with 
TIC. 
Role of Specific Layers in Annular Remodeling with TIC 
While the muscle tissue surrounding and within the mitral annulus is presumably 
the primary contributor to annular contraction, and almost certainly contributed to the 
alterations in annular contraction found with TIC, this study demonstrated remodeling of 
all three layers within the annular region of MV leaflet. Additionally, many of the 
correlations between changes in protein expression and changes in annular lengths were 
present in all three layers. Although ECM changes in the atrialis and fibrosa layers of the 
annulus may exert less influence mechanically than the muscle layer, these findings do 
suggest an integral role for the insertion portion of the mitral leaflet in the process of 
annular remodeling with TIC. Indeed, a previous study found that ablation of the annular 
muscle resulted in decreased pre-systolic contraction of the annulus and altered shape of 
the SEPT leaflet, but no change in total annular contraction,15 suggesting that there are 
additional contributors to annular contraction besides the annular muscle component. 
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Annular Compositional Changes with TIC in the Context of LV Remodeling 
The relationships between measures of LV remodeling and the annular 
compositional changes observed in this study highlight the global changes associated 
with DCM and confirm the integral role the annulus plays in maintaining LV structure 
and function. Simple measurements of annular segment length changes cannot account 
for how these global changes can influence the complex array of forces applied to the 
annulus as a result of alterations to the 3D configuration of the annulus,5 hemodynamics, 
and LV torsional and recoil mechanics.16 The finding that these correlations between LV 
remodeling and annular changes were distinct for the different annular segments again 
confirms the heterogeneity of the annulus in relationship to LV structure, function, and 
response to DCM. It is particularly interesting that correlations between EF and 
compositional changes appeared almost exclusively in SEPT. 
Implications 
Based on the observed association between altered annular length changes and 
abnormal annular composition, altered annular length changes imposed by an 
annuloplasty ring17 may similarly lead to alterations in valve cell phenotype and mitral 
annular composition, which could potentially cause further deterioration in MV function. 
Clearly further study is warranted in this arena; however, such studies could further 
motivate the refinement of annuloplasty design to maintain physiologic annular length 
changes. Furthermore, the results of this study implicate cells demonstrating the 
myofibroblast phenotype as contributing to the heterogeneous alterations in annular 
composition that underlie the annular remodeling associated with DCM. While future 
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studies are needed to confirm similar changes in human DCM, myofibroblasts may prove 
to be important therapeutic targets for prevention and treatment of the annular remodeling 
associated with DCM, which could have a considerable impact on its morbidity and 
mortality. 
Limitations 
While TIC is an excellent animal model for DCM, one limitation is its short time 
course relative to human DCM, which occurs over a period of years. Additionally, while 
the ovine MV has very similar dynamics to the human MV,18' 19 there are a number of 
anatomic differences such as less redundancy in the ovine MV.20*21 TIC may also have 
subtle distinctions from DCM, although previous studies have shown that the 
hemodynamics22 and neurohormonal23 changes elicited by TIC match those of human 
DCM. Another study limitation is the variability of immunohistochemistry, which was 
quantified to be 13.7% within batches. In order to limit this variability two sections were 
taken for SEPT and LAT and for a given segment and protein, TIC and CTRL sections 
were stained in the same batch. Despite these limitations of short time course and 
variability in immunohistological analysis, significant results were found. Another 
limitation is that hemodynamic and segment length analyses were made comparing pre-
TIC and TIC animals, while histological analyses compared TIC and CTRL animals. 
While explanted pre-TIC tissue was not available to compare to explanted TIC tissue, the 
authors did verify that there were no significant differences between the radiopaque 
marker measurements of pre-TIC and CTRL animals. Additionally, the tantalum markers 
(total mass ~20mg) could have affected leaflet motion. However, previous studies have 
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shown that even when enough markers are added to overload the ovine MV (total 
mass=184mg), MV motion does not change significantly.24 Furthermore, these markers 
were present in both TIC and CTRL, therefore they could not explain the differences 
found between TIC and CTRL. Finally, this study found a large number of correlations 
between MV annular structure, composition, and function, but further research will be 
required to determine causation. 
CONCLUSIONS 
In this study, heterogeneous compositional and cell phenotype changes in the 
mitral annular region were associated with changes in annular segmental lengths in 
experimental DCM, suggesting that cell-mediated alterations in annular composition may 
underlie annular remodeling with DCM. Furthermore, the results of this study suggest 
that the myofibroblast may play a key role in this annular remodeling in DCM. 
This chapter is the third of three chapters (Chapters 15-17) analyzing the 
mitral valve in the context of "functional" mitral regurgitation and dilated 
cardiomyopathy. The topic of examining valves in the setting of various disease 
states continues in the next chapter with a study of mitral valve wound healing in 
response to iatrogenic injury. 
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Chapter 18: Extracellular Matrix Remodeling in Response to 
Mitral Leaflet Injury 
This chapter continues the topic of examining valves in the setting of various 
disease states with a study of mitral valve wound healing in response to iatrogenic 
injury. 
ABSTRACT 
Background: The details of valvular leaflet healing following valvuloplasty and leaflet 
perforation from endocarditis are poorly understood. In this study, the synthesis and 
turnover of valvular extracellular matrix due to healing of a critical sized wound was 
investigated. 
Methods: 29 sheep were randomized to either CTRL (n=l 1) or HOLE (n=18), in which 
a 2.8-4.8 mm diameter hole was punched in the posterior mitral leaflet. After 12 weeks, 
posterior leaflets were harvested and histologically stained to localize extracellular matrix 
components. Immunohistochemistry was also performed to assess matrix components 
and markers of matrix turnover. A semi-quantitative grading scale was used to quantify 
differences between HOLE and CTRL. 
Results: After 12 weeks the hole diameter was reduced by 71.3±25.8% (p<0.001). 
Areas of remodeling surrounding the hole contained more activated cells, greater 
486 
expression of proteoglycans and markers of matrix turnover (prolyl 4-hydroxylase, 
metalloproteases, and lysyl oxidase, each p<0.025), along with fibrin accumulation and 
neovascularization. Two distinct remodeling regions were evident surrounding the hole, 
one directly bordering the hole rich in versican and hyaluronan and a second adjacent 
region with abundant collagen and elastic fiber turnover. The remodeling also caused 
reduced delineation between valve layers (p=0.002), more diffuse staining of matrix 
components and markers of matrix turnover (pO.OOl), and disruption of the collagenous 
fibrosa. 
Conclusions: Acute valve injury elicited distinct, heterogeneous alterations in valvular 
matrix composition and structure, resulting in partial wound closure. Because these 
changes could also affect leaflet mechanics and valve function, it will be important to 
determine their impact on healing wounds. 
The work contained in this chapter is under preparation for submission to Journal 
of Thoracic and Cardiovascular Surgery. 
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INTRODUCTION 
The restoration of valvular integrity after valve perforation secondary to 
endocarditis or surgical procedures depends on proper valvular wound healing. 
Abnormal tissue growth during healing can lead to stenosis1 and inadequate mechanical 
integrity of the wound can lead to valve failure.2 Proper valve healing is especially 
important given that valve repair is generally preferred over replacement, particularly in 
pediatrics.3 While much is known regarding wound repair in other connective tissues, 
given the relatively limited vasculature in valves4 and large proportion of extracellular 
matrix (ECM) relative to cells makes valvular wound healing unique.5 Furthermore, 
valvular wound healing occurs in the presence of constant mechanical stresses on the 
wound site, including tension, compression, bending, and shear, that could disrupt the 
healing process. Previous investigations of valvular wound healing have been limited to 
the pathology of slicing injury and sutures in valves,5'6 denudation injury in a valve organ 
culture system,7 and a "scratch" wound in cultured valve cells.8"10 While hole injury is 
routinely used to study wound healing in other tissues," there have been no studies, 
however, that examine valvular healing after the creation of a discrete mechanical hole. 
The aforementioned previous studies in valvular wound healing studies important insight 
into the formation and cellular makeup of different granulation tissues, but the role of 
specific ECM components in valve wound healing remains unknown. 
The ECM is integrally involved in valve maintenance and function both 
biologically and mechanically. Turnover of collagen, which provides the valve with 
tensile strength,12 occurs throughout life within normal valves13 and is altered in valve 
disease.14"16 Moreover, collagen synthesis within valves has been linked to mechanical 
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stimulation and therefore would likely respond to altered strain magnitudes around a 
wound site. Proteoglycans (PGs) and glycosaminoglycans (GAGs) not only contribute to 
the material behavior of the valve,18 but are also responsive to mechanical stimulation. 9 
PGs and GAGs are also involved in a number of cellular processes required for wound 
healing including cell growth and migration, growth factor regulation, and collagen 
fibrillogenesis.20 Because ECM undergoes mechanobiological regulation, is involved in 
processes necessary to wound healing, and contributes to valve function, it was 
hypothesized that the ECM would be altered following acute valve injury and that this 
remodeling would promote the restoration of tissue integrity. 
Given the clinical relevance of understanding valve wound repair, and the paucity 
of in vivo valve wound repair experiments, in this study a 2.8-4.8 mm diameter hole was 
punched in the center of the posterior leaflet of the mitral valve (PML) of sheep. Unlike 
a slicing injury or suture, a hole-punch creates a large defect that may not heal completely 
and hence could be considered representative of an exacerbated acute valve injury 
complete with altered hemodynamics. After 12 weeks, sections were taken from PML in 
the region of the hole-punch. Histology and immunohistochemistry on these sections 
was used to assess the quantity and distribution of PGs, GAGs, collagen, enzymes 




Experimental Animal Protocol 
All animals received humane care in accordance with the guidelines developed by 
the National Institutes of Health (US Department of Health and Human Services NIH 
Publ. 85-23, Revised 1985). Twenty-nine 1-2 year-old sheep were randomized to either 
control (CTRL, n=ll) or experimental (HOLE, n=18) groups. A left thoracotomy and 
atriotomy were employed to access the mitral valve, and after establishment of 
cardiopulmonary bypass a 2.8-4.8 mm diameter hole was created in the central scallop of 
the PML of HOLE animals with an aortic hole-puncher.21 CTRL animals underwent the 
exact same operation without the hole-punch. On a weekly basis, a blinded 
echocardiographer performed transthoracic echocardiography and graded the MR on the 
basis of color Doppler regurgitant jet extent and width.22 Animals were monitored daily 
for signs of distress after the hole-punch procedure, but did not show any. After 12 
weeks, the upper bound of range for time required for ovine valve wound healing,5 the 
MVs were harvested and fixed in formalin. 
Histology and Immunohistochemistry 
The PML was isolated and a 5 mm wide strip cut from annulus to free edge (Fig. 
18-1 A), embedded in paraffin, and sectioned to a thickness of five microns. Movat 
pentachrome stained sections were used to assess the characteristics of layer delineation, 
collagen content, and collagen diffusivity (presence of saffron-staining collagen outside 
of fibrosa). Masson's trichrome stain was performed to assess fibrin accumulation and 
neovasculatization. Picrosirius red staining was performed to examine the collagen 
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content and alignment and infer type of collagen (red=collagen I, yellow/green=reticular 
collagen III23). Immunohistochemistry (IHC) was also performed on CTRL and HOLE 
hole punch 
J^Atrial is 
Fibrosa^-*; « lAHHUIUS 
Mid-Leaflet^ 
C. 
Intensity=1 lntensity=4 Delineation=1 Delineation=4 
i . 
- d > • - • # . . . » X ~ -
Fig. /# - / : ^ Diagram showing location from which PML cross-sections were taken. AML 
indicates anterior leaflet of MV. Sections were cut from annulus to free edge, as indicated by 
the dashed lines. B) Anatomy of the normal MV posterior leaflet illustrating valve regions and 
histological layers in a Movat-stained section. C) Examples of grading rubrics for the 
characteristics staining intensity and delineation. For the characteristic delineation, "1" 
indicates little differentiation in intensity between layers. "4" indicates maximum for each 
characteristic. Separate rubrics were made for the delineation of different regions of the valve 
(annulus, mid-leaflet, and free edge). 
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with hole-punch diameters of 4-4.8 mm to demonstrate the PGs decorin and biglycan 
(DCN, BGN, courtesy of Dr. Larry Fisher, NIH), versican (VC, Seikagaku, Japan), and 
the glycosaminoglycan (GAG) hyaluronan (HA, Seikagaku); elastic fiber-related proteins 
elastin, fibrillin (both Abeam, Cambridge, MA), and lysyl oxidase (LOX, Imgenex, San 
Diego, CA, involved in crosslinking both collagen and elastin); collagen type III (Col III, 
courtesy of Larry Fisher, NIH) which tends to be dysregulated in remodeling tissues; 
markers of collagen synthesis prolyl 4-hydroxylase (P4H, Chemicon, Temecula, CA) and 
heat shock protein-47 (HSP47, Abeam); markers of matrix degradation matrix 
metalloproteases (MMPs)-l, -2, -9, and -13 (all Assay Designs, Ann Arbor, MI, except 
MMP13, Chemicon); and markers of valve cell activation smooth muscle alpha-actin 
(SMaA, Dakocytomation, Denmark) and non-muscle myosin (NMM, Covance, Berkeley, 
CA). A semi-quantitative grading scale from 0 to 4 was used to assess staining intensity 
and delineation of stain between valve layers for all markers except SMaA and NMM in 
which staining was very localized. Grading was performed both for the leaflet as a whole 
and for the specific regions of the annulus, mid-leaflet/hole-punch region, and free edge 
(Fig. 18-IB, C). The hole-punch region was further subdivided into the region 
immediately proximal (closer to the valve annulus) and distal (closer to the free edge) to 
the hole. 
Assessment of Cell Density, Leaflet Thickness, and Hole Closure 
Cell density was determined by counting valvular interstitial cell nuclei in images 
(captured using a Leica DM LS2 microscope (Wetzlar, Germany)) using Image Pro 
software (Media Cybernetics, Bethesda, MD). Regions assessed included the annulus, 
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mid-leaflet, and the regions proximal and distal to the hole. Valve thickness was 
evaluated using Image Pro software for each of the above regions as well as the free 
edge. Percent hole closure (% closure) was calculated as the difference between the 
original hole diameter (diameter of aortic hole-punch) and final hole diameter normalized 
to the original hole diameter. The final hole diameter was measured as the distance 
between the leaflet tissues proximal and distal to the hole on the paraffin embedded tissue 
blocks (see Fig. 18-2A). 
Statistical Analysis 
Data are presented as mean and standard error of the mean, unless otherwise 
noted. Multifactorial analysis of variance (ANOVA) was performed using SigmaStat 
(SPSS, Chicago, IL), as described in Chapter 4. Correlations were calculated using 
Pearson and Spearman tests, as described in Chapter 5, and significance was adjusted for 
the number of correlations tested. 
RESULTS 
Remodeling in Thickened, Cell-Dense Areas Reduced Hole Diameter 
MR was greater in HOLE vs. CTRL throughout the study (MR at 12 weeks: 
CTRL 0.5±0.04 vs. HOLE 2.6±0.05, pO.OOl). Substantial matrix production occurred 
around the hole-punch reducing the hole diameter by 71.3±1.4% from its original 
dimensions (pO.OOl, Fig. 18-2A). These areas of remodeling were 228±60% thicker in 
the region proximal to the hole and 219±48% thicker in the region distal to the hole 
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compared to adjacent leaflet regions (Fig. 18-2B). Fibrin accumulation and 
neovascularization was found adjacent to the hole (Fig. 18-2C-F). The thickness of the 
Fig. 18-2: A) Substantial areas of remodeling significantly decreased hole diameter (Movat 
pentachrome stain). Red block markers spanned by arrows indicate initial diameter of hole-
punch; the black dashed line on the right tissue section indicates the measurement made to 
determine the final hole diameter. B) Areas surrounding hole-punch show significant thickening 
as indicated by arrows (Movat pentachrome stain). Thickening was not always symmetric around 
the hole, as demonstrated by right image. C) Masson's trichrome stain demonstrating 
accumulation of fibrin around hole. D-F) Masson's trichrome stain illustrating examples of 
neovascularization and fibrin accumulation adjacent to hole. Scale bars indicate 200fjm. 
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mid-leaflet/hole region of HOLE and CTRL positively correlated with average MR 
(average of MR at 6-week and 12-week time points, r=0.54, p=0.007). Average MR 
positively correlated with final hole diameter (r=0.55, p=0.024 (trend), see Fig. 18-3A) 



























Fig. 18-3: A) Initial and final hole diameters for HOLE samples. B) Cell density was 
increased in areas of remodeling compared to the annulus of the same HOLE leaflet as well 
as compared to CTRL. *=p<0.001. Error bars indicate the standard error of the mean. 
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Fig. 18-4: A) Intensity of PG and GAG staining in region around hole-punch in HOLE 
PML versus comparable regions in CTRL. Overall p<0.001. B) Intensity of collagen-
related marker staining in regions around hole-punch in HOLE PML versus comparable 
regions in CTRL. Overall p<0.001. C) Average delineation of markers between layers in 
HOLE PML compared to CTRL. Overall p<0.001. Error bars indicate the standard error 
of the mean. 
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(r=-0.66, p=0.011). Within PMLs with hole diameters of 4-4.8 mm, cell density in the 
region proximal to the hole was greater than the region distal to the hole (p=0.019) and 
the annular region (p=0.011, Fig. 18-3B). The regions proximal and distal to the hole 
also had considerably higher cell densities than the mid-leaflet of CTRL PMLs 
(pO.OOl). 
Matrix Turnover and Cell Activation 
Compared to the equivalent region in CTRL PMLs, the hole-punch region showed 
significantly greater expression of VC, BGN, DCN and HA (each p<0.006, Fig. 18-4A) 
and markers of matrix metabolism P4H, the MMPs (1, 2, 9, 13), and LOX (each p<0.025, 
Fig. 18-4B). NMM and SMaA often co-localized with the MMPs, suggesting an 
activated myofibroblast phenotype. 
Strong and localized staining of MMPs was also noted outside the hole-punch 
region, such as in the atrialis layer of the annulus of many HOLE PMLs. The free edge 
of HOLE also showed localized expression of several matrix turnover enzymes including 
MMPs, most commonly MMP1 and MMP9. Several samples also demonstrated a 
localized increase in elastin (co-localized with MMP9 and LOX) in the leaflet free edge. 
Patterns of Remodeling 
Two distinct regions, each containing different ECM, were present within the 
remodeling tissue surrounding the hole-punch. Region 1 (Rl) directly bordered the hole, 











Fig. 18-5: A) Two regions of remodeling (Rl, R2) were evident as indicated by the red arrows: 
Rl-immediately adjacent to the hole, rich in VC, HA, and demonstrating alcian-blue staining in 
Movat-stained sections; R2=located interior to Rl relative to the hole-punch, rich in DCN, 
MMPs, Col 111, and elastin. B) Decreased delineation (indicated by red arrow) in HOLE PML 
compared to CTRL. C) Visualization of picrosirius red-stained tissue under polarized light 
demonstrates disruption of collagen backbone in HOLE PML. Scale bars for all images 
represent 1 mm. 
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punch (Fig. 18-5A). Rl was apparent in Movat-stained sections as a pocket of alcian 
blue staining, which was predominantly composed of VC and HA (Fig. 18-5A). VC was 
primarily localized to Rl while HA was more diffusely present. In contrast, R2 showed 
strong staining for MMPs, DCN, and to a lesser extent BGN. Elastin staining in R2 was 
consistently co-localized with MMP9 and LOX, suggesting elastic fiber remodeling. 
Compared to samples with <60% closure (n=4), those with >90% closure (n=5) 
had more P4H, MMP13, and Col III (<60% closure 0.95±0.09, >90% closure 1.39±0.11, 
p=0.009), less PG and HA (<60% closure 1.26±0.07, >90% closure 0.77±0.11, p=0.002), 
and less delineation of PGs and HA staining in the hole region (<60% closure 0.64±0.08, 
>90% closure 0.20±0.12, p=0.007). 
Structural and Global Leaflet Changes 
The hole-punch also affected the layered structure of the PML. In the hole region, 
Movat-stained sections showed decreased delineation between layers (HOLE 0.6±0.3, 
CTRL 1.9±0.3, p=0.002, Fig. 18-5B) and staining for PG, HA, P4H, Col III, and MMP13 
was more diffuse in the HOLE samples (Fig. 18-4C, together p<0.001). Visualization of 
picrosirius red-stained tissues under polarized light illustrated disruption of the 
collagenous fibrosa in HOLE PML (Fig. 18-5C). Matrix changes in the HOLE PML, 
however, were not limited to the immediate vicinity of the hole-punch. PGs, Col III, and 
total collagen (Movat) were more diffusely present throughout the leaflet in HOLE vs. 
CTRL (HOLE 0.7±0.1, CTRL 1.1±0.1, p=0.004), and there was a reduction in overall 




After 12 weeks, the hole-punch-wounded PML demonstrated significant 
remodeling that substantially reduced the hole diameter and thickened the leaflet adjacent 
to the hole. Areas of remodeling contained elevated densities of activated cells, abundant 
PGs, greater ECM turnover, fibrin accumulation, and neovascularization. Samples with 
greater hole closure displayed greater collagen turnover and less expression of PGs and 
HA. Two distinct remodeling regions surrounded the hole-punch, one directly bordering 
the hole that was rich in VC and HA, and a second adjacent region rich in enzymes 
regulating collagen and elastic fiber turnover. The remodeling also affected leaflet 
structure, causing reduced delineation between valve layers and disruption of the 
collagenous fibrosa. 
Increased Collagen Turnover in Hole-Punch Region 
The increase in markers of collagen synthesis (P4H, LOX), collagen degradation 
(MMPs), and the PGs BGN and DCN (given their role in collagen fibrillogenesis20) in the 
mid-leaflet/hole portion of HOLE compared to CTRL indicates increased collagen fiber 
turnover in the hole-punch region. Increased collagen turnover is further evidenced by 
co-localization of markers of collagen synthesis and degradation, the positive correlation 
between P4H and Movat saffron-staining collagen, and the disruption of the collagen-rich 
fibrosa evident in picrosirius red stained sections of HOLE leaflets. Such collagen 
turnover has been shown to be present to a limited extent in normal porcine valves 
throughout development and aging,13 is increased in other types of non-acute valve 
500 
injury, and appears greatly increased in this case of injury. Both MMPs and DCN have 
been reported to be important to dermal wound healing, and in particular scarless wound 
healing.26"28 The localized increase in MMPs in the annulus atrialis and free edge of 
HOLE found in this study likely reflect altered stress in these regions. 
Cells in Remodeling Tissue Show an Activated Phenotype 
The co-localization of NMM and SMaA with MMPs in the areas of remodeling 
suggests that these cells are myofibroblasts. These results are consistent with reports of 
SMaA expression by cells at the cut edges of dissected portions of the MV cultured in an 
organ system7 as well as SMaA expression in granulation tissue of a MV slice wound.5 
Elevated SMaA expression has also been reported in chronic valve diseases as well as 
throughout development.16' 29 Therefore, the expression of SMaA by valvular cells 
appears to be necessary for normal valve growth and acute repair, but is also involved in 
remodeling responses to chronic or acute injury. 
The increased cell density found surrounding the wound in this study was also 
observed in the slice injury study5 and increased cell proliferation was reported at the site 
of dissection in the organ culture study.7 This evidence for cell proliferation, in 
conjunction with data regarding cell migration in valve injury ' suggests that the greater 
cell density local to the wound found in this study could be due to both cell migration and 
proliferation. It is also interesting to note that in the suture wound study healing started 
on the annular side of the injury and was delayed in the free edge.6 Correspondingly, we 
found significantly greater abundance of cells on the proximal side of the wound (closer 
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to the annulus) compared to the distal side. Areas of remodeling also demonstrated fibrin 
accumulation and neovascularization, consistent with previous reports. 
Distinct Areas of Remodeling Surrounding Hole-Punch 
The existence of two regions surrounding the hole-punch (the VC/HA-rich Rl 
region bordering the hole and the adjacent R2 region of collagen and elastic fiber 
remodeling) suggests that remodeling occurs in two separate or at least temporally 
distinct processes. The distinct nature of these processes is supported by the strong 
segregation of matrix and enzyme expression. These regions are also consistent with 
previous studies of valve slice wounds in which two types of granulation tissue were 
reported, a "fibrous" variety and a "myxoid" variety that appeared to contain more PGs.5 
The two regions demonstrated here are also reminiscent of findings in artery-vein 
anastomoses in which PG staining was found closer to the lumen while collagen and 
elastin were found deeper within the intima.31 HA and VC have been reported as 
principal components of the provisional matrix in dermal wounds32'33 and elastin has also 
been reported to be present in dermal wounds,34"36 although neither in those studies nor in 
the anastomoses study31 were distinct regions reported. Given the myriad roles of VC 
and HA in cell migration,37'38 their presence in the Rl remodeling region may facilitate 
the migration of different cell types during the repair process.5 Indeed, a generalized 
model of wound healing postulates that granulation tissue composed of HA and fibrin 
forms a temporary matrix into which fibroblasts and endothelial cells migrate.39'40 
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Characteristics of Greater Wound Closure 
HOLE leaflets with greater wound closure showed more characteristics of 
collagen fiber turnover, less expression of hydrated PGs and GAGs, and less delineation 
of PGs and HA staining in the hole-punch region. One interpretation for these results 
could be that collagen turnover promotes wound repair better than hydrated PGs and HA; 
there is debate in the dermal wound literature regarding whether various PGs inhibit or 
promote wound healing.32 In light of the discussion of Rl and R2 above, another 
interpretation could be that the wounds showing greater closure are more mature, i.e., 
they have transitioned from a preliminary HA/VC matrix (Rl) to collagen remodeling 
(R2). This interpretation would be consistent with previous reports of PGs increasing in 
abundance in valve slice wounds up to 12 weeks and collagen bundle formation 
increasing through 18 weeks.5 
Limitations 
The authors acknowledge that there were several limitations to this analysis. In 
the future, it will be important to examine the temporal changes in the distribution of the 
different ECM components and unique remodeling regions first addressed in this study. 
It should also be noted that the healing process in diseased valve tissue may be 
significantly different from that of normal tissues, both in terms of time course and the 
nature of ECM remodeling. In terms of the relevance to valve leaflet perforation in 
endocarditis, this model lacks the bacterial component and immunological sequelae of 
endocarditis. In the histological analysis, the main limitation was the subjective nature of 
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grading, which was combated by the use of a grading rubric and evaluating all leaflets 
stained for a given marker together. Variability in staining intensities between batches of 
IHC was avoided by staining all PML together. Although some variability remained, 
statistically significant differences between groups were found. Furthermore, subsequent 
studies in our lab have shown this semi-quantitative grading method yields results 
comparable to those performed using computerized methods. 
The use of a hole-punch to create the acute injury, standard in dermal wound 
studies,41 has multiple benefits, but also some limitations. One advantage of the hole-
punch injury was it simulated an exacerbated wound complete with MR. The circular 
geometry of the hole-punch facilitated quantifying the amount of remodeling tissue 
produced, but does not directly mimic the types of incisions used in valvuloplasties and 
may result in different forces being applied to the tissue. Future studies could further 
investigate the interaction of the acute injury wound healing process with the altered 
hemodynamics such a defect creates. Another limitation was that the final hole diameter 
was measured from the tissue blocks, as opposed to the intact PMLs. Furthermore, 
percentage closure is a limited measure of the adequacy of healing (and may simply 
reflect differences in the speed of healing), as successful healing has a number of 
components including restoration of the mechanical integrity of the tissue. Regardless, 
these measurements did provide a useful overview of the changes in HOLE animals. 
CONCLUSIONS 
This study provides a detailed characterization of valvular ECM remodeling in 
response to acute injury in valves in terms of a wide range of individual matrix proteins, 
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as well as markers of matrix synthesis and degradation. Distinct remodeling processes, 
including one rich in HA and VC and another related to collagen and elastic fiber 
turnover, were noted and may prove necessary for the restoration of valve integrity after 
acute injury. 
This chapter, which addressed mitral valve wound healing in response to 
iatrogenic injury, continued the topic of examining valves in the setting of various 
disease states. In the next chapter, the disease of study is myxomatous mitral valve 
disease. In that chapter, the potential role of the mitogen-activated protein kinase 
(MAPK) signaling pathway in myxomatous mitral valve disease is analyzed. 
505 
REFERENCES 
Dekker A, Black H, Von Lichtenberg F. Mitral valve restenosis: a pathologic study. J 
Thorac Cardiovasc Surg. 1968;55(3):434-446. 
Gillinov A, Cosgrove D, Lytle B, Taylor P, Stewart R, McCarthy P, Smedira N, 
Muehrcke D, Apperson-Hansen C, Loop F. Reoperation for failure of mitral valve repair. 
J Thorac Cardiovasc Surg. 1997; 113(3):467-473. 
Chauvaud S, Fuzellier J, Houel R, Berrebi A, Mihaileanu S, Carpentier A. Reconstructive 
surgery in congenital mitral valve insufficiency (Carpentier's techniques): long-term 
results. J Thorac Cardiovasc Surg. 1998;115(1 ):84-92. 
I-Ida T, Tamura K, Tanaka S, Asano G. [Blood vessels in normal and abnormal mitral 
valve leaflets]. J Nippon MedSch. 2001;68(2):171-180. 
Tamura K, Jones M, Yamada I, Ferrans VJ. Wound healing in the mitral valve. J Heart 
Valve Dis. 2000;9(l):53-63. 
Tamura K, Murakami M, Washizu M. Healing of wound sutures on the mitral valve: an 
experimental study. Gen Thorac Cardiovasc Surg. 2007;55(3):98-104. 
Lester WM, Damji A, Gedeon I, Tanaka M. Interstitial cells from the atrial and 
ventricular sides of the bovine mitral valve respond differently to denuding endocardial 
injury. In Vitro Cellular & Developmental Biology - Animal. 1993;29A:41-50. 
Durbin A, Nadir N, Rosenthal A, Gotlieb AI. Nitric oxide promotes in vitro interstitial 
cell heart valve repair. Cardiovasc Pathol. 2005;14(1):12-18. 
Fayet C, Bendeck M, Gotlieb A. Cardiac valve interstitial cells secrete fibronectin and 
form fibrillar adhesions in response to injury. Cardiovasc Pathol. 2007;16(4):203-211. 
Gotlieb A, Rosenthal A, Kazemian P. Fibroblast growth factor 2 regulation of mitral 
valve interstitial cell repair in vitro. J Thorac Cardiovasc Surg. 2002;124(3):591-597. 
Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, Cheverud 
JM, Lieberman P, Heber-Katz E. Lack of p21 expression links cell cycle control and 
appendage regeneration in mice. Proc Natl Acad Sci USA. 2010;107(13):5845-5850. 
Sacks M, Yoganathan A. Heart valve function: a biomechanical perspective. Philos Trans 
R Soc Lond B Biol Sci. 2008;363(1502): 1369-1391. 
Stephens EH, Grande-Allen KJ. Age-related changes in collagen synthesis and turnover 
in porcine heart valves. Journal of Heart Valve Disease. 2007;16(6):672-682. 
Fondard O, Detaint D, lung B, Choqueux C, Adle-Biassette H, Jarraya M, Hvass U, 
Couetil JP, Henin D, Michel JB, Vahanian A, Jacob MP. Extracellular matrix 
remodelling in human aortic valve disease: the role of matrix metalloproteinases and their 
tissue inhibitors. Eur Heart J. 2005;26(13): 1333-1341. 
506 
15. Koullias GJ, Korkolis DP, Ravichandran P, Psyrri A, Hatzaras I, Elefteriades JA. Tissue 
microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid 
aortic valves with or without pathology of the ascending aorta. Eur J Cardiothorac Surg. 
2004;26(6):1098-1103. 
16. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Schoen FJ. Activated interstitial 
myofibroblasts express catabolic enzymes and mediate matrix remodeling in 
myxomatous heart valves. Circulation. 2001;104(21):2525-2532. 
17. Merryman WD, Youn I, Lukoff HD, Krueger PM, Guilak F, Hopkins RA, Sacks MS. 
Correlation between heart valve interstitial cell stiffness and transvalvular pressure: 
implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol. 
2006;290(1):H224-231. 
18. Bhatia A, Vesely I. The effect of glycosaminoglycans and hydration on the viscoelastic 
properties of aortic valve cusps. ConfProc IEEE Eng Med Biol Soc. 2005;3:2979-2980. 
19. Gupta V, Grande-Allen KJ. Effects of static and cyclic loading in regulating extracellular 
matrix synthesis by cardiovascular cells. Cardiovasc Res. 2006;72(3):375-383. 
20. Kinsella MG, Bressler SL, Wight TN. The regulated synthesis of versican, decorin, and 
biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev 
Eukaryot Gene Expr. 2004;14(3):203-234. 
21. Nguyen TC, Itoh A, Carlhall CJ, Bothe W, Timek TA, Ennis DB, Oakes RA, Liang D, 
Daughters GT, Ingels NB, Jr., Miller DC. The effect of pure mitral regurgitation on 
mitral annular geometry and three-dimensional saddle shape. J Thorac Cardiovasc Surg. 
2008;136(3):557-565. 
22. Helmcke F, Nanda N, Hsiung M, Soto B, Adey C, Goyal R, Gatewood Jr R. Color 
Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 
1987;75(1):175-183. 
23. Zhang H, Sun L, Wang W, Ma X. Quantitative analysis of fibrosis formation on the 
microcapsule surface with the use of picro-sirius red staining, polarized light microscopy, 
and digital image analysis. J Biomed Mater Res. 2006;76A:120-125. 
24. Lis Y, Burleigh MC, Parker DJ, Child AH, Hogg J, Davies MJ. Biochemical 
characterization of individual normal, floppy and rheumatic human mitral valves. 
BiochemJ. 1987;244(3):597-603. 
25. Stephens EH, Nguyen TC, Itoh A, Ingels NB, Jr., Miller DC, Grande-Allen KJ. The 
effects of mitral regurgitation alone are sufficient for leaflet remodeling. Circulation. 
2008;118(14 Suppl):S243-249. 
26. Manuel J, Gawronska-Kozak B. Matrix metalloproteinase 9 (MMP-9) is upregulated 
during scarless wound healing in athymic nude mice. Matrix Biol. 2006;25(8):505-514. 
27. Jarvelainen H, Puolakkainen P, Pakkanen S, Brown E, H66k M, Iozzo R, Sage E, Wight 
T. A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair 
Regen. 2006;14(4):443-452. 
507 
28. Peled Z, Phelps E, Updike D, Chang J, Krummel T, Howard E, Longaker M Matrix 
metalloproteinases and the ontogeny of scarless repair: the other side of the wound 
healing balance. Plast Reconstr Surg. 2002;110(3):801-811. 
29. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ. 
Human semilunar cardiac valve remodeling by activated cells from fetus to adult: 
implications for postnatal adaptation, pathology, and tissue engineering. Circulation. 
2006;113(10):1344-1352. 
30. Durbin AD, Gotlieb AI. Advances towards understanding heart valve response to injury. 
Cardiovasc Pathol. 2002; 11(2):69-77. 
31. Swedberg S, Brown B, Sigley R, Wight T, Gordon D, Nicholls S. Intimal fibromuscular 
hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, 
immunocytochemical, light and electron microscopic assessment. Circulation. 
1989;80(6):1726-1736. 
32. Cattaruzza S, Perris R. Proteoglycan control of cell movement during wound healing and 
cancer spreading. Matrix Biol. 2005;24(6):400-417. 
33. Singer A, Clark R. Cutaneous wound healing. N Engl J Med. 1999;341(10):738-746. 
34. Ashcroft G, Kielty C, Horan M, Ferguson M. Age-related changes in the temporal and 
spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous 
wounds of healthy humans. J Pathol. 1997; 183(1 ):80-89. 
35. Raghunath M, Hopfner B, Aeschlimann D, Luthi U, Meuli M, Altermatt S, Gobet R, 
Bruckner-Tuderman L, Steinmann B. Cross-linking of the dermo-epidermal junction of 
skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue 
transglutaminase. J Clin Invest. 1996;98(5):1174-1184. 
36. Zheng Q, Choi J, Rouleau L, Leask R, Richardson J, Davis E, Yanagisawa H. Normal 
wound healing in mice deficient for fibulin-5, an elastin binding protein essential for 
dermal elastic fiber assembly. J Invest Dermatol. 2006; 126(12):2707-2714. 
37. Ricciardelli C, Russell D, Ween M, Mayne K, Suwiwat S, Byers S, Marshall V, Tilley 
W, Horsfall D. Formation of hyaluronan- and versican-rich pericellular matrix by 
prostate cancer cells promotes cell motility. J Biol Chem. 2007;282(14):10814-10825. 
38. Ang L, Zhang Y, Cao L, Yang B, Young B, Kiani C, Lee V, Allan K, Yang B. Versican 
enhances locomotion of astrocytoma cells and reduces cell adhesion through its Gl 
domain. JNeuropathol Exp Neurol. 1999;58(6):597-605. 
39. Weigel P, Fuller G, LeBoeuf R. A model for the role of hyaluronic acid and fibrin in the 
early events during the inflammatory response and wound healing. J Theor Biol. 
1986;119(2):219-234. 
40. Weigel P, Frost S, McGary C, LeBoeuf R. The role of hyaluronic acid in inflammation 
and wound healing. Int J Tissue React. 1988;10(6):355-365. 
508 
41. Davis T, Amare M, Naik S, Kovalchuk A, Tadaki D. Differential cutaneous wound 
healing in thermally injured MRL/MPJ mice. Wound Repair Regen. 2007;15(4):577-588. 
509 
Chapter 19: MAPK Pathway in Myxomatous Mitral Valve 
Disease 
In this chapter the topic of examining valves in the setting of various disease 
states continues with a study of myxomatous mitral valve disease. Specifically in 
this chapter the potential role of the mitogen-activated protein kinase (MAPK) 
signaling pathway in myxomatous mitral valve disease is analyzed. Chapter 24, in 
the Appendix, also involves characterization of myxomatous mitral valves, 
specifically alterations in proteoglycan and glycosaminoglycan content. While that 
study provides important background for this chapter, I was not the lead researcher 
on the study and it was not considered integral to this thesis; therefore, the study 
was placed in the Appendix. 
ABSTRACT 
Background: Myxomatous mitral valve disease is known to involve altered mechanics 
and increased myofibroblast-like valvular interstitial cells (VICs), however, the pathways 
involved in the activation of these VICs in myxomatous mitral valve disease have largely 
not been investigated. The mitogen-activated protein kinase (MAPK) pathway is 
involved in myofibroblast activation and mechanotransduction, and potentially could be 
the pathway by which myofibroblast activation occurs in myxomatous mitral valve 
disease. Therefore the aim of this study was to use immunohistochemistry to determine 
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whether MAPK pathway markers co-localized with that of myofibroblast markers within 
normal and myxomatous human mitral valves. 
Methods: Human mitral valve posterior leaflets (control n=5-6, myxomatous n=14-17, 
mean age 60-63 for all groups) were histologically stained with Movat-pentachrome and 
immunohistochemically stained for markers of the myofibroblast cell phenotype, 
including smooth muscle alpha-actin (SMaA) and non-muscle myosin (NMM); proteins 
involved in the mitogen-activated protein kinase (MAPK) pathway, including 
extracellular signal-regulated kinase (ERK)-l, -2, phosphorylated ERK (pERK); as well 
as transforming growth factor-beta (TGF(3). Samples were also stained for the 
proteoglycans biglcyan (BGN), decorin (DCN), and versican (VC). 
Results: Myxomatous mitral valves contained greater myofibroblast marker expression 
relative to control mitral valves, particularly in the internal leaflet. Significant 
remodeling was noted in the myxomatous mitral valves, with disruption of leaflet layers 
and areas of elastic fiber staining in the internal leaflet where elastic fibers are normally 
not found. Strong co-localization was noted between proteins in the MAPK pathway, 
and with TGFp, NMM, and SMaA. These MAPK pathway markers, particularly ERK, 
co-localized with areas of elastic fiber remodeling, where it was found with VC. 
Conclusions: Greater abundance of myofibroblast^ cells in myxomatous mitral valve 
leaflets, and co-localization of MAPK pathway proteins within those leaflets suggest the 
involvement of MAPK pathway signaling in these phenotypic changes. Co-localization 
of myofibroblast markers with areas of elastic fiber remodeling suggested direct 
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involvement of this cell type in the pathological compositional changes present in 
myxomatous mitral valve disease. While further in vitro studies are needed to verify 
these findings, these results could have important implications for possible treatment 
strategies for myxomatous mitral valve disease. 
The work contained in this chapter represents a pilot study, and will not be 
submitted for publication. 
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INTRODUCTION 
Myxomatous mitral valve disease is a common valvulopathy and the etiology 
most frequently underlying mitral valve prolapse, which is estimated to afflict 
approximately 2.4% of the general population.1 Myxomatous mitral valve disease is 
characterized by proliferation of the spongiosa layer and collagen and elastic fiber 
fragmentation,2"6 resulting in substantially decreased material strength of the valve.7 
Previous studies have also shown the enrichment of these myxomatous mitral valves with 
valvular interstitial cells (VICs) expressing myofibroblast markers, including smooth 
muscle alpha-actin and nonmuscle myosin, along with matrix metalloproteases (MMPs) 
and cathepsins.8 Although these studies have implicated the activated myofibroblast-like 
VICs in myxomatous mitral valve disease,8 and the involvement of the mitogen-activated 
protein kinase (MAPK) pathway in myofibroblast activation has been studied extensively 
in other connective tissues9"12 and in the context of other valve diseases,13"17 investigation 
of the MAPK pathway in myxomatous mitral valve disease has been largely 
overlooked.18 Given that myxomatous mitral valves have altered mechanics and the 
mechanosensitive nature of the MAPK pathway, the involvement of the MAPK pathway 
could be based on altered strains in myxomatous mitral valve disease.19"21 Determining 
the pathway by which healthy VICs are activated into pathological myofibroblast-like 
cells in myxomatous mitral valve disease may lead to novel treatment strategies, as well 
as an enhanced understanding of the pathogenesis of myxomatous mitral valve disease. 
In vitro studies have demonstrated that VICs from porcine aortic valves can be activated 
to demonstrate these same myofibroblast-like cell markers via the MAPK pathway.14'15 
Therefore, the aim of this study was to use immunohistochemistry to determine whether 
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MAPK pathway markers co-localized with that of myofibroblast markers within normal 
and myxomatous human mitral valves. 
METHODS 
Sample Set 
Mitral valve posterior leaflets were obtained from controls at autopsy (patients not 
demonstrating cardiovascular disease, Table 19-1) and valves with primary myxomatous 
mitral valve disease surgically resected during reparative procedures. Tissues for this 
study were provided by St. Luke's Episcopal Hospital (Houston, TX), Ben Taub Hospital 
(Houston, TX), and the Cooperative Human Tissue Network. The research use of these 
tissues was approved by the Institutional Review Boards at all institutions. Radial strips 
from each leaflet were cut from the annulus to free edge and fixed in 10% formalin 
overnight. Fixed tissue sections were then paraffin embedded, sectioned to a thickness of 
5 [Am, and mounted on glass slides according to standard procedures. 
Table 19-1. Subject Demographics. 
ERK1 ERK2 pERK TGFft NMM SMaA PGs 
Normal 
(control) age 60.3±12 60.3±12 60.3±12 63.2±11 60.3±12 63.2±11 59.4±13 
sample # 6 6 6 5 6 5 5 
(#M/#F) 5/1 5/1 5/1 4/1 5/1 4/1 4/1 
Myx age 60.5±10 60.9±10 61.1±11 62.6±13 62.1±13 62.1±13 64.1±10 
sample # 17 16 15 14 16 16 12 
(#M/#F) 7/10 7/9 7/8 8/6 9/7 9/7 6/6 
Myx=myxomatous; age is given as mean ± standard deviation; #M/#F=number of males/number 
of females. *Due to the small size of some tissues, it was not possible to obtain histological 
sections for all stains from all subjects' tissue blocks. PGs=proteoglycans biglycan, decorin, and 
versican. For other abbreviations, please see the text. 
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Histology and Immunohistochemistry 
Tissue sections were stained with Movat pentachrome to demonstrate overall 
leaflet structure microstructure including the leaflet layers atrialis, spongiosa, fibrosa, and 
ventricularis. Immunohistochemistry (IHC) was performed to demonstrate markers of 
the myofibroblast cell phenotype, including smooth muscle alpha-actin (SMaA, Table 19-
2) and non-muscle myosin (NMM); proteins involved in the mitogen-activated protein 
Table 19-2. Antibodies Used in Immunohistochemistry. 
Protein Role 
Myofibroblast Cell Phenotype Markers 
Smooth Muscle Alpha-Actin (SMaA)* Marker of myofibroblast cell phenotype 
Non-muscle Myosin (NMM)A Marker of myofibroblast cell phenotype 
Proteins in Mitoqen-Activated Protein Kinase (MAPK) Pathway 
Extracellular signal-regulated kinase (ERK)-1f Kinase activated by MAPK kinase (a.k.a MEK) 
ERK2" Kinase activated by MAPK kinase (a.k.a MEK) 
Phosphorylated ERK1 /2 (pERK)** Activated form of ERK1, 2 
Growth Factors 
Transforming Growth Factor-beta (TGFp)AA Growth factor integral to myofibroblast differentiation 
Proteoglycans (PG) and Glycosaminoqlycans (GAG) 
Decorin (DCN) PG involved in collagen fibrillogenesis 
Biglycan (BGN) n PG involved in collagen fibrillogenesis 
Versican (VC) PG involved elastic fiber formation, compressibility 
*Dakocytomation (Denmark); ACovance (Berkeley, CA); TChemicon (Temecula, CA); "Abeam 
(Cambridge, MA); **Upstate (Lake Placid, NY); AABiovision (Mountain View, CA); ^ gift of Dr. 
Larry Fisher, NIH (Bethesda, MD); * Associates of Cape Cod. 
kinase (MAPK) pathway, including extracellular signal-regulated kinases (ERK)-l, -2, 
phosphorylated ERK1/2 (pERK); as well as transforming growth factor beta (TGF|3), 
which is well known to be involved in the signaling pathway leading to myofibroblast 
differentiation.11' 12' 22 The proteoglycans versican (VC), decorin (DCN), and biglycan 
(BGN), which are increased in myxomatous mitral valves,23 were also examined in 
relation to myofibroblast and MAPK pathway markers. 
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RESULTS 
Distribution of SMaA 
In normal mitral valve posterior leaflets, SMaA staining was limited and when 
present was predominantly found in the atrialis layer in the annular region (Fig. 19-1 A), 
but sometimes was also evident in the mid-leaflet atrialis layer. SMaA staining was 
largely located in the subendothelium but sometimes extended more interiorly into the 
Fig. 19-1: A) Representative image illustrating the distribution of SMaA staining in 
control (normal) mitral valve posterior leaflets. Portion of leaflet shown is annular 
region. Asterisk marks punctate SMaA staining in the atrialis layer of the annular region. 
Scale bar represents 200^m. 
atrialis approaching the fibrosa. Staining was also often usually linear along a small 
portion of the length of the leaflet. At times clusters of SMaA staining were evident 
characteristic of muscle fibers as opposed to myofibroblast-like valvular interstitial cells. 
The overall amount of SMaA staining was very limited. 
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In myxomatous mitral valve posterior leaflets in which layers were visible, SMaA 
staining was found largely in atrialis layer but usually extended more interiorly than in 
normal leaflets, including staining in the fibrosa and spongiosa. In some cases SMaA 
staining was evident throughout layers (Fig. 19-IB). The overall amount of SMaA 
staining in myxomatous posterior leaflets was considerably greater than in controls, more 
often present in the mid-leaflet and more often found interiorly compared to control. In 
some cases in which layers were no longer discernable, SMaA could be found diffusely 
throughout the interior of the internal leaflet, (Fig. 19-1C), and other times concentrated 
in specific areas. 
mm 
Fig. 19-1 (cont'd): B) Image illustrating SMaA staining evident throughout the leaflet 
layers in myxomatous mitral valve posterior leaflet. Portion of leaflet shown is annular 
region. Scale bar represents 200\xm. 
Co-localization of SMaA and NMM 
NMM staining in both myxomatous and normal mitral valve posterior leaflets was 
more diffuse compared to SMaA staining. While NMM staining was predominantly 
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strong wherever SMaA staining was found, NMM staining was not limited to those areas 
of positive SMaA staining. NMM staining was also not as punctate, limited to the 
individual cells, as with SMaA staining. 
Fig. 19-1 (cont'd): C) SMaA and NMM staining in the interior region of a myxomatous mitral 
valve posterior leaflet in a sample in which leaflet layers were no longer distinguishable. Staining 
of SMaA and NMM appears abundant and distributed throughout the region. Scale bar represents 
200^im. 
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Co-localization of MAPK Markers, TGFfJ, and Myofibroblast Markers 
In myxomatous valves tight co-localization was noted between ERK1, ERK2 and 
pERK, with pERK staining being substantially less intense than ERK1 and ERK2. TGF(3 
staining also appeared to co-localize with proteins in the MAPK pathway (Fig. 19-2). 
NMM and SMaA staining co-localized with all of the MAPK markers (Fig. 19-3). While 
in normal valves instances of co-localization between the MAPK markers and 
myofibroblast markers were noted, these were usually limited to the annulus atrialis 
where myofibroblast marker staining was evident (as discussed above). 
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Fig. 19-2: Image illustrating the relative locations of staining for members of the 
MAPK pathway and TGF/3 demonstrating significant co-localization throughout the 
leaflet. Scale bar represents 2.5 mm. 
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F/g. 19-3: Image depicting the relative locations of SMaA, NMM, pERK, ERK1, ERK2, 
and TGF/3 in a myxomatous mitral valve leaflet. Portion of the valve imaged is the mid-
leaflet region. Scale bar represents 200fxm. 
Distribution of MAPK Markers Relative to Histological Layers 
In normal mitral valve posterior leaflets ERK1, ERK2, and pERK were 
predominantly localized to the atrialis of the annulus with weak staining in the fibrosa, 
although some staining was also noted in the mid-leaflet. Some samples also showed 
increased expression in the free edge. In myxomatous valves ERK1 and ERK2 were not 
only evident in the atrialis, but this staining spread internally, where it bordered collagen 
staining evident in the corresponding Movat pentachrome stained section. ERK staining 
was particularly intense in areas of elastic fiber remodeling (Fig. 19-4) and/or bordering 









F/g. iP--/: Areas of remodeling in myxomatous leaflets showed strong co-localization of elastic 
fibers with ERK1 and ERK2. Although ERK2 stain is included in this figure, ERK1 stain 
showed similar distribution. Scale bar represents 200 pan. 
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Fig. 19-5: Areas of elastic fiber remodeling in myxomatous leaflets showed strong co-
localization with NMM (arrows). Scale bar represents 1 mm. 
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Distribution of MAPK Markers Relative to Proteoglycans 
In normal valves DCN and BGN demonstrated strong co-localization. These PGs 
demonstrated staining in the spongiosa layer of the mid-leaflet as well as co-localization 
with collagen in the fibrosa layer. VC, in contrast, demonstrated strong staining intensity 
in the atrialis layer and little intensity in the fibrosa. Strong co-localization was noted 
between VC and elastic fibers, as previously reported.23 In the posterior leaflets of 
myxomatous mitral valves, PG staining was increased, as previously reported. The 
normal organization of leaflet layers was disrupted in myxomatous mitral valves making 
evaluation of localization of specific PGs to particular layers problematic, but VC tended 
to co-localize with elastic fibers both in areas in which the layers were disrupted and the 
atrialis when that layer was found intact. DCN usually localized with collagen and BGN 
localized with collagen as well as elastic fibers. In the posterior leaflets of myxomatous 
valves ERK2 and versican appeared to be generally localized with areas of elastic fiber 
remodeling (areas of elastic fibers on Movat-stained sections internal to the leaflet where 
elastic fibers are not normally found), bordering collagen staining on the Movat stain. 
These areas also showed strong NMM staining (Fig. 19-5). 
DISCUSSION 
Myxomatous mitral valves contained a greater number of VICs expressing 
myofibroblast markers relative to control mitral valves. Co-localization of proteins in the 
MAPK pathway with TGF|3, NMM, and SMaA in myxomatous mitral valves suggested 
that the MAPK pathway is involved in myofibroblast activation in this disease. Co-
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localization of myofibroblast markers with areas of elastic fiber remodeling suggested 
direct involvement of this cell type in the pathological changes present in myxomatous 
mitral valve disease. 
MAPK Pathway in Myofibroblast Activation 
Myofibroblast activation has been studied in cells derived from a number of 
different tissues. While multiple pathways for myofibroblast activation have been 
demonstrated and debate continues as to which pathways are most functionally relevant, 
it is proposed that there are generally three elements necessary for myofibroblast 
activation in tissues: 1) increased amounts of TGFp\ 2) the involvement of certain 
specific extracellular matrix proteins, such as the extra domain A (ED-A) splice variant 
of fibronectin, and 3) increased extracellular stress.24 The specific cell signaling 
pathways thought to be involved in myofibroblast activation include the smad pathway, 
ERK2/Ras, p38 MAPK, and Rho/c-Jun N-terminal kinase (JNK) pathways.25 However, 
some of these pathways appear to be tissue specific. For instance, studies investigating 
pulmonary fibrosis suggest that the smad pathway is key to TGF(3 mediated SMaA 
transcription in pulmonary myofibroblast activation,26' 27 however the pathways 
implicated in these studies are distinct from those of smooth muscle cells. Studies 
related to mechanical stress and myofibroblast activation have emphasized the 
importance of the fibronexus and its maturation in the myofibroblast differentiation 
process.29 Indeed, studies in lung myofibroblast activation have shown that the 
downstream transcriptional effects of TGF(3 are closely related to focal adhesion kinase 
and fibronexus maturation;30 therefore, there appears to be a strong interrelationship 
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between biological and mechanical cues in myofibroblast activation. Mechanical stress 
has been demonstrated to induce myofibroblast activation via the ERK2 and JNK, but not 
p38 pathway by some scientists in cardiac fibroblasts,31 but by the p38 pathway by others 
using rat-2 cells.32'33 While the specific pathways by which myofibroblast activation 
occurs in different tissues continues to be debated, it is agreed that myofibroblast 
activation involves both biological cues and mechanical forces in the context of the cell 
remodeling its environment and the extracellular environment affecting the cell. 
MAPK Pathway in VICs 
Cushing et al. have investigated the role of fibroblast growth factor (FGF) in 
repressing myofibroblast activation in aortic valve VICs.14' 15 In the context of these 
studies they show that FGF signaling, at least in aortic valve VICs, appears to occur 
through the classical MAPK pathway (via ERK1, 2).14' 15 From the present study it 
appears that the ERK1,2 MAPK pathway may be involved in myofibroblast VIC 
activation in the context of myxomatous mitral valve disease. MAPK markers also 
demonstrated some co-localization with myofibroblast markers in the limited areas of 
control valves where myofibroblast markers were expressed. This could suggest that 
VIC myofibroblast activation generally occurs by the MAPK pathway but is simply 
increased with altered distribution in myxomatous mitral valve disease, but considerably 
more work, including in vitro studies, would need to be done to verify this. 
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MAPK Pathway in Myxomatous Mitral Valve Disease 
Recent work in a canine animal model of myxomatous mitral valve disease 
suggested that the MAPK pathway is more active in myxomatous mitral valve disease 
relative to control canine mitral valves.18 In this study pERK was increased in 
myxomatous mitral valve disease but total ERK1,2 was not. The TGF|3 receptors 1,2 and 
latent TGF(31 were also increased in myxomatous mitral valve disease relative to normal 
valves.18 This study also investigated the role of serotoninergic signaling in this animal 
model of myxomatous mitral valve disease and found an increase in key serotoninergic 
signaling proteins and an enzyme involved in serotonin metabolism to be decreased in 
myxomatous mitral valves relative to normal valves.18 The results from this study, 
although in a canine model of myxomatous mitral valve disease, also support the findings 
from the present study and the overarching hypothesis that myofibroblast VIC activation 
in myxomatous mitral valve disease occurs via the MAPK/ERK pathway. 
Myofibroblast Phenotype and Compositional Changes in Myxomatous Mitral Valve 
Disease 
Previous studies have demonstrated altered matrix composition of myxomatous 
mitral valves relative to age-matched normal mitral valves, including greater water 
content, more DNA, and an increase in GAGs, particularly 6-sulfated chondroitin.34 We 
previously showed that the abundance of the proteoglycans DCN, VC, and BGN were all 
increased in myxomatous mitral valves relative to control.23 Studies have reported 
increased collagen content, particularly collagen type III, in myxomatous mitral valves,35 
as well as collagen fragmentation,2, 3' 6' 8 although the ability of VICs to synthesize 
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collagen was retained in VICs within myxomatous mitral valves. Elastic fibers in 
myxomatous mitral valves have also been shown to be increased and fragmented relative 
to normal mitral valves.3'6'8'36 These findings of elastic and collagen fiber fragmentation 
are consistent with reports of myxomatous mitral valves enriched in myofibroblast-like 
VICs expressing the gelatinase enzymes MMP2, 9 and the collagenase enzymes MMP1 
and 13.8 In fact, previous studies have observed that VICs expressing myofibroblast 
markers and MMP13 were localized to areas of myxoid stroma with fragmented elastic 
fibers and loosely arranged collagen fibers,8 suggesting a direct link between the 
myofibroblast-like VIC and the compositional changes observed in myxomatous mitral 
valve disease. These previous observations of VICs expressing myofibroblast markers in 
areas of myxoid remodeling are consistent with the observations of strong NMM staining 
in areas of elastic fiber remodeling in the present study. 
Myofibroblast Phenotype in Valvulopathies 
The myofibroblast-like VIC has not only been implicated in the pathogenesis of 
myxomatous mitral valve disease, but other valve diseases including calcific aortic valve 
disease and functional mitral regurgitation. In calcific aortic valve disease, VICs 
expressing SMaA have been demonstrated to be present early in the calcification 
process;37"39 TGF(3 signaling has also been shown to increase calcification of VICs in 
culture40"43 and be greater in calcified aortic valves relative to control.44 Mitral valve 
compositional changes in ovine models of functional mitral regurgitation also have 
implicated the VIC myofibroblast-like cell phenotype in the pathogenesis of these valve 
diseases.45'46 Therefore this myofibroblast-like activation of VICs, and the pathway(s) 
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by which it occurs, is not only important to understand because of its potential role in 
myxomatous mitral valve disease, but because of its implicated role in other valve 
diseases. To this end our laboratory has been pursuing means of separating this VIC 
subpopulation from normal and myxomatous mitral valves for further in vitro study. 7 
Implications 
While this study does not directly demonstrate a causative link between the 
MAPK pathway and myofibroblast activation in myxomatous mitral valve disease, the 
association of MAPK markers and myofibroblast phenotype markers and matrix 
remodeling in this study is compelling and deserves further attention. More in depth 
analysis of elastic remodeling, such as the gelatinases MMP2 and 9 as well as lysyl 
oxidase, and its association with myofibroblastic activation would be informative. 
Similarly, further analysis is warranted to understand how PGs such as versican, which 
are known to be increased in myxomatous mitral valve disease,23 relate to these 
phenotypic changes and potentially signaling pathways. Further verification of the 
pathway by which myofibroblast activation occurs in myxomatous mitral valves, such as 
using in vitro cell culture-based studies, would provide a signaling mechanism of 
activation for this cell-type thought to be an effector of the deleterious changes in 
myxomatous mitral valve disease. Moreover, verification and further elucidation of this 
pathway of activation could open opportunities for pathway and protein-specific 
molecular treatment strategies for this widespread, debilitating disease. 
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Limitations and Future Studies 
Limitations of this study include difficulty in identifying the distinct characteristic 
leaflet layers within the myxomatous valve sections, lack of female patients in the control 
group, and overall small number of control sections. Future analysis quantifying staining 
intensity would strengthen the observations of this study. Most importantly, this study is 
limited in that it only demonstrates an associative relationship between MAPK pathway 
markers and the myofibroblast-cell phenotype by co-localization of marker staining, 
which in conjunction with previous in vitro studies suggests a causal relationship, 
however, further study confirming and elucidating a causative relationship is warranted. 
Such future studies investigating the role of this MAPK pathway could involve both 
normal VICs and VICs isolated from myxomatous mitral valves, as well as manipulation 
of the myofibroblast-like subpopulation of normal VICs. Additional pathways may also 
be involved in the activation of VICs and should be investigated. 
CONCLUSIONS 
In summary, the co-localization of MAPK pathway markers, myofibroblast 
markers, and areas of matrix remodeling in myxomatous mitral valves suggested that the 
deleterious compositional changes that occur in myxomatous mitral valve disease could 
occur via MAPK-pathway dependent myofibroblast activation of VICs. While further in 
vitro studies remain to be performed demonstrated a direct, causative relationship 
between MAPK signaling and valve compositional changes, these findings could lead to 
novel treatment strategies for myxomatous mitral valve disease. 
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This chapter, which analyzed the mitogen-activated protein kinase (MAPK) 
signaling pathway in myxomatous mitral valve disease, continued the topic of valve 
alterations in various disease states. It should be noted that Chapter 24 in the 
Appendix also analyzes valve changes in myxomatous mitral valve disease 
(specifically characterizing changes in proteoglycan and glycosaminoglycan 
content), and provides important context for the present study. As stated in the 
preface, that study was placed in the Appendix because I was not the lead 
researcher on the study and it was not considered integral to this thesis. The next 
two chapters (Chapters 20 and 21) move from studying myxomatous mitral valves 
to characterization of valve alterations in calcific aortic valve disease. Specifically in 
the next chapter a study analyzing proteoglycan and glycosaminoglycan content 
relative to calcified nodules is presented. 
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Chapter 20: Differential Proteoglycan and Hyaluronan 
Distribution in Calcified Aortic Valves 
In this chapter the topic of examining valves in the setting of various disease 
states continues with the first of two chapters (Chapters 20 and 21) related to 
calcific aortic valve disease. Specifically in this chapter, analysis of proteoglycan 
and glycosaminoglycan content relative to calcified nodules is presented. 
ABSTRACT 
Background: While the prevalence of calcified aortic valve disease continues to rise and 
no pharmacological treatments exist, little is known regarding the pathogenesis of the 
disease. Proteoglycans and the glycosaminoglycan hyaluronan are involved in 
calcification in atherosclerosis and their characterization in calcified aortic valves may 
lend insight into the pathogenesis of the disease. 
Methods: 14 calcified aortic valves removed during valve replacement surgery were 
immunohistochemically stained for the proteoglycans (PGs) decorin, biglycan, and 
versican, as well as the glycosaminoglycan hyaluronan. Staining intensity was evaluated 
in the following regions of interest: center of calcified nodule, edge of nodule, tissue 
directly surrounding nodule; center and tissue surrounding small "prenodules"; and 
fibrosa layer of normal regions of the leaflet distanced from the nodule. 
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Results: Decorin, biglycan, and versican, as well as hyaluronan, were abundantly 
present immediately surrounding the calcified nodules, but minimal within the nodule 
itself. Expression of decorin and biglycan in and surrounding prenodules was greater 
than in the edge and center regions of mature nodules. The levels of expression of the 
PGs and hyaluronan highly correlated with one another in the different regions of the 
valve. 
Conclusions: The PGs decorin, biglycan, and versican, as well as the 
glycoasminoglycan hyaluronan, demonstrated distinctive localization relative to mature 
nodules within calcified aortic valves, where they likely mediate lipid retention, cell 
proliferation, and extracellular matrix remodeling, and motivate further study. 
Comparisons between expression of these components in mature nodules and prenodules 
suggest distinct roles for these components in nodule progression, especially in the 
tissues surrounding the nodules. Comparisons between expression of these components 
in mature nodules and prenodules suggest distinct roles for these components in nodule 
progression, especially in the tissues surrounding the nodules. 
The work contained in this chapter is under review by the journal Cardiovascular 
Pathology: 
Stephens EH, Saltarelli JG, Baggett LS, Nandi I, Kuo JJ, Davis AR, Olmstead-Davis EA, 
Reardon MJ, Morrisett JD, Grande-Allen KJ. Differential Proteoglycan and 




The prevalence of calcific aortic valve disease (CAVD) is rising and represents 
the second most common indication for cardiac surgery in elderly patients. CAVD is 
associated with aging,1 male gender2 metabolic syndrome,3 and is only treatable by 
surgical replacement of the stenotic valve with a mechanical, bioprosthetic or biological 
valve.4 CAVD is marked by lipid retention and monocyte infiltration in its early sclerotic 
stage, resulting in leaflet thickening, whereas the later stenotic stage is characterized by 
thickened, stiff, calcified leaflets containing heterotopic bone.5 At the present time, there 
are no pharmacological therapies designed expressly for the treatment of CAVD, largely 
due to our limited understanding of the disease mechanisms. The use of statins initially 
appeared promising as a means of preventing or reversing CAVD in patients, based on 
the ability of these lipid-lowering drugs to reduce valve calcification in vitro6' 7 and in 
animal models,8"11 but unfortunately that promise has not translated to a significant 
improvement in prospective clinical trials.12"14 For these reasons, numerous investigators 
are examining calcified heart valve lesions and valve cells to determine the roles of 
osteogenic and inflammation-related genes, various extracellular matrix components, 
matrix remodeling enzymes, lipids, oxidative stress, and mechanical stress.11'15"' 
A potential role of the extracellular matrix in the initiation and progression of 
CAVD is suggested by early valve lesions specifically developing within the unique 
extracellular matrix composition of the fibrosa layer within the leaflet. This layer 
contains highly aligned collagen as well as the proteoglycans (PGs) decorin and 
biglycan.19' 20 A PG consists of a core protein covalently linked to at least one 
538 
glycosaminoglycan (GAG) chain; with the exception of hyaluronan (HA), all GAGs exist 
in vivo as components of PGs. The small leucine-rich PGs decorin and biglycan are 
themselves interesting because these PGs mediate collagen fibrillogenesis21 and sequester 
transforming growth factor-beta (TGF(3),22 and their GAG chains are well known to bind 
to lipids and lipoproteins in the progression of atherosclerosis. HA also demonstrates 
the ability to retain lipids.24'25 In atherosclerosis, lipid retention and oxidation triggers 
inflammation, the proliferation and transdifferentiation of smooth muscle cells, 
angiotensin receptor activation, and free radical formation, among other processes;16' 
23,26,27
 s jm j i a r mechanisms may occur in aortic valve sclerosis. Intriguingly, O'Brien 
et al. suggested that biglycan and decorin are co-localized with apolipoprotein-E and 
apolipoprotein-B in these lipid-rich valve lesions,28 but this notion was never fully 
explored. The ability of HA to attract and promote the accumulation of monocytes in 
atherosclerosis suggests an additional potential role for these GAGs in the chronic 
inflammation of valve disease.29'30 Finally, HA has also been shown to be an effective 
medium for the delivery of bone morphogenic protein (BMP)-2, ' which mediates both 
normal bony ossification and abnormal heterotopic ossification in many tissues including 
heart valves.16 The PGs decorin, biglycan, and versican, as well as all four classes of 
GAGs, are found in varying abundance in heart valves,33'34 and have been studied in 
bioprosthetic aortic valves35 and myxomatous mitral valves,36 but have received little 
attention regarding CAVD. 
Therefore, the purpose of this study was to assess the location and abundance of 
specific PGs and the GAG HA relative to calcific nodules in diseased aortic valves. Such 
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characterization could improve our understanding of this common valve disease and 
contribute towards developing novel treatments. 
METHODS 
Tissue Procurement and Decalcification 
Calcified aortic valves that were removed during valve replacement surgery and 
did not show signs of rheumatic disease were obtained from Baylor College of Medicine 
(BCM) and Cooperative Human Tissue Network (CHTN) (n=14, mean age 65±15, 80% 
male). The Institutional Review Board at each institution approved the research use of 
these tissues. The 10 calcified aortic valves obtained from BCM were either stored in 
50% glycerol in phosphate-buffered saline (PBS) at -20°C or in RNAlater (Applied 
Biosystems, Foster City, CA) at -80°C. Prior to histological processing, glycerol or 
RNAlater was removed by dialyzing overnight in fresh PBS. Afterwards, several two to 
three millimeter radial strips were cut from each leaflet and placed into 10% formic acid 
at room temperature for 12-24 hours (depending on level of calcification) to decalcify the 
sections allowing routine paraffin embedding; it has been previously shown that formic 
acid treatment decalcifies tissues without damaging antigenicity. ' Once an 
appropriate level of decalcification was achieved, as determined by palpation, diseased 
valves were embedded in paraffin and sectioned according to routine procedures. The 4 
specimens obtained from the CHTN were already decalcified and embedded in paraffin 
and were similarly sectioned. The exact method of decalcification for the CHTN samples 
is undetermined; however, the CHTN stained tissues could not be distinguished from 
samples from BCM. 
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Histology and Immunohistochemistry 
Sections were stained with Movat pentachrome to demonstrate the heterogeneous 
microstructure of the leaflet. Immunohistochemistry (IHC) was performed to localize the 
PGs decorin, biglycan and versican within the valve tissues using antibodies against their 
respective core proteins. Briefly, tissue slides were processed through a series of graded 
alcohols and hydrated to water. All slides were pretreated with chondroitinase ABC (200 
mU/ml, 37°C, 1 hour) to remove the GAG chains from the PG core proteins. Sections 
were blocked with 10% goat-serum (Sigma, St. Louis, MO), then incubated with primary 
antibodies against PGs overnight at 4°C. The rabbit anti-human decorin (LF-136, 
dilution 1:800) and biglycan antibodies (LF-51, dilution 1:2000) were generously 
provided by Larry Fisher, Ph.D., NIH, Bethesda, MD;39 the murine antibody against 
mammalian versican (clone 2-B-l, dilution 1:5000) was purchased from Associates of 
Cape Code (East Falmouth, MA). After rinsing in PBS, biotinylated secondary 
antibodies were applied (goat anti-mouse or anti-rabbit IgG, Jackson Immunoresearch 
Inc., West Grove, PA) for 1 hour at room temperature. Positive staining was 
demonstrated by a chromogen reaction using Vectastain Elite ABC and diaminobenzidine 
kits (Vector Laboratories, Burlingame, CA). The presence of HA was demonstrated by 
histochemical binding to an HA binding protein (HABP),40 which contains the "link" 
domain protein that normally binds HA to aggrecan in the formation of an aggrecan 
aggregate. This HA staining procedure required blocking with 2% fetal bovine serum, 
treating with biotinylated HABP (exactly as described by Lara et al.40), then performing 
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chromogenic detection as described above. All samples were counterstained with 
hematoxylin. To minimize variability, multiple samples were taken from a given 
patient's valve. Negative controls for all markers were performed in the absence of the 
primary antibody or HABP. 
Analysis of Immunohistochemical Staining 
Several regions of the radially oriented leaflet sections stained for PGs and HA 
were evaluated to quantify the 8-bit intensity of brown staining using ImageJ software 
(NIH, Bethesda, MD). Because the binding of lipids by GAGs and PG is speculated to 
be an early event in the progression of CAVD,41 calcified nodules were categorized as 
large and presumably mature ("nodule") or small and presumably early-stage 
("prenodule"). Prenodules were identified as subsidiary, substantially smaller nodules 
(typically <l/2 of leaflet cross-sectional width), which were not continuous with the main 
nodule; prenodules were generally located closer to the annulus than was the main 
nodule. Regions of interest were identified in the nodule center (innermost 2/3), edge 
(outermost 1/3), and surrounding tissue; in the prenodule center and surrounding tissue; 
and in the fibrosa layer of a normal-appearing region of the same leaflet far away from 
the nodules. 
Statistical Analysis 
Statistical analysis of data was performed using SAS (Cary, NC). A 
multifactorial analysis of variance (ANOVA) test was used with the level of significance 
set at 0.05. Multiple comparisons of group means were performed using the Tukey-
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Kramer method for controlling maximum experimentwise error rate. Correlations 
between staining intensities of different proteins within individual leaflet regions (to 
assess protein co-localization) were calculated using Pearson Product Moments. For 
correlations between intensities of different matrix components, the level of significance 
was reduced to 0.0125 to account for 4 markers being considered. 
RESULTS 
As expected from numerous previous pathological descriptions,4'5'26'33 the Movat 
pentachrome staining showed that the diseased aortic valves contained large calcific 
nodules, often occupying approximately one-third of the full radial length. The 
calcifications were stained dark purple by the Voerhoff s hematoxylin component of the 
Movat stain, making it straightforward to localize the boundaries of the nodules and thus 
identify nodule center, edge, and surrounding tissue. All 14 diseased valves had mature 
nodules, whereas only 7 of the valves had prenodules (Fig. 20-1). The distal regions of 
most valve leaflets (far away from the nodules) demonstrated a normal appearing layered 
structure in which the fibrosa layer (stained yellow by the saffron component of the 
Movat stain) could be identified. 
The proteoglycans and HA demonstrated greatest expression in the valve tissue 
immediately surrounding the mature nodules (Fig. 20-2; overall ANOVA p<0.0001 for 
decorin, biglycan, and versican; p=0.0104 for HA). There was often a distinct border of 
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Fig. 20-1: Upper two images: Movat pentachome stain of two calcified 
aortic valves showing large nodules at the distal end and small prenodules 
(indicated by arrows) more proximal to the annular edge of the leaflet. 
Lower two images: one of the same calcified valve stained for hyaluronan 
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Fig. 20-2: Intensities of staining for PGs and HA in different regions of calcified aortic 
valves. Error bars indicate standard error of the mean. fp<0.05 compared to Nod Surr. 
*p<0.05 compared to Fibrosa. }p<0.05 compared to Prenod Nod Ctr = innermost 2/3 of the 
large nodule. Nod Edge = outer 1/3 of the large nodule. Nod Surr — tissue immediately 
surrounding the large nodule. Prenod = prenodule. Prenod Surr = tissue immediately 
surrounding the prenodule. 
expression ending at the nodule, although in some valves there was some degree of PG 
and HA expression within the nodule as well. Versican and HA expression in the tissue 
immediately surrounding the nodule was significantly greater than in the nodule edge 
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Fig. 20-3: Calcified valve stained with Movat pentachrome and histochemically 
stained for decorin, biglycan, hyaluronan (HA), and versican. Scale bars=l mm. 
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Fig. 20-4: Calcified valve stained with Movat pentachrome and immunohistochemically 
stained for decorin and biglycan. Asterisk indicates normal fibrosa; scale bars=l mm. 
and prenodule (Fig. 20-1 to 20-3). Versican expression surrounding the nodule was also 
greater than in the nodule center and in the normal fibrosa; versican expression in the 
nodule center and edge was lower than in the distal normal fibrosa. While strong 
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versican expression often directly abutted the nodule, HA expression often tapered off, 
being externally high and then decreasing approaching the edge of the nodule. Versican 
expression in the nodule center and edge was also lower than in the distal normal fibrosa. 
Expression of biglycan within the center and edge of the nodule was significantly lower 
than in the tissue surrounding the nodule, in the prenodule, and in the distal normal 
fibrosa (Fig. 20-3, 20-4). Expression of decorin showed a similar regional pattern with 
expression being significantly lowest in the nodule edge and center. The expression of 
decorin and biglycan within and surrounding prenodules was also greater than in the edge 
and center regions of mature nodules. 
The levels of expression of the different PGs and HA were highly correlated with 
each other in different regions of the diseased aortic valves. In the tissue immediately 
surrounding the nodule, biglycan expression was positively correlated with expression of 
versican (r=0.80, p=0.0003) and HA (r=0.71, p<0.002). HA and versican were also 
correlated in this same region (r=0.79, p=0.004). Decorin and biglycan were positively 
correlated in the edge (outermost 1/3) of the nodule (r=0.64, p<0.008), and even more 
strongly correlated in the tissue surrounding the pre-nodule (r=0.98, p=0.0005). 
Interestingly, in the pre-nodule, biglycan was negatively correlated with HA (r=-0.95, 
p<0.004). No other significant correlations were found between the various PGs or HA 
in the center (inner 2/3) of the nodule nor in the distal fibrosa. 
DISCUSSION 
In this study, we showed that the PGs versican, decorin, and biglycan, as well as the 
GAG HA, which are normally abundant in distinct regions of the aortic valve, are richly 
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present within the tissue immediately surrounding the calcified nodules, but generally 
absent from the nodules. We also found that versican and HA are strongly abundant in 
the vicinity of the larger nodules, but less so in the smaller "prenodules." These 
differences in the distribution of small leucine-rich PGs and the large, hydrated PG and 
GAG suggest that distinctive remodeling processes are occurring throughout the diseased 
aortic valve leaflets. 
The small leucine-rich PGs decorin and biglycan were abundant throughout the 
calcified aortic valve leaflets, where they were likely involved with active pathological 
remodeling in the tissue surrounding the nodules. In normal human aortic valves, decorin 
and biglycan are ubiquitously distributed,42 yet frequently co-localized with collagen, 
which would support their role in collagen fibrillogenesis.43 The core proteins of these 
small PGs are also able to bind to growth factors such as TGF0 and epidermal growth 
factor, and thus could influence cell proliferation. In addition, the chondroitin sulfate 
GAG chains on these PGs are known to bind to lipids and retain them within the local 
region of the calcific nodule, thereby facilitating the ability of oxidized lipids to initiate 
further pathological remodeling.44 The ability of these GAG chains to bind lipids is 
influenced by their fine structure, meaning their chain length, the extent and pattern of 
sulfation, and the isoform of the uronic acid moiety.45'46 As we could not determine by 
immunohistochemical detection of the PG core proteins whether or not there were 
differences in the fine structure of the GAG chain, it will be important to examine these 
small PGs and their GAG chains in the future to discern if the GAG chains in the tissue 
surrounding the nodule show enhanced lipid binding properties. 
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The novel finding of the PG versican and HA in the tissue surrounding the 
calcific nodule further underscores the active remodeling occurring with this area. 
Versican is a very large PG that contains a multi-domain core protein from which 
emanates 15-20 very long chondroitin sulfate GAG chains. The Gl domain of the 
versican core protein is known to destabilize adhesive contacts47 and has another region 
that promotes binding to HA to create a versican aggregate.4 The G3 domain is also 
multifunctional, and contains an epidermal growth factor-like region that promotes cell 
proliferation.49 The GAG chains attached to the center of the core protein imbue the PG 
with substantial hydration. As a result, the overall versican PG has considerable 
capability to swell tissues and influence regional cell proliferation and migration. 
Normally, versican is primarily located within the central spongiosa layer of aortic 
valves,19'20 where it is believed to aid in the tissue's resistance to cyclic compression and 
where it can provide lubrication to the outer fibrosa and ventricular layers. Similarly to 
decorin and especially biglycan, the GAG chains on versican could also bind lipids, as is 
demonstrated in atherosclerosis.50 Versican is linked with numerous additional 
pathological processes in atherosclerosis as well, including interactions with 
inflammatory cells and cytokines, roles in platelet aggregation, interference (specific and 
nonspecific) with normal extracellular matrix assembly, and upregulating cell 
proliferation.50 Recently, it was found that the genes for versican, biglycan, and several 
enzymes involved in GAG chain assembly (such as xylosyltransferase-I, (3-1,4-N-
acetylgalactosaminyltransferase) were upregulated in mesenchymal stem cells cultured in 
osteogenic medium, and that the expression of these genes was strongly and temporally 
associated with expression of alkaline phosphatase and osteopontin as well as von Kossa 
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staining for mineralization.51 Taken together, there is growing evidence pointing towards 
active roles of these PGs in the progression of CAVD. 
The well recognized abilities of HA to influence cell and tissue behavior are also 
likely to play roles in the tissue surrounding the calcific nodules. HA is normally a linear 
chain of repeating, unmodified disaccharide units that exists as a distinct molecule 
thousands of disaccharides long - yielding a potential length up to 10 um measured end 
to end. HA can account for up to 50%-60% of all valve GAGs 34"36 and is secreted by 
valvular interstitial cells (VICs).52'53 In normal heart valves, HA is attributed with many 
of the same biophysical characteristics as is versican, namely to promote tissue hydration, 
lubrication, and resistance to compression.19 However, HA is abundant in atherosclerotic 
lesions,54 and based on selected other similarities between atherosclerosis and CAVD it is 
compelling to consider what factors influence HA regulation in atherosclerosis. 
Atherosclerotic lesions stain strongly for TGF(3, as well as for PDGF-AB54 and both have 
been shown to regulate HA synthesis (as well as PG synthesis and GAG chain fine 
structure55) by numerous cell types.56 VICs treated with TGF|3 also upregulate HA 
secretion.53 HA has been implicated in tissue responses to injury including monocyte 
adhesion and activation and the proliferation and migration of vascular smooth muscle 
cells and leukocytes.54' 57 Proliferating vascular smooth muscle cells and fibroblasts 
synthesize more HA,57 often as cables that bind and retain monocytes.58 HA also 
demonstrates the ability to retain lipids,24' 25 leading to the development of sclerotic 
lesions. 
Other potential therapeutic targets for atherosclerosis, and potentially for CAVD, 
include the three HA synthases (HAS-1, HAS-2, and HAS-3) and the HA receptors on 
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the cell surface, namely CD44, RHAMM (the receptor for hyaluronic acid mediated 
motility), and HARE (HA receptor for endocytosis). It is known that in general, HA 
ligation to CD44 mediates leukocyte, monocyte, and macrophage recruitment, the 
production of several inflammatory mediators, vascular cell activation,24' 58 tyrosine 
kinase activity of pl85HER"2 and src and the activation of Rho and Rac-1. CD44-null 
mice crossed with apolipoprotein-E null mice had less atherosclerosis than the uncrossed 
apolipoprotein-E null mice, despite equivalent cholesterol levels.24 Binding of HA to 
RHAMM activates downstream signaling via src and Ras.58 In vitro, the addition of low 
molecular weight HA caused a CD44-dependent upregulation of smooth muscle cell 
proliferation (an effect also reported in VICs59) and VCAM-1 synthesis;24 other HA 
receptors may also be involved in early lesion development.24 In vivo, these low 
molecular weight HA fragments would be generated by hyaluronidases such as Hyal-1 
and Hyal-2.60 Taken together, the various factors that promote the formation of an HA-
rich matrix likely regulate sclerotic lesion development and inflammatory responses in 
heart valves as well as vessels, although the roles of HA receptors, synthases, and 
degrading enzymes in CAVD are presently unknown. 
The differences in abundance and correlations between the small PGs and the 
larger, hydrated versican and HA across the diseased leaflets suggests the presence of 
distinctive remodeling mechanisms. Each of the examined PGs and HA were more 
abundant surrounding the nodules compared to the interior of the nodule, which suggest 
that these molecules are not involved in mineralization. Decorin and biglycan, in 
particular, were also significantly more abundant in the prenodule and region surrounding 
the prenodule compared to the main nodule edge and center. This pattern suggests that 
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these components are expressed and accumulate early in nodule formation, but then as 
the nodule matures and becomes more mineralized, their expression within the nodule is 
reduced and they are more involved in the remodeling of the surrounding tissue. 
Versican and HA, in contrast, were negatively correlated with decorin and biglycan in the 
prenodule, suggesting that they are less involved in the early nodule formation and more 
involved in remodeling surrounding the mineralized tissues. It may be that versican and 
HA are subjected to some form of paracrine regulation that is distinctive between the 
prenodules and large mineralized nodules. Others have similarly shown that smaller 
calcific nodules are more highly vascularized than are larger nodules.61 The presence of 
HA and versican surrounding the larger nodules might be a way to promote improved 
diffusion of nutrients and oxygen through these valve regions, since diffusion would be 
enhanced with more highly hydrated tissues. 
CONCLUSIONS 
In conclusion, we have shown that the PGs decorin, biglycan, and versican, and 
the GAG HA demonstrate distinctive patterns of expression in the vicinity of large and 
small nodules in calcified aortic valves. The diverse biological and biophysical functions 
of these extracellular matrix molecules, and the complexities of their regulation, make 
them compelling subjects for future investigations of the development and treatment of 
CAVD. 
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In this chapter, which analyzed proteoglycan and glycosaminoglycan content 
relative to calcified nodules, the topic of examining valves in the setting of various 
disease states continued. The next chapter contains the second of these two studies 
on calcific aortic valve disease, in which markers of hypoxia, hyaluronan 
homeostasis, brown adipocytes, and osteogenesis and chondrogenesis were analyzed 
relative to calcified nodules. 
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Chapter 21: Hyaluronan Turnover and Hypoxic Brown 
Adipocytes are Co-localized with Endochondral Ossification in 
Calcified Aortic Valves 
This chapter contains the second of two studies on calcific aortic valve 
disease (Chapters 20 and 21). In this chapter markers of hypoxia, hyaluronan 
homeostasis, brown adipocytes, and osteogenesis and chondrogenesis were analyzed 
relative to calcified nodules. 
ABSTRACT 
Background: While calcified aortic valve disease is the most common adult heart valve 
disease and incurs a substantial burden on today's society, little is known regarding the 
mechanisms involved in the pathogenesis of this disease. The aim of this study was to 
assess markers related to hypoxia, hyaluronan homeostasis, brown fat, and bone/cartilage 
formation in different regions of valves with calcified nodules. Characterization of these 
markers' expression both relative to nodules at different stages in development as well as 
relative to other markers could lend insight into the mechanisms involved in nodule 
formation in CAVD. 
Methods: 14 calcified aortic valves removed during valve replacement surgery were 
immunohistochemically stained for markers from different mechanistic families 
potentially involved in nodule formation: hypoxia/brown fat, hyaluronan homeostasis, 
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and ossification. Staining intensity was evaluated in the following regions of interest: 
center of calcified nodule (NodCtr), edge of nodule (NodEdge), tissue directly 
surrounding nodule (NodSurr); center and tissue surrounding small "prenodules" 
(PreNod, PreNodSurr); and fibrosa layer of normal regions of the leaflet distanced from 
the nodule (CollFibr). 
Results: Region-specific localization of markers from the different mechanistic families 
was evident, with strong correlations between markers from the different mechanistic 
families that were distinct with respect to region. Osteogenic markers were found to 
primarily localize to the nodule, along with markers related to hyaluronan turnover and 
hypoxia. Markers of brown fat cells were found to co-localize with markers of hypoxia. 
In NodCtr as well as NodSurr, the expression of hyaluronidase-1, which degrades 
hyaluronan, strongly correlated with both markers of brown fat and ossification markers. 
In NodEdge, however, the marker of hyaluronan synthesis, HAS-2, demonstrated 
strongly correlated with markers of brown fat, hypoxia, and ossification. Tumor necrosis 
factor-a stimulated gene-6 (TSG-6) protein, which when bound to hyaluronan will 
promote ossification, strongly correlated with ossification markers and hyaluronidase in 
the regions surrounding the nodules (NodSurr, PreNodSurr). 
Conclusions: This study demonstrates for the first time a role for hyaluronan 
homeostasis and the promotion of hypoxia by brown fat cells in calcific aortic valve 
disease. Interactions between markers from the different mechanistic families were 
heterogeneous relative to calcific nodules, suggesting distinct roles for these mechanisms 
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within the complex microanatomy of nodule pathogenesis. Future work examining 
causative relationships between these factors will expand upon the associative findings 
demonstrated in this study. 




Valve disease is widely prevalent in our society, with valve replacement or repair 
1 7 
in almost 100,000 people in the United States and 275,000 people worldwide each year. 
The most common heart valve disease is calcific aortic valve disease (CAVD), also 
known as calcific aortic stenosis. CAVD is associated with aging and the obesity-driven 
metabolic syndrome and thus is predicted to become an ever increasing clinical problem 
in the U.S. population3 whose treatment will represent substantial health care costs. 
Despite these statistics, there are no treatments for CAVD other than surgical aortic valve 
replacement, nor are there any medications that specifically target CAVD. Moreover, 
investigators have only begun to explore possible mechanisms for the progression of 
CAVD in the last several years. 
Several previous mechanistic studies of the development and progression of 
CAVD have related to the deposition of calcific nodules, which is a hallmark of the 
advanced valvular sclerotic lesion, and which cause the leaflets to become stiff and the 
valve stenotic. These nodules, which may appear as hydroxyapatite crystals and show 
characteristics of heterotopic bone,4 are found in association with lipids both in human 
valves and in animal models. Calcified aortic valve leaflets also contain osteoblast-like 
cells5 and an abundance of several osteogenic mediators, including bone morphogenic 
protein-2 (BMP-2).6'7 Investigations of heterotopic bone formation in a mouse muscle 
model8 have shown associations between overproduction of BMP-2, rapid production of 
brown fat cells that stimulate hypoxic conditions, and heterotopic endochondral 
ossification. In this model, three days after the delivery of excess BMP-2 to the muscle, 
gene expression was strongly upregulated for several markers that are also reportedly 
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elevated in either atherosclerosis or CAVD, including CD44, E-selectin, apolipoprotein 
E, cycloxygenase-2, prostaglandins, and the small proteoglycan decorin. Expression of 
many of these markers is regulated by the inflammatory cytokine tumor necrosis factor-a 
(TNF-a), which is intriguing because the TNF-a stimulated gene-6 protein (TSG-6) 
provides a mechanistic link between BMP-2 and the glycosaminoglycan hyaluronan 
(HA). 
Due to the complex ability of HA to bind to lipids and monocytes,10' " the many 
regulators of HA homeostasis (synthases, receptors, and degrading enzymes) have been 
strongly associated with the progression of atherosclerosis,10' 12"14 and these same 
regulators may potentially impact CAVD as well. HA can also bind to TSG-6 through a 
Link-protein-like domain; TSG-6 binds to BMP-2 through this same domain, thereby 
inhibiting BMP-2 mediated ossification.15 In the presence of HA, the TSG-6 Link 
domain is bound to HA, and therefore TSG-6 cannot inhibit BMP-2. Perhaps for this 
reason, HA has been shown to be a very efficient carrier of BMP-2 promoting the 
mineralization of tissue engineered bone and bony ingrowth into implants.16'17 
The purpose of this study was to investigate the relationships between BMP-2, 
hypoxia, HA regulation, and endochondral ossification by performing 
immunohistochemistry on calcified aortic valves. The two primary hypotheses examined 
were first, that BMP-2-potentiated hypoxia, as demonstrated by markers of brown 
adipocytes, would be associated with markers for bone and chondrocytes. The second 
hypothesis was that in leaflet regions demonstrating overall HA synthesis, TSG-6 would 
be unable to bind to BMP-2 and thus BMP-2 could promote calcification, but otherwise 
TSG-6 could bind and inhibit BMP-2 activity. 
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METHODS 
Tissue Procurement and Decalcification 
[For a complete description of Tissue Procurement and Decalcification for this 
study, please see Chapter 20] 
Calcified aortic valves that were removed during valve replacement surgery and 
did not show signs of rheumatic disease were obtained from Baylor College of Medicine 
(BCM) and Cooperative Human Tissue Network (CHTN) (n=14, 80% male, mean age 
65±15). After decalcification, diseased valves were embedded in paraffin and sectioned 
according to routine procedures. 
Histology and Immunohistochemistry 
Sections were stained with Movat pentachrome to demonstrate the general 
microstructure of the leaflet. Sections were also stained immunohistochemically for a 
range of proteins related to osteogenesis and chondrogenesis, hyaluronan homeostasis, 
and hypoxia (Table 21-1). Briefly, sections were deparaffinized using xylene and then 
were rehydrated using a decreasing gradient of ethanol. Hydrated sections underwent 
citrate buffer-based antigen retrieval (Antigen Decloaker, Biocare Medical, Concord, 
CA) or enzymatic pre-treatment appropriate for each antibody. Sections were blocked 
with 10% goat-serum (Sigma, St. Louis, MO), then incubated with primary antibodies at 
37°C for one hour. After rinsing in PBS, biotinylated secondary antibodies were applied 
(goat anti-mouse or anti-rabbit IgG, Jackson Immunoresearch Inc., West Grove, PA) for 
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Tabic 21-1. Antibodies Used in Immunohistochemistry. 
Protein Function 
Hyaluronan (HA)-related 
Hyaluronan receptor for endocytosis
 TT. . c . . , x 
rHARFY1 HA clearance from bloodstream 
Hyaluronan synthase-2 (HAS-2)b HA synthesis 
CD168C Receptor for HA mediated motility 
Hyaluronidase-1 (Hyal-l)d HA degrading endolyase 
Hypoxia-related 
Uncoupling protein-1 (UCP-l)e Identifies brown adipocytes 
Peroxisome proliferator-activated
 T, . _ . ,.__ . ^ ,, ,. 
,.
 x , /r>^^, , ,f Identifies newly differentiated brown adipocytes receptor y, co-activator 1 a (PGC-la) 
Hypoxia inducible factor-1 (HIF-lct)8 Expressed in the setting of oxygen deprivation 
Ossification-related 
Bone morphogenic protein-2 (BMP-2)h Involved in osteoblast cell differentiation 
S-100' Identifies chondrocytes 
Tumor necrosis factor a simulated gene-
 T . . . . „»,„ - ,. x , .„ 
, , . sr-c^ ,.j Inhibits BMP-2 mediated ossification 
6 protein (TSG-o/ 
Periostin8 Osteoblast specific factor 
"gift from Dr. Paul Weigel, University of Oklahoma Health Science Center (Oklahoma City, OK); bgift 
from Dr. Melanie Simpson, University of Nebraska (Lincoln, NE); cLeica Microsystems (St. Louis, MO); 
dAbnova (Niehu, Taipei, Taiwan); eChemicon/Millipore International (Billerica, ME); fEMD/Calbiochem 
(Gibbstown, NJ); 8R&D Systems (Minneapolis, MN); hLifespan Biosciences (Seattle, WA); 'ThermoFisher 
Scientific (Fremont, CA); JSanta Cruz Biotechnology (Santa Cruz, CA). 
1 hour at room temperature. Positive staining was demonstrated by a chromogen reaction 
using Vectastain Elite ABC and diaminobenzidine kits (Vector Laboratories, Burlingame, 
CA). All samples were counterstained with hematoxylin. To minimize variability, 
multiple samples were taken from a given patient's valve. Negative controls for all 
markers were performed in the absence of the primary antibody. 
Analysis of Immunohistochemical Staining 
Several regions of the radially oriented leaflet sections were evaluated to quantify 
the 8-bit intensity of brown staining using Image J software (NIH, Bethesda, MD). 
Calcified nodules were categorized as large and presumably mature ("nodule") or small 
and presumably early-stage ("prenodule"). Prenodules were identified as subsidiary, 
substantially smaller nodules (typically <l/2 of leaflet height), which were not continuous 
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with the main nodule; prenodules were generally located closer to the annulus than was 
the main nodule. Regions of interest were identified (Fig. 21-1) in the nodule center 
(NodCtr, innermost 1/3), edge (NodEdge, outermost 1/3), and surrounding tissue 
(NodSurr); in the prenodule center (PreNod) and surrounding tissue (PreNodSurr); and in 
the fibrosa layer of a normal-appearing region of the same leaflet far away from the 
nodules (CollFibr). 
Fig. 21-1: Representative Movat stained section illustrating different regions analyzed: 
NodCtr=nodule center, NodEdge=outermost edge of nodule, NodSurr=region surrounding 
nodule, PreNod=prenodule center, PreNodSurr=region surrounding prenodule, CollFibr= 
collagenous fibrosa from normal-appearing portion of leaflet. Scale bar indicates 1 mm. 
Statistical Analysis 
Statistical analysis of data was performed using SAS (Cary, NC). Correlations 
between staining intensities of different proteins within individual leaflet regions (to 
assess protein co-localization) were calculated using Pearson Product Moments. For 
correlations between intensities of different matrix components, the level of significance 
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was reduced to 0.0045 to account for 11 markers being considered. Correlations for 
which p<0.01 were considered trends. 
RESULTS 
Co-localizations between Markers 
BMP-2 was primarily demonstrated within the calcific nodule (meaning both 
NodCtr and NodEdge, unless otherwise noted), with some staining in NodSurr as well. 
BMP-2 was often co-localized with staining for Hyal-1 (Fig. 21-2) and to a lesser extent 
HIF-la (Fig. 21-3). HIF-la staining was generally observed inside the nodule as well 
(where usually staining in NodCtr appeared stronger than NodEdge), and was usually co-
localized with S-100, BMP-2, and PGC-la (Fig. 21-3). TSG-6 was often localized to the 
inside of the nodule (with PGC-la and UCP-1), but could also be found in NodSurr; 
TSG-6 was partly co-localized with BMP-2. Similarly, Hyal-1 and HAS-2 were most 
often demonstrated within the nodule, but were also found in NodEdge, where Hyal-1 
was often co-localized with TSG-6. Periostin was predominantly localized to within and 
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F/#. 27-J: Co-localization of BMP-2, PGC-la, UCP-1, and HIF-la relative 
to nodules in calcified aortic valves. Scale bars indicate 1 mm. 
Correlations within Mechanistic Families 
There were numerous correlations among markers in the same mechanistic 
family, which was to be expected (Table 21-2). For the regulators of HA, CD 168 was 
significantly and very strongly associated with Hyal-1 in NodSurr; this same association, 
albeit less strong, was also a trend in CollFibr. HARE was also significantly associated 
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Fig. 21-4: Periostin staining relative to nodules in calcified aortic valves demonstrating 
stronger staining in the center of and at the edge of nodules relative to surrounding tissues. 
Scale bars indicate 1 mm. 
with Hyal-1 in CollFibr. For hypoxic regulators, HIF-la was strongly associated with 
markers for brown fat differentiation (PGC-la in NodEdge and UCP-1 in PreNodSurr); a 
less strong link with UCP-1 was also suggested as a trend in NodSurr. PGC-la and 
UCP-1 were also associated in NodCtr. Finally, there were numerous associations 
between the markers of endochondral ossification; BMP-2, S-100, and TSG-6 were all 
significantly associated with each other in NodSurr. TSG-6 had trends of association 
with S-100 in NodEdge and BMP-2 in PreNodSurr. Periostin was also significantly and 
strongly associated with TSG-6 in NodCtr. 
Correlations between Mechanistic Families 
The findings of correlations between markers from different mechanistic families 
suggest interactions between these agents in distinct regions of the leaflet (Table 21-3). 
Correlations between these markers were unique depending on the different regions 
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NodSurr=tissue surrounding nodule, NodEdge=edge of nodule, 
PreNodSurr=tissue surrounding prenodule, NodCtr=center of nodule, 
CollFibr=normal appearing fibrosa far from nodules. 
Non-italicized p-values are significant correlations (p<0.0045). 
Italicized p-values are trends (p<0.01). 
suggesting distinct processes relative to the microstructure of the nodule. In NodCtr, HA 
degradation (Hyal-1) strongly correlated with markers of brown fat differentiation (UCP-
1 and PGC-la), and had a trend of association with chondrogenic differentiation (S-100). 
S-100 was also significantly correlated with UCP-1 in this region, as was BMP-2 and 
PGC-la. In contrast to NodCtr, in NodEdge HA synthesis (HAS-2) was significantly 
associated with the brown fat marker PGC-la and marker of hypoxia HIF-la, as well as a 
trend of association with BMP2. Chondrogenic differentiation and hypoxia were also 
linked by a significant moderate association between S-100 and UCP-1 in NodEdge. In 
this region periostin demonstrated a trend of association with HAS-2, HIF-la, and PGC-
la. 
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Table 21-3. Correlations between Different Mechanistic Families. 




































































































































NodSurr=tissue surrounding nodule, NodEdge=edge of nodule, 
NodCtr=center of nodule, PreNod=center of prenodule, 
PreNodSurr=tissue surrounding prenodule, 
CollFibr=normal appearing fibrosa far from nodules. 
Non-italicized p-values are significant correlations (p<0.0045). 
Italicized p-values are trends (p<0.01). 
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Far more significant correlations were found between mechanistic families in 
NodSurr. Significant interactions between HA regulation and endochondral ossification 
were demonstrated by correlations of BMP-2, TSG-6, and S-100 with Hyal-1 and 
CD 168. Specifically, Hyal-1 showed strong correlations with the brown fat marker UCP-
1, as well as BMP2. Significant interactions between hypoxic regulation and HA 
regulation were also shown by correlations of UCP-1 with CD 168. Links between UCP-
1 and endochondral ossification were more moderate, with only a significant correlation 
with S-100. TSG-6 demonstrated a trend of associations with BMP-2 and HYAL-1. 
In PreNod and PreNodSurr, the number of correlations between mechanistic 
families was smaller, but the correlations were extremely strong. Within the PreNod, 
endochondral ossification and HA regulation showed strong associations with Hyal-1 
strongly correlating with the ossification markers S-100 and BMP-2, HARE associating 
with S-100, and a correlation trend evident between TSG-6 and Hyal-1. In PreNodSurr, 
Hyal-1 was significantly correlated with BMP-2 and TSG-6. 
In CollFibr, several moderate correlations between mechanistic families were 
present. Hypoxic regulation (UCP-1) was significantly correlated with HA regulation 
(CD 168, Hyal-1). Links between hypoxic regulation and endochondral ossification were 
also demonstrated by a significant correlation between PGC-la and periostin, and a 
correlation trend between UCP-1 and S-100. Finally, HA regulation (HARE) was linked 
with endochondral ossification (S-100). 
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DISCUSSION 
This work provides evidence indicating the presence of hypoxia and brown fat 
driven mechanisms within calcified aortic valves, as well as mechanisms linked to 
hyaluronan balance and TSG-6, a molecule that can either promote or suppress BMP-2-
induced calcification depending on the presence or absence of HA. These results support 
the proposed hypotheses and also highlight the role of Hyal-1, which was strongly linked 
with both hypoxic and endochondral ossification markers. The mechanistic roles of 
brown fat and hyaluronan regulation have not been previously investigated in CAVD. 
Role for Hypoxia and Brown Fat in Calcification 
The demonstration of two markers signifying the differentiation of brown fat 
cells, UCP-1 and PGC-la, that were found together with HIF-la within and surrounding 
the nodules of these calcified aortic valves provides a tantalizing new direction for 
investigation of disease mechanisms and possibly the development of novel therapies. In 
murine models of heterotopic ossification within muscle, brown adipocytes begin to 
accumulate with 24 hours of delivery of adenovirus transduced cells expressing BMP2.8, 
18
 These brown adipocytes generated hypoxic stress within the muscle tissue8 and 
expressed vascular endothelial growth factor,18 thus driving the early stages of 
heterotopic endochondral ossification. Lowering oxygen tension within soft tissue 
creates the correct environment for chondrogenesis, and promoting the formation of new 
blood vessels aids in the delivery of osteoblastic progenitor cells; together these steps are 
critical to the differentiation of cartilage and the transition to bone. Furthermore, many 
of the novel correlations between the markers for brown fat, hypoxia, and endochondral 
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ossification were present in the nodule region but not present in the normal collagenous 
fibrosa, thus corroborating our hypothesis that these agents are relevant to the nodule 
formation. Interestingly, these correlations were completely absent from the prenodule 
region, which suggests that differential remodeling is occurring between the smaller and 
larger nodules. 
Correlations between brown fat-generated hypoxia and HA turnover also suggest 
future research directions. Although more precise details regarding the interactions of 
these mechanisms cannot be determined using immunohistochemistry, we speculate that 
hypoxia promotes HA synthesis in the nodule boundary (NodEdge). More towards the 
interior of the nodule (NodCtr), the action of hyaluronidases would generate HA 
fragments that may aid in promoting the differentiation of brown fat cells. Others have 
also reported the involvement with HA and the balance between HAS-2 and 
hyaluronidase in the differentiation of pre-adipocytes and mature adipocytes.19' 20 
Interestingly, TSG-6 is also expressed during the process of adipocyte maturation.21 The 
production of low molecular weight HA chains by hyaluronidases has also been shown to 
induce unique effects on chondrocytes in a variety of previous reports;22 the presence of 
HA was also found to promote chondrogenic differentiation of adipose derived stem cells 
in vitro?1 As noted above, these relationships between HA, brown fat, and hypoxia were 
primarily present in the nodules and surrounding tissues, but generally absent in the 
normal-appearing fibrosa, with the exception of a correlation between Hyal-1 and UCP-1. 
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Role for HA Regulation in Calcification 
Our hypothesis that HA homeostasis could affect TSG-6 to either promote or 
inhibit BMP-2 mediated calcification was supported by correlations between HA 
homeostasis markers, ossification markers, and TSG-6 that were unique depending on 
leaflet region. While Hyal-1 demonstrated correlations with markers of brown fat and 
ossification in PreNod and NodCtr, as well as NodSurr and PreNodSurr, no such 
correlations were evident in NodEdge. In contrast, in NodEdge HAS-2 showed strong 
correlations with these same markers of brown fat and ossification. Furthermore, TSG-6 
was associated with Hyal-1 and BMP-2 in NodSurr. This association of TSG-6 with 
BMP-2 could indicate TSG-6 inhibiting BMP-2 in promoting ossification, and may be 
related to Hyal-1 whose degradation of HA would allow TSG-6 to bind BMP-2. In 
NodEdge, however, HAS-2 appeared to be more active in ossification as demonstrated by 
numerous correlations with other markers. In the future, it will be important to 
investigate this hypothesis further, especially by assessing the activity of the other HA 
synthases (HAS-1 and HAS-3) in addition to HAS-2. 
We speculate, as shown in Figure 21-5, that the presence of newly synthesized 
HA at the nodule boundary (NodEdge), as opposed to HA degraded by Hyal-1, would 
have competed with BMP-2 for the same binding site on TSG-6, and as a result more 
BMP-2 would have been free to promote calcification and growth of the nodule at the 
boundary. In the other regions, the degraded HA may not have been able to bind to TSG-
6; the binding of HA to the glycoprotein hyaluronectin, a hyaladherin, was previously 
reported to be size dependent with smaller fragments (from 10 to <60 disaccharides) 
having lower binding affinity to hyaluronectin.24 Absent or reduced 
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Fig. 21-5: Hypothesized mechanism for inhibition of calcification outside of the nodule, in 
comparison to calcification processes occurring at the nodule edge. Outside of the nodule 
Hyal-1 appears more active than HAS-2, leading to net HA degradation. Therefore HA 
does not displace BMP-2 from binding TSG-6. BMP-2, while bound to TSG-6, is not able 
to promote calcification in the region outside of the nodule. However, at the nodule edge, 
HAS-2 appears more active than Hyal-1, resulting in net HA synthesis. This HA displaces 
BMP-2 such that BMP-2 is able to promote calcification in the nodule edge region. 
binding between HA fragments and TSG-6 would thus allow the sequestration of BMP-2 
and inhibit new calcification deep within the mature nodule (NodCtr), within the 
prenodule, and in the tissues surrounding the nodule (NodSurr, PreNodSurr). 
Hyaluronidases have not been previously investigated in calcified aortic valves, but with 
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regards to atherosclerosis their ability to generate low molecular weight HA has been 
linked with proliferation of smooth muscle cells (an effect also reported in valvular 
interstitial cells25) and VCAM-1 synthesis in vitro.12 In three-dimensional in vitro 
cultures of chick limb-bud mesenchymal cells or cartilage slices, the addition of 
hyaluronidase promoted increased mineral accumulation.26'27 HA itself appears to have 
a complicated relationship with calcification, with some reports suggesting that HA 
promotes the late osteogenic differentiation of cells28 while others have integrated HA 
into biomaterial scaffolds and found either enhancement29 or prevention ° of 
mineralization. Although there have been no published investigations of the HA 
synthases in heart valves, the signaling pathways regulating the activity of HAS-1, HAS-
2, and HAS-3 represent therapeutic targets for atherosclerosis and potentially should be 
investigated for CAVD as well. 
The results also showed roles for the HA binding receptors CD 168 and HARE in 
NodSurr and PreNodSurr, respectively. This work was the first demonstration of CD 168, 
also known as RHAMM (receptor for hyaluronic acid mediated motility) in heart valves. 
Our group has previously demonstrated the presence of HARE (HA receptor for 
endocytosis) in normal and myxomatous mitral valves,32 but its role in those valves as in 
these calcified valves is uncertain. In the kidney, HARE enables the clearance of HA and 
selected galactosaminoglycan proteoglycans from the bloodstream and is thought to be 
associated with HA turnover.33 The binding of HA to HARE causes phosphorylation of 
extracellular signal-regulated kinases 1 and 2 (ERK1/2) in a dose- and time-dependent 
manner.34 Moreover, the presence of HARE in heart valves is rather unique since this 
receptor is not found in other cardiovascular tissues. The finding that HARE is highly 
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correlated with the abundance of S-100 suggests that these diseased valves may have 
alterations in HA metabolism or intracellular signaling. Interestingly, the distribution of 
CD44 was unremarkable and did not show profound correlations with valve calcification 
(data not shown), despite its well known roles in inflammatory mediation in 
atherosclerosis10, n and in regulating tyrosine kinase activity of pl85HER"2 and src and the 
activation of Rho and Rac-1. CD44 was primarily involved with other HA regulatory 
mediators in the normal collagenous fibrosa. 
Distinctions among Nodule Regions and Prenodules 
The specificity and strength of the correlations between different mechanistic 
families was rather distinct between the inside and outside of the nodules, as well as 
between the nodules and prenodules. Although these overall mechanistic interactions 
tended to occur in almost every region, the specific markers involved tended to vary 
across the microanatomy. Correlations involving Hyal-1 were found in all nodule 
regions (NodCtr, PreNod) and surrounding tissues (NodSurr, PreNodSurr) except for 
NodEdge, where HAS-2 and HIF-la correlations were found. NodSurr had the greatest 
numbers of correlations between mechanistic families, suggesting that more active cell-
mediated remodeling was occurring within that region. PreNod and PreNodSurr were 
characterized by many very strong correlations between HA regulation and endochondral 
ossification, but no interactions between these mechanisms and the hypoxic/brown fat 
mechanism, which suggests that the prenodules are undergoing remodeling that is 
distinctive from the mature nodules and may represent an earlier stage of the nodule 
maturity. Indeed, others have noted that smaller nodules have a greater degree of 
580 
neovascularization compared with large nodules, which perhaps counters the brown-fat-
generated hypoxic conditions in the prenodules. 
Limitations 
Although numerous correlations between different remodeling mechanisms were 
highly significant, the heterogeneous nature of the microstructural remodeling amongst 
the leaflet samples made it difficult to demonstrate significant differences in the 
abundance of the various markers through an analysis of variance. As a result, the work 
was primarily descriptive. In the future, it may be useful to examine the interactions 
between these mechanisms in well-controlled animal or in vitro models. 
CONCLUSIONS 
This research demonstrated the first evidence that the regulation of HA turnover, 
as well as the promotion of hypoxic conditions by brown fat cells, is associated with 
endochondral ossification in calcific aortic stenosis. Additionally, the interactions 
between these mechanisms vary between large and small nodules and between the 
nodules and their surrounding tissues, with the tissues surrounding the nodules showing 
the greatest active remodeling. Further investigation of these regulatory and remodeling 
mechanisms, and their interactions with other pathways such as wnt, may offer insight 
into novel medical therapies that could intervene in numerous important pathological 
processes within the progression of this disease. 
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This chapter, which analyzed markers of hypoxia, hyaluronan homeostasis, 
brown adipocytes, and osteogenesis and chondrogenesis relative to calcified nodules, 
completes the set of two studies on calcific aortic valve disease (Chapters 20 and 21), 
as well as the portion of the thesis analyzing valve alterations in various diseased 
states (Chapters 13-21). Among other purposes, these studies analyzing valves in 
diseased states were intended to develop negative design criteria for a tissue 
engineered heart valve, which could be combined with the studies of normal valves 
(Chapters 2-12) providing positive design criteria for such a valve. The next chapter 
presents preliminary work towards the development of a tissue engineered heart 
valve. In this study, functionalized poly(ethylene) glycol hydrogels were used to 
investigate age- and valve-region-specific responses of mitral valvular interstitial 
cells to substrate stiffness. In the future, these functionalized poly(ethylene) glycol 
hydrogels can potentially serve as scaffolds for a tissue engineered heart valve. 
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Chapter 22: Age- and Valve-Region-Specific Responses of 
Mitral Valvular Interstitial Cells to Substrate Stiffness 
While the studies in the earlier portions of the thesis addressed developing 
positive design criteria (by analyzing normal valves, Chapters 3-12) and negative 
design criteria (by analyzing valves in various diseased states, Chapters 13-21) for a 
tissue engineered heart valve, this chapter presents preliminary work in 
constructing a tissue engineered heart valve. In this chapter functionalized 
poly(ethylene) glycol hydrogels, which potentially can serve as scaffolds for a tissue 
engineered heart valve, were used to investigate age- and valve-region-specific 
responses of mitral valvular interstitial cells to substrate stiffness. 
ABSTRACT 
Background: While work has been performed developing scaffolds for a tissue 
engineered heart valve (TEHV) with proper mechanical properties, little attention has 
been paid to the role of scaffold stiffness in influencing valvular interstitial cell (VIC) 
phenotype, and resultant matrix synthesis. Additionally, recent studies suggest the need 
for an age-specific TEHV. Given that different aged VICs reside in matrices with 
different stiffnesses, we hypothesized that there may be an age-specific response of VICs 
to substrate stiffness. Similarly, VICs derived from regions of the mitral valve (MV) 
known to have different stiffnesses may display distinct responses to substrate stiffness. 
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Methods: To test these hypotheses, 6-week, 6-month, and 6-year-old porcine VICs from 
the anterior center of the mitral valve (MVAC) and the posterior mitral leaflet (PML) 
were seeded onto poly(ethylene) glycol (PEG) hydrogels of different stiffnesses and 
stained for markers of VIC activation (smooth muscle alpha-actin (SMaA) and collagen 
synthesis (heat shock protein-47 (HSP47) and prolyl 4-hydroxylase (P4H)). 
Results: While 6-week-old MVAC VICs demonstrated decreased SMaA, P4H, and 
HSP47 on stiffer gels, 6-week-old PML VICs only demonstrated decreased HSP47. 
While 6-month-old MVAC VICs demonstrated no differences in marker expression when 
seeded on the two stiffnesses, 6-month-old PML VICs demonstrated decreased SMaA, 
P4H, and HSP47 on the stiffer gels. 6-year-old MVAC VICs demonstrated decreased 
P4H and HSP47 on the stiffer gels, while 6-year-old PML VICs demonstrated decreased 
P4H and increased HSP47 on the stiffer gels. 
Conclusions: The results from this study demonstrated both age-specific and valve-
region-specific responses of VICs to substrate stiffness. These findings should be taken 
into consideration in the design of an age-specific tissue engineered heart valve, as well 
as future investigations into heart valve mechanobiology. 
The work contained in this chapter is under review by the journal Biomaterials: 
Stephens EH, Durst CA, West JL, Grande-Allen KJ. Age- and Valve-Region Specific 




Valve disease affects a large portion of the population: 1-2% of 26-84 year-olds 
are afflicted by mitral valve disorders and approximately 1 % of the population have a 
bicuspid aortic valve.2 Valve disease incurs significant morbidity and mortality, 
requiring over 100,000 surgeries in the U.S. each year.3 While mechanical and 
bioprosthetic valves are currently used as surgical replacements for diseased valves, they 
are suboptimal in terms of complications and long-term durability. A tissue engineered 
heart valve made of autologous cells, however, could provide a much improved treatment 
option for the many afflicted by valve disease. Such a valve would be especially 
advantageous for the pediatric population, in which complications and durability of 
mechanical and bioprosthetic valve replacements are particularly problematic. 
Additionally, these valve replacements do not grow with the child; therefore, even if 
issues related to anti-coagulation, calcification, and long-term durability were resolved, 
these patients would still require surgeries every few years to replace their outgrown 
valves. A tissue engineered heart valve, however, could be designed to grow with the 
patient and after initial implantation additional re-operations could be avoided. 
Ongoing work in a number of laboratories toward the development of a tissue 
engineered heart valve covers topics ranging from assessment of potential cell sources, 
design of bioreactors for mechanical conditioning of tissue engineered constructs, and 
optimization of scaffold technology. While developing a scaffold with material 
properties that can withstand physiologic pressures and flows has been extensively 
investigated,4 the role of scaffold stiffness in affecting valvular interstitial cell (VIC) 
phenotype has largely not been studied, with the exception of preliminary investigations 
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into the role of stiffness in VIC calcification.5 It is well known that cells of many types 
respond to substrate stiffness;6 stiffness affects cell proliferation, matrix production, and 
even cell differentiation,6 all properties that would be important in the long-term success 
of a tissue engineered heart valve. 
Recent work demonstrating significant changes in valve composition7"9 and 
material properties with age10 suggests the need for an age-specific tissue engineered 
heart valve. Given that different aged VICs reside in valves with distinct stiffnesses,10 it 
was hypothesized that there may be an age-related response of VICs to substrate stiffness. 
Similarly, different regions of the MV have different stiffnesses,11 therefore the VICs 
from these distinct regions may also respond to substrate stiffness differently. In order to 
test this hypothesis, different aged VICs and VICs from different regions of the MV from 
the same hearts were cultured on poly(ethylene) glycol (PEG) hydrogels of different 
stiffnesses for 48 hours and VIC expression of cell phenotype and collagen synthesis 
markers was assessed using immunocytochemistry (ICC). 
PEG hydrogels were chosen for this experiment based on their promise as a 
potential platform for the design of scaffolds for tissue engineered heart valves. PEG 
hydrogels are extremely hydrophilic, providing prevention against protein adsorption, a 
critical step in the immunogenicity and degradation of bioprosthetics.12 PEG hydrogels 
are also highly permeable allowing the exchange of nutrients and waste materials. 
Their stiffness can be regulated by changing the molecular weight and concentration of 
PEG.14 However, one of the factors that makes these gels particularly attractive is the 
ability to customize them by conjugating to the PEG backbone various peptides, 
including cell ligands and growth factors, as well as incorporating enzyme degradable 
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sequences allowing tunability of the degradation rate of the hydrogel. This designer 
biofunctionality makes PEG hydrogels ideal for the tissue engineering of heart valves. In 
the present study PEG hydrogels were conjugated with an Arg-Gly-Asp-Ser (RGDS) 
peptide, enabling VIC attachment to the hydrogel, and methacrylated heparin, which is 
necessary for normal VIC morphology.15, 16 These functionalized PEG hydrogels of 
different stiffnesses were formulated to keep the concentration of biological cues 
constant, thus isolating the effect of stiffness on VIC phenotype. 
METHODS 
Preparation and Purification of PEG-Diacrylate (PEG-DA) 
PEG-diacrylate (PEG-DA) of 3400 Da MW was synthesized from PEG (Sigma-
Aldrich, St. Louis, MO, unless otherwise indicated all reagents used were obtained from 
Sigma-Aldrich) as previously described.14 Briefly, 0.014 moles of 3400 Da MW PEG 
dissolved in anhydrous dichloromethane was combined under anhydrous conditions with 
0.028 moles of triethyl amine. The solution was allowed to mix for 5 minutes before the 
addition of 0.056 moles acryloyl chloride. The solution was allowed to react overnight 
(Fig. 22-1). The following day 56 mL of 2 M K2CO3 was added and the solution shook 
vigorously. The reaction vessel was then allowed to sit overnight allowing the two 
phases to separate (the upper aqueous phase consisting of triethyl amine-Cl and lower 
organic phase consisting of PEG-DA). The lower organic phase containing PEG-DA was 
then drained and the upper aqueous phase discarded. Anhydrous MgS04 (Fisher) was 
added to the organic phase and the solution was filtered. PEG-DA was precipitated out 
of solution using diethyl ether (Fisher). The resulting precipitate was dried under vacuum 
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and stored at -20°C under argon until use. *H NMR analysis revealed >95% acrylation 
(Fig. 22-2). *H NMR spectra of all PEG components were taken at 25 °C on a Varian 
800 MHz Inova NMR spectometer (Palo Alto, CA) equipped with a 5 mm inverse HCN 
cold probe. Samples were prepared in 600 [iL D2O w/ 28 i^M 3-
(Trimethylsilyl)propionic acid (TSP) added as a proton standard. Proton ID spectra were 
acquired using a 90 degree pulse, a 3 second acquisition time, and a 3 second recycle 
delay for a total interpulse delay of 6 seconds; 32 transients were collected. The spectra 
were processed using the VNMRJ2.2D software (Varian). 
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PEG acryloyl chloride PEG-DA 
Fig. 22-1: PEG-DA reaction schematic. PEG is reacted with acryloyl chloride in a 2 
acyrloyl chloride: 1 PEG molar ratio. The product contains acrylate groups that allow 
























































































































































































































































Preparation and Purification of PEG-RGDS and PEG-WRGDS 
The Arg-Gly-Asp-Ser (RGDS) peptide (Bachem, Bubendorf, Switzerland), which 
allows cell adhesion to PEG hydrogels, was attached to hetero-bifunctional PEG (PEG-
SCM, Laysan Bio, Arab, AL) by reacting the peptide PEG-SCM and catalyst 
diisopropylamine in dimethyl sulfoxide (DMSO) (1.2 M RGDS : 1.0 M PEG-SCM : 2.0 
M disopropylamine). Briefly, the 20 mg of the RGDS peptide was dissolved in DMSO. 
The base catalyst diisopropylamine was added to the RGDS solution in a 2 
diisopropylamine: 1.2 RGDS molar ratio. Then PEG-SCM dissolved in DMSO was 
added drop-wise to the RGDS/diisopropylamine solution in a 1 PEG-SCM: 1.2 RGDS 
molar ratio (Fig. 22-3). The resulting solution was vortexed and placed on an orbital 
shaker overnight. The next day the solution was placed on ice and ultrapure water was 
added to double the reaction volume. The resulting solution was then dialyzed against 
ultrapure water using a 1000 MWCO membrane (Spectrum Laboratories, Rancho 
Dominguez, CA) and lyophilized to dryness. The product was stored at -20°C under 
argon until use. The Tryp-Arg-Gly-Asp-Ser (WRGDS) peptide (GenScript, Piscataway, 
NJ) was attached to PEG-SCM and purified in the same manner. Percent conjugation 
was evaluated using gel permeation chromatography. Samples were dissolved in 
dimethylformamide with 0.1% ammonium acetate at a concentration of ~2 mg/ml, run on 
a PLgel column (5 urn, 500 A, Polymer Laboratories, Shropshire, UK), with an 
evaporative light scattering detector (Polymer Laboratories), and resultant peak areas 
analyzed using PL ELS 1000 software (Polymer Laboratories). Evaluation of PEG-
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RGDS by gel permeation chromatography revealed 81% conjugation (Fig. 22-4). 
Similarly, evaluation of PEG-WGRDS by NMR revealed 83% conjugation (Fig. 22-5). 
o^O^o 
+ RGDS RGDS 
PEG-SCM PEG-RGDS 
Fig. 22-3: PEG-RGDS reaction schematic. PEG-SCM is reacted with RGDS peptide 
yielding PEG-RGDS. Incorporation of PEG-RGDS in PEG hydrogels allows cell 
adhesion. The reaction schematic for PEG-WRGDS is equivalent. 
Preparation and Purification of Methacrylated Heparin 
Methacrylated heparin was synthesized as published previously.15 Briefly, a 10 
mg/ml solution of heparin dissolved in ultra pure water was reacted with 40 fold molar 
excess methacrylic anhydride. The pH of the solution was adjusted to 7.5 using 4M 
NaOH and stirred for 24 hours. Methacrylated heparin was then precipitated using cold 
95% ethanol. The precipitate was then filtered, dried, and dialyzed against ultra pure 
water using a 1000 MWCO membrane (Spectrum Laboratories). The product was then 
lyophilized and stored at -20°C under argon until use. *H NMR analysis revealed 5% 
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Elution Time (min) 
Fig. 22-4: Gel permeation chromatography of PEG-RGDS. The conjugated product, with 
its higher molecular weight elutes faster from the column and appears as the first peak (1), 
while the unconjugated PEG-SCM elutes later and appears as the second peak (2). Analysis 

















Elution Time (min) 
Fig. 22-5: Gel permeation chromatography of PEG-WRGDS. The conjugated product, with 
its higher molecular weight, elutes faster from the column and appears as the first peak (1), 
while the unconjugated PEG-SCM elutes later and appears as the second peak (2). Analysis 




















a> s ca a, 






Polymerization of Functionalized PEG Hydrogels 
Functionalized PEG hydrogels were synthesized by dissolving the appropriate 
amounts of PEG-RGDS, methacrylated heparin, and PEG-DA in phosphate-buffered 
saline. Then 10 uL/mL 2,2-dimethoxy-2-phenyl-acetophenone (300 mg/mL in l-vinyl-2-
pyrrolidone) was added and the solution was poured between two sterile glass slides 
separated by a 0.4 mm spacer and exposed to UV light for 2 minutes (365 nm, 10 
mW/cm2). Hydrogels were then removed from the mold and soaked in phosphate-
buffered saline with 2% antibiotic (Mediatech, Herndon, VA) for at least 24 hours 
allowing the hydrogels to swell to equilibrium and any unreacted reagents to diffuse out 
of the hydrogels. Hydrogel thickness was optically measured using a Leica DFC 320 
CCD camera (Wetzlar, Germany) and ImagePro acquisition software (Media 
Cybernetics, Bethesda, MD). Hydrogel thicknesses were determined from the acquired 
images using Image J software (NIH, Bethesda, MD). 
Quantification of Methacrylated Heparin in Functionalized PEG Hydrogels 
The concentration of methacrylated heparin in polymerized, swollen gels was 
determined using an uronic acid assay, as described by Blumenkrantz and Asboe-
Hansen.17 Briefly, hydrogels were hydrolyzed by reacting them with 0.1N NaOH for 34 
hours at 37°C. The solutions were then neutralized using 0.1 N HC1. An aliquot was 
then added to cold sulfuric acid tetraborate (12.5 mM sodium tetraborate in sulfuric acid). 
The solution was heated at 100°C for 5 minutes, and then cooled in a room temperature 
water bath for 5 minutes. Half of the solution was transferred to separate tubes to serve 
as blanks in the assay, while 10 i^l of hydroxyphenyl (0.15% m-hydroxyphenol in 0.5% 
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NaOH) was added to samples. Samples and blanks were aliquoted in triplicate into a 96-
well plate and read on a spectrophotometer (SpectraMax M2, Molecular Devices, 
Sunnyavale, CA, absorbance read at 532 nm with background subtraction of 750 nm). A 
standard curve of methacrylated heparin was similarly created allowing quantification of 
the amount of methacrylated heparin in the polymerized, functionalized PEG hydrogels. 
Quantification of PEG-RGDS in Functionalized PEG Hydrogels 
Quantification of the amount of RGDS in the polymerized, swollen functionalized 
PEG hydrogels was performed utilizing tryptophan (which was detected by its 
absorbance at 280 nm) in the RGDS peptide (WRGDS). PEG-DA/PEG-
WRGDS/methacrylated heparin hydrogels were synthesized in the same manner as 
described above and biopsy punches taken from these swollen gels were read on a 
spectrophotometer (SpectraMax M2). The absorbance of these samples at 280 nm was 
then compared to a PEG-WRGDS standard curve and the amount of PEG-WRGDS in the 
hydrogels calculated. 
Optimization of Functionalized PEG Hydrogels 
Optimization studies were performed to determine the concentrations of PEG-
RGDS and methacrylated heparin in the pre-polymer solution necessary to yield 
equivalent amounts of PEG-RGDS and methacrylated heparin in the swollen, 
polymerized gels of the two different weight-volume fractions of PEG-DA. The 
concentration of methacrylated heparin in polymerized, swollen gels was determined 
using an uronic acid assay, as described above determined that 9.0 mg/ml of 
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methacrylated heparin in the pre-polymer hydrogel solution for the 5% weight-volume 
PEG-DA hydrogel and 10.6 mg/ml of methacrylated heparin in the solution for the 15% 
weight-volume PEG-DA hydrogel yielded equivalent concentrations of methacrylated 
heparin in the polymerized, swollen gels of the different PEG-DA weight-volume 
fractions (Fig. 22-7). Optimization studies utilizing tryptophan (described above), 
determined that 7.49 mg/ml of PEG-RGDS in the pre-polymer solutions for both weight-
volume PEG-DA hydrogels yielded equivalent final concentrations of PEG-RGDS in the 
swollen, polymerized gels (Fig. 22-8). 
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Fig. 22-7: Concentration of methacrylated heparin in different weight-volume fraction 
PEG swollen gels as determined by uronic acid assay. Error bars on all graphs 
indicate standard error of the mean. 
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Fig. 22-*: Optimization of PEG-WRGDS in different weight-volume fraction PEG 
swollen gels by varying concentration of PEG-WRGDS in the pre-polymer solutions. 
Concentration of PEG-WRGDS was determined by absorption at 280 nm. 
Determination of Elastic Modulus of Functionalized PEG Hydrogels 
Strips of each weight-volume fraction PEG hydrogel (5 mm in width) were 
uniaxially tensile tested using an EnduraTec ELF 3200 (Bose, Eden Prairie, MN). The 
strain-rate was 10 mm/sec and load-elongation data recorded until failure occurred. 
Displacement was converted to strain based on the initial hydrogel length between grips. 
The elastic modulus was determined as the slope of the least-squares linear fit to the 
stress-strain curve. 
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Cell Culture and Cell Seeding onto PEG 
Mitral valves were dissected from hearts from 6-week, 6-month, and 6-year-old 
pigs obtained from an abattoir (6-week and 6-month-old from Fisher Ham and Meat, 
Spring, TX; 6-year old from Animal Technologies, Tyler, TX). Valvular interstitial cells 
(VICs) were isolated from the anterior leaflet center (MVAC) and the posterior leaflet 
1 8 
(PML) from the same hearts according to previously published protocols; previous 
studies have demonstrated that the MVAC is stiffer than the PML.11 Cells were cultured 
in medium containing 10% bovine growth serum (HyClone, Logan, UT) and 2% 
antibiotic/antimycotic (Mediatech). Media was changed every 2-3 days and cells were 
passaged after reaching 80-90% confluence. Experiments were performed on cells from 
passage 5-6. Cells were seeded onto functionalized PEG hydrogels at a cell density of 
6,000 cells/cm2 and maintained in 10% serum media with 2% antibiotic/antimycotic. 
Immunocytochemistry 
After 48 hours of culture the gels were fixed by incubation in 10% formaldehyde 
in PBS for 30 minutes at room temperature. Samples of dimensions 4 mm x 6 mm were 
cut from cell-seeded gels and transferred to the wells of an 8-well cover glass chamber 
(LabTek II, Nalge Nunc International, Naperville, IL) for immunocytochemical (ICC) 
staining and subsequent imaging. ICC was performed for markers of collagen synthesis 
prolyl 4-hydroxylase (P4H, Chemicon, Temecula, CA), heat shock protein 47 (HSP47, 
Assay Designs, Ann Arbor, MI), as well as markers related to valve cell phenotype 
vimentin (Dakocytomation, Denmark) and smooth muscle alpha-actin (SMaA, 
Dakocytomation), with AlexaFluor 488 secondary antibodies (Invitrogen Molecular 
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Probes, Eugene, OR). Stained gels were imaged using LSM 5 LIVE 5 DuoScan (Zeiss, 
Oberkochen, Germany) and staining intensity and as well as cell morphology (area and 
circularity) were quantified using ImageJ software. 
Statistical Analysis 
Multifactorial analysis of variance to compare differences between 
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Fig. 22-9: Stiffness of different weight-volume fraction functionalized PEG gels 
as determined by uniaxial tensile testing. 
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RESULTS 
Stiffness of Different Weight-Volume Fraction Functionalized PEG Hydrogels 
Uniaxial testing revealed that functionalized 5% weight-volume PEG gels had a 
mean modulus of 34.5 kPa while functionalized 15% weight-volume PEG gels had a 
mean modulus of 323.3 kPa (Fig. 22-9). 




















































Fig. 22-10: Fraction of VICs displaying positive SMaA staining on gels of different 
stiffnesses, *p=0.06, Ap=0.1 5% vs. 15% gels. 
SMaA Expression of VICs on Gels of Different Stiffnesses 
Not all VICs stained positively for SMaA, as expected. Analysis of the fraction 
of VICs expressing SMaA (SMaA+ VICs) on the different gels revealed a trend towards 
decreased SMaA+ VICs on the 15% gels compared to the 5% in the 6-week-old MVAC 
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VICs (Fig. 22-10, p=0.1), but no difference between gels for 6-week-old PML VICs. 6-
month and 6-year-old MVAC VICs did not display a difference in the fraction of SMaA+ 
VICs between gels, but 6-month and 6-year-old PML VICs showed a trend toward 
decreased SMaA + VICs on the 15% gels relative to the 5% gels (p=0.06). Analysis of 
the intensity of SMaA stain in SMaA+ VICs on the different gels revealed a trend 
towards decreased intensity in SMaA+ VICs for 6-week-old MVAC VICs (Fig. 22-11, 
p=0.087), but no difference for 6-week-old PML VICs. 6-month-old MVAC 
demonstrated no change in SMaA intensity in MVAC VICs, but decreased SMaA 
intensity in PML VICs (p<0.05). No difference in SMaA intensity between gels was 
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Fig. 22-11: SMaA staining intensity for positive SMaA staining VICs on gels of 
different stiffnesses, *p<0.05, *p=0.087 5%vs. 15% gels. 
604 
P4H Expression of VICs on Gels of Different Stiffnesses 
Analysis of P4H intensity, which was expressed by all VICs, demonstrated 
decreased intensity in 6-week-old MVAC VICs on the 15% gels relative to the 5% gels 
(p<0.05), but no difference between gels for 6-week-old PML VICs. 6-month-old 
MVAC VICs demonstrated no difference in P4H intensity between gels, but 6-month-old 
PML VICs demonstrated decreased intensity on the 15% gels relative to the 5% gels (Fig. 
22-12, p<0.05). 6-year-old MVAC and PML VICs both demonstrated decreased P4H 
intensity on the 15% gels relative to the 5% gels (MVAC p<0.05, PML p<0.085 (trend)). 
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Fig. 22-12: P4H staining intensity of VICs on gels of different stiffnesses, 
*p<0.05, Ap<0.085 5% vs. 15% gels. 
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HSP47 Expression of VICs on Gels of Different Stiffnesses 
Analysis of HSP47 intensity, which was expressed by all VICs, demonstrated 
decreased intensity in both 6-week-old MVAC and PML VICs on the 15% gels relative 
to the 5% gels (Fig. 22-13, both p<0.05). 6-month-old MVAC VICs demonstrated no 
difference in HSP47 intensity between gels, but 6-month-old PML VICs demonstrated 
decreased HSP47 intensity on the 15% gels relative to the 5% gels (p<0.05). 6-year-old 
MVAC demonstrated no difference in HSP47 intensity between gels, but 6-year-old PML 
VICs demonstrated increased HSP47 intensity on the 15% gels relative to the 5% gels 
(p<0.05). 
HSP47 Intensity in VICs 
2.5E+04 
MVAC PML MVAC PML MVAC PML 
6wk 6mo 6yo 
Fig. 22-13: HSP 47 staining intensity of VICs on gels of different stiffnesses, 
*p<0.05 5% vs. 15% gels. 
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VIC Morphology on Gels of Different Stiffnesses 
For both MVAC and PML VICs of each age and on each gel, two populations of 
VICs were noted: one with a spindle-shaped cell morphology, and a second with a 
cuboidal cell morphology (Fig. 22-14). Analysis of staining intensity of cuboidal and 
spindle-shaped subpopulations revealed that for given age- and valve-region VICs that 
responded to substrate stiffness, both subpopulations demonstrated a response (data not 
shown). Cell morphology analysis of vimentin-stained VICs revealed decreased cell area 
of 6-month-old PML VICs on the 15% gels relative to the 5% gels (p<0.02). No 






Fig. 22-14: Images ofvimentin-stained VICsfrom each age group demonstrating 
two distinct VIC morphologic sub-populations: spindle-shaped cells and cuboidal 
cells. These distinct sub-populations were evident for VICs isolated from both 
MVAC and PML and on PEG gels of both stiffnesses. Shown here are MVAC VICs 
on 15% PEG gels. Scale bars indicate 50 jum. 
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DISCUSSION 
In this study, mitral VICs grown on functionalized PEG hydrogels demonstrated 
both age-specific and valve-region specific (MVAC vs. PML) responses to substrate 
stiffness. While 6-week-old MVAC VICs on the gels of different stiffnesses 
demonstrated differences in SMaA, P4H, and HSP47 expression, 6-week-old PML VICs 
only demonstrated altered HSP47 expression. In contrast, 6-month-old MVAC VICs 
demonstrated no differences in marker expression on the gels of different stiffnesses, 
while 6-month-old PML VICs demonstrated differences in SMaA, P4H, and HSP47 
expression. 6-year-old MVAC and PML VICs displayed a more complex response to the 
gels of different stiffnesses: 6-year-old MVAC VICs demonstrated no difference in 
SMaA intensity between the two gels, but decreased P4H and HSP47 on the stiffer gels. 
6-year-old PML VICs also demonstrated no difference in SMaA intensity between the 
two gels, but decreased P4H and increased HSP47 intensity on the stiffer gels. These 
results underscore the range of unique phenotypes found in valvular cells depending on 
anatomic region and age. 
Previous Studies of VICs and Substrate Stiffness 
While the response of cells to substrate stiffness has been studied extensively in 
cell-types from many other tissues (see excellent review by Nemir, et al.6), very limited 
investigation has been performed on the response of VICs to substrate stiffness. 
Furthermore, no published studies to date have examined the response of MV VICs to 
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substrate stiffness and no studies have investigated a potential age-specific or valve 
region-specific response of VICs to substrate stiffness. 
Work in fibroblasts from different tissues examining cell phenotype and 
morphology changes in response to substrate stiffness has documented increased actin 
fibers in response to increased substrate stiffness,6 appearance of stress fibers on 
stiffnesses 10 kPa and above,19 and an increase in cell spreading that was maximum on 
substrate stiffnesses of 8-10 kPa.19' 20 However, all of these studies were performed 
within a range of substrate stiffnesses that was much lower (i.e. 1 kPa to 100 kPa ) than 
the stiffnesses used in the present study. While the in vivo stiffness of the MVAC 
continues to be debated,21' 22 and the in vivo stiffness of the PML remains to be 
determined, these stiffnesses are certainly considerably greater than the 1-10 kPa range of 
substrate stiffness commonly utilized in fibroblast experiments. The two gel stiffnesses 
used in this study were chosen to be in the same general range that could be consistent 
with in vivo stiffnesses of the MVAC and PML, and yet two stiffnesses that were 
different enough to potentially elicit age- and valve-region specific VIC responses. 
In the context of aortic valve (AV) calcification, three studies have analyzed the 
effect of substrate stiffness on the calcification potential and activation of porcine AV 
VICs. In a study by Benton et al.,23 10% 4.6 kDa PEG-dimethacrylate (PEG-DM) 
hydrogels (compressive modulus of ~ 100 kPa) were functionalized with fibronectin or 
fibrin. The calcification potential of AV VICs cultured on these surfaces was then 
compared to AV VICs cultured on unmodified tissue culture polystyrene (TCPS, much 
stiffer substrate), as well as TCPS coated with fibrin and fibronectin.23 Cells were seeded 
at confluence (allowing cell-to-cell interaction) and cultured for 6 days on their respective 
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substrates before assaying for markers of VIC activation (SMaA) and calcification. 
One of the key findings of this study was that the response of VICs to substrate stiffness 
differed depending on the matrix coating the substrate. AV VICs cultured on fibronectin-
coated TCPS and fibronectin-functionalized PEG both did not show increases in 
calcification markers relative to controls, but VICs cultured on fibrin-coated TCPS 
showed increases in calcification markers while VICs cultured on fibrin-coated PEG did 
not.23 In another study of AV VIC calcification potential using collagen gels of different 
stiffnesses, Yip et al.5 found that porcine AV VICs did not display any difference in 
calcification potential with varying substrate stiffness in normal media, but in 
calcification media AV VICs developed different types of calcific nodules depending on 
the stiffness of the collagen gels. In an earlier study by Pho et al.,24 SMaA expression in 
AV VICs was increased on stiffer collagen gels; however, unlike in the study by Yip et 
al. in which collagen gels stiffness was varied by altering the gel thickness, in the study 
by Pho et al. stiffness was varied by altering collagen concentration. Therefore, in the 
study by Pho et al. VICs on the gels of different stiffnesses were also exposed to different 
concentrations of collagen fibers, and the potential difference in biological cues given to 
the VICs on the different substrates may have confounded their results.24 
Age-Specific and Valve-Region Specific Responses of VICs to Substrate Stiffness 
In the present study both age-specific and region-specific responses of VICs to 
different substrate stiffnesses were evident. Based on ex vivo experiments of material 
properties of different aged porcine MVs and different regions within the porcine MV 
(MVAC vs. PML), one would expect the 6-week-old VICs to be accustomed to a less 
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stiff substrate relative to 6-month and 6-year-old VICs. Similarly, given studies 
demonstrating that MVAC tissues are stiffer than PML tissues," one would expect VICs 
isolated from the MVAC to be accustomed to a stiffer substrate than VICs isolated from 
the PML. Unfortunately, the actual in vivo stiffness of the MVAC remains unclear, with 
only a few reports citing vastly differing values,21'22 and no reports exist citing values for 
the in vivo stiffnesses of different aged MVAC and PML. Potentially, the results from 
this study could be explained by differences in "optimal" stiffness for each VIC 
population assessed. Just as "optimal" stiffnesses have been demonstrated for stem cell 
lineage specification and the expression of associated cellular markers,25 in VICs 
expression of myofibroblast phenotype and collagen synthesis markers may reach a 
maximum at a certain stiffness, and this stiffness could be unique for each VIC 
population. Based on the mechanical testing studies cited above, potentially the 
"optimal" stiffness for 6-week-old PML would be less than 6-month-old PML and 6-
week-old MVAC. Where the stiffnesses of the 5% and 15% gels used in this study fall 
upon this hypothetical marker expression-stiffness curve for a particular VIC population 
could explain whether differences in marker expression were observed for that VIC 
population seeded on the 5% and 15% gels (Fig. 22-15). Clearly, substantial future work 
is needed to investigate this hypothesis further; nevertheless, the results from this study 
demonstrate that there are age- and valve region-specific responses of VICs to substrate 
stiffness. 
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Fig. 22-15: Schematic illustrating how differences or lack of differences in marker expression 
between VICs seeded on 5% and 15% gels observed in this study may relate to a hypothetical 
marker expression-substrate stiffness continuum. These curves could be distinct for each VIC 
population (i.e., age and valve-region). A) The stiffnesses of the 5% and 15% gels fall on the 
marker expression-substrate stiffness curve such that marker expression of VICs on the 5% 
gels is greater than on the 15% gels. B) The stiffnesses of the 5% and 15% gels fall on the 
marker expression-substrate stiffness curve such that marker expression of VICs on the 5% 
gels is equal to the marker expression of VICs on the 15% gels. 
In terms of specific protein expression, SMaA expression and proportion of 
SMaA+ cells generally paralleled changes in collagen synthesis markers in 6-week-old 
and 6-month-old MVAC and PML VICs. However, in 6-year-old VICs changes were 
evident in markers of collagen synthesis despite no detectable change in SMaA intensity. 
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Benton et al. similarly found a disparity between changes in SMaA expression and 
calcification potential in studying AV VICs, where on some surfaces no change in SMaA 
expression was noted, while markers of calcification demonstrated significant changes.23 
While the results for HSP47 largely paralleled those of P4H, in 6-year-old PML VICs 
P4H expression was decreased on 15% gels relative to 5% gels, while HSP47 was 
increased. Previous studies have shown that HSP47 can be induced by mechanical stress 
in tendon cells independent of collagen synthesis.26 Additionally, transforming growth 
factor-beta (TGF(3) in fibroblasts induces HSP47,27 and VICs on heparin-coated surfaces 
produce more TGFp\ which is then bound by heparin, allowing this growth factor to 
modulate VIC cell phenotype.28 Certain enzymes, such as lysyl hydroxylase 2, also have 
demonstrated differential regulation of HSP47 and P4H in dermal fibroblasts.29 
Therefore, there is the potential for HSP47 to show distinct changes in response to 
substrate stiffness relative to P4H. 
While the decrease in SMaA in some of the VIC populations on stiffer gels in this 
study at first glance may appear to contradict the findings of Pho et al.,24 it should be 
noted that there were substantial differences between these studies. In the study by Pho 
et al. AV VICs were studied, cells were seeded near confluence allowing cell-cell 
interactions, collagen gels were used as substrates, and collagen concentrations (and 
therefore cell-matrix signaling) between the gels of different stiffnesses varied.24 
Furthermore, the stiffer gel in the study by Pho et al. was considerably less stiff than the 
15% PEG gel used in the present study.24 Work by Engler et al.25 has demonstrated that 
for stem cells there exists a stiffness at which there is a maximum in myofibroblast 
marker expression, and above this stiffness myofibroblast marker expression actually 
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decreases, which would be consistent with the findings of this study. Differences in the 
results between the Pho, et al. study and the present study may also be influenced by the 
matrix components used in the substrates of different stiffnesses. In studying the 
calcification potential of AV VICs in response to substrate stiffness, Benton found that 
AV VICs responded to the same substrate stiffness differently depending on what matrix 
component coated the surface.23 Additionally, studies have demonstrated differences in 
AV and MV VICs in response to growth factors,30'31 therefore, VICs from the AV and 
MV may also demonstrate distinct responses to substrate stiffness. 
VIC Subpopulations 
Distinct VIC subpopulations, including the spindle-shaped and cuboidal cell 
morphologies evident in this study, have been previously documented.32'33 The spindle-
shaped cells demonstrate qualities similar to fibroblasts, while those with cuboidal 
morphology are similar to myofibroblasts and are associated with valve remodeling and 
various valve pathologies. " These subpopulations also demonstrate differences in 
adhesion to different substrates and matrix components, such as fibronectin.37'38 In the 
present study, when a difference in marker expression in VICs between the gels of 
different stiffnesses was evident, both subpopulations appeared to display this difference. 
Recent advancements in the isolation of these subpopulations could allow a more in-
depth investigation of these subpopulations with respect to substrate stiffness.37'38 
Implications 
The age- and region-specific differences of VICs in response to substrate 
stiffness observed in this study should be taken into consideration in selecting cell 
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sources for tissue engineered heart valves. These results suggest that substrate stiffness 
should be carefully orchestrated in the context of specific VIC populations to optimize 
cell phenotype and matrix production. Furthermore, in light of the fact that these 
different VIC populations (from different aged valves and from different regions) reside 
in matrices of different stiffnesses, these results suggest that the in vivo mechanical 
environment in which VICs reside has a profound, fundamental impact on the 
responsiveness of VICs to their external environment (i.e., their baseline intracellular 
signaling framework), even in the ex vivo setting. 
Limitations and Future Studies 
While the results of this study provide fundamental knowledge regarding how 
MV VICs respond to substrate stiffness, substantial work remains in this area and certain 
study limitations should be noted. While the concentrations of biological cues presented 
to these cells (RGDS and methacrylated heparin) were carefully orchestrated to be the 
same between the two substrates, there may be differences in how different aged VICs 
and VICs from different valve regions respond to the same concentration of these 
biological cues (for example, if cultured on tissue culture plastic). Future studies 
investigating this further, and perhaps assessing differences in how these cells interact 
with their substrate (i.e., expression of integrins) would add insight in this area. 
Additionally, the mechanism(s) by which these cells respond differently to their substrate 
warrants investigation. For instance, while PEG is highly hydrophilic and does not 
adsorb proteins, heparin is known to bind growth factors. Therefore, differences in 
amounts or types of growth factors produced by these different VICs in response to 
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different substrates could then be sequestered by heparin in the gels and propagate 
changes in VIC phenotype. Future investigation into inherent differences between these 
VIC populations could also lend insight into the results found in this study. Ultimately, a 
larger range of substrate stiffnesses, including stiffnesses that match those in which these 
different VICs reside in vivo could allow the determination of an "optimal" substrate 
stiffness for each VIC population. However, this has been difficult given limited, 
conflicting reports regarding the in vivo stiffnesses of the MVAC,21' 22 and no in vivo 
studies of the PML. The goal of this set of experiments was to first determine whether 
there were age- and valve-region specific responses to substrate stiffness. 
CONCLUSIONS 
In this study, for the first time the response of MV VICs to substrate stiffness has 
been investigated. VIC populations taken from different regions of the same MV and 
VICs of different ages cultured on PEG hydrogels of different stiffnesses demonstrated 
age- and valve-region-specific responses to substrate stiffness. These findings should be 
taken into consideration in the design of an age-specific tissue engineered heart valve and 
in future investigations of heart valve mechanobiology. 
This chapter, which analyzed the response of mitral valvular interstitial cells 
from different aged valves and different valve regions to substrate stiffness, also 
involved the development of functionalized poly(ethylene) glycol hydrogels that 
potentially can serve as scaffolds for a tissue engineered heart valve. Therefore, this 
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chapter not only built upon earlier findings in this thesis (i.e., that different aged 
valves and valve regions demonstrated differences in matrix and material 
properties, suggesting that the valvular interstitial cells may behave differently), but 
brought these insights to bear upon preliminary work towards engineering a valve 
replacement. This chapter concludes the studies portion of the thesis (Chapters 2-
22). In the next chapter key findings from this thesis work will be briefly 
summarized, contributions that this thesis makes to our understanding of valve 
mechanobiology will be highlighted, and future directions will be outlined. 
Additionally, the insight that this thesis work provides for tissue engineered heart 
valve design will be discussed. 
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Chapter 23: Conclusions 
In this chapter key findings from this thesis work are briefly summarized, 
contributions that this thesis makes to our understanding of valve mechanobiology 
highlighted, and future directions outlined. Additionally, the insight that this thesis 
work provides for tissue engineered heart valve design is discussed. 
A. Summary of Principal Findings and their Implications 
In this section the main findings from this body of work are highlighted, along 
with their implications. 
/. Age-Related Changes in Valves 
This body of work demonstrated significant changes in valve matrix composition, 
structure, and material properties with age, both throughout fetal and postnatal life. 
Furthermore, a direct relationship between compositional/structural changes and material 
properties changes was demonstrated. These results have implications for our 
understanding of certain valve pathologies, cardiac mechanics, and aging, as well as the 
design of a tissue engineered heart valve (TEHV). A number of valve diseases show 
increased prevalence in certain age groups; potentially, these pathologies could relate to 
abnormalities of the aging process. Therefore, understanding how valves normally age 
could lend insight into some of these pathologies. This need for greater understanding 
applies not only to postnatal valve pathologies, but to congenitally diseased valves as 
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well. The results from these studies with respect to aging also provide insight into 
cardiac physiology. As cardiac hemodynamics change throughout fetal and postnatal 
life, valve composition, structure, and material properties change as well, with the 
material properties likely affecting hemodynamics and function, the 
mechanoenvironment affecting valve composition and structure, and valve composition 
and structure affecting material properties. Therefore, these results suggest a dynamic 
interplay between structure and function within valves throughout life. Lastly, given the 
age-related differences demonstrated in these studies, an optimal TEHV would be age-
specific with specific composition, structure, and material properties that are appropriate 
for a normal valve of that age. These studies provide a baseline for the design of such a 
TEHV. 
//. Valve and Valve-Region Heterogeneity 
This work also demonstrated structural and compositional differences between 
valves and valve regions, and similar to the age-related results, correlated these to 
differences in material properties. This evidence for valve and valve-region 
heterogeneity adds to our understanding of cardiac physiology as well as informs the 
design of a TEHV. In terms of cardiac physiology, the mitral and aortic valves (MV, 
AV) are exposed to different mechanical environments; the observed compositional, 
structural, and material property differences likely allow the valves and valve regions to 
function properly within their respective mechanoenvironments, and likely are even at 
least partly determined by that mechanoenvironment. Therefore, these findings provide 
further insight into the relationship between structure and function in the valve. These 
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results also have applications in the design of a TEHV; specifically, the valve and valve-
region heterogeneity demonstrated in this body of work suggests that in order to 
faithfully emulate native valves, TEHVs should be developed with the specific properties 
of a particular valve, complete with regional heterogeneity. Furthermore, the 
compositional, structural, and material property characterization contained in this body of 
work provides baseline design criteria for such a TEHV. 
Hi. Normal Valve Physiology 
The studies of normal MV physiology expounded upon the above studies of 
valve-region heterogeneity by examining the regional compositional and structural 
heterogeneity of the MV leaflets and annulus around the full circumference of the valve 
in the context of the in vivo strains experienced by each region. These studies 
demonstrated significant structural and compositional differences between the 
commissural leaflets, the posterior leaflet, and the anterior leaflet that related to the in 
vivo strains of these regions. Additionally, the MV annulus was characterized and 
similarly found to vary along the circumference of the MV in a manner that correlated 
with the strains experienced by each region. These studies demonstrated the complexity 
of the MV, and provided further characterization necessary for the design of a tissue 
engineered MV. In particular, these studies provided much needed characterization of 
the junction of the MV annulus and the myocardium that is required for the continuity 
between the MV leaflets and the rest of the heart. The structure and mechanics of this 
interface will be important to consider in the design of a tissue engineered MV. These 
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studies additionally provided insight into the relationship between structure and function 
in the in vivo MV. 
iv. Involvement of Valves in Acquired Cardiac Diseases 
This work demonstrated that the MV is affected by and involved in "functional" 
mitral regurgitation and dilated cardiomyopathy (DCM), both diseases commonly 
considered to predominantly involve abnormalities in the left ventricle and to spare the 
MV. Additionally, these studies demonstrated a relationship between altered leaflet 
strains and composition, suggesting that altered strain may have played a role in the 
compositional changes. Furthermore, results from these studies implicated the valvular 
interstitial cell (VIC) myofibroblast phenotype in both the compositional and mechanical 
changes. These studies have important potential implications for our understanding of 
"functional" mitral regurgitation and DCM, their pathogenesis, as well as potential 
treatments. In the context of "functional" mitral regurgitation, the compositional 
changes observed suggested that mitral regurgitation (MR) induced leaflet remodeling 
that could worsen the regurgitation, thereby providing a potential mechanism for the 
clinically observed "MR begets MR." The results from the DCM studies suggest that 
altered strain could have caused the changes in MV composition; if this supposed 
mechanism is correct, and these compositional changes were found to be detrimental, it 
would further motivate the refinement of annuloplasty design to retain or restore normal 
physiological MV strains. The study examining the MV annulus in particular provides a 
potential mechanism for the annular dilation critical to DCM pathogenesis; further work 
in this area could potentially lead to novel treatments involving modification of the 
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extracellular matrix and/or valve cells. Nonetheless, overall these studies demonstrated 
that the MV is involved in these cardiac diseases and suggest that the MV should be 
taken into consideration for understanding the pathophysiology of these diseases and for 
providing context for various repair strategies. 
v. Acquired Valve Disease 
In calcific aortic valve disease, this body of work demonstrated that 
proteoglycans, hyaluronan homeostasis, and hypoxia are associated with nodule 
formation. Furthermore, results suggested that these matrix components and mechanisms 
interact with one another within the calcification process, and that the interactions 
between these factors were different within the various regions within and surrounding 
mature and preliminary nodules. The results with respect to hyaluronan homeostasis in 
particular suggest a novel mechanism that could underlie the pathogenesis of calcific 
aortic valve disease. The observed regional heterogeneity in matrix composition and 
interaction of matrix regulators relative to mature and preliminary nodules also provides 
understanding into the progression of nodule formation. While further studies are needed 
to demonstrate and elucidate the causal relationship between these factors in vitro and in 
vivo, as well as the time dependent nature of nodule formation, the studies contained in 
this work can lay groundwork for future investigations that could ultimately lead to novel 
therapeutics for this widespread disease. 
In myxomatous mitral valve disease, this work characterized the specific 
proteoglycans increased in these diseased valves (see Chapter 24 in the Appendix) and 
demonstrated that the mitogen-activated protein kinase (MAPK) pathway is likely a 
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signaling mechanism for the increased number of activated myofibroblast-like VICs in 
the disease. Additionally, this work demonstrated correlations between myofibroblast 
markers and regional extracellular matrix disarray, suggesting that these myofibroblasts 
are involved in the matrix dysregulation that leads to the deterioration in valve function. 
Although the studies of the MAPK pathway in this body of work are limited to 
documenting associations between factors, further study regarding this pathway could 
lead to therapeutics that target the MAPK pathway for the treatment of myxomatous 
mitral valve disease. 
In terms of the iatrogenic valvulopathy of a surgical wound, this body of work 
demonstrated that two distinct regions of remodeling are present in normal wound 
healing. This work characterized these regions in terms of specific matrix components, 
VIC phenotype, and microstructural changes. This characterization of normal valve 
wound healing could provide insight into the mechanisms that underlie abnormal wound 
healing. These studies could also provide insight into how to improve the healing 
process after valve repair surgeries. 
vi. Congenital Valve Disease 
With respect to congenital valve disease, this work characterized the specific 
matrix abnormalities found in congenitally diseased semilunar valves. These valves 
demonstrated significant alterations related to collagen and elastic fiber turnover that 
were distinct depending on pathology. Plaques evident on these valves similarly 
displayed altered matrix composition and turnover; furthermore, the relatively normal-
appearing regions underlying the plaques displayed alterations that could relate to the 
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development of these plaques. The characterization of these congenitally diseased valves 
contained in this work may lend insight into disease pathogenesis, as well as pave the 
way for more specific pathological diagnoses of these valves, with potential prognostic 
and therapeutic implications. Furthermore, analysis of VICs isolated from these diseased 
valves revealed alterations in phenotypic markers as well as general cell morphology. 
These results suggest inherent abnormalities in VICs contained within congenitally 
diseased valves that likely relates to the altered composition of the leaflet itself, as well as 
has implications for autologous cell sources for a TEHV for this population. 
vii. Structure-Function Relationship in the Valve 
A number of the studies within this body of work demonstrated significant 
correlations between the observed structural and compositional differences (whether 
between valves, valve regions, or different ages), and functional differences (such as 
differences in strains, material properties, or the hemodynamic environment). The 
demonstration of such a relationship between structure and function has a number of 
important implications. For example, in instances in which the strain of the leaflet has 
been altered, such as in the placement of an annuloplasty ring, the composition of the 
valve may be affected, which could potentially alter valve mechanics and ultimately 
valve function. As another example, when various disease processes or aging affects 
valve composition, the material properties of the valve may be altered, which similarly 
could result in altered valve function. These studies demonstrating a link between 
structure and function also have implications for a TEHV, since these studies provide 
design criteria in terms of valve composition and structure in order to create a valve with 
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the material properties desired. In addition, these studies suggest that physiologic flow 
loops or other means of imposing physiologic, regionally heterogeneous strains on a 
TEHV construct could provide an important mechanical stimulus enabling the TEHV to 
remodel to generate structural, composition, and even material properties that are more 
similar to the native valve. 
viii. Valvular Interstitial Cells 
While analysis of VIC cell phenotype comprised a portion of a number of valve 
composition studies, in terms of experiments whose focus was on VICs, this body of 
work demonstrated that VICs appear to act within a dynamic VIC-collagen functional 
unit within the valve. This finding has a number of implications. First, it provides a 
mechanism for leaflet force generation, and potentially for leaflet stiffness modulation 
evident in vivo. Secondly, it provides a potential framework for understanding 
valvulopathies (i.e., any part of that functional unit can be perturbed and contribute to 
valvulopathies). Thirdly, it further emphasizes the importance of VICs, and suggests 
their necessary inclusion in a TEHV (as opposed to an acellular scaffold), at the very 
least for baseline valve tonus. 
Additionally this body of work showed that VICs demonstrate an age- and valve-
region-specific response to substrate stiffness. This age-specific response to substrate 




This body of work included the development of a number of methods related to 
the study of valve physiology and pathology. First, the method for enzymatic isolation of 
VICs was optimized for porcine valves of different ages. Another study explored the use 
of differential adhesion of VICs to tissue culture polystyrene (TCP) and fibronectin (FN) 
as a means for isolating the VIC myofibroblast subpopulation. Results from that study 
demonstrated that differential adhesion to FN yielded a subpopulation with enhanced 
expression of myofibroblast-related markers. The subsequent functional characterization 
of this VIC subpopulation revealed that these cells also contracted and remodeled 
collagen gels in a manner consistent with myofibroblasts. Based on these results, 
differential adhesion of VICs to FN may be a useful means for studying the VIC 
myofibroblast subpopulation, a cell-type implicated in valve pathologies but previously 
difficult to study because there were no means for isolating this population. Another 
method developed in the context of this body of work was the radius of transition 
curvature. This parameter quantifies the acuteness of the transition region of a stress-
strain (or tension-strain) curve from the low stress to high stress region. In valves, during 
this transition region collagen fibers align and begin bearing load, therefore a lower 
radius of transition curvature suggests that collagen fibers are more aligned or more 
homogenously crimped compared to a higher radius of transition curvature, although 
additional study remains to verify this. The radius of transition curvature could be a 
useful parameter to characterize stress-strain curves of all types of biological tissues and 
engineered constructs possessing a biphasic shape. Another method developed within the 
body of this work was a strain-load device that fits within the stage of a confocal 
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microscope. This device allows the visualization of valve microstructure during various 
manipulations, such as addition of various vasoactive agents or manual strain of the 
tissue, while simultaneously measuring load. Lastly, the feasibility of poly(ethylene) 
glycol (PEG)-RGDS-methacrylated heparin hydrogels as a platform for a TEHV was 
demonstrated. These hydrogels are a promising scaffold material providing flexibility in 
design parameters including scaffold stiffness, proteins or peptides presented to the 
seeded cells, and size and shape of the construct. An additional key advantage of a PEG-
based scaffold is that PEG hydrogels themselves are bio-inert and therefore 
immunocompatible. 
B. Unique Contributions to the Literature 
While the specific unanswered questions that each study addresses have been 
discussed within each chapter, in this section certain key ways in which this body of work 
provides unique contributions to our current understanding of valve physiology and 
pathology are highlighted. Within this section, select previous studies relevant to a given 
topic have been referenced; for more complete discussions of previous work in a given 
area and accompanying references, please see individual chapters. 
/'. Age-Related Changes in Valves 
While compositional changes with aging, predominantly related to embryological 
development as well as some analysis of changes in the elderly, have been previously 
studied, this body of work provides important additional insight into valve aging later in 
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life as well as novel insight into the changes that occur during fetal and earlier postnatal 
life. In terms of the older age groups, this body of work characterized both AV and MV 
from the same animals, and demonstrated that the aging process is distinct within the 
different valves; the aging process is even distinct within different regions of the MV. 
Additionally, this work provides characterization of changes in material properties with 
late postnatal aging, which was heretofore lacking. 
In terms of the earlier age groups, the results from this body of work demonstrate 
that significant changes in valve composition, structure, and material properties are not 
limited to the elderly, but occur throughout postnatal life. Similarly, the results from fetal 
and perinatal valves demonstrate that changes in valve composition and structure are not 
limited to the early fetal period of valvulogenesis. In sum, the age-related results from 
this body of work suggest that valve aging occurs throughout life. 
//. Valve and Valve-Region Heterogeneity 
While previous studies had examined differences between various regions of the 
MV in terms of composition and material properties,1' 2 there were no previous 
investigations of differences between AV and the regions of the MV from the same 
animals. Furthermore, the differences in material properties among these valves and 
valve regions had never before been directly related to compositional and structural 
differences within the same valve samples. Additionally, the examination of the aging 
process in terms of composition and material properties of these different regions of the 
MV and AV represents a unique contribution to the literature. 
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//*. Normal Valve Physiology 
It has been well documented that valves respond to alterations in strain in 
previous in vitro experiments,3'4 and various studies (including early studies comprising 
this body of work) have demonstrated that valve matrix undergoes constant remodeling. 
However, the idea that the degree of strain experienced by certain regions in the normal 
valve in vivo could be related to collagen turnover in that region had not been explored 
prior to this body of work. 
An additional novel component to the normal valve physiology studies was the 
characterization of the mitral annulus and commissural leaflets. While the mitral annulus 
has been implicated in a number of diseases, including DCM and "functional" mitral 
regurgitation, the composition and structure of this critical junction connecting the valve 
to the remainder of the heart has largely been overlooked. Similarly, prior compositional 
and structural studies of the MV leaflets have overlooked the commissural leaflets. 
Hi. Involvement of Valves in Acquired Cardiac Diseases 
Heretofore, both "functional" mitral regurgitation and DCM were thought to be 
ventricular diseases, therefore MV composition and structure in these diseases largely 
had not been studied. While MV geometry and closing dynamics have been studied with 
respect to the degree of regurgitation in these diseases, the leaflets themselves were 
largely thought to be normal and the regurgitation due to geometric changes in the 
ventricle to which the valve was anchored. This body of work, expounding upon studies 
by Grande-Allen et al.,5 provides novel insight into these diseases by demonstrating that 
valve structure and matrix composition are significantly altered in this disease. These 
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results suggest that "functional" mitral regurgitation and DCM are diseases of the MV as 
well as the ventricle. Furthermore, novel studies in which in vivo leaflet strains were 
directly correlated to regional leaflet composition implicated a role for altered strain in 
the context of these diseases. These results further elucidated the relationship between 
structure and function in the valve. Moreover, these studies add to a growing body of 
evidence that the valves are not passive, but are actively involved in normal cardiac 
function as well as pathologies. 
iv. Acquired Valve Disease 
While a number of researchers are actively investigating the process of 
calcification of the aortic valve, the examination of the potential role for hypoxia and 
hyaluronan metabolism in this process represents a unique contribution to the literature. 
Additionally, the consideration of the regional heterogeneity of the calcification process, 
i.e., evaluation of protein expression within the nodules, at the edge of the nodule, and 
immediately surrounding the nodule, as well as in "prenodules," represents a novel 
advance in understanding the calcification process. In terms of myxomatous mitral valve 
disease, while increased numbers of myofibroblast-like VICs have been demonstrated in 
the disease, and the MAPK pathway has been investigated in the context of calcific aortic 
valve disease, the role of the MAPK pathway in myxomatous mitral valve disease is a 
novel contribution of this body of work. 
With respect to wound healing in valves, previous in vivo studies have been 
limited to pathological studies of valve slice and suture wounds.6'7 In this body of work 
a systematic study was undertaken to investigate in vivo matrix remodeling, specific 
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matrix composition, and VIC phenotype in response to iatrogenic injury, providing 
further characterization of the normal in vivo wound healing process in the valve. 
v. Congenital Valve Disease 
The majority of previous studies of congenital valve diseases have examined 
either their gross anatomical configurations (i.e., number and attachments of leaflets), or 
the embryological processes leading to these congenitally malformed valves. 
Furthermore, standard pathological examination of congenitally diseased valves involves 
broad categorizations, such as "dysplastic," that are often based on gross anatomical 
examination. However, the studies contained in this body of work provide novel 
information as to the specific matrix components that are dysregulated in congenital 
valve disease and also provide more detailed characterization of the microstructural 
changes. Furthermore, these studies also examined the VICs from congenitally diseased 
valves, which had not previously been done. 
vi. Structure-Function Relationship in the Valve 
The examination of structure in relation to function, which was performed in a 
number of studies, is another area in which this body of work makes novel contributions 
to the literature. While the relationship between stresses and/or strains and valve 
composition has been studied in vitro, this relationship had not been previously studied in 
vivo, nor have direct correlations been made between regional strains and composition 
within the same heart. Results from this body of work suggest that strains play a role in 
determining valve structure and function both in the healthy leaflet and in different 
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valvulopathies. Similarly, while the material properties of valves have been studied for 
decades, the direct relationship between these material properties and valve composition 
and structure has largely been overlooked, and certainly this relationship in the context of 
different aged valves never had been addressed previously. 
Lastly, consideration of the material properties of a TEHV scaffold with respect 
to valvular cell phenotype is a novel investigation. While certainly much effort has been 
applied toward developing a TEHV with sufficient strength to withstand in vivo 
hemodynamics, the role of the material properties of the TEHV in determining valvular 
cell phenotype, which could effect the subsequent matrix production and matrix 
remodeling potential of the VICs, has received very little attention. 
vii. Valvular Interstitial Cells 
Previous studies have demonstrated VICs in proximity to collagen within fixed 
valve specimens,8'9 however this body of work demonstrated, for the first time, VICs 
functionally interacting with collagen in ex vivo leaflets. Furthermore, this work 
demonstrated a functional role for integrins in the leaflet; previously integrins on VICs 
have only been documented using flow cytometry on enzymatically isolated VICs or via 
immunohistochemistry of valve sections.10' " This work specifically identified the 
alpha2betai integrin as an important receptor by which VICs interact with collagen, a 
receptor necessary for force generation in the valve. While force generation in the valve 
has been studied previously,8' 12"17 the investigation of the microstructure and molecular 
mechanisms that underlie force generation in the valve contained in this body of work is 
unique. 
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The study of differences between VICs from different aged valves, as well as 
VICs from different regions of the MV that undergo different loading patterns, is 
relatively novel. Furthermore, the demonstration of age- and valve-region specific 
differences in the response of VICs to substrate stiffness by this body of work represents 
a unique contribution to the valve literature. 
viii. Methods 
Of the various methods developed within this body of work, the development of 
the radius of transition curvature was particularly novel, and could be applied to stress-
strain curves of many types of biological and engineered materials. While additional 
studies remain to verify that the radius of curvature in valves corresponds to collagen 
alignment and crimp, this is a useful parameter to quantify differences between stress-
strain curve shapes that may have a variety of meanings in the context of different tissues. 
The strain-load device was also a novel development in allowing real-time visualization 
of microstructural changes in relationship to macrostructural tissue mechanics. Lastly, 
further development of the PEG-RGDS-methacrylated heparin builds upon considerable 
work previously done in the area of PEG scaffolds, but will be particularly important 
moving forward in the development of a TEHV. 
C. Unifying Themes 
The studies that embody this thesis are quite varied, and in some respects could 
appear disparate; however, there are several broad underlying themes that unify this body 
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of work. While some of these themes have been touched upon in earlier sections, they 
warrant specific discussion, which is done in the following section. Figure 23-1 
illustrates these themes in relationship to the various valve components. 
Fig, 23-1: Schematic illustrating key themes underlying this thesis work in relation to 
components of heart valves. ECM=extracellular matrix; CVD=congenital valve disease. 
L lmip©ift§in€® ©f th® Exttrmellutes' /Matrix 
The importance of the extracellular matrix was a constant thread running through 
a number of the studies. Not only did this body of work characterize the composition and 
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structure of the extracellular matrix in various valves and valve regions of different ages, 
but it showed that matrix remodeling occurs throughout life. Moreover, this thesis work 
demonstrated the role of this extracellular matrix in the material properties of the valve 
samples examined. This body of work also demonstrated the interrelationship between 
the extracellular matrix and strains in both normal and diseased states. These results, 
again, point to the dynamic nature of the extracellular matrix. In fact, the dynamic 
myofiber coupling seen in ventricular myocardial strains (Chapter 26 of the Appendix) 
implicates a dynamic role of extracellular matrix in cardiac mechanics. Results within 
this thesis also show that the valve extracellular matrix is altered in diseases previously 
thought to spare the valve leaflets; these matrix alterations could explain some of the 
functional problems in these diseases and points to the potential importance of restoring 
the extracellular matrix in treating these diseases. In relation to VICs, this thesis showed 
alterations in VICs were associated with changes in the extracellular matrix. The 
extracellular matrix (fibronectin) was also used in one of the methods developed in this 
thesis as a tool for isolating of VIC subpopulations. Given that the extracellular matrix is 
altered in myxomatous mitral valve disease, a disease in which the myofibroblast-like 
VIC is enriched, this altered extracellular matrix was used for isolating these cell types. 
In the course of assessing this isolation technique, it was also observed that fibronectin 
could be used to modulate the myofibroblast VIC phenotype. Lastly, this body of work 
demonstrated a dynamic, functional relationship between VIC and the extracellular 
matrix component collagen at the microstructural level. 
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ii. Importance of Valvular Interstitial Cells 
A second underlying theme that unified this body of work was the role of the VIC 
in valve function and disease. As alluded to above, VICs were associated with both 
matrix remodeling that occurs in normal valves throughout life and alterations in matrix 
in various diseased states. In particular, the myofibroblast VIC phenotype appeared 
central to this remodeling in both normal and diseased states. In terms of the 
myofibroblast VIC phenotype, this body of work demonstrated that the VIC 
myofibroblast phenotype shows differential expression at various times during fetal 
development as well as postnatal life. This phenotype was also enhanced in a number of 
diseased states. Furthermore, the results suggested that the VIC myofibroblast phenotype 
could have played a role in both the observed changes in composition and strains, and 
even act as a link between these two components. Given the potential importance of this 
VIC subpopulation, as evident both in the aforementioned studies within this work and in 
other studies, a method for isolating this important VIC subpopulation was developed. 
An additional study examined the pathway potentially responsible for the differentiation 
of VIC into the VIC myofibroblast phenotype in myxomatous mitral valve disease. 
Other key findings of this thesis also centered on VICs. Importantly in the study 
of congenitally diseased valves it was shown that VICs in these valves have altered 
markers of collagen synthesis, cellular activation, and cellular morphology. Similar to 
the other valvulopathies studied, these VIC phenotypic changes in congenitally diseased 
valves could be important to the disease's pathogenesis and potential novel therapeutics. 
These findings also have significant ramifications for cell source decisions for TEHVs for 
this patient population. The study investigating the VIC-integrin-collagen unit also 
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centered on VICs. This study showed the importance of VICs functionally interacting 
with collagen and potentially modulating leaflet stiffness in vivo. Lastly, this body of 
work documented an age- and valve-region-specific response of VICs to substrate 
stiffness, which will be important to take into consideration for the design of age-specific 
TEHVs. 
Hi. Importance of the Valve Mechanical Environment 
Another theme woven throughout this body of work was the role of the valve's 
mechanical environment in determining valve composition and structure in both normal 
and diseased valves. This relationship was evident, for instance, in analysis of perinatal 
changes in valve composition and hemodynamics, as well as mitral leaflet strains and 
composition in normal and diseased states. The importance of the mechanical 
environment was also evident in relationship to VICs in the study demonstrating that 
substrate stiffness affected VIC phenotype, and that this response of VICs to substrate 
stiffness was dependent upon age and valve region. Further understanding of the 
interaction between the valve and its mechanical environment could aid both our 
understanding of valve diseases, as well as how to use mechanical stimulation to create 
the composition desired in a TEHV. 
iv. Structure-Function Relationship 
Another recurring theme was the interrelation between valve composition and 
structure and valve function. For instance, valve composition and structure, for a variety 
of valves and valve regions of different ages, were demonstrated to correlate to material 
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properties as well as measured strains. Examination of the valve microstructure revealed 
the VIC-integrin-collagen functional unit that underlies valve force generation. 
Throughout these studies significant interactions were evident between the different valve 
components (cells, matrix, and tissue), as well as between these components and the 
valve's mechanical environment; these complex interrelationships likely are important 
determinants of overall valve function. Continued study to better understand these 
relationships between structure and function will be essential to obtaining the ultimate 
goal: maintaining or restoring proper valve function. 
v. Valve Heterogeneity 
Throughout this body of work heterogeneity was apparent at multiple levels and 
in multiple parameters. Heterogeneity in valve composition and material properties was 
apparent among different regions of the MV, between the MV and AV as well as the AV 
and PV, and between different ages. These different valves and valve regions also were 
distinct in how their compositions changed with age. Heterogeneity was also observed in 
terms of regional valve structure, such as the mitral annular insertion structure. Strains 
among different regions of the MV, both along the annular circumference and along the 
length of the leaflet, were also heterogeneous. Similarly, heterogeneity in VICs was 
evident in their adhesive properties (i.e., to fibronectin), among VIC subpopulations 
isolated by differential adhesion, and among VICs from different valve regions and ages 
in terms of their response to substrate stiffness. These multiple levels of heterogeneity (at 
the level of the tissue, matrix, and cells) reveal the complexity of the valves, and present 
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a substantial challenge for the ultimate goal of developing TEHVs that closely mimic 
native valves at various ages. 
D. Future Directions 
While this body of work addresses many previously unanswered questions, a 
considerable number of questions remain or arise from these studies that should be 
addressed in the future. This section will discuss several potential future studies that 
could build upon the knowledge obtained from this body of work. 
/'. Age-Related Changes in Valves 
While age-related compositional and structural differences were demonstrated in 
this body of work, future studies are warranted to elucidate the mechanisms by which 
these differences are created. Factors such as signaling molecules, potentially interacting 
with mechanical and hemodynamic cues, likely are important determinants. 
Examination of how VICs from different aged valves are different is also 
warranted. Because the matrix composition that the VICs produce and material 
properties of the valves in which the VICs reside differs with age, there are also likely 
age-related differences in the VICs themselves. Such differences would likely impact 
their use as a cell-source for age-specific TEHVs. Furthermore, additional examination is 
warranted regarding how VICs of different aged valves interact and respond to their 
environment, including both the material properties (i.e., stiffness) and the biological 
cues of that environment. For instance, these VICs from different aged valves could 
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express different arrays of integrins or secrete differing amounts or types of growth 
factors in response to mechanical and biological cues from their environment. Further 
elucidation of the age-specific nature of VIC-extracellular matrix/substrate interaction 
will be important in the development of an age-specific TEHV. 
ii. Valve and Valve-Region Heterogeneity 
While regional heterogeneity within the MV has been examined in this body of 
work and related to differences in material, regional heterogeneity in the AV has been 
largely overlooked. Various regions of the AV are known to undergo different loading 
patterns, therefore it is likely that these regions have different matrix components, 
structures, and material properties. Preliminary work was performed within this thesis in 
this area, but further investigation is needed, particularly addressing whether these 
regions undergo distinct age-related changes. 
Hi. Involvement of Valves in Acquired Cardiac Diseases 
While the series of studies presented here provide an important foundation for 
understanding the role of the MV in acquired cardiac diseases, these studies should be 
expounded upon by demonstrating a functional role for the observed MV compositional 
and structural changes in terms of cardiac dynamics as well as altered MV material 
properties. Furthermore, these changes should optimally be demonstrated in humans. 
Lastly, given the involvement of the MV in "functional" mitral regurgitation and DCM, it 
would be interesting to investigate whether the specific MV matrix and structural 
alterations found in "functional" mitral regurgitation and DCM in this body of work were 
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similarly altered in the MV in ischemic mitral regurgitation and other cardiomyopathies, 
or whether the valve pathologies of each of these diseases are distinct. 
iv. Acquired Valve Disease 
While the studies in this body of work investigating valve changes in 
myxomatous mitral valve disease and calcific aortic valve disease showed associations 
suggestive of mechanisms for the pathogenesis of these diseases, work in vitro is 
warranted to demonstrate a causative role for certain factors, such as hypoxia in calcific 
aortic valve disease, and even signaling pathways involved in the pathogenesis of these 
diseases. Further elucidation of these pathways would allow for potential novel 
therapeutic interventions for these diseases. 
v. Congenital Valve Disease 
While much is still to be learned regarding congenital valve disease, one finding 
that particularly warrants subsequent investigation is how the VICs from congenitally 
diseased valves differ from similarly aged normal valves. While preliminary work within 
this thesis addresses this question, more information in this area could both aid in the 
understanding of congenital valve disease pathogenesis. Moreover, such studies could 
lead to the development of methods to modulate the congenitally diseased VIC phenotype 
sufficiently in vitro such that the patient's own cells could be used in a TEHV. This 
approach would be particularly advantageous to the patient by avoiding the immune 
response to foreign cells. Additionally, further characterization of the different types of 
congenital valve disease, as well as the mechanisms behind the pathogenesis of these 
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different diseases, should be pursued. Clearly, a greater number of patients with age-
matched controls would be necessary for such further study, and the confounding factor 
of hemodynamics should be addressed, since this is often altered in congenital valve 
disease. 
vi. Structure-Function Relationship in the Valve 
A number of studies within this body of work suggested an interaction between 
structure and function, however further investigation is needed to better understand and 
characterize this interaction. In vitro experiments in which a single variable can be 
isolated and carefully manipulated would aid in this regard. Once this interrelationship 
and its dynamics are better understood, it would be interesting to investigate whether this 
coupling between structure and function is disrupted in various diseased states. 
vii. Valvular Interstitial Cells 
A number of studies could potentially follow from the work on VICs contained in 
this thesis. For instance, further characterization of the proposed VIC-collagen-integrin 
functional unit is warranted, along with studies assessing how various factors affect that 
functional unit. Additionally, a number of studies within this body of work suggested 
that VIC myofibroblasts may have played a role in the compositional and mechanical 
changes observed; further research should be pursued to verify this role and elucidate the 
mechanism for these changes. Lastly, given the regional, valve, and age-specific 
compositional differences demonstrated in this body of work, it would follow to 
characterize the VICs within these regions and valves of different ages to understand how 
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these differences came about. The results of such a study might also have implications 
for VIC cell sources, or even the manipulation of cells other than VICs, for the use in 
TEHVs that are age and valve-specific. 
viii. Methods 
A number of future studies could be performed using the methods developed in 
this body of work. First and foremost, further investigation is needed to understand what 
factors the radius of transition curvature actually measures in valves. Once this 
validation has been done, the investigation of the use of these parameters in other tissues 
could be performed. Additional study is also warranted to further understand the 
mechanism that underlies the isolation of the VIC myofibroblast subpopulation using 
differential FN adhesion, and to further characterize that subpopulation. Perhaps most 
importantly for the ultimate goal of a TEHV, further work remains to continue to develop 
the PEG-RGDS-methacrylated heparin hydrogels. Future work could include 
incorporation of features such as regional heterogeneity and anisotropy in material 
properties, regional heterogeneity in peptide ligands and cell types, layering, mechanical 
conditioning, and incorporating degradable peptide sequences. Clearly, much of this 
thesis was working towards this TEHV frontier. PEG-RGDS-methacrylated heparin 
hydrogels can serve as a platform upon which many of the findings of this thesis can be 
implemented as we strive to engineer a physiologic, age-specific, valve-specific TEHV. 
The implementation of this thesis work as it relates to TEHV design is covered in the 
subsequent section. 
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E. Design Criteria for a Tissue Engineered Heart Valve 
/. Overview 
As stated in the Abstract and Background, the overarching goal of this thesis work 
was to study valve mechanobiology in normal states, including normal aging, as well as 
diseased states, to inform design criteria for a TEHV. In this section first the insight that 
this thesis contains with respect to the final characteristics desired in this TEHV will be 
discussed. Then, considering that different approaches are being proposed for obtaining 
this end-product, these approaches to constructing a TEHV will be briefly outlined, 
followed by a discussion of how this thesis work informs each of those approaches. 
Lastly, the remaining data required with respect to developing TEHV design criteria will 
be summarized. 
//. Insight of Thesis Work into Tissue Engineered Heart Valve 
Characteristics 
Regardless of the approach taken to construct the TEHV end-product, this thesis 
has substantial insight into the characteristics that the ideal TEHV should ultimately 
possess. Overall the goal in the design of a TEHV is to construct a heart valve with 
physiologic function that is capable of growth with the patient, in the case of the pediatric 
population, the ability to effectively remodel and adapt to the valve's changing in vivo 
mechanoenvironment, and lastly immunocompatibility. Therefore this TEHV needs to be 
dynamic, remodeling throughout life, and responsive to its mechanical environment. 
Based on this thesis work, TEHVs need to be designed to be age-specific and valve-
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specific, with regional heterogeneity, layer specific matrix composition, and 
accompanying differences in material properties. The insights that this thesis has on 
these various features are discussed below. 
A. Age-Specific, Valve-Specific Design Criteria for Tissue Engineered Heart 
Valves 
One of the key contributions that this thesis work makes to TEHV design is that 
TEHVs should be both age-specific and valve-specific. The data contained in this thesis 
demonstrating substantial changes in valves with age and differences between the 
different valves, implies that one TEHV design will not suit all valves or patients of all 
ages. This concept of an age-specific, valve-specific TEHV fundamentally changes the 
TEHV paradigm. Issues related to the age-specific and valve-specific aspects of different 
TEHV components are discussed in the following sections, but this fundamental shift in 
thinking deserved special attention before detailed discussion of specific TEHV features. 
B. Cellular Component of a Tissue Engineered Heart Valve 
This thesis demonstrated the importance of the cellular component of valves in 
normal valve mechanobiology. VICs affect valve material properties, providing baseline 
tonus and affecting valve flexural stiffness,18 as well as potentially imparting dynamic 
stiffness modulation as shown in this thesis. This thesis work also showed that VICs are 
involved in normal collagen turnover throughout life; this collagen turnover is likely part 
of important repair processes that maintain valve durability. It was also demonstrated in 
this thesis that VICs play a role in remodeling valves in response to altered strains in 
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diseased states. Given the importance of VICs in normal valve mechanobiology, their 
incorporation, or the incorporation of cells with similar characteristics, in a TEHV will be 
essential. In a TEHV, the cellular component is what enables the TEHV to be a dynamic 
structure, to remodel in response to alterations in the mechanoenvironment, grow with the 
patient, and even undergo the normal repair processes in response to the repeated loading 
that the valve experiences, which are likely necessary for long-term durability. 
C. Material Properties of a Tissue Engineered Heart Valve 
In terms of the material properties desired in a TEHV, they should be specific for 
the age of the patient and the valve it will be replacing. For all age groups and valves, the 
TEHV will need to exhibit anisotropy, with the stiffness greater and extensibility less in 
the circumferential direction compared to the radial direction. Based on this thesis work, 
the stiffness of the TEHV designed for an older adult patient should be greater and 
extensibility less than a TEHV designed for a younger adult or child. In terms of 
differences between a TEHV designed to replace an AV compared to a MV, the MV 
TEHV should be stiffer. These material properties will also need to vary among the 
different valve regions. For instance, the anterior center region of the MV (MVAC) 
circumferential stiffness should be greater than that of the MV free edge region (MVF). 
D. Macrostructure and Matrix Composition of a Tissue Engineered Heart 
Valve 
As demonstrated in this thesis, the material properties of valves are integrally 
linked to the valve's macrostructure and matrix composition. Therefore, in terms of the 
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corresponding matrix composition of these age-specific and valve-specific TEHV, valves 
designed for older patients should have thicker leaflet layers, with more collagen 
throughout the layers, but particularly in the fibrosa and ventricularis layers. Ideally, this 
collagen should have a crimped conformation allowing the extensibility seen in native 
valves. The MVAC should consist almost exclusively of collagen, while the 
corresponding annular region of the AV should have a fibrosa that occupies ~l/3 of the 
leaflet thickness. In the MVF, the predominant matrix component should be 
proteoglycans and glycosaminoglycans (GAGs); the fibrosa layer should occupy less than 
-1/4 of the leaflet thickness. In terms of specific types of GAGs that should comprise 
these leaflets, the MVAC should have more 4-sulfated GAGs, especially 4-sulfated 
iduronate and hypersulfated GAGs than the MVF. The AV should have high total 
amounts of GAGs relative to the MVAC, especially glucuronate and hyaluronan, with a 
high 6:4 sulfation ratio. Overall with age the MV and AV TEHVs should have increased 
hyaluronan, decreased unsulfated glucuronate and 6-sulfated glucuronate, and a decrease 
in the chondroitin sulfate:dermatan sulfate ratio. In terms of valve and valve-region 
specific aging, with age the MVAC should have less 6-sulfated GAGs and more 4-
sulfated iduronate, while the MVF should have less 4-sulfated GAGs and more 6 sulfated 
GAGs. With age the AV should have less 6-sulfated and more 4-sulfated GAGs, 
particularly 4-sulfated iduronate. In terms of other matrix components, this thesis work 
demonstrated that overall the AV should have greater expression of collagen-related 
markers than the MV. There were also significant differences in the expression of these 
markers between the corresponding layers of the AV and MV. For instance collagen-
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turnover in the spongiosa of the AV was higher than other AV layers, while in the MV 
collagen-turnover was highest in the inflow ventricularis layer. 
E. Heterogeneity within a Tissue Engineered Heart Valve 
As discussed briefly in the sections on TEHV material properties and 
macrostructure and matrix composition, these TEHVs should demonstrate heterogeneity 
at multiple levels. The layers within the TEHV should be designed with distinct matrix 
compositions, and the MVAC and MVF should be designed to have different material 
properties and corresponding matrix compositions. This thesis also demonstrated that the 
MV commissural leaflets have unique compositions, and preliminary work assessing AV 
regional GAG composition suggests that the AV may similarly have regional differences 
in GAG composition. Regional variation in AV composition was also demonstrated in 
terms of markers of collagen synthesis, with greater expression of these markers in the 
free edge region compared to the annular region. These elements of heterogeneity should 
also be taken into consideration in the design of a TEHV. With regards to the MV, this 
thesis work characterized the structure of the MV leaflet annular insertion region and 
found it to be distinct depending on the location around the mitral annulus. This 
attachment between the leaflet and the myocardium is important both for integrity of the 
leaflet/annular complex and for preventing the potential complication of annular dilation. 
Careful design of this attachment region will be crucial for long-term durability and 
function of a TEHV. 
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///. Different Approaches for Constructing a Tissue Engineered Heart Valve 
While the end goal is to create a TEHV with the features outlined above 
(physiologic function, capability for growth and remodeling, and immunocompatibility), 
this end-product can be arrived at via different avenues. In the following section 
different approaches for obtaining the desired features will be discussed in turn. In the 
subsequent section (part "iv"), the insight that this thesis brings to bear on these different 
approaches to obtaining these features will be discussed. 
A. Macrostructure and Material Properties for Physiologic Function 
Proper physiologic valve function depends on a number of factors, but most 
importantly in terms of a TEHV are the material properties of the valve. These include 
its tensile strength, flexural properties, ability to withstand shear stress, and ultimately the 
durability of the TEHV to bear the repeated, complex loading that the valve experiences 
thousands of times a day for years on end. As demonstrated in this thesis work, as well 
as by previous researchers, the material properties of a valve depend on its complex 
macrostructure, including its layered leaflet structure. Additionally, this thesis work, as 
discussed above, demonstrated substantial regional heterogeneity in valve composition, 
structure, and material properties that will likely need to be emulated in order to obtain 
physiologic function of a TEHV. However, these desired macrostructural features of a 
layered structure with regional heterogeneity could be obtained using a number of 
different strategies. In the following paragraphs three strategies that appear most 
promising will be summarized. 
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The first strategy for obtaining the desired macrostructure and material properties 
would be to construct the valve using the desired matrix components with patterning that 
mimics the native valve's macrostructure. This could be accomplished using a matrix 
layering approach: a glycosaminoglycan/proteoglycan-rich layer to simulate the 
spongiosa, an elastic fiber-rich layer to simulate the ventricularis of the AV and the 
atrialis and ventricularis in the MV, and a collagen-rich layer simulating the fibrosa layer. 
Indeed Shi et al. have illustrated the potential for using such an approach;19 in their 
outlined strategy, collagen fiber bundles would be layered with cross-linked hyaluronan; 
smooth muscle cells would then be utilized, seeded on top of the hyaluronan layer, to 
create a layer of elastin.19 A challenge with this approach would be how to create 
sufficient integration between the layers to prevent layer dehiscence. Another limitation 
to this approach is that native leaflet layers are not comprised of one component; for 
instance, collagen is present in the ventricularis. It will be a challenge to design a matrix 
layering approach in which these layers themselves are composites of these different 
components and more accurately resemble the matrix composition of native leaflet layers. 
A strategy related to this matrix layering approach is the use of decellularized valves. 
The advantage of this approach is that the complex macrostructure, including the correct 
matrix components and even the anisotropic material properties, are already in place. 
However, this approach has been severely limited by the inability to remove all the 
immunogenic cellular components20 (see part "B" of this section), and so is not discussed 
in depth. 
The second strategy would be to use a bottom-up approach and seed the 
appropriate VICs in the appropriate locations in a TEHV construct. Based on inherent 
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differences between VI Cs of different ages, valves, and regions, and based on the 
hypothesis that these cells would contain the proper information to synthesize the 
appropriate matrix, this approach would rely on the cells to synthesize the necessary 
matrix and macrostructure for physiologic valve function. With this strategy, the cells 
would need a preliminary construct in which to be seeded and culture conditions that 
would support the appropriate synthesis of matrix components by these cells. Likely, this 
would entail a degradable scaffold that would provide initial support and degrade at a rate 
inversely proportional to the amount of matrix synthesized by the cells. A PEG scaffold 
with an MMP degradable sequence,21 for instance, could be used for such an application. 
Considerations would need to be made of what mechanical stimulation these cells might 
need and what input from the scaffold (i.e., certain matrix components and/or preliminary 
macrostructure) these cells might need to be encouraged to synthesize the correct matrix 
and form the correct native valve macrostructure. 
A third approach to obtaining the desired macrostructure of a TEHV would be to 
rely on the appropriate mechanical stimulation. We know that VICs and valve tissue 
overall are responsive to their mechanical environment, and as demonstrated in this 
thesis, there is a strong link between the mechanical forces that the valve experiences in 
vivo and its matrix composition and structure. It may be that the mechanical cues are 
central to the development of proper macrostructure and material properties in a TEHV. 
In this approach, the focus would be on developing a bioreactor that faithfully simulated 
the in vivo hemodynamics that the valve experiences. A preliminary TEHV construct 
would then be placed in this bioreactor, and given the correct mechanical cues, induced to 
remodel and create the proper macrostructure and material properties. Key questions 
655 
with this approach include what the initial construct would need to be comprised of, 
including what cells would need to be used (i.e., VICs, or whether all cell types would 
respond appropriately), and what type of initial macrostructure is necessary. 
While these different strategies have been presented as three independent 
approaches used in isolation, most likely a combination of these strategies is necessary, 
and in fact there is considerable overlap between these approaches. As discussed in the 
bottom-up VIC approach, these cells would likely need the mechanical stimulation that is 
central to the third mechanoenvironment-based approach, as well as some initial 
macrostructure or matrix cues central to the first matrix layering approach. Similarly, the 
first matrix layering approach would still need cells to remodel the matrix and maintain 
TEHV durability (as discussed below). And in the third mechanoenvironment-based 
approach, an initial construct seeded with cells would have to be placed in this carefully 
designed mechanical environment, harkening back to the first and second approaches. 
Common to both the bottom-up VIC approach and the mechanoenvironment-based 
approach is the need for a scaffold. 
B. Capability for Growth and Remodeling 
The capability of a TEHV to grow and remodel relies on cells. Key features of 
the cells used in a TEHV include: 1) responsive to the mechanoenvironment and properly 
remodel the valve in response to changes in that environment, and 2) age appropriately, 
facilitating the normal growth and aging process to occur in the TEHV. Different 
approaches can be used to obtain these features. VICs seem the optimal choice in that 
they would theoretically have built-in the ability to respond appropriately to the 
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mechanoenvironment and facilitate normal valve growth and aging. However, as 
demonstrated in this thesis work, congenitally diseased valves contain VICs that are 
abnormal and would not be appropriate cell sources for a TEHV. Other issues, such as 
difficulty in procuring autologous VICs, make VICs a less attractive option. An 
alternative approach is to condition non-valve cells to act like VICs in terms of 
responding to the mechanoenvironment and facilitating valve growth and remodeling. 
Concerns related to this approach include how to ensure that these non-valve cells 
maintain their VIC-like features long-term, as well as how to condition these cells to 
function like VICs. 
C. Immunocompatibility 
The immunocompatibility desired in a TEHV also can be obtained via various 
approaches, and in part depends on other aspects of a given TEHV's design strategy. 
Generally, issues concerning immunocompatibility can be divided into those related to 
the scaffold or matrix being employed and those related to cell sources. With respect to 
scaffolds and matrices being utilized to create the TEHV macrostructure, if a natural 3D 
matrix is used, the key for making this scaffold immunocompatible is complete removal 
of cellular components. As mentioned above, this task has proven exceedingly difficult. 
Strategies include various detergents, enzymatic digestions, and freeze drying 
techniques.20 With these decellularization strategies, the goal is to completely remove the 
cells and any cellular debris while preserving as much of the matrix as possible, and in 
the process create a porous enough scaffold for successful cell seeding. If a matrix 
layering approach is being employed, careful purification of these components is 
657 
essential for immunocompatibility of the scaffold. The advantage of a polymeric scaffold 
in this regard is that it can be inherently immunocompatible (without any immunogenic 
components). However, polymeric scaffolds can allow protein adsorption once 
implanted in the body, which can lead to activation of the coagulation cascade and device 
complications. The possibility of toxic metabolites in the case of degradable polymeric 
scaffolds should also be considered. The key advantage of PEG scaffolds is that their 
extreme hydrophilicity prevents protein adsorption; therefore, these scaffolds are 
biocompatible. 
The second component of a TEHV that affects its immunocompatibility is the cell 
source. Of course, optimally an autologous cell source is preferred, and based on the 
hypothesis that VICs have an inherent capability to respond to their mechanoenvironment 
and synthesize appropriate matrix for a TEHV, autologous VICs would be ideal. 
However, in cases in which VICs from a patient are abnormal, or given the difficulty in 
procuring VICs from a given patient, autologous VICs may not be an option. In these 
cases the question becomes whether it is better to use another autologous cell source from 
a patient, such as dermal fibroblasts, or whether the inherent capabilities of VICs 
procured from a human or animal valve outweigh the disadvantage of their potential 
immunogenicity. 
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iv. Application of Thesis Work in Relation to Different Tissue Engineered 
Heart Valve Approaches 
The data contained in this thesis can inform each of the approaches to 
constructing a TEHV with the desired macrostructure and material properties, as well as 
the issues of designing a TEHV with remodeling/growth potential and 
immunocompatibility. Each of these topics is discussed in the subsequent section. 
A. Insights into Different Approaches for Obtaining Macrostructure and 
Material Properties for Physiologic Function 
In terms of the matrix layering based approach to constructing a TEHV, this thesis 
work demonstrates that these layers' composition and thickness, particularly of the 
collagenous fibrosa layer, should be substantially different based on valve region as well 
as age. Ideally, the fibrosa layer should be created with the collagen in a crimped 
conformation, since that would allow the extensibility seen in native valves. Potentially, 
modifying the degree of collagen crimp within this construct could be used to create the 
specific extensibility desired in the TEHV. In order to create the desired stiffness, 
collagen content could be varied as well as the degree of crosslinking. While one of the 
age-related changes observed in this thesis was changes in delineation between the layers, 
it remains a challenge how variations in leaflet layer delineation could be created using 
this approach. Another consideration with this approach, and the other approaches, is 
how the leaflet insertion into the myocardium should be designed. 
In terms of using a decellularized valve to create the desired valve macrostructure, 
this thesis and previous studies have shown that the valve's anisotropic material 
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properties, regional heterogeneity, and layered leaflet structure are key to proper valve 
function. The advantages of this approach, as discussed above, are that these properties 
are already built into the scaffold. An additional advantage to this approach is that 
different aged valves could be decellularized, providing an easy means for modifying the 
basic TEHV design with age-specific features such that the TEHV could be specific for 
any age. Given the substantial changes in valve macrostructure, matrix, and material 
properties in valves with aging demonstrated in this thesis, this is a key advantage to this 
approach. The major limitation, however, as discussed above, is the decellularization 
process. 
In terms of the cell-based approach for constructing the macrostructure desired in 
a TEHV, this thesis work suggests that the specific cell type used will be crucial. Given 
the demonstration that VICs from different aged valves and different valve regions 
possess inherent differences in their synthetic and phenotypic response to substrate 
stiffness, the initial scaffold used in this approach will be important. Furthermore, given 
these inherent differences between VICs of different valve regions, utilizing different 
VIC populations in different regions of the preliminary TEHV scaffold results in a 
macrostructure with the regional heterogeneity desired. Similarly, utilizing appropriately 
aged VICs within this approach could lead to the formation of a TEHV that reflects age-
related differences in macrostructure and material properties desired. 
With respect to the mechanoenvironment-based approach, this thesis work 
suggests that the mechanoenvironment closely relates to normal valve composition, 
structure, and VIC phenotype. Therefore, creating the correct mechanoenvironment 
could be a powerful tool for inducing the desired macrostructure and material properties. 
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This strategy requires an initial TEHV construct complete with cells, and so it would 
likely be combined with other strategies. 
B. Capability for Growth and Remodeling 
In terms of the various approaches for designing a TEHV capable of growth and 
remodeling (i.e., VICs vs. non-valve cells), this thesis work showed that VICs display the 
key traits desired for a cell source in a TEHV capable of remodeling, including 
demonstrating remodeling in association with altered strains in diseased states. However, 
this thesis did not directly demonstrate VICs facilitating valve growth. In terms of cell 
sources for a TEHV, this thesis work only involved VICs; therefore it remains to be seen 
whether non-valve cells can be induced to possess similar traits. It should be noted that I 
performed preliminary work (not included in this thesis) demonstrating the capability of 
dermal fibroblasts to express myofibroblast markers in response to TGF|3 similar to VICs 
(as also demonstrated by Narine et al. ), suggesting that this cell type might have 
potential for use in a TEHV. However, much more remains to be done in that regard. 
C. Immunocompatibility 
With respect to scaffolds and immunocompatibility issues, this thesis has 
demonstrated the feasibility of PEG-RGDS-methacrylated heparin scaffolds (similar to 
those used by Cushing et al. ), for use in a TEHV. As stated earlier, one of the main 
advantages of these PEG-based scaffolds is that they are immunocompatible. 
In terms of cell sources and their accompanying immunocompatibility issues, this 
thesis work has demonstrated inherent abnormalities in VICs isolated from congenitally 
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diseased valves. Therefore, in the case of a patient with a congenitally diseased valve, we 
could either modulate the phenotype of the VICs from that patient, or use an alternative 
autologous cell source, such as dermal fibroblasts, and promote the differentiation of 
those cells into VIC-like cells. As stated above, I have done preliminary studies showing 
that such modulation of dermal fibroblasts is feasible; the disadvantage of using an 
alternative cell type is that these cells may be missing some of the inherent information 
allowing them to form matrix and macrostructure of native valves, respond appropriately 
to the mechanical environment, and remodel the matrix around them accordingly. This 
would be particularly disadvantageous when using a bottom-up, cell-based TEHV 
approach. This thesis work has developed a method for separating VIC subpopulations 
from myxomatous human valves. In cases of valve disease in which some of the VICs 
are normal, it may be possible to isolate that subpopulation and use it to seed a TEHV. 
While autologous VICs certainly are ideal in terms of immunocompatibility, they 
may not be an optimal cell source because of difficulty in harvesting these cells. Of 
course, in cases in which multiple surgical interventions are planned and the native valve 
has normal morphology, it may be possible to harvest VICs from that patient during the 
first surgical intervention, (either by surgical removal of the native valve and placement 
of a mechanical or bioprosthetic valve until the next surgical intervention, or if the native 
valve can remain until the second surgical intervention, harvesting a very small portion of 
the valve such that valve function is not impaired), and in the interim grow the TEHV 
using the patient's VICs that could then be surgically implanted during the second 
operation. Therefore, in the future cell source decisions may need to be patient-specific, 
made in coordination with the overall treatment plan. 
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v. Remaining Data Required 
A. Cellular Component of a Tissue Engineered Heart Valve 
While the data contained in this thesis addresses many aspects of TEHV design, 
multiple questions remain. Those include unanswered questions with respect to the 
cellular component of a TEHV, its growth and remodeling, its macrostructure and 
material properties, as well as the different approaches for constructing the desired TEHV 
end-product. 
In terms of remaining questions related to the cellular component of a TEHV, one 
of the largest questions is: what cell phenotype is optimum? While the myofibroblast 
VIC subpopulation has been implicated in a number of valve diseases,24 it has also been 
observed in remodeling in TEHV25 and in this thesis was observed in association with 
normal collagen turnover. Therefore some expression of myofibroblast markers in this 
optimum cell phenotype may be desired so that remodeling, particularly during initial 
formation of a TEHV, can occur. However, long-term expression of myofibroblast 
markers in a TEHV, or cells that do not appropriately become activated and then become 
quiescent in response to the mechanoenvironment, may prove detrimental. Better 
understanding of the regulators and signaling pathways governing cell activation would 
be helpful in this regard. Time-dependent control of cell activation, should it be 
considered necessary, could prove particularly challenging. A subsidiary question is: 
what is the desired cell phenotype for different aged valves? 
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Other issues that remain with respect to the cellular component of a TEHV 
include how the desired cell phenotype can be maintained long-term. This issue of long-
term stability of cell phenotype is particularly a concern if non-valve cells are used after 
having been treated or conditioned in some manner to more closely resemble VICs. It 
will be important to determine what cues these cells need in order to remain in that 
phenotypic niche. Of course, if stem cells are being used, there is the concern of de-
differentiation and tumorogenic potential. 
Another remaining question with respect to cell sources in a TEHV is whether 
some of the VICs within congenitally diseased valves are normal. As discussed above, 
this thesis work has demonstrated that, as a group, VICs isolated from congenitally 
diseased valves are abnormal, which precludes their use in a TEHV. However, if a 
subpopulation of VICs from congenitally diseased valves is normal, this subpopulation 
could potentially be isolated and used for an autologous TEHV. The advantage of this 
approach is that it avoids the challenges related to how to make non-valve cells behave 
like VICs and maintain those characteristics long-term. Similar questions could be asked 
of adult acquired valve diseases. For instance, in a myxomatous mitral valve that needs 
replacing, could the normal subpopulation be isolated, such as by using differential 
adhesion to fibronectin as developed in this thesis, and seeded into a TEHV? 
Lastly, much remains to be learned about valvular endothelial cells, their role in 
normal valve mechanobiology, and how to incorporate them into a TEHV. 
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B. Growth and Remodeling in a Tissue Engineered Heart Valve 
Additional questions also remain regarding growth and remodeling in a TEHV. 
While VICs demonstrated remodeling potential in this thesis, VICs were not directly 
observed facilitating valve growth. Therefore, further work is needed to understand the 
processes governing valve growth and the role that VICs play. For instance, if VICs 
from a young child are used to construct a TEHV, and that TEHV is implanted back into 
that child, will those VICs inherently "know" how to create a valve of the right size and 
material properties as the child grows? Or is growth mechanically induced? Can non-
valve cells be used and growth occur in a TEHV? Clearly, these questions relate to the 
more basic issue of understanding what induces growth in valves and what prevents too 
much growth. 
Another question related to growth and remodeling in a TEHV is whether the 
remodeling processes in a valve are different at different ages. While this thesis 
demonstrated that valve remodeling occurs throughout life, there could be differences in 
these processes. A subsidiary question is: how would these differences be incorporated 
into a TEHV? 
C. Macrostructure and Material Properties of a Tissue Engineered Heart 
Valve 
With respect to TEHV macrostructure and material properties, knowledge of what 
range of strains a valve experiences in vivo would aid in the testing of TEHV constructs, 
since we would know what portion of the stress-strain curve was most important to 
emulate. Similarly, knowledge of the in vivo stiffness of valves of different ages would 
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help us refine our TEHV design and evaluate TEHV constructs. This knowledge of in 
vivo stiffness would also aid in evaluating how VIC phenotype changes in response to 
substrate stiffness within a physiologically meaningful range of stiffnesses (in the current 
thesis work experiments were performed using different stiffnesses, but it is unclear 
where those stiffnesses lie relative to in vivo valve stiffness) and what other biological 
cues might be necessary to combine with the mechanical input of scaffold stiffness to 
obtain the VIC phenotype desired. Other material property data that would be useful 
includes biaxial tensile testing of fresh leaflets in which cells have been kept alive, given 
evidence that in vivo stiffness of the MV leaflets exceeds ex vivo stiffness (in which cells 
have not been kept alive)26'27 and the suggestion that VICs may play an important role in 
valve material properties (evident in both this thesis work and in work by Merryman et 
al.18). Similarly, flexural stiffness data for freshly excised valves of different ages is 
needed. These sets of data would also be useful for evaluation of TEHV constructs. 
In terms of information still needed regarding valve macrostructure, further 
regional characterization of AV composition and structure of different ages would 
provide necessary information regarding the regional heterogeneity of the AV. This 
thesis work provided limited preliminary data for regional GAG composition of aged AV 
and some analysis of heterogeneity of matrix components along the length of the AV 
leaflet, but a more complete analysis of regional matrix composition and valve 
macrostructure of the AV is lacking. Furthermore, analysis of the pulmonic valve in 
these respects is completely lacking, even though there is substantial clinical motivation 
for a tissue engineered pulmonic valve. 
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D. Different Approaches for Constructing a Tissue Engineered Heart Valve 
A number of unanswered questions remain with respect to different strategies for 
constructing a TEHV. In the context of using a matrix layering strategy, it remains to be 
determined how these layers can be constructed to integrate with one another, as well as 
how to create regional heterogeneity (other than by varying layer thickness). Yet another 
issue to be addressed using this approach is how to create layers that are a heterogeneous 
blend of different matrix components, more reflective of the native valve, or how to 
create the crimped collagen conformation seen in the native valve. In the context of the 
bottom-up VIC approach, it remains to be determined what matrix signals and 
macrostructure are necessary to prompt VICs to produce the right macrostructure and 
material properties. In the mechanoenvironment-based approach it is unclear whether 
non-valve cells can be induced by a valve-specific mechanoenvironment to create valve 
macrostructure and material properties, and how closely the initial TEHV construct must 
resemble a valve for the remodeling process to be successful. For many of these 
approaches, questions regarding the scaffold remain. For instance, continued work is 
needed to tailor the degradation rate of a degradable TEHV scaffold such that lost matrix 
is immediately replaced by newly synthesized matrix, without a decline in material 
properties. 
E. General Considerations 
In terms of more general considerations, we need design criteria obtained from 
human valves. While the data in this thesis using animal models provides a starting 
point, and both pig and sheep are considered relatively good animal models for human 
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heart valve mechanobiology, " the ovine MV is known to have less redundancy than 
the human MV33' 34 and there may be other species-specific differences that prove 
important. Therefore, we need data on valve composition and material properties of 
different aged human valves. 
Another more general question that remains to be answered is whether a TEHV 
with properties of an elderly valve would function better in an elderly patient than a 
TEHV with properties of a middle-aged adult. In other words, we are assuming that the 
matrix and material property changes evident in elderly valves enable them to withstand 
the altered hemodynamics that accompanies this aging process, but it may be that these 
normal aging changes in valves in fact are detrimental to valve function. 
An additional more general consideration with respect to TEHV design is which 
of the features we observe in a native valve are necessary for proper valve function. In 
other words, just because a feature is evident in a native valve does not necessarily mean 
it needs to be emulated in a TEHV. Furthermore, given the incredible complexity and 
heterogeneity of native valves, it is likely nearly impossible to perfectly emulate a native 
valve in every respect. Moving forward, it will be important to determine which are the 
key features of native valves that allow proper valve function and long-term durability. 
F. Conclusion 
In summary, this thesis work provides foundational knowledge in valve 
mechanobiology that will be necessary in the continued pursuit of developing a 
physiologic TEHV. Key insights into valve aging and heterogeneity; how the VICs, 
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matrix, and tissue mechanics interact with one another; and the role of VICs and the 
matrix in determining proper valve function will be particularly important as the field 
moves forward. Additionally, in the course of these studies, insights into a variety of 
valve diseases, including both congenital and acquired valve disease, and the 
involvement of valves in cardiac diseases, provide insight into pathogenesis of these 
diseases as well as potential targets for therapeutic interventions. 
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Chapter 24: Abundance and Location of Hyaluronan and 
Proteoglycans within Myxomatous Mitral Valves 
In this chapter the topic of examining valves in the setting of various disease 
states (the subject of Chapters 13-21) continues with a study of myxomatous mitral 
valve disease (also the subject of Chapter 19). Specifically in this chapter alterations 
in proteoglycan and glycosaminoglycan content in myxomatous mitral valves are 
analyzed. While this study certainly adds to our understanding of myxomatous 
mitral valve disease and serves as background for the study analyzing the mitogen-
activated protein kinase (MAPK) signaling pathway in myxomatous mitral valves 
(Chapter 19), I was not the lead researcher on this study and it was not considered 
integral to this thesis; therefore, this study was placed in the Appendix. 
ABSTRACT 
Background: Extracellular matrix changes occur in many heart valve pathologies. For 
example, myxomatous mitral valves are reported to contain excess proteoglycans (PGs) 
and hyaluronan (HA). However, it is unknown which specific PGs are altered in 
myxomatous valves. Because PGs perform varied functions in connective tissues, this 
study was designed to identify and localize three matrix-associated PGs as well as HA 
and the HA receptor for endocytosis (HARE) within myxomatous and normal mitral 
valves. 
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Methods: Human mitral posterior leaflets (control n=6-9, myxomatous n=14-21, mean 
age 61 for all groups) were histochemically stained for PG core proteins, HA, and HARE. 
Stain intensity was semi-quantitatively graded to determine differences in marker 
abundance between normal and myxomatous valves. The PGs were localized to different 
regions of the leaflet by correspondence to parallel Movat stained sections. 
Results: The PGs decorin, biglycan and versican were more abundant in myxomatous 
valves than in normal controls (p<0.03). There was a gender effect on PG presence but 
no age related trends were observed. HA and HARE were distributed throughout all 
valves. There was no significant difference in HA between groups, but HARE 
expression was reduced in myxomatous valves compared to normal controls (p<0.002). 
Conclusions: Excess decorin, biglycan and versican may be associated with the 
remodeling of other matrix components in myxomatous mitral valves. Decreased 
expression of HARE in myxomatous valves suggests that HA metabolism could be 
altered in myxomatous mitral valve disease. These finding contribute towards 
elucidating the pathogenesis of myxomatous mitral valve disease and developing 
potential new therapies. 
The work contained in this chapter was published as: 
Gupta V, Barzilla JE, Stephens EH, Mendez JS, Lee E, Collard CD, Weigel P, Grande-
Allen KJ. Abundance and Location of Hyaluronan and Proteoglycans within 
Myxomatous Mitral Valves. Cardiovascular Pathology, 2009; 18(4): 191-197. 
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INTRODUCTION 
Myxomatous mitral valve disease is a common valve abnormality with an 
incidence of 2.4-5%.' Myxomatous degeneration is the most common cause of mitral 
regurgitation in older patients,2 but the cause and progression of myxomatous disease 
remains unclear. Myxomatous mitral valves are characterized by floppy leaflets and 
elongated or ruptured chordae tendineae, which have profoundly weakened material 
behavior compared to normal valve tissues.3 Previous histological studies of 
myxomatous valves have revealed collagen disruption,4 elastic fiber fragmentation,5 and 
the accumulation of matrix metalloproteinases and glycosaminoglycans (GAGs).6 
Currently, the only treatment for this disease is surgical repair; no medical therapies are 
available to treat the matrix changes associated with myxomatous degeneration. 
Although there are a number of different theories regarding the pathogenesis of 
myxomatous mitral valve disease, including the diminished healing response of aging 
valve tissue to mechanical stress,2 genetic abonormalities,7 collagen and matrix 
dissolution or abnormal accumulation of proteoglycans (PGs), there is no consensus as 
to the mechanism of myxomatous degeneration. It is, however, evident by histological 
examination that GAGs and PGs, as a general matrix class, are abnormally distributed 
within myxomatous mitral valves, but exactly which PGs are overabundant within 
myxomatous valves has not been previously investigated. 
Given the diverse nature of different PGs and their associated GAG chains, and 
their functions in mediating extracellular matrix organization,9 it is compelling to ask 
which specific PG or PGs could be involved in the remodeling and resultant dysfunction 
of myxomatous mitral valves. PGs consist of at last one GAG chain attached to a core 
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protein. All GAG types exist as components of a PG, except for hyaluronan (HA), which 
is unsulfated and frequently present as a free molecule, although HA may be non-
covalently bound to the core protein of some of the larger hyalectin PGs through a link 
protein, also known as HA binding protein (HABP). The diverse group of PGs, as well 
as HA, performs many functions related to the growth, development and pathology of 
tissues,10 and likely performs many such roles in heart valves as well. It has been shown 
that three particular PGs (decorin, biglycan, and versican) are present in the mitral valve 
and that their relative abundance varies according to the type of loading experienced by 
specific valve regions.11 In the regions that experienced tension, the small leucine-rich 
PGs decorin and biglycan were more abundant; these PGs mediate collagen 
fibrillogenesis12 and sequester transforming growth factor-beta.13 The large hyalectin PG 
versican was also found in the mitral valve; versican can aggregate with HA14 to provide 
hydrated compressive resistance to tissues. Versican often co-localizes with elastic fibers 
and numerous cell associated molecules to regulate cell adhesion, proliferation and 
migration.14 We have previously reported that there are elevated concentrations of 
selected GAG classes within myxomatous mitral valve chordae and posterior leaflets as 
compared to normal control tissues,15 but have not investigated specific classes of PGs 
within these valves. Therefore, the primary purpose of this study was to assess the 
location and abundance of specific PGs and the GAG HA within myxomatous and 
normal mitral valves to improve our understanding of this common valve disease and 
contribute towards developing novel treatments for this disease. 
The secondary purpose of this study was an initial step towards investigating the 
mechanisms of turnover of PGs and GAGs, including HA, within heart valves. 
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Understanding how the synthesis and degradation of PGs and GAGs are regulated within 
these tissues is important not only for myxomatous mitral valve disease but also for 
calcific aortic valve disease16 and the design of bioprosthetic valves. In addition, 
understanding this regulation may lead to the development of novel medical therapies for 
valve disease or offer opportunities for earlier intervention. Because gaining this 
knowledge will be a profound undertaking, in this particular study we only investigated 
the potential for the turnover of HA in mitral valves via the HA receptor for endocytosis 
or HARE.17 HARE, a.k.a. stabilin-2, is a cell receptor that enables the scavenging and 
clearance of HA and other GAGs from the blood.18 Most abundant in lymph nodes, 
spleen, and liver, HARE has also been found in the heart valves of mice,19 but is absent 
from any other cardiovascular tissues. Based on the previously reported excess of HA in 
myxomatous tissues it was speculated that the abundance of HARE in human 
myxomatous heart valves, might be different from that of control valves. Therefore, in 
this study the abundance of specific PGs, HA, and HARE within normal and 
myxomatous mitral valves was measured using histochemical techniques. 
METHODS 
Tissue Procurement 
Normal control mitral valve posterior leaflets were obtained after autopsy. 
Control subjects demonstrating any cardiovascular disease were excluded from this 
study. Myxomatous mitral valve posterior leaflets were surgically resected from patients 
undergoing a surgical repair procedure to correct mitral regurgitation resulting from 
primary myxomatous degeneration (all had regurgitation grades of 3+/4+). The 
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demographic makeup of all groups is shown in Table 24-1. Tissues for this study were 
provided by the Cleveland Clinic Foundation (Cleveland, OH), St. Luke's Episcopal 
Hospital (Houston, TX), Ben Taub Hospital (Houston, TX), and the Cooperative Human 
Tissue Network. The research use of these tissues was approved by the Institutional 
Review Boards at all institutions. Radially oriented segments of the leaflets were cut 
from the annulus to free edge and fixed immediately in 10% formalin to minimize 
autolysis. After overnight fixation, the tissue sections were paraffin embedded, cut in 5 
pirn full thickness sections, and mounted on glass slides according to standard procedures. 
Table 24-1. Subject Demographics. 
r* o u- * * Gender Age 
Group Subjects*




























Data represented as mean ± standard deviation. 
*Due to the small size of some tissues, it was not possible to obtain histological 
sections for all stains from all subjects' tissue blocks. 
Histochemistry 
Immunohistochemistry (IHC) was performed to localize the PGs decorin, 
biglycan and versican within the valve tissues using antibodies against their respective 
core proteins, as described in Chapter 20. A set of mitral valves was also stained for 
HARE and HA. The immunohistochemical staining for HARE was performed as for PGs 
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except that the pretreatment was performed using 0.1 N HC1 for 15 minutes at 37°C and 
the mAbl59 antibodies for human HARE were developed in Dr. Weigel's laboratory.17 
The presence of HA was demonstrated by histochemical binding to an HA binding 
protein (HABP),20 which contains the "link" domain protein that normally binds HA to 
aggrecan in the formation of an aggrecan aggregate. This HA staining procedure 
required blocking with 2% fetal bovine serum, treating with biotinylated HABP (exactly 
as described by Lara et al.20), then performing chromogenic detection as described above. 
To minimize variability, all normal and myxomatous tissues were stained together in one 
batch. 
Negative controls for all markers were performed in the absence of the primary 
antibody. After staining, samples were blinded and graded on a scale of 0-4 to evaluate 
overall intensity. Grade "0" was chosen for no staining, " 1 " for weak stain in <50% of 
tissue, "2" for weak stain in >50% of tissue or strong stain in <10% of tissue, "3" for 
strong stain in >10% but <50% of tissue and "4" for strong stain in >50% of tissue.6 
Between 1 to 3 sections of a given valve sample were stained for a given marker and the 
staining intensity of all tissue sections was graded twice. Replicates were averaged and 
the staining and grading variability was calculated to be less than 15%. 
Localization 
Parallel sections of the posterior leaflets were also stained with Movat 
pentachrome to co-localize the different PGs, which stained blue/green, with collagen 
and elastin, which were stained yellow and black, respectively. Mapping the ECM 
composition of these sections also enabled the comparison of PG localization between the 
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deep spongiosa layer and the more superficial atrialis and fibrosa layers of the mitral 
valve. 
Statistical Analysis 
A one-way ANOVA (SigmaStat, San Jose, CA) was used to compare 
immunohistochemical data between the normal and myxomatous valve groups. A two-
way ANOVA with post hoc Tukey testing was performed to examine the effect of gender 
by choosing factor 1 as valve condition (normal vs. myxomatous) and factor 2 as gender 
(male vs. female). A Spearman rank order correlation was performed to determine if 
there were any age related trends in the data. In all cases, the level of significance was 
chosen as 0.05. 
RESULTS 
IHC for Decorin, Biglycan, and Versican 
Myxomatous valve sections showed overall higher PG staining intensity, with 
significantly greater abundance of decorin (pO.OOl), biglycan (p<0.003) and versican 
(p<0.03) as compared to normal valves (Figs. 24-1 and 24-2). The staining intensity of 
versican in the myxomatous mitral valves was almost a full grade stronger than in the 
normal valves and the staining intensities of decorin and biglycan were more than a full 
grade stronger in the myxomatous valves. The negative control grading for PG staining 
was found as 0.16 ± 0.28 (mean ± standard deviation, n=24) for normal valves and 0.07 ± 





Fig. 24-1: Normal and myxomatous valve sections immunohistochemically stained for the 
core proteins ofdecorin, biglycan and versican. The scale bar for each valve represents 1 
mm. Images of the same valve stained with Movat pentachrome are provided to 
demonstrate the leaflet's layered microstructure. 
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Fig. 24-2: Abundances of decorin, biglycan and versican in normal and 
myxomatous mitral valves. Grading was performed on immunohistochemically 
stained valve sections using a scale of 0 to 4. Data represented as mean ± 
standard deviation. 
IHC for HA and HARE 
There was no significant difference found in HABP staining for HA between 
normal and myxomatous valves (Figs. 24-3 and 24-4). However, there was almost one 
full grade less HARE expression in myxomatous valves than in normal valves (p<0.002). 
The negative control grading for HA staining was 0.22 ± 0.42 (mean ± standard 










Fig. 24-3: Normal and myxomatous valve sections histochemically stained for HA and HARE. 
The scale bar for each valve represents 500 fxm. Images of the same valve stained with Movat 
pentachrome are provided to demonstrate the leaflet's layered microstructure. 
Co-localization of Specific PGs and Other Extracellular Matrix Components 
Comparison of Movat Pentachrome stained valve tissues with the histochemically 
stained tissues revealed many interesting patterns regarding the location of PGs. The 
Movat stain demonstrated the three layers of the normal mitral valve: the collagen-rich 
fibrosa (upper outer layer), the PG-rich spongiosa (deep inner layer), and the atrialis 
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F/g. 24--/: Abundances of HA and HARE in normal and myxomatous mitral valves. Grading 
was performed on histochemically stained valve sections using a scale of 0 to 4. Data 
represented as mean ± standard deviation. 
difficult to distinguish the layered structure in Movat stains of myxomatous valves as 
these valves were deformed, irregularly shaped and had disorganized ECM. In both 
normal and myxomatous valve sections, staining for decorin was co-localized with 
collagen (Fig. 24-1). However, biglycan was found in locations that also stained strongly 
for both collagen and elastin. Interestingly, versican staining corresponded to leaflet 
regions that were rich in PG and elastic fibers for both normal and myxomatous valves. 
HA staining was found to be greater in the presence of elastin but lower in the 
presence of collagen (Fig. 24-3). Similarly, HARE binding was strong in elastin rich 
regions (Fig. 24-3). 
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Effect of Gender and Age on Abundance of PGs 
Of all the PGs, only the abundance of versican had any relation to gender. This 
association with gender was found in both normal and myxomatous valves. Interestingly, 
versican staining was stronger for females (compared to males) in normal controls (male 
1.7±0.5 vs. female 3.2±1.1; p<0.01) but showed a trend of being lower in myxomatous 
valves (male 3.0±0.7 vs. female 2.4±0.5; p=0.07). Also, when data describing the 
abundance of each PG were grouped together, myxomatous valves from males showed a 
trend of greater PG abundance than found in valves from females (3.5±0.6 vs. 3.1±0.8, 
p=0.06). There was no significant correlation between age and the abundance of specific 
PGs. However, HARE expression in normal valves significantly increased with age (R2 
= 0.62; Spearman correlation, pO.OOl). 
DISCUSSION 
This study demonstrated differences in the abundance and localization of 
specific PGs within normal and myxomatous mitral valves. Decorin, biglycan and 
versican, three PGs previously found in normal mitral valves,11 were present in 
significantly greater abundance in myxomatous valves. We did not find significant 
differences in the presence of HA within normal and myxomatous valve sections, 
although the abundance of HARE was stronger in normal valves. This is the first study 
to demonstrate the presence of HARE in human heart valves. 
The stronger immunohistochemical staining for all three PGs within 
myxomatous valves was unexpected, given our previous analysis of GAGs using 
fluorophore-assisted carbohydrate electrophoresis (FACE).15 FACE analysis showed 
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that myxomatous valves are particularly rich in 6-sulfated GAGs, which are strongly 
associated with the PG versican,21 but not decorin or biglycan. We speculate that these 
differences between the FACE and immunohistochemical results arose because FACE 
measures GAGs, whereas these valve samples were stained for the core proteins of the 
different PGs. The amount, type, or sulfation pattern of the GAGs associated with the 
different PGs may be responsible for these differences. More specifically, decorin and 
biglycan have 1 and 2 GAG chains respectively, so their GAG content may represent 
only a small percentage of total leaflet GAGs measured by FACE, even if their core 
proteins are shown to be abundant within the tissues. Versican, in contrast, contains 15-
20 GAG chains and hence the numerous GAGs from versican may be disproportionally 
abundant in a FACE analysis. The relative amount of GAG per PG may also explain the 
location of these PGs within the different layers of the valve. Versican immunostaining 
was strong in areas of the leaflet that also stained strongly with alcian blue from the 
Movat pentachrome stain, indicating an abundance of GAGs, but decorin and biglycan 
were not strongly stained in the blue regions. There are also significant differences in the 
preparation of the tissue between these two methods. In the future, it will be important to 
confirm these patterns of PG abundance using biochemical methods such as western 
blotting. 
Although there has been very little investigation of the upregulation of specific 
types of PGs in myxomatous valves, our results are consistent with a previous report 
showing increased decorin gene expression in myxomatous leaflets.22 In this study, 
decorin was strongly co-localized with collagen fibers in both normal and myxomatous 
valves; localization of decorin with collagen fibers has also been shown by others.12' 23 
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This co-localization is understandable given that decorin is known to regulate collagen 
fibrillogenesis.12 Biglycan, which is a small leucine-rich PG closely related to decorin, 
was found in both collagen and elastin rich regions of the leaflets. Biglycan has been 
shown to bind to tropoelastin and may influence elastic fiber formation.24 Versican, 
which was strongly co-localized with elastic fibers, has been shown to bind to fibulin and 
fibrillin, microfibrillar proteins that are components of elastic fibers.14 Interestingly, 
abnormal fibrillin distribution has been proposed as a factor in the development of 
myxomatous degeneration.4 Collagen and elastin fragmentation has been shown before 
during myxomatous remodeling4' 5 and the link between PGs and these ECM fibrous 
protein may explain the compensatory mechanism during myxomatous valve remodeling. 
The fact that each of these three proteoglycans - each of which is differentially regulated 
and likely to perform a distinct function within the ECM - was more abundant 
demonstrates the complexity of matrix changes in myxomatous valve remodeling. These 
numerous matrix changes suggest that there may not be a single primary cause of 
myxomatous degeneration. 
We did not find significant differences in HA staining between normal and 
myxomatous leaflets, which is consistent with our previous biochemical findings using 
FACE.15 Although our previous FACE analyses demonstrated elevated amounts of HA 
in myxomatous chordae, that study also showed that the myxomatous posterior leaflets 
did not contain more HA than normal posterior leaflets. 
This is the first study to demonstrate the presence of HARE in human heart 
valves. Previously, HARE has been found in the heart valves of mice.19 HARE is a cell 
receptor that enables the clearance of HA and thought to be associated with HA 
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turnover.18 In addition, it was recently demonstrated that the binding of HA to HARE 
causes phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in a 
dose- and time-dependent manner.25 The finding of less HARE expression in 
myxomatous mitral valves suggests that diseased valves may have alterations in HA 
metabolism or intracellular signaling. In general, the demonstration of HARE in these 
tissues opens new avenues for research into the turnover and function of HA in valve 
remodeling and pathology. HA also interacts with other receptors such as CD44, which 
have been previously demonstrated in heart valves,26 and the receptor for HA-mediated 
motility (RHAMM) during cell migration and ECM remodeling.27 HA turnover is also 
regulated by enzymes such as the HA synthases and hyaluronidases.28 Any one or more 
of these receptors and enzymes may regulate the abundance and activity of HA during 
myxomatous degeneration, and should be examined in greater detail in future studies. 
Other limitations of this study included our difficulty in identifying the distinct 
characteristic leaflet layers within the myxomatous valve sections, which restricted us to 
PG localization based on collagen or elastin as opposed to layers. In addition, some of 
the valve sections showed clear "onlays" or superficial plaques29 that were not part of any 
valve layer, but stained for PGs. Compared to rest of the valve section, onlays in normal 
valve sections (n=3) tended to stain strongly for decorin and versican whereas in 
myxomatous valve sections (n=4) onlays stained stronger only for biglycan. In another 
investigation, myxomatous valve onlays have been shown to contain similar amount of 
GAGs and collagen compared to rest of the valve.29 
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CONCLUSIONS 
In summary, the PGs decorin, biglycan and versican were significantly more 
abundant in myxomatous mitral valves compared to normal valves, a difference that may 
either contribute to or be a consequence of the valve remodeling. Although HA 
expression was unaltered between two leaflet groups, HARE expression was lower in 
myxomatous valves, suggesting that HA homeostasis may be altered in myxomatous 
mitral valve disease. In the future, it will be important to investigate the regulation of 
matrix synthesis and degradation within these diseased valves in order to identify the 
regulatory molecules or cell population(s) responsible for valve remodeling. Such 
information will be essential for the development of medical therapies to target the 
responsible agents and would provide a platform to treat myxomatous degeneration 
without requiring valve surgery. 
This chapter, which characterized alterations in proteoglycan and 
glycosaminoglycan content in myxomatous mitral valves, provided important 
background for the analysis of mitogen-activated protein kinase (MAPK) signaling 
pathway in myxomatous mitral valves in Chapter 19. While this study certainly 
adds to our understanding of myxomatous mitral valve disease, I was not the lead 
researcher on the study and it was not considered integral to this thesis; therefore, 
this study was placed in the Appendix. 
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Chapter 25: The Myocardium Overlying the Papillary Muscle 
Contributes to the A ntero-Lateral Left Ventricular Wall 
Deformation Continuum 
In this series of two chapters (Chapters 25 and 26), analysis of left 
ventricular myocardial mechanics using transmural headsets is presented. While 
these chapters provide important insight into cardiac mechanics and left ventricular 
heterogeneity in transmural strains in particular, these studies do not directly relate 
to the overarching goals of this thesis. Therefore, these studies have been included 
in the Appendix. In the first of these two studies, analysis of transmural strains at 
end-diastole and end-systole at sites across the left ventricle demonstrates an antero-
lateral continuum in transmural strain profiles. 
ABSTRACT 
Background: Previous studies of transmural left ventricular (LV) strains suggested that 
the myocardium overlying the papillary muscle displays depressed deformation, 
suggesting significant regional heterogeneity. However, these comparisons were made 
using different hearts, one group in which an anterior region was studied and another in 
which the region overlying the papillary muscle was studied. We wanted to extend these 
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studies by examining three equatorial regions in the same heart, during the same heart 
beat. Therefore, we compared the transmural strains in the LV myocardium overlying 
the antero-lateral papillary muscle (PAP) to regions on the same transverse equatorial 
plane located directly anteriorly (ANT) and laterally (LAT). 
Methods; Transmural radiopaque headsets were placed into ten sheep in three locations 
(ANT, LAT, and PAP) along the equatorial LV wall. Biplane videofluoroscopy was 
performed allowing the in vivo measurement of radial, circumferential, and longitudinal 
strains at each of three LV wall depths (subepicardial, midwall, and subendocardial) in 
the three locations for each heart beat. Myofiber angle measurements at each depth in 
each location from histological sections post-mortem allowed transformation of these 
strains into fiber and cross-fiber strains. 
Results: LAT normal longitudinal and radial strains, as well as major principal strains, 
were less than ANT, while those of PAP were intermediate. Subepicardial and midwall 
myofiber angles of LAT, PAP, and ANT were not significantly different, but PAP 
subendocardial myofiber angles were significantly higher. Subepicardial and midwall 
myofiber strains of ANT, PAP, and LAT were not significantly different, but PAP 
subendocardial myofiber strains were less. Transmural gradients in circumferential and 
radial normal strains, and major principal strains, were evident in each region. 
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Conclusions: The three main findings of this study were: 1) PAP strains are largely 
consistent with adjacent free wall regions, 2) there is a continuum of strains across the 
anterolateral equatorial LV despite similarities in myofibers, and 3) transmural strain 
gradients were evident in all regions. These findings point to the heterogeneity of the 
LV, and suggest that regional differences in myofiber coupling may constitute the basis 
for such heterogeneity. 
The work contained in this chapter is under preparation for submission to American 
Journal of Physiology-Heart and Circulatory Physiology. 
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INTRODUCTION 
The mitral valve (MV) papillary muscles are important for normal LV function as 
part of the subvalvular apparatus,1"6 and have been implicated in a number of disease 
states.7"15 The importance of the chordal-papillary complex to cardiac function has been 
highlighted by experimental studies in which chordal severing resulted in substantial 
decreases in LV function,1"6 as well as worsened LV function and clinical outcomes in 
patients with MV replacement without chordal preservation relative to those with chordal 
preservation.16"21 Additional experimental studies suggest that the papillary muscles may 
be key to decreased LV function after chordal severing.22' 23 Papillary muscle 
dysfunction9"15 and/or displacement7'8 have also been implicated in functional mitral 
regurgitation (MR), and has inspired papillary re-location techniques as part of functional 
MR treatment.24"27 
Although the importance of the papillary muscles has been well established, 
questions remain regarding their functional integration into the LV myocardium. The 
papillary muscles structurally link the MV to the LV myocardium within the valvular-
ventricular complex. While the LV myocardium is known to be composed of sheets of 
98 9Q 
complex but largely helically arranged fibers, ' fibers within the papillary muscles 
themselves are highly aligned in the direction of tension30'31 and there is an abrupt 
change in myofiber angle from the LV compacta to the papillary muscles, particularly in 
the last 1-2 mm of the subendocardial LV wall.30'31 Functionally, papillary muscle 
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contraction appears to occur in concert with LV contraction, shortening during ejection 
and lengthening during diastole.32 Recent studies analyzing transmural myocardial 
strains overlying the papillary muscles have raised the question of whether the 
myocardium overlying the papillary muscles is unique relative to adjacent regions of LV 
myocardium. Holmes et al.30 in a study of dogs found decreased deformation in regions 
overlying the antero-lateral papillary muscle compared to more anteriorly located LV. 
However, these findings were derived from comparisons between different hearts. We 
wanted to extend these studies by examining three equatorial regions in the same heart, 
during the same heart beat. 
METHODS 
All animals received humane care in compliance with the "Principles of 
Laboratory Animal Care" formulated by the National Society for Medical Research and 
the Guide for the Care and Use of Laboratory Animals prepared by the National 
Academy of Sciences and published by the National Institutes of Health (U.S. 
Department of Health and Human Services, NIH Publication 85-23, Revised 1985). This 
study was approved by the Stanford Medical Center Laboratory Research Animal Review 
Committee and was conducted according to Stanford University policy. 
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Surgical Transmural Beadset Placement 
The methods for the surgical placement of the transmural headsets and data 
acquisition have been described in detail elsewhere33"35 and therefore, are only 
summarized herein. Ten adult Dorsett hybrid sheep (52±4 kg) were pre-medicated with 
Ketamine (25mg/kg intramuscularly) for venous and arterial catheter placement and 
monitoring. Anesthesia was induced and maintained with inhalational isoflurane (1.5-
2.5%) and supplemental oxygen. Through a left thoracotomy, the pericardium was 
opened and the heart was confirmed to have no more than mild insufficiency in the aortic 
and mitral valves by epicardial color Doppler echocardiography (Sonos 5500, Hewlett-
Packard, Palo Alto, CA). Thirteen miniature tantalum radiopaque subepicardial markers 
were implanted to silhouette the LV: 4 markers spaced equally along the longitudinal 
meridians of 3 transverse planes (basal, equatorial, and apical, Fig. 25-1A) and one 
marker located on the LV apex. Diastolic LV wall thickness was measured by epicardial 
echocardiography in three adjacent segments on the equatorial level (Fig. 25-1C): 
anterior wall (ANT), LV wall over the antero-lateral papillary muscle (PAP) and mid-
lateral wall between the antero-lateral and postero-medial papillary muscles (LAT). This 
wall thickness was then used to determine the implantation depth for 3 transmural 
headsets (Fig. 25-1B). A plexiglass template was used guide insertion of the headsets, 
perpendicular to the LV wall, at each of the three locations, in a manner similar to those 
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Fig. 25-1: A) Locations of markers silhouetting the L V: 4 markers spaced equally along the 
longitudinal meridians of 3 transverse planes (basal, equatorial, and apical), and one 
marker located at the L V apex. Three transmural headsets are shown placed in specific L V 
regions: anterior (ANT), LV overlying the antero-lateral papillary muscle (PAP), and 
lateral (LAT), as determined by epicardial echocardiography. B) Close-up of one of the 
three transmural headsets. Markers were spaced evenly from endocardium to epicardium 
in a column oriented normal to the epicardial tangent plane. The deepest (subendocardial) 
beads were implanted at 90% of the echocardiographically determined end-diastolic wall 
thickness. For each videographic frame, a local coordinate system was defined with the 
origin (O) at the center of the epicardial equilateral triangle of beads, the radial (Xp) axis 
defined as 180 degrees from the LV chamber, the longitudinal (Xi) axis defined at the 
intersection of XR and the long axis (K) in the epicardial tangent plane, and the 
circumferential (XQ) axis orthogonal to the previously defined axes. Myofiber angle (a) was 
defined relative to the circumferential (XQ) axis. 
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Fig. 25-1 (cont'd): C) Diagram of LV transverse equatorial short-axis plane as 
viewed from the L V apex illustrating the location of the three transmural headsets 
(ANT, PAP, and LAT) relative to the antero-lateral (APM) and postero-medial 
papillary muscles (PPM). RV=right ventricle, LV=left ventricle. 
previously described.34'36 The deepest (subendocardial) beads were implanted at 90% of 
the echocardiographically determined end-diastolic wall thickness and two additional 
0.7mm beads were placed to span the myocardium. For each column a fourth 1.7 mm 
bead was sutured onto the overlying epicardium. In order to compare the pure LV wall 
motion in all segments, the deepest beads of PAP were adjusted at the same level as ANT 
and LAT and did not penetrate into the papillary muscle. Upon study completion the 
hearts were excised and thoroughly examined to confirm correct bead placement with 
magnetic resonance imaging and histological examination. 
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In Vivo Marker Data Acquisition 
Immediately after the operation, animals were transferred to the catheterization 
laboratory and studied in the right decubitus position with the chest open. Two 
micromanometer-tipped pressure transducers (model MPC-500; Millar Instruments, 
Houston, TX) were calibrated and inserted into the LV and ascending aorta via carotid 
artery catheters. Simultaneous biplane videofluoroscopic images of markers (60 Hz, 
Philips Medical Systems, Pleasanton, CA), ECG, LV pressure (LVP) and aortic pressure 
were recorded during three consecutive heart beats in normal sinus rhythm with 
ventilation transiently arrested at end-expiration, as previously described.34 Data from 
the two 2D videofluoroscopic views were merged using 3D helical phantom image data 
and custom software,37 thus yielding the 3D coordinates of each marker centroid every 
16.7 msec. The accuracy of these 3D reconstructions has previously been shown to be 
0.1 ±0.3 mm.38 
Quantitative Analysis of Myofiber Angle 
At the end of the study the animals were euthanized by intravenous administration 
of KC1 (80 mEq) under 5% isoflurane. LVP was adjusted to match in vivo LV end-
diastolic pressure with left atrial exsanguination. While the pressure was maintained, the 
hearts were fixed in situ with 300 ml of 5% buffered glutaraldehyde into the left coronary 
artery balloon catheter (Guidant, AguiTrac Peripheral Catheter, Santa Clara, CA). The 
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hearts were then excised and stored in 10% formalin for 48 hours. A LV long axis was 
defined as the line passing through the LV apex and mid-anterior mitral leaflet. Each 
transmural headset was excised surrounded by a rectangular cuboid, with a 15 x 15 mm 
square face, whose sides paralleled the local circumferential (Xc), longitudinal (XL) and 
radial (XR) lines (Fig. 25-IB). Each block was sliced into sequential 1-mm-thick sections 
parallel to the epicardial plane (Xc-XL) from the epicardium to endocardium, providing a 
series of slices for measurement of myofiber angle (a). The myofiber angle, a, defined as 
the average angle between the local muscle fiber axis (Xf) and circumferential axis (Xc), 
was determined at 20, 50 and 80% depths using MATLAB 2007b (The Mathworks, Inc, 
Natick, MA), as described previously.33'39 
Analysis of Strains 
The three transmural headsets permitted 3D LV wall deformation measurements 
in the ANT, PAP, and LAT regions. The analysis of normal, principal, fiber and cross-
fiber strains have been described in detail previously.33'34 Briefly, for each transmural 
beadset in each videographic frame a local, orthogonal coordinate system (Fig. 25-IB) 
was defined relative to the three beads sewn on the epicardium. The origin of this 
coordinate system (O) was defined as the center of this equilateral triangle of beads in the 
epicardial tangent plane, the radial (XR) axis was defined as 180 degrees from the LV 
chamber, the longitudinal (XL) axis was defined at the intersection of XR and the long 
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axis (X, through the origin (O) and the LV apex marker, Fig. 25-1 A) in the epicardial 
tangent plane, and the circumferential (Xc) axis defined as orthogonal to the previously 
defined axes (XR and XL). 
Each cardiac cycle for each beat was visualized by pressure-volume loop for 
concrete timing definition of end-diastole (ED) as undeformed state (reference), and end-
systole (ES) as the deformed state. 
For each beat, the displacement of the beads relative to ED was characterized by a 
continuous polynomial position field with quadratic dependence in ER and linear 
dependence in EL and ER using least-squares fits.40 As described previously, ' the 
material gradient of the position field is the local deformation gradient tensor (F) and the 
Lagrangian strain (E) is then calculated as E=(FTF-I)/2, where I is the identity tensor. In 
terms of the coordinate system used in this study (Xc, XL,and XR), the three normal 
strains (Ecc, ELL, and ERR) measure local elongation or shortening along the 
circumferential (Ecc), radial (ERR), and longitudinal (ELL) axes. The three shear strains 
(ECL, ELR, and ECR) represent angle changes between orthogonally oriented axes. The 
major principal strain (Ei) was calculated as the maximum eigenvalue of E. Strains were 
interpolated along the central axis of each transmural bead column at 1% increments of 
wall depth from the epicardium to the most subendocardial bead. The four beads are 
approximately located at depths of 0%, 30%, 60%, and 90% of wall depth at ED, where 
0% is at the epicardium and 100% is at the endocardium. The three depths chosen for 
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detailed strain analysis were defined as 20% (subepicardium), 50% (midwall), and 80% 
(subendocardium) of the depth of the deepest bead measured from the epicardial surface 
as each time point, which approximately represents transmural depths of 18%, 45%), and 
72%.34 
The myofiber angles (a) calculated at each depth were used to express myocardial 
strains at each depth in terms of myofiber (Ef,ber) and cross-fiber (Ecr0ss) strains. The strain 
tensor at a given depth was transformed from the local myocardium coordinate system 
(XR, XL, and Xc) into that relative to myofiber axis (Xf) and the perpendicular axis to Xf 
(Xc) at a given depth in planes parallel to the epicardial tangent plane. 
Statistical Analysis 
Data are reported as mean ± standard deviation. Comparisons between groups 
(LV location: ANT, LAT, PAP; transmural depth: subepicardium, midwall, 
subendocardium) were performed using 2 way repeated measures (RJV1) ANOVA with a 
Bonferroni correction using SigmaStat (version 3.5, SPSS, Inc. Chicago, IL). 
Significance level was set at p=0.05. 
RESULTS 
Hemodynamic data for the animals are reported in Table 25-1. The normal strains 
ELL and ERR were significantly different between the ANT and LAT regions (Table 25-2), 
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Table 25-1. Hemodynamics. 
Body weight (kg) 54 ± 7 
Heart rate
 9Q ± g 
(beats/min) 
ESLVP(mmHg) 83 ± 7 
LVESV(mL) 84 ± 1 2 
LVEDV(mL) 122 ± 1 5 
dP/dtmax (mmHg/s) 1,270 ± 80 
N=10, data mean ± SD. ESLVP=end systolic LV pressure, 
LVESV=LV end systolic volume, LVEDV=LV end diastolic volume. 
with LAT ELL and ERR at all transmural depths (except subepicardial ERR) significantly 
less than those of ANT. No significant differences were found between ANT and LAT in 
Ecc. PAP normal strains, especially ERR, were largely intermediate between those of 
ANT and LAT at each depth (ANT>PAP>LAT), with the exception of PAP 
subendocardial Ecc which was less than both ANT and LAT. LAT Ecc was significantly 
greater than ELL (p<0.001), whereas Ecc and ELL were comparable in ANT, as was true in 
PAP. A transmural gradient of strain (subendocardium>midwall>subepicardium) was 
evident in Ecc for all regions, ERR for ANT and PAP, and a partial transmural gradient 
(subendocardium>subepicardium) was evident in LAT ERR. ELL demonstrated a partial 
transmural gradient (subendocardium>subepicardium) in ANT and PAP. 







































































N=10, data mean ± SD. ANT, anterior wall; PAP, LV over the papillary muscle; LAT, lateral 
wall on the equatorial level. PO.05 # vs. ANT, § vs. PAP by 2-way RM ANOVA with 
Bonferroni correction. Significant transmural gradients (bold) were observed in Ecc (ANT, PAP, 
and LAT) and ERR (ANT and PAP). Significant partial gradients (subepi vs. subendo, in bold) 
were observed in ANT and PAP in ELL, and LAT in ERR. 
Shear strains were small in magnitude and largely not significantly different 
between regions (Table 25-3). Transmural gradients were also largely not evident in the 
various regions. 
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N=10, data mean ± SD. V<0.05 vs. ANT by 2-way RM ANOVA with Bonferroni 
correction. 
Principal strains in LAT were significantly smaller in magnitude than ANT for the 
major (Ei) and minor (E3) principal strains at the subendocardial and midwall depths 
(Table 25-4). PAP principal strains largely appeared intermediate between those of ANT 
and LAT (i.e., magnitude of ANT>PAP>LAT). Transmural gradients were evident in the 
major (Ei) principal strains of ANT and PAP and a partial transmural gradient in Ei was 
evident in LAT. 
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N=10, data mean ± SD. PO.05 # vs. ANT, § vs. PAP by 2-way RM ANOVA with Bonferroni 
correction. Significant transmural gradients (bold) were observed in Ei ANT and PAP. Partial 
gradients (bold) were seen in: Ei LAT (subepi<subendo), E2 LAT (subepi<midwall, subendo), 
and E2 ANT and PAP (midwall>subepi>subendo). All regions in E3 presented significant 
differences between depths (subendo<subepi<midwall). 
Myofiber angles in LAT were not significantly different from those of ANT at 
any transmural depth (Fig. 25-2), nor were the myofiber angles of PAP significantly 
different from ANT or LAT at the subepicardial or midwall depths. However, the PAP 
subendocardial myofiber angle was significantly higher (i.e., more radial orientation, as 
opposed to circumferential) than ANT and LAT. All regions displayed a transmural 
gradient with myofiber angle increasing from the subepicardium to the subendocardium. 
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Fig. 25-2: Box plot illustrating 
myofiber angles in ANT, PAP, 
and LAT on the equatorial level 
in subepicardium (20% depth), 
midwall (50% depth) and 
subendocardium (80% depth). 
Diamond indicates group mean 
(N=10), left side of box indicates 
lower 25%, right side of box 
indicates 75%, central line 
indicates median, left whisker 
indicates lowest value, and right 
whisker indicates highest value. 
^Transmural gradient (i.e., 
depths are significantly different, 
P<0.001). #P<0.02 vs. ANT and 
LAT by 2-way RM ANOVA with 
Bonferroni correction. 
Myofiber strains (Efjber) were not significantly different between ANT and LAT at 
any transmural depth (Table 25-5). PAP Ef,ber at the subepicardial and midwall depths 
were not significantly different than either ANT or LAT, but PAP Efiber at the 
subendocardial depth was significantly less than both ANT and LAT. Cross-fiber strains 
(ECross) in ANT were significantly greater than LAT at all transmural depths. PAP Ecr0ss 
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were also greater than LAT at all transmural depths. Partial transmural gradients 
(subendocardium>subepicardium) were evident for Ecr0ss in all regions, as well as for 
Efiber in the ANT and LAT regions. 
Table 25-5. Fiber and Cross-fiber Strains. 
ANT PAP LAT 
Efiber Subepi -0.09 ± 0.04 -0.08 ± 0.04 -0.08 ± 0.04 
Midwall -0.14 ±0.03 -0.11 ±0.03 -0.12 ±0.03 
Subendo -0.15 ±0.05 -0.11 ±0.05* -0.17 ±0.02 
Ecross Subepi -0.08 ± 0.03* -0.07 ± 0.03* -0.03 ± 0.04 
Midwall -0.10 ± 0.02* -0.12 ± 0.04* -0.04 ± 0.02 
Subendo -0.17 ± 0.04* -0.18 ± 0.04* -0.09 ± 0.06 
N=10, data mean ± SD. P<0.05 *vs. ANT and LAT, *v*. LAT by 2-way RM ANOVA with 
Bonferroni correction. Significant transmural gradients (bold) were observed in Ecross in all 
regions and partial gradients (subepi vs. subendo, in bold) were observed in Efjber ' n ANT and 
LAT. 
DISCUSSION 
The three main findings of this study were: 1) the myocardium overlying the 
papillary muscles displayed a transmural strain profile that is not unique, but rather 
consistent with adjacent free wall regions, 2) there was a continuum of transmural strain 
profiles across the anterolateral equatorial LV despite similarities in myofibers, and 3) a 
transmural strain gradient was evident in all regions. When measured at the same 
transverse plane in the same animals during the same heartbeats, transmural strains in the 
anterior LV (ANT) were greater than those of the lateral region (LAT); strains in the 
myocardium overlying the antero-lateral papillary (PAP) were largely intermediate 
between those of ANT and LAT, consistent with its location within this continuum. 
711 
LV Myocardium Overlying Antero-Lateral Papillary is Not Unique 
The myocardium overlying the antero-lateral papillary muscle (PAP) displayed 
normal and major principal strains that were largely intermediate between those of the 
anterior (ANT) and lateral (LAT) regions of the LV. Similarly, the shear strains in PAP 
were largely not different from those of ANT or LAT, nor were myofiber angles or 
strains. These results suggest that PAP is not functionally unique relative to adjacent 
regions of the LV. 
The few instances in which PAP displayed unique strains all were found in the 
subendocardium, and largely can be explained by the greater PAP subendocardial 
myofiber angle relative to that of the other regions. For instance, the subendocardial Ef,ber 
in PAP, which was less than that of ANT and LAT, is derived from the subendocardial 
strain tensor E by the cosine of a. Therefore, for similar strains, regions with higher 
myofiber angles (i.e., PAP) will have lower Efiber- Ecc and ECR were both slightly, but 
significantly, different in PAP subendocardium relative to LAT and ANT. These 
differences may also relate to the difference in PAP subendocardial myofiber angle given 
that myofibers in the adjacent regions were predominantly circumferentially oriented. 
Others have noted an abrupt increase in myofiber angle within 1-2 mm of the 
junction between the myocardium and antero-lateral papillary muscle.30'31 Given that the 
myofibers within the papillary muscle are highly aligned at an acute angle to the LV 
myocardium,30'31 it is logical that the myofiber angle in the subendocardium bordering 
the papillary muscle would greatly increase to dovetail with the fibers in the papillary 
muscle itself. 
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In light of these results, it appears that the myocardium overlying the antero-
lateral papillary muscle may not be severely depressed relative to other regions of the 
LV, as previously proposed.30'41 It should be noted that in these previous studies the 
myocardium overlying the papillary muscles was compared to regions located more 
anteriorly and in different hearts. Based on the results of the present study, the 
previously observed decreased deformation of the myocardium overlying the papillary 
muscle could, at least in part, be explained by the antero-lateral continuum found here, 
where the anterior region displays strains of greater magnitude than regions located more 
laterally. 
A number of other limitations may have influenced the conclusions of Holmes et 
al. Compared to the normal and principal strains reported in this study and similar 
studies,33'34'39'42 the anterior LV strains reported by Holmes were significantly less 
(-half) for both transmural depths measured ("inner wall" and "outer wall"), suggesting 
overall decreased myocardial function in their animals. It also is worth noting that in 
their study the majority of the animals underwent mitral valve replacement.30 Based on 
studies demonstrating mitral valve annuloplasty alters transmural strains,43 the mitral 
valve replacements likely affected their results. The study by Holmes was further limited 
because comparisons were made between the two regions from different animals during 
different heart beats.30 
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Antero-Lateral Continuum of LV Transmural Strains Despite Similarities in 
Myofibers 
A continuum of LV transmural strains in which strains decreased moving from 
the anterior to lateral equatorial LV, is supported by greater ERR and ELL, greater major 
and minor principal strains, and greater Ecross, in ANT compared to LAT. These 
differences were evident in the subendocardium and midwall, but were not always 
statistically significant at the subepicardium. Ecc was not significantly different between 
regions, nor were shear strains. Surprisingly, myofiber angles and Efiber were not 
significantly different between regions. This suggests that regional differences in normal 
and principal strains were not due to inherent differences in myofibers. 
The finding of ~2x greater wall thickening (ERR) in ANT than LAT is consistent 
with the findings of Cheng et al.,42 although in that study the lateral and anterior regions 
were at different transverse planes (lateral equatorial vs. anterior basal). As in the present 
study, Cheng et al.42 found no significant differences in myofiber angles or myofiber 
strains between the two locations despite differences in wall thickening. The results of 
these two studies, suggest that differences in coupling between these fundamental 
contractile units (myofibers) within the macrostructure of the myocardium likely 
accounts for the observed macroscopic differences in wall thickening. Possible 
mechanisms related to differences in coupling were studied in detail by Cheng et al.42 
Regional differences in LV geometry may also relate to these differences in strain. 
According to Bogeart et al.,44 the anterior portion of the LV has a larger radius of 
curvature compared to the lateral LV in the same transverse plane. This greater radius of 
curvature in the anterior LV would yield less pressure development for a given amount of 
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wall thickening, therefore greater wall thickening in ANT may be a compensatory 
mechanism to develop greater force to overcome its geometric shortcoming. Even with 
greater wall thickening in the anterior LV, however, Bogeart et al.44 found that the 
anterior LV region contributed less to the ejection fraction relative to the lateral LV. In 
this study, ED thicknesses between the different regions were chosen to be comparable, 
therefore differences in strain can not be attributed to differences in thickness, but rather 
must be due to fundamental differences in the mechanics of the different regions. 
Longitudinal strains (ELL) were also found to be greater in ANT than LAT. Given 
that Bogeart et al.44 found the radius of curvature in both the circumferential and 
longitudinal directions to be greater in ANT compared to LAT, greater ELL in ANT may 
again be a compensatory mechanism. It is also interesting to note that in LAT ELL was 
significantly less than Ecc, whereas in ANT Ecc and ELL were comparable. While the 
finding of comparable Ecc and ELL in ANT is consistent with that of Costa et al.,45 this 
finding is in contrast to the work of Villarreal et al.46 who found that, at least in the 
midwall of dogs using a triangular array of three piezoelectric crystals, Ecc was greater 
than ELL in the anterior equatorial LV, whereas Ecc and ELL were comparable in the 
lateral equatorial LV. 
Transmural Gradients Evident throughout Regions 
All three regions demonstrated significant transmural gradients (in which all three 
transmural depths were statistically different) or partial transmural gradients (in which 
subendocardium and subepicardium depths were different) in Ecc and ERR, and ANT and 
PAP demonstrated partial gradients in ELL- Similarly, all regions demonstrated 
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transmural or partial transmural gradients in the major principal strain (Ei). Transmural 
gradients in myofiber angles were also noted in all regions, and myofiber strains 
demonstrated a partial gradient in ANT and LAT. 
Transmural gradients in normal strains have been demonstrated in a number of 
previous studies using various modalities. Transmural gradients in radial strains (wall 
thickening) have been particularly well characterized in a variety of species using a 
number of imaging modalities.45' 47"53 Transmural gradients in Ecc have also been 
previously demonstrated.30'44'45 Given that the LV myocardium is a constant volume 
system with a roughly cylindrical shape, mechanically there must be a transmural 
gradient in wall thickening during contraction, as reasoned by Gallagher et al.49 While 
this is true theoretically, the LV is not homogeneous and displaced volume during 
contraction does not necessarily need to accumulate in the subendocardium in all regions 
of the LV. In fact, previous studies of transmural strains 8 weeks after bead set 
implantation showed a loss of the transmural ERR gradient despite maintained cardiac 
function.34 Nevertheless, globally the LV must have a transmural gradient in wall 
thickening, as well as in Ecc and ELL, for systolic contraction to occur. 
The transmural gradient in myofiber angle has been well characterized and 
appears conserved across species.45'54"56 This gradient is fundamental to LV torsion,57"5 
which in turn is key to LV force development, as well as minimization of transmural 
gradients of myofiber work and O2 consumption.58'60'61 Indeed, computational modeling 
has shown that myofiber orientation dramatically affects LV wall stress.62"64 The partial 
transmural gradient in myofiber strain (subendocardium significantly greater than 
subepicardium) found in this study is consistent with studies in the LV lateral equatorial 
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region using the same transmural headset technique ' and in humans using MRI, 
although others have not found evidence for such a transmural gradient.4 ' 5 
Transmural Strains of Myocardium Overlying Papillary Implicate Robust Cardiac 
Structure 
Based on what is known regarding papillary muscle mechanics, the finding of this 
study that the myocardial muscle overlying the antero-lateral papillary muscle displays 
transmural strains consistent with those of adjacent regions is rather surprising. The 
papillary muscles undergo considerable motion and contraction throughout the cardiac 
cycle,32' 67 and given that the papillary muscles are mechanically contiguous with the 
overlying myocardium, one might expect the myocardium in that region to experience 
distinct forces relative to adjacent regions, and therefore demonstrate unique transmural 
strain profiles. The lack of the distinction in transmural strains of the myocardium 
overlying the papillary muscles, however, can be seen as evidence for the robust nature of 
the cardiac structure. That is, the complex helical myofiber structure is built able to 
withstand these forces of the papillary muscles, and when these forces are removed LV 
function in that area that delicate balance of forces is altered and that region's contractile 
properties do appear to change. ' ' 
Implications 
The main findings of this study have a number of implications for our 
understanding of cardiac physiology and pathology. The finding that the myocardium 
overlying the papillary muscle is not unique despite the complex dynamics of the 
717 
attached papillary muscle, points to a finely tuned, complex system. The heterogeneity of 
the LV, as demonstrated by the anterolateral continuum in strains and transmural strain 
gradients, further points to the complexity of the LV and suggests that strategies such as 
engineered cardiac patches should optimally be designed to be regionally and depth-
specific. Lastly, the importance of coupling between the fundamental contractile unit of 
the myocyte suggested by the results of this study, similarly points to the complexity of 
the LV, specifically the importance of the configuration of myocytes within the 
macrostructure of the myocardium: their orientation, interconnections with one another, 
and interaction with the ECM. These aspects of myocyte configuration should optimally 
be taken into account in clinical interventions such as engineered cardiac patches or the 
introduction of stem cells. Furthermore, the importance of this coupling points to the 
significant role of the extracellular matrix in cardiac function,69' 70 and provides a 
mechanism for decreased cardiac function in disease states in which matrix components 
such as collagen are abnormal.71"73 Potentially interventions preventing or reversing such 
matrix changes could improve cardiac function in these patients, although this remains to 
be demonstrated. 
Limitations 
While the transmural beadset technique and accompanying analysis used in this 
study provides substantial insight into myocardial strains at different transmural depths in 
the beating heart, several limitations to this technique should be noted. First, while 
beadset implantation does not require cardiopulmonary bypass and the markers are 
relatively small, it is likely that the markers themselves and the process of implantation 
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may subtly affect overall cardiac function as well as myofiber mechanics in the localized 
region of implantation. Second, this study was performed in anesthetized ovine, 
therefore some of the results may be altered by anesthesia and be species specific, 
although certainly some characteristics of myocardial architecture and mechanics (i.e., 
gradient of myofiber angle across the LV wall45'54"56) appear to be conserved across 
species. Third, there are inherent uncertainties in myofiber angle measurements, 
variability in final depth of bead placement, limitations in the number of beads that can 
be placed transmurally, uncertainty in computational fitting to bead data and the 
videographic imaging modality itself. However, these uncertainties are relatively small 
and would not account for the regional differences found in this study. Fourth, this study 
included analysis at three equatorial locations spanning from the anterior LV to the lateral 
LV; analysis of transmural myocardial strains at more locations would be necessary to 
confirm a true anterolateral gradient in transmural myocardial strains as suggested by the 
results of this study. While previous studies have analyzed transmural strains in terms of 
laminar sheets utilizing p angles, considerable controversy remains about the usefulness 
of such measurements. These measurements are also technically difficult and subject to 
multiple errors. For instance, while the major (3 is used for calculations at a given depth, 
there are multiple |3s evident at each depth, especially at the subendocardium, and it is not 
appropriate to average them.42'74 Furthermore, P measurements are subject to artifacts in 
tissue preparation and assume tissue homogeneity, whereby measurements from very 
small areas are taken to be representative of much larger regions. Clearly, laminar sheets 
severely oversimplify the complexity of myocyte arrangement in the myocardium.75 
Because of these limitations, laminar sheet analysis was not performed in this study. 
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CONCLUSIONS 
In summary, in this study we have demonstrated that the LV myocardium 
overlying the antero-lateral papillary muscle is not unique relative to adjacent equatorial 
regions, but rather is consistent with an antero-lateral gradient in strains with transmural 
strains greatest in the anterior region and least in the lateral region. Furthermore, these 
differences in transmural strains were demonstrated despite similar myofiber strains, 
suggesting that while the contracting myofiber units in the different regions are similar, 
their coupling is distinct leading to differences in normal strains. The findings contained 
in this study add to our understanding of LV function, as well as contain potential 
implications regarding the role of the extracellular matrix in contributing to LV function 
by connecting myofibers and potential clinical implications for interventions involving 
the implantation of myocytes with or without scaffolds. 
This chapter, which demonstrated an antero-lateral continuum in 
transmural strain profiles of the left ventricle, is the first of two chapters (Chapters 
25 and 26) on left ventricle myocardial mechanics. In the next chapter, analysis of 
transmural myocardial strains throughout the cardiac cycle reveal significant 
temporal and regional heterogeneity in left ventricular strain development. 
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Chapter 26: Temporal and Regional Heterogeneity in Left 
Ventricular Deformation: Implications for Myofiber Coupling 
This chapter is the second in a series of two chapters (Chapters 25 and 26) 
that investigate left ventricular myocardial mechanics using transmural headsets. 
While these chapters provide important insight into cardiac mechanics and left 
ventricular heterogeneity in transmural strains in particular, these studies do not 
directly relate to the overarching goals of this thesis. Therefore, these studies have 
been included in the Appendix. In this second study, analysis of transmural strains 
at different left ventricular sites throughout the cardiac cycle demonstrates 
significant temporal and regional heterogeneity in left ventricular strain 
development. 
ABSTRACT 
Background: Given the constant volume constraint of the isovolumic contraction (IVC) 
portion of the cardiac cycle, it was commonly believed that little myocardial strain or 
shear developed during this time period. However, a recent study demonstrated 
significant myocardial deformation during IVC. In light of known regional heterogeneity 
in transmural LV myocardial strain at end-systole, we investigated regional heterogeneity 
in transmural strains in different anterolateral equatorial LV locations (anterior (ANT), 
myocardium overlying the anterolateral papillary muscle (PAP), and lateral (LAT)) 
throughout the cardiac cycle, with particular attention paid to IVC and early ejection. 
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Methods: Transmural radiopaque headsets were placed into ten sheep in three locations 
(ANT, LAT, and PAP) along the equatorial LV wall. Biplane videofluoroscopy was 
performed allowing the in vivo measurement of radial, circumferential, and longitudinal 
strains at each of three LV wall depths (subepicardial, midwall, and subendocardial) in 
the three locations for each heart beat. Myofiber angle measurements at each depth in 
each location from histological sections post-mortem allowed transformation of these 
strains into fiber and cross-fiber strains. 
Results: While transmural thickening clearly dominated the radial strain curve 
throughout the cardiac cycle, initially transmural thinning was noted that was greater in 
LAT compared to the other regions. The longitudinal strain profile of LAT throughout 
the cardiac cycle was also substantially different than the other regions, with LAT 
lengthening during early ejection while the other regions contracted. During IVC 
circumferential lengthening was noted, particularly in ANT and PAP. Fiber strains 
during throughout the cardiac cycle were equivalent across regions, despite substantial 
regional differences in transmural strain development. 
Conclusions: Therefore, the three principal findings of this study were: 1) regional 
heterogeneity in transmural strains throughout the cardiac cycle, 2) relative regional 
differences varied within the cardiac cycle, and 3) regional differences occurred despite 
similarities in myofibers, which not only suggests underlying static regional differences 
in myofiber coupling, but a temporal component to this coupling. These findings have 
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implications for the mechanism of pressure development in the LV, as well as myofiber 
coupling and related myocardial and myofiber clinical interventions. 
The work contained in this chapter is under preparation for submission to American 
Journal of Physiology-Heart and Circulatory Physiology. 
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INTRODUCTION 
During isovolumic contraction (IVC) the left ventricular (LV) volume remains 
constant; therefore it was commonly believed that during IVC the LV myocardium 
developed little strain or shear, but rather underwent isometric contraction in preparation 
for the rapid, complex LV deformation that occurs during ejection. However, a recent 
study by Ashikaga et al.1 demonstrated that the canine anterior LV myocardium 
undergoes significant transmural deformations during IVC. Considering known 
regional2' 3 variability in myocardial strains, the aim of this study was to investigate 
regional heterogeneity in transmural strains and shears in different anterolateral 
equatorial LV locations throughout the cardiac cycle, with particular attention paid to 
IVC and early ejection. To accomplish this aim, transmural beadsets were inserted 
without cardiopulmonary bypass into normal ovine hearts in three sites across the 
anterolateral LV at the same transverse equatorial plane, allowing analysis of transmural 
strains developed simultaneously throughout the cardiac cycle in the same heart during 
the same heartbeats. 
METHODS 
The methods for surgical transmural beadset placement, data acquisition, analysis 
of fiber angles, and quantification of strains have been described in Chapter 25 of this 
thesis. 
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Analysis of Strain Development Throughout the Cardiac Cycle 
For assessment of regional and transmural differences during IVC and early 
ejection, comparisons between strains in each region and transmural depth were made for 
the time points of mid-IVC (33.3 msec), end-IVC (66.7 msec), and early ejection (100 
msec). Analysis was also performed on the magnitude of strain peaks (maximum or 
minimum), irrespective of when it occurred within the cardiac cycle, as the timing of that 
peak relative to end diastole. 
Statistical Analysis 
Data are reported as mean ± SEM. Comparisons between groups (LV location: 
ANT, LAT, PAP; transmural depth: subepicardium, midwall, subendocardium) were 
performed using 2 way repeated measures (RM) ANOVA with a Bonferroni correction 
using SigmaStat (version 3.5, SPSS, Inc. Chicago, IL). Significance level was set at 
p=0.017 for analysis of strains at mid-IVC, end-IVC, and early ejection time points (since 
3 time points were analyzed) and p=0.05 for analysis of strain peaks throughout the 
cardiac cycle. 
RESULTS 
Transmural Thickening (Radial Normal Strain) 
Maximum transmural thickening (ERR) for all regions occurred substantially after 

















































































































































































followed by PAP, and then LAT (pO.OOl). A transmural gradient in the magnitude of 
this maximum peak was also evident with subendo>midwall>subepi (pO.OOl). 
While clearly transmural wall thickening dominated ERR throughout the cardiac 
cycle, transmural thinning was evident during IVC. Overall during IVC there appeared 
to be an anterolateral gradient in this transmural thinning, with LAT thinning the most 
and the peak of this thinning occurring the latest. Specifically, at mid-IVC LAT ERR was 
significantly less than ANT (p=0.007), and ANT was significantly different from LAT 
and PAP at end-IVC and early ejection (each p<0.01). A partial transmural gradient 
(subendo>subepi) in ERR was evident in ANT at the early ejection time point (pO.OOl), 
and ANT and LAT were significantly different within the subepicardium at this time 
point (p=0.002), while ANT was significantly different from LAT and PAP in the 
midwall and subendocardium (each p<0.016). Analysis of the magnitude and timing of 
the minimum peak of this transmural thinning revealed that the transmural thinning peak 
of LAT was greater than and occurred later than that of ANT and PAP (each p<0.001), 
and the magnitude of thinning peak of the subendocardium was greater than midwall and 
subepicardium (pO.OOl). 
Longitudinal Normal Strains 
The overall shape of the transmural longitudinal normal strain (ELL) throughout 
the cardiac cycle was substantially different in LAT compared to ANT and PAP (Fig. 26-
2). During the first portion of systole LAT ELL was straining, while ANT and PAP ELL 







































































































































































































































































































































revealed regional differences in magnitude with LAT less than ANT and PAP (p=0.047), 
and that the minimum peak of subendo>midwall>subepi (pO.OOl). This minimum peak 
in LAT midwall and subepicardial layers also occurred significantly later than the same 
layers in ANT (each -100 msec later, each p<0.07). 
The curves of ELL during IVC and early ejection for each region also showed 
significantly different strain patterns in LAT compared to ANT and PAP; while ANT and 
PAP ELL began to contract during this period, LAT ELL lengthened. Indeed statistical 
analysis revealed that LAT ELL was significantly greater than ANT and PAP at mid-IVC, 
end-IVC, and the early ejection time points (each pO.OOl for each time point). 
Transmural gradients were also evident in LAT and ANT including LAT subepicardium 
ELL significantly different from the other LAT layers at end-IVC (each p<0.014). 
Transmural gradients in ANT ELL included subendocardium less than subepicardium at 
mid-IVC (p=0.003), subendocardium less than midwall and subepicardium at end-IVC 
(each p<0.013), and subendocardium less than subepicardium (pO.OOl) at early ejection. 
In terms of regional differences within individual layers, LAT was significantly greater 
than ANT and PAP in the subendocardium and midwall at mid-IVC, end-IVC, and early 
ejection (each p<0.001 for each time point for each layer) and in the subepicardium LAT 
was greater than ANT (p=0.010) at end-IVC and LAT was greater than ANT (p=0.002) 











































































































































































Circumferential Normal Strains 
Circumferential normal strains became minimum (contraction) during isovolumic 
relaxation (Fig. 26-3). Only a slight trend in regional differences between the magnitudes 
of the circumferential strain peaks was evident (p=0.076). However, during IVC 
circumferential lengthening was evident, particularly in ANT and PAP. Also, significant 
regional differences were evident during IVC; these included LAT Ecc was significantly 
less than PAP at mid-IVC (p=0.015) and LAT E c c was significantly less than PAP at 
end-IVC (p=0.010). No transmural differences were evident. 
Myofiber Fiber and Cross-fiber Strains 
Transmural fiber strains (Ef) of the different regions throughout the cardiac cycle 
appeared similar (Fig. 26-4A), each with a transmural gradient. While the magnitude of 
the minimum Ef peak of ANT and LAT were not different, that of PAP was less than 
LAT and ANT (each p<0.025). A transmural gradient in the magnitude of the minimum 
Ef peak was also statistically significant, with subendo>midwall>subepi (p<0.001). The 
similarity in ANT and LAT Ef strains contrasted with substantial differences in 
transmural strain development during the same time periods (Fig. 26-4B). During IVC 
and early ejection Ef of the different regions displayed no significant differences at any of 



































































































































































































































subepicardial myofibers of LAT and PAP in particular were stretching while 
subendocardial myofibers were simultaneously contracting. The subepicardial Ef for the 
different regions were significantly different from subendocardial Ef at end-IVC 
(p=0.004) and early ejection (p=0.002). 
Transmural cross fiber strains (Ecr0ss) throughout the cardiac cycle (Fig. 26-5) 
displayed significant regional and transmural differences. The magnitude of the Ecr0Ss 
minimum peak of LAT was significantly less than ANT and PAP (each p<0.025) and an 
anterolateral gradient in the timing of Ecr0ss minimum peak was evident (p<0.001), with 
the peak of ANT first, followed by PAP and then LAT. A transmural gradient in the 
magnitude of the Ecr0Ss minimum peak was also evident with subendo>midwall>subepi 
(p<0.001). Regional and transmural differences were also noted in Ecr0ss during IVC and 
early ejection. While LAT Ecr0ss stretched, Ecr0ss in ANT and PAP contracted. Statistical 
analysis revealed that LAT Ecr0ss was greater than ANT and PAP at mid-IVC (each 
p<0.002), and LAT was different from ANT and PAP at end-IVC and early ejection 
(each p<0.001 for each time point). 
Of note was the difference in the interrelationship between Ecr0ss and Ef in LAT 
compared to ANT and PAP (Fig. 26-6). While in both ANT and PAP (PAP not shown, 
but similar to ANT) Ecr0ss and Ef strain curves were comparable in shape and magnitude, 
in LAT Ecross was significantly greater than Ef during IVC and early ejection. In all the 
regions Ecross generally mirrored ERR throughout the cardiac cycle. Interestingly, LAT 
Ecross during IVC continued to mirror ERR despite ERR being negative during that time 
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Fig. 26-6: Ecross and Ef during IVC and early ejection demonstrating significant 
differences between Ecross and Ef in LA T (left plot) that were not evident in ANT (right 








































































































































































































































































































































































































The three principal findings of this study were: 1) regional heterogeneity in 
transmural strains was evident throughout the cardiac cycle, 2) regional differences 
varied within the cardiac cycle, and 3) regional differences occurred despite similarities 
in myofibers, which not only suggests underlying static regional differences in myofiber 
coupling, but a temporal component to this coupling. When measured at the same 
equatorial transverse plane, in the same heart, during the same heart beats the anterior 
(ANT), lateral (LAT), and myocardium overlying the anterolateral papillary muscle 
(PAP), displayed transmural normal strains that varied substantially throughout the 
cardiac cycle and relative to one another. This regional and temporal heterogeneity in 
LV strain is of particular interest with respect to the mechanism of pressure development 
in the LV, as well as implications for myofiber coupling and related myocardial and 
myofiber clinical interventions. 
Temporal and Regional Heterogeneity in Transmural Thickening 
While transmural thickening clearly dominated the ERR strain curve throughout 
the cardiac cycle, initially transmural thinning was noted. While this early transmural 
thinning has been visually apparent in curves of transmural thickening throughout the 
cardiac cycle included in other studies,1'4 this finding has largely been overlooked. It is 
also interesting to note that the maximum transmural thickening occurs substantially after 
systole. This could be due to the decrease in the afterload that the fibers must contract 
against as the pressure drops. 
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Regional differences in transmural thickening were evident throughout the cardiac 
cycle, not just at end systole as previously reported (see Chapter 25). There was an 
anterolateral gradient in the magnitude of maximum transmural thickening 
(ANT>PAP>LAT), which occurred after end systole, but this gradient was not evident 
during IVC. Instead, during IVC LAT was significantly different from the other two 
regions, displaying the greater transmural thinning whose peak occurred later than the 
other two regions. Therefore, while regional differences were evident throughout various 
parts of the cardiac cycle, these differences varied, with LAT appearing part of an 
anterolateral gradient after systole, but appearing distinct from the other regions during 
IVC and systole. 
Temporal and Regional Heterogeneity in Longitudinal Strain 
Significant variability in longitudinal strain was noted throughout the cardiac 
cycle particularly in the LAT region, which lengthened during IVC and a large portion of 
systole, and then contracted during the remainder of the cardiac cycle. Substantial 
regional heterogeneity was apparent, including lengthening in LAT which was not 
evident in the other regions, as well as differences in the magnitude and timing of the 
longitudinal contraction peak (the LAT peak had a lower magnitude and occurred later 
than ANT and PAP). However, this regional heterogeneity also varied within the cardiac 
cycle; while the longitudinal transmural strain curves of LAT were drastically different 
from that of ANT and PAP during the early part of the cardiac cycle, late in the cardiac 
cycle LAT longitudinal transmural strain curves appeared quite similar to those of ANT 
and PAP. 
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Temporal and Regional Heterogeneity in Circumferential Strain 
As was found for the transmural thickening peak, the peak of circumferential 
contraction occurred after end systole. This again could be because the fibers, that are 
already contracting and are largely oriented circumferentially, experience a decrease in 
afterload as the pressure drops. In fact the Ef strain curves display a similar peak after 
end systole. In terms of regional heterogeneity, unlike the other normal strains 
circumferential strains did not display significant regional differences in their strain 
peaks. However, during IVC regional differences were noted including a significant 
lengthening in ANT and PAP that was not evident in LAT. As noted by Ashikaga et al.,1 
the ANT subepicardium at end-IVC was straining while the subendocardium was 
contracting. The data from our curves suggest that this is a brief phenomenon related to 
timing as the subepicardial layer took longer to move from initial lengthening to 
contracting compared to the subendocardium. As in the other normal strains, a temporal 
component to regional heterogeneity was evident in circumferential strain, with the 
circumferential strains in LAT significantly different from the other regions during IVC, 
but similar to the other regions during the remainder of the cardiac cycle. 
Temporal and Regional Strain Heterogeneity Despite Similarities in Myofibers 
While regional differences were noted in all the normal strains curves, and these 
relative regional differences even varied within the cardiac cycle, the myofibers of the 
different regions (ANT and LAT in particular) remained remarkably similar throughout 
the cardiac cycle. The myofiber angles of ANT and LAT were not significantly different 
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at any transmural depth, nor were there any differences between ANT and LAT in terms 
of Ef strains during IVC and early ejection, or in the magnitude of the Ef peak throughout 
the cardiac cycle. Subtle differences in PAP Ef from that of ANT and LAT likely reflect 
differences in myofiber angle as the papillary muscle fibers connect to the myocardium in 
that region, as discussed previously (see Chapter 25). All regions during IVC displayed 
subepicardial fibers stretching and subendocardial fibers contracting, which Ashikaga 
noted in ANT and attributed to IVC "untwisting."1 
Yet despite the myofibers of ANT and LAT behaving the same, the strains 
generated in each region were substantially different, and these relative differences varied 
throughout the cardiac cycle. For instance, late in the cardiac cycle after systole LAT ELL 
appeared to have the same, albeit lower magnitude, transmural strain profile as ANT ELL, 
whereas early in systole ANT and LAT ELL demonstrated completely opposite strain 
behavior: ANT was contracting while LAT was lengthening. Meanwhile, Ef of both 
regions were contracting to the same degree. These results suggest that the observed 
regional heterogeneity is not due to inherent regional differences in myofiber contraction, 
but regional differences in how the myofibers are coupled. The hypothesis that regional 
differences in coupling of myofibers account for regional differences in normal strains is 
also supported by the observed regional differences in Ecross-
Furthermore, the observed temporal variation to this regional heterogeneity 
suggests that there is some temporal component to myofiber coupling. This idea of 
temporal myofiber coupling is further supported by the dramatic differences in strain 
behavior in a given region despite relatively uniform fiber contraction. As discussed 
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above, LAT longitudinal strain changes dramatically during late systole, from 
lengthening to contraction, while the fibers continue to contract. 
Additionally it is interesting to note that while Ef and Ecr0ss demonstrate similar 
strain profiles throughout the cardiac cycle in ANT, Ef and Ecross strain profiles are 
distinct in LAT. This difference between ANT and LAT could reflect differences in 
coupling between Ef and Ecr0Ss in ANT and LAT and/or differences in transmural 
coupling. 
Components Contributing to Early Rise in LV Pressure 
While the various regions and strains displayed different behavior throughout the 
cardiac cycle, only some of those regions and normal strains appeared to be contributing 
significantly to the functionally important steep rise in LV pressure during IVC. 
Examining which regions and strains were contributing to the development of LV 
pressure in the normal heart also has important implications for disease. Transmural 
thickening (or radial normal strain) did not appear to be contributing significantly, but 
rather all regions displayed transmural thinning during IVC and only ANT ERR was even 
positive by end-IVC. The subendocardial layer of ANT was contracting in the 
longitudinal direction during IVC, and therefore could have been contributing to LV 
pressure development during that time period. The PAP subendocardial layer may have 
been contributing somewhat at end-IVC, but the remaining layers and all the layers of 
LAT were lengthening and therefore were not contributing to pressure development. 
Circumferential strain in all the layers of LAT (but most particularly the subendocardial 
layer), as well as the subendocardial layer of ANT did appear to be contracting 
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significantly during IVC, and therefore could have been contributing to the pressure rise; 
but the remaining layers were lengthening. Meanwhile, the subendocardial and midwall 
fibers were contracting during IVC. These results are consistent with those of Bogaert et 
al.5 using MRI tagging who found that circumferential shortening, as opposed to wall 
thickening or longitudinal shortening, correlated well with different regions' contribution 
to the ejection fraction. It is particularly interesting that transmural thickening does not 
appear to be a major factor in early pressure development, as LV wall thickening is a 
commonly utilized metric for LV function and when the entire cardiac cycle is 
considered ERR dominates the other normal strains in terms of magnitude. It also should 
be noted that some of this pressure rise may be the result of the contraction of the apical 
LV which occurs before these equatorial regions, or the posterior wall that was not 
assessed in this study. Nonetheless, these results suggest that certain regions and layers 
may be functionally important to the development of LV pressure, which may have 
clinical relevance. 
Relationship of Results to Previous Studies of End Systole LV Transmural Strain 
Heterogeneity 
We previously reported regional heterogeneity based on the strains calculated at 
end systole relative to the undeformed state of end diastole (see Chapter 25). One of the 
findings of that study was that LAT displayed depressed ELL deformation relative to the 
other regions. However, in examining LAT ELL throughout the cardiac cycle, we see that 
in only analyzing the strain at end systole some of the LAT ELL contraction was not 
accounted for because it occurs after end systole. LAT ELL contraction also was delayed 
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relative to the other regions, therefore analysis of ELL strain of the various regions at end 
systole made that of LAT appear less than the other regions. Nevertheless, when analysis 
was performed on the minimum ELL peak throughout the cardiac cycle, as done in the 
present study, LAT ELL strain was still less than the other regions. The other normal 
strains, ERR and Ecc, peak after end systole, therefore in studies in which analysis is 
performed of the strain at end systole relative to end diastole, some of this strain is 
missed. 
Implications 
The findings of this study suggesting that myofiber coupling underlies regional 
and temporal transmural strain heterogeneity raise important implications. Given 
increasing interest in the use of stem cells and other myocyte progenitors to aid cardiac 
function, the importance of the scaffolding and the manner by which myofibers are 
coupled to properly develop cardiac strain should be taken into account. The obvious 
heterogeneity in the LV should also be considered in the design of myocardial patches. 
This evidence supporting the importance of myofiber coupling also draws attention to the 
importance of the extracellular matrix to proper myocardial function, and conversely 
extracellular matrix dysfunction as potentially contributing to various cardiomyopathies. 
In cardiomyopathies in which study of the affected myocytes have not revealed myocyte 
abnormalities, future research may reveal that the extracellular matrix coupling these 
myocytes actually causes the myocardial dysfunction. 
Furthermore, the finding that equatorial transmural wall thickening does not 
appear to be a key contributor to the rapid LV pressure rise during IVC has important 
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clinical implications. While transmural wall thickening is a commonly utilized, easy to 
measure parameter to clinically assess LV function and identify pathology, the results of 
this study suggest that circumferential shortening may be more important to the ability of 
the LV to develop pressure during early ejection. As imaging modalities in use clinically 
continue to be refined, measures of circumferential shortening may become more useful 
in assessing the functional impact of LV lesions. 
Limitations 
While the transmural beadset technique and accompanying analysis used in this 
study provides substantial insight into myocardial strains at different transmural depths in 
the beating heart, several limitations to this technique should be noted. First, while 
beadset implantation does not require cardiopulmonary bypass and the markers are 
relatively small, it is likely that the markers themselves and the process of implantation 
may subtly affect overall cardiac function as well as myofiber mechanics in the localized 
region of implantation. Second, this study was performed in anesthetized ovine, 
therefore some of the results may be altered by anesthesia and be species specific, 
although certainly some characteristics of myocardial architecture and mechanics (i.e., 
gradient of myofiber angle across the LV wall ' " ) appear to be conserved across species. 
Third, there are inherent uncertainties in myofiber angle measurements, variability in 
final depth of bead placement, limitations in the number of beads that can be placed 
transmurally, uncertainty in computational fitting to bead data and the videographic 
imaging modality itself. However, these uncertainties are relatively small and would not 
account for the regional differences found in this study. While previous studies have 
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analyzed transmural strains in terms of laminar sheets utilizing |3 angles, considerable 
controversy remains about the usefulness of such measurements. These measurements 
are also technically difficult and subject to multiple errors. For instance, while the major 
P is used for calculations at a given depth, there are multiple (3s evident at each depth, 
especially at the subendocardium, and it is not appropriate to average them. ' 
Furthermore, p measurements are subject to artifacts in tissue preparation and assume 
tissue homogeneity, whereby measurements from very small areas are taken to be 
representative of much larger regions. Clearly, laminar sheets severely oversimplify the 
complexity of myocyte arrangement in the myocardium.10 Because of their limitations, 
laminar sheet analysis was not performed in this study. 
CONCLUSIONS 
In summary, in this study we have demonstrated regional variation in LV 
transmural strain profiles throughout the cardiac cycle. Furthermore, these differences in 
regional transmural srains changed relative to one another throughout the cardiac cycle 
while myofiber contraction in the different regions remained similar. These findings 
suggest regional differences in myofiber coupling, such that contractile units that function 
similarly can be interconnected in distinct manners resulting in regional differences in 
normal strains. Furthermore, these results suggest a temporal component to this 
coupling. These findings have potential implications for understanding myofiber 
coupling and its contribution to cardiac function, as well as clinical interventions 
involving implantation of myocytes with or without connecting scaffolds. 
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This chapter, which demonstrated substantial temporal and regional 
heterogeneity in transmural strain development in the left ventricle, is the second of 
two chapters (Chapters 25 and 26) addressing left ventricle myocardial mechanics. 
As stated in the preface of this chapter, these studies provide important insight into 
cardiac mechanics, but do not directly relate to the goals of this thesis and, 
therefore, have been included in the Appendix. 
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